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Abstract
The Notch signalling system is a highly conserved method of cell-to-cell 
communication involved in cell fate decisions in many cell types. Until recently, the 
importance of the Notch signalling pathway was recognized in the embryonic but not in 
the adult vasculature. This project has successfully identified the presence of 
components of this pathway in adult vascular smooth muscle cells (VSMC). The effect 
of this pathway on serum deprivation- and cyclic strain-induced VSMC apoptosis has 
also been determined. This study reports that over-expression of components of the 
Notch signalling pathway results in a decrease in serum deprivation-induced VSMC 
apoptosis, whereas endogenous inhibition of the pathway increases apoptosis in these 
cells. The effect of the Notch signalling pathway on VSMC apoptosis is mediated, at 
least in part, in a CBF-1-dependent manner. A possible mechanism of the Notch 
signalling pathway regulation of apoptosis is through interaction with members of the 
Bcl-2 family of apoptotic proteins. Notch over-expression decreases pro-apoptotic bax, 
and increases anti-apoptotic bcl-xi expression in VSMC in a CBF-1-dependent manner. 
In addition, this study has shown previously unreported interaction of the Notch and 
N FkB  signalling pathways in VSMC. Additionally, the effect o f cyclic strain, a 
biomechanical force increased in many vascular disease states, was determined on 
components o f the Notch signalling pathway and also on VSMC apoptosis. Increased 
cyclic strain results in decreased Notch signalling pathway component expression, and 
increased apoptosis. Over-expression of the Notch receptor, Notch 3, attenuates the 
cyclic strain-induced apoptosis in a bcl-xi-caspase 3-dependent manner. In vivo 
validation of the effects of altered biomechanical forces was performed through analysis 
of carotid artery, and hepatic portal vein, ligation models. In correlation with the in 
vitro results obtained, increased alterations in cyclic strain results in an inverse 
relationship between the Notch signalling pathway and apoptosis in the vessel. These 
findings may be relevant in the future management of vascular diseases.
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Chapter 1
Introduction
Chapter 1 Introduction
1 1 Cardiovascular Disease
Cardiovascular diseases are any disease of the circulatory system, chief among 
which are myocardial infarction, cerebrovascular disease, and other peripheral vascular 
diseases Changes in the structure, function and integrity of arterial blood vessels is 
central to the pathogenesis of many cardiovascular diseases The arterial blood vessel 
in an active, integrated organ composed of endothelial cells (EC), smooth muscle cells 
(SMC) and fibroblasts divided into three structural layers, termed the tunicas mtima, 
media and adventita The innermost layer, the tunica mtima, is a simple squamous 
epithelium surrounded by a connective tissue basement membrane with elastic fibres 
The underlying tunica media is primarily comprised of SMC, which play a key role in 
maintaining vascular tone and function SMC are orientated circumferentially in the 
outer media, but closer to the lumen they present in a more random fashion 
(Gittenberger-de Groot et a l , 1999) Several studies have demonstrated a marked 
heterogeneity of SMC phenotypes in the vessel wall of both human and animal models 
These phenotypes are classified as synthetic and contractile, and are evident 
embryomcally but become more prominent as the vessel matures Whilst both the 
intimal and medial layers contain a mixture of both phenotypes, the synthetic phenotype 
is most commonly associated with the intimal layer and with vascular remodelling 
These cells resemble immature, dedifferentiated SMC, with lower levels of contractile 
proteins (e -actin, myosin, calpomn, smoothelm) and fewer myofilaments than their 
medial counterparts (Shanahan et a l , 1993, Bochaton-Piallat et a l , 1995, Gittenberger- 
de Groot et a l , 1999) These intimal cells are said to be similar in both morphology and 
gene expression to foetal or embryonic SMC, and have been shown to be more prone to 
both physiological and pathophysiological apoptosis than the medial SMC (Bochaton- 
Piallat et a l , 1995, Rao et a l , 1997, Slomp et a l , 1997) The contractile SMC, on the 
other hand, are most commonly associated with the tunica media, and express 
differentiated cell markers associated with contractile function, and are involved in the 
synthesis and maintenance of extracellular components of the vessel wall The 
outermost layer, which attaches the vessel to the surrounding tissue, is termed the tunica 
adventita This is a layer of connective tissue, with varying amounts o f elastic and 
collagenous fibres The connective tissue is dense adjacent to the tunica media, but 
changes to loose connective tissue near the periphery of the vessel
1
Internal membrane
Figure I: Arterial blood vessel. Diagrammatic representation o f arterial blood vessel structure.
Cardiovascular diseases are the leading cause of death in the western world, 
accounting for 40% of all deaths in the United States. An estimated 17 million people 
die due to cardiovascular disease per annum, which translates into one death every 30 
seconds. The incidence of cardiovascular disease in Ireland is the highest in the 
European Union (EU), with 53 deaths per 100,000 population compared to the EU 
average of 32. In addition, it is estimated that one quarter of people in the western 
world live with cardiovascular disease, resulting in a significant economic impact, both 
in terms of health care expenditures and lost productivity (World Health Organisation, 
American Heart Foundation). Therefore, an increased understanding of the 
mechanisms underlying the pathology of cardiovascular diseases is imperative both in 
the prevention and management of this condition.
A number of risk factors are associated with the development of cardiovascular 
disease, these include genetic pre-disposition, gender, age and race. Many factors, 
however, are lifestyle determined, including poor nutrition, obesity, lack of exercise and 
smoking. A diet high in saturated fat and cholesterol can increase the risk of developing 
certain cardiovascular disorders. Whilst cholesterol has important functions in the 
body, such as the formation of cellular membranes, it is important that the correct ratio 
of cholesterols within the body is maintained. Cholesterol is insoluble in blood and is 
transported via lipoproteins, these are high density lipoproteins (HDL), low density 
lipoproteins (LDL) and very low density lipoproteins (VLDL), the ratio of HDL to LDL 
is an important factor in determining the risk that cholesterol presents. Elevated LDL 
and low HDL levels are key risk factors in the development of atherosclerosis (Sharrett 
et al., 1994). In addition, an increased level of homocysteine in the blood is also a 
major risk factor for cardiovascular disease, and can be caused due to dietary 
deficiencies in vitamins B6, B12 and folic acid (Boers 2000). Obesity is also a key risk 
factor in the development of cardiovascular disease, and is a considerable problem in
Ireland, where 47% of people are considered overweight or obese Regular exercise can 
help combat or prevent obesity, in addition to increasing HDL levels in the circulation 
(Irish Heart Foundation) Smoking directly damages the endothelium, increases 
vascular tone, increases platelet activation, and promotes LDL oxidation (Muscat et a l , 
1991) Smoking increases the risk of developing cardiovascular disease by 50% and 
contributes to one fifth of all cardiovascular related deaths (American Heart Association 
website)
1 2 Hypertension
Hypertension (high blood pressure) can develop due to a genetic pre-disposition, 
or may be environmentally induced due to poor diet, obesity, smoking and lack of 
exercise In addition, the development of hypertension is itself a major risk factor in the 
development of cardiovascular diseases, such as arteriosclerosis Normal blood pressure 
is considered to be 120/80 mm Hg, whereas blood pressure of above 140/90 mm Hg is 
considered to be high, and can result in vascular SMC (VSMC) hypertrophy and 
hyperplasia, and a subsequent increase in peripheral vascular resistance (Molloy et a l , 
1999)
1 3  Atherosclerosis
Atherosclerotic vascular disease, the primary cause of all cardiovascular 
diseases, is a systemic disease involving the intima of large and medium arteries, 
including the aorta, and the carotid, coronary and peripheral arteries (Corti et a l , 2002) 
Atherosclerosis is characterized by a dysfunctional endothelium, chronic inflammation, 
lipid accumulation, aberrant regulation of VSMC fate decisions, and often calcification, 
which clinically manifests as an atherosclerotic plaque The generation of obstructive 
plaques can result in additional cardiovascular disorders, for example, an obstructive 
coronary plaque can cause a critical reduction in coronary blood flow, and subsequent 
myocardial ischaemia (Schroeder and Falk 1995) Atherosclerotic plaques occur 
preferentially at bifurcations and curvatures of arterial blood vessels (Glagov et a l , 
1988)
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1.3.1 Molecular Process of Atherosclerosis
Normal endothelial function plays a pivotal role in vascular homeostasis, and 
limits the development of atherosclerosis. Endothelial dysfunction, therefore, is an 
initial pathological sign of atherosclerosis. Cardiovascular risk factors and surgical 
interventions, such as balloon angioplasty and vascular reconstruction, can impair 
endothelial function. EC function as a semi-permeable barrier, and also as a dynamic 
paracrine and endocrine organ, exerting considerable influence on the underlying 
VSMC, or on circulating blood elements such as platelets. EC are, for example, 
involved in maintaining the non-thrombogenic blood-tissue interface by regulating 
thrombosis, thrombolysis, platelet adherence, vascular tone and blood flow. This is 
achieved through the production of thrombogenic (thromboxane) and anti-thrombogenic 
(thrombomodulin) factors, and pro- and anti-inflammatory mediators, such as leukocyte 
adhesion molecules and nitric oxide respectively. In addition, the endothelium can 
release substances that act as SMC promoters and vasoconstrictors, such as angiotensin 
II, or as SMC inhibitors and vasodilators, such as prostacyclin (Corti et al.y 2002). 
Therefore, endothelial dysfunction can result in the accumulation of cellular 
components, lipids and extracellular matrix (ECM) to yield a fibrofatty plaque, which 
can ultimately narrow the arterial lumen (Geng and Libby 2002).
Figure 2: Initiation, Progression and Com plication o f Human Atherosclerotic Plaque
Stage: 1 2 3 4 5 6 7
Figure 2: Human atherosclerotic plaque progression. Refer to text (Libby 2001).
Damage to the normal endothelium (Figure 2: stage 1) results in the initiation of 
an inflammatory response. The endothelium expresses adhesion and chemoattractant
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molecules, that act to recruit inflammatory leukocytes, such as monocytes and T- 
lymphocytes, in addition, extra-cellular LDL begins to accumulate in the tunica intima, 
in part by binding to proteoglycans, and undergoes oxidative modification (Figure 2 
stage 2) (Berliner et a l , 1997, Williams and Tabas 1998) Accumulated monocytes in 
the arterial wall subsequently express scavenger receptors, bind to oxidized-LDL (ox- 
LDL), and transform to lipid-laden foam cells, facilitated in part by macrophage colony- 
stimulating factor (Rohrer et a l , 1990, Qiao et a l , 1997) In addition, leukocytes and 
endogenous cells of the vascular wall can secrete inflammatory cytokines and growth 
factors than further amplify leukocyte recruitment and cause VSMC migration and 
proliferation (Figure 2 stage 3) The formation of this mtimal macrophage-rich fatty 
streak, the precursors o f atherosclerotic lesions, appears to be ubiquitous in humans, and 
can develop over many years, in fact, these possible pre-cursors to atherosclerosis have 
been found in the intima of infants (Stary et a l , 1994) Lesion progression (Figure 2 
stage 4) can occur due to the expression of tissue factor, a potent coagulant, and matrix- 
degrading protemases that can act to weaken the integrity of the plaque If the plaque 
subsequently ruptures (Figure 2 stage 5), coagulation factors in the blood gain access to 
the thrombogemc, tissue factor-containing lipid core resulting in thrombosis 
Depending on the balance between pro-thrombogemc and fibrinolytic mechanisms, an 
occlusive thrombus could occur at this stage, with deleterious clinical consequences or 
death Alternatively, resorption of the thrombus (Figure 2 stage 6) results in the release 
of thrombin and other mediators from de-granulatmg platelets These include platelet- 
derived growth factor (PDGF) and transforming growth factor-8 (TGF-s) This results 
in collagen and SMC accumulation, and the progression of the lesion from a fibrofatty 
to an advanced fibrous and often calcified plaque, oftentimes causing significant 
stenosis o f the vessel In some cases, occlusive thrombi arise from superficial erosion 
of the endothelial layer (Figure 2 stage 7), and often complicate advanced stenotic 
lesions (Libby 2001)
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Figure 3 Schematic Representation of Molecular Processes of Atherosclerosis
Figure 3 Schem atic representation o f m olecular processes o f  atherosclerosis Calcium acts as a 
second m essenger in atherogenic processes EDRF, endothelium -derived relaxing factor, EDGF, 
endothelium -derived growth factor, PDGF, platlet-derived growth factor, MGDF, m acrophage-derived 
growth factor, GAG, glycosam inoglycans, PG, proteoglycans, GP, glycoprotein, IEL, internal elastic 
lamina, LDL, low density lipoprotein, LTB, leukotriene B (adapted from KLramsch 1995)
However, not all fatty streaks evolve into advanced atherosclerotic lesions The 
balance between pro- and anti-atherogenic factors determines whether a fatty streak 
progresses to form an atherosclerotic lesion or regresses In addition to inflammatory 
cell infiltration, the progression of an atherosclerotic lesion requires the participation of 
VSMC, which are a principal source of the ECM that constitutes a large volume of an 
advanced atheroma (Geng and Libby 2002) Proliferation and migration of SMC play 
an important role in the regulation o f SMC number within an atherosclerotic plaque, 
however, the importance of SMC apoptosis in the atherosclerotic plaque is being 
increasingly recognized By counterbalancing proliferation, apoptosis may limit the cell 
accumulation in the intimal compartment, elimination of the lipid-laden foam cell, and a 
decrease in overall cell number, can lead to a regression of the fatty streak (Geng and 
Libby 2002)
1 3  2 Apoptosis in the Atherosclerotic Plaque
Apoptosis has been observed at many stages of the development of an advanced 
atherosclerotic plaque (Kockx et a l , 1998) Atherosclerotic plaques typically consist of 
a Iipid-nch core in the central portion of a thickcned tunica intima, containing lipids, 
connective tissue, and dead cells or cell debris The lipid-core is bound on its luminal 
aspect by a fibrous cap, at its edges by what is termed the “shoulder” region, and
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on its abluminal side by the base o f the plaque (Libby 1995) Apoptosis is important in 
the progression of atherosclerotic lesions, resulting in the formation of a mature lesion 
containing a dense ECM and a relatively sparse cell population Apoptosis is 
concentrated in the lipid-rich core of the plaque, and occurs in both macrophage/foam 
cells and VSMC However, the high percentage of apoptosis in the lesion does not 
translate to a decrease in tissue volume, therefore it is postulated that the system of 
phagocytosis of apoptotic cells operates poorly in an atherosclerotic plaque Several 
mechanisms may be responsible for this, for example, intracellular accumulation of 
lipids may decrease the ability of macrophages and SMC to phagocytose apoptotic cells, 
increased apoptosis o f macrophages in the lesion decreases the population of apoptotic 
scavenging cells, and cross-linking of macromolecules can result in the stabilization of 
apoptotic cells withm the lesion (Aeschhmann and Thomazy 2000) The presence of 
apoptotic cells or bodies has recently been shown to increase calcification and fibrosis 
of atherosclerotic lesions (Geng and Libby 2002)
Atherosclerosis is considered to be a relatively benign disease as long as 
complicating thrombosis can be prevented Thrombosis underlies the most acute 
complication of atherosclerosis, notably unstable angina and acute myocardial 
infarction in the coronary circulation The lipid-rich core o f an atherosclerotic lesion 
contains large amounts of tissue factor, which is a powerful coagulant that stimulates 
thrombus formation when in contact with the blood (Wilcox et a l , 1989, Schroeder and 
Falk 1995, Libby 2001) Most thrombus formations are due to a fracture in the 
protective fibrous cap of the atherosclerotic plaque, which usually occurs at the 
“shoulder” region Therefore the integrity of the fibrous cap fundamentally determines 
the stability of a plaque, and its clinical implications
In 1995, Libby et a l , dubbed VSMC the “guardians of the integrity of the 
fibrous cap” As its name implies, the fibrous cap is made up of a dense fibrous ECM, 
primarily composed of collagens and elastm It is now well established that the fibrous 
cap can undergo continuous remodelling, which is largely influenced by VSMC 
VSMC synthesize and assemble the interstitial collagen, which accounts for the bulk o f 
the ECM of the fibrous cap Therefore, apoptosis of VSMC and a subsequent reduction 
in cell number can seriously compromise the integrity of the fibrous cap In addition, 
the integrity of the fibrous cap can be weakened by the breakdown of existing ECM 
proteins through induction of proteolytic enzymes, such as matrix metal loprotemases, 
by inflammatory cells (Libby 2001) SMC of the arterial plaque also produce matrix 
metalloproteinases, however, these enzymes primarily effect SMC migration and
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vascular remodelling (Plutzky 1999)
The realization that the probability o f the atherosclerotic plaque rupture, rather 
than the severity of plaque stenosis, determines its clinical implications led to the 
classification of atherosclerotic plaques as stable or vulnerable plaques Most 
myocardial infarctions, for example, occur in lesions of less than 70% stenosis, with 
plaque rupture being the underlying pathological event (Falk et a l , 1995)
Figure 4 Characteristics o f  Vulnerable and Stable Atherosclerotic Plaques
Figure 4 Schem atic representation o f vulnerable and stable atherosclerotic plaques (Kramsch 1995)
The stable atherosclerotic plaque is not considered likely to rupture, and as such, 
is clinically not as serious as its “vulnerable” counterpart The stable plaques are 
described as hard, sclerotic plaques, with a high VSMC and collagen content, a 
subsequently thick fibrous cap, and a limited amount of lipid-laden inflammatory cells 
In contrast, the vulnerable plaque usually has a large lipid-core, a thin fibrous cap, a 
high density of inflammatory cells, particularly at the “shoulder region” where rupture 
often occurs (see Figure 4) and a paucity of VSMC An atherosclerotic plaque is 
considered vulnerable when its lipid-nch core accounts for more than 40% of the total 
plaque volume (Schroeder and Falk 1995, Plutzky 1999, Corti et a l , 2002)
Three major factors determine the vulnerability of the fibrous cap, these are 
lesion characteristics (location, size and consistency), blood flow characteristics, and 
consequent vessel wall stress or “cap fatigue” Inflammation is also a key factor in 
plaque disruption Inflammatory cells are a source o f plaque tissue factor, and lesion 
thrombogemcity correlates with its tissue factor content (Moreno et a l , 1996) In 
addition, inflammatory cells can secrete cytotoxic substances and proteolytic enzymes 
that induce VSMC apoptosis and degradation of the fibrous ECM Mechanical forces
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experienced by blood vessels are critical in determining both plaque formation and 
disruption (Schroeder and Falk 1995).
1.4 Mechanical Forces 
1.4.1 Introduction
All tissues in the body are subjected to physical forces, which can originate 
either from environmental factors, or from tension created by the cells themselves 
(Traub and Berk 1998; Zou et al., 1998; Xu 2000). Almost all vessels carrying fluids 
within the body are distensible, and interactions between internal blood flow and vessel 
wall deformation contribute both to a vessels biological function and dysfunction. The 
vascular wall is an integrated functional component of the circulatory system that is 
constantly exposed to mechanical forces of haemodynamic origin. In vivo, the vessel 
walls are exposed to two principal haemodynamic forces, shear stress and cyclic 
circumferential strain (Davies 1995; Patrick and Mclntire 1995).
1.4.2 Haemodynamic Forces
Figure 5: Haem odynam ic Forces Experienced by Arterial Blood Vessels
Figure 5: H aem odynam ic Forces Experienced by Arterial Blood Vessels. Diagrammatic 
representation of the force exerted by shear stress and cyclic strain on arterial blood vessels.
Shear stress is described as the dragging frictional force resulting from blood 
flow. Under normal physiological conditions, EC are primarily subjected to this 
haemodynamic shear stress. However, under conditions of endothelial dysfunction or
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denudation, shear stress can also exert its affect on the underlying VSMC In arterial 
circulation, based on altering vessel wall diameters, the mean wall shear stress is 10 — 
70 dyn/cm2 Changes in shear stress can result from changes in pulse pressure, which is 
defined as the difference between peak systolic and diastolic blood pressure EC, which 
contain shear stress response elements, respond to physiological or pathological 
alterations in shear stress by releasing vasoactive agents and pro- or anti-atherogenic 
substances (Davies 1995, Traub and Berk 1998)
Another well characterized haemodynamic force associated with the vasculature 
is cyclic circumferential strain (cyclic strain) Cyclic strain in arterial vessels is due to 
the repetitive pulsatile force on the vessel wall due to arterial blood pressure Cyclic 
strain can be multi-dimensional as the pulsatile force acts perpendicular to the blood 
vessel, resulting in “stretching” of the vascular cells in multiple planes All cells of the 
vessel wall experience cyclic strain under normal physiological conditions VSMC, 
which constitute the major component of the vessel wall, together with elastin and 
collagenous components, absorb most of the pressure-induced cyclic strain Normal 
blood pressure is considered to be 120/80 mm Hg, whereas blood pressures o f above 
140/90 mm Hg and below 90/60 mm Hg are considered high and low respectively 
Factors ranging from physical exertion to psychological stress can result in a transient 
rise in blood pressure, and a consequent transient increase in cyclic stress Genetic 
predisposition to hypertension can lead to a chronic increase in cyclic stress, resulting in 
potentially serious clinical manifestations Conversely, factors such as electrolyte 
imbalance, ischaemic heart disease and systemic sepsis can result in transient 
hypotension, and a consequent transient decrease in cyclic stress (American Heart 
Association website)
14  3 Role of Haemodynamic Forces
Haemodynamic forces are known to exert both physiological and non- 
physiological effects of the vascular wall Haemodynamic forces play a critical role in 
the regulation of vascular tone, remodelling, and influence vascular cell homeostasis 
(Folkow 1995, Thubrikar and Robicsek 1995, Zou et a l , 1998, Li and Xu 2000) The 
arterial wall is continuously exposed to such forces, changes in which directly regulate 
vascular structure Shear stress, for example, stimulates the release of nitric oxide and 
prostacyclin from EC resulting in vessel relaxation (Rubanyi et a l , 1986, 
Bhagyalakshmi and Frangos 1989) The effect of cyclic strain on blood vessel structure
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and function is mediated primarily by VSMC VSMC are a major constituent o f blood 
vessels, and as such, contribute prominently to the regulation of tissue strength A 
certain level of mechanical strain due to blood flow is essential to develop and maintain 
a differentiated and functional SMC phenotype (Birukov et a l , 1998) VSMC 
contribute to the regulation of vascular tone by synthesizing and organizing the extra­
cellular matrix, and regulating its degradation (Schlumberger et a l , 1991, Galis et a l ,
1994) Many studies have shown that changes in cyclic strain results in changes in both 
gene expression and protein synthesis of many components o f the VSMC Increases in 
cyclic strain also results in increased synthesis of matrix components in vitro (Leung et 
a l , 1976, Cheng et a l , 1997)
14  4 Clinical Implications of Altered Biomechanical Forces
A common feature of vascular disease is altered or elevated biomechanical 
stress Spontaneous atherosclerotic lesions, for example, occur preferentially at 
bifurcations and curvatures of arterial blood vessels, where haemodynamic forces are 
disturbed (DeBakey et a l , 1985, Thubrikar and Robicsek 1995) In additon, venous 
vessels do not develop atherosclerosis when maintained in their normal low-pressure 
environment, however, atherosclerosis can be observed following arterial vein grafts 
due to the increased biomechanical force on the venous vessel (Xu 2000) Alterations 
in VSMC fate decisions have been associated with numerous vascular disease states 
Proliferation of VSMC contributes to the pathogenesis of hypertension, intimal 
hyperplasia, atherosclerosis and the arterial response to injury (Vinters and Berliner 
1987, Thubrikar and Robicsek 1995, Traub and Berk 1998) Mechanical forces 
associated with blood flow have been implicated in the regulation of vascular cell fate 
as a fundamental feature in the pathogenesis o f vascular disease An alteration in the 
balance between VSMC proliferation and apoptosis, or an increase in VSMC migration, 
can result in remodelling of the vasculature (Wang et a l , 1999a) In addition, 
mechanical strain has been implicated in alterations in VSMC phenotype, resulting in an 
altered response of the cells to mechanical forces (Cappadona et a l , 1999), and 
subsequent vascular remodelling
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1.4.5 Vascular Remodelling
Remodelling is both a physiological and pathological process in the vasculature. 
Remodelling can be defined as a change in the calibre of the vessel, and can be sub­
divided into hypertrophic, hypotrophic or eutrophic remodelling, due to an increase, 
decrease or no change in the overall tissue mass respectively. Remodelling can result 
in a decrease or increase in both wall:lumen ratio and vessel luminal diameter, termed 
inward and outward remodelling respectively (Mulvany 1999). The biological 
processes that can affect vascular remodelling include VSMC proliferation, apoptosis 
and migration, adventitial fibrosis and migration of adventitial fibroblasts (Scott et a l, 
1996; Shi et a l, 1996; Shi et al., 1997). These processes can exert major changes in 
arterial architecture either alone, or in co-ordination with each other (Bennett 1999).
Figure 6: Vascular Rem odelling
Figure 6: Vascular Rem odelling. The starting point for vascular remodelling is represented by the 
vessel at the centre of the figure. Hypotrophic, eutrophic and hypertrophic remodelling are illustrated. 
This remodelling can be inward or outw ard, resulting in a reduced or increased luminal diam eter 
respectively (M ulvany 1999).
Physiological remodelling is evident during vascular remodelling after birth. 
Closure of the ductus arteriosus, for example, is due to vascular remodelling 
accompanied by increased VSMC apoptosis, and concomitant changes in VSMC 
proliferation and matrix synthesis (Slomp et al., 1997). Inappropriate vascular 
remodelling, including its absence, is a prominent feature of the pathogenesis of many 
vascular diseases. Many studies have demonstrated that changes in intravascular forces 
that occur in disease states, such as hypertension, result in a decreased lumen and 
increased media:lumen ratios in arterial blood vessels, as seen in essential hypertensive 
as compared to normotensive patients (Nordborg et al, 1983).
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1 4  6 Mechanical Force-induced Apoptosis
Apoptosis plays a pivotal role both in normal vasculogenesis and in the 
pathobiology of the vascular system Apoptosis is virtually absent in normal adult 
vessels, but is a prominent feature o f pathological conditions involving vascular 
remodelling This suggests a direct relationship between mechanical force and the 
regulation of apoptosis In recent years, many studies have independently proven the 
relationship between increased mechanical forces and increased levels of VSMC 
apoptosis Analysis o f atherosclerotic lesions in both human and animal models reveal 
high levels of VSMC apoptosis (Kockx 1998, Mayr and Xu 2001) Isolated human 
SMC from atherosclerotic plaques display a higher tendency to undergo both 
spontaneous and induced apoptosis than VSMC isolated from normal vessels (Bennett
1999) In addition, a study of biomechamcal-induced apoptosis in the development of 
vein graft arteriosclerosis revealed that the number o f apoptotic VSMC in the vein wall 
increased for at least eight weeks following grafting to an artery, but not to any vein, 
thus proving the effect of increased mechanical forces on apoptosis (Xu 2000, Mayr et 
a l , 2002) Apoptotic cell death following vascular injury is a highly regulated process 
governed, at least in part, by activation of the mitogen-activated protein kinase (MAPK) 
signalling pathway and the relative expression of apoptotic genes (Xu 2000) However, 
the mechanisms of signal transduction converting alterations m biomechanical force to 
alterations in apoptosis have not been fully elucidated Recent studies have implicated 
both the endothelin and £ i-integrm receptors as possible mediators of VSMC apoptosis 
due to increased cyclic strain in vitro (Cattaruzza et a l , 2002, Wemig et a l , 2003)
14  7 Mechanosensors
The transduction of alterations in mechanical forces to either physiological or 
pathological alterations in VSMC morphology and function, involves sensing of the 
physical stimulus by the VSMC, which is achieved by a mechanosensor Mechanical 
stress may initiate signalling by physically perturbing the cell surface or altering 
receptor conformation in a non-biochemical manner This can result in activation of 
signalling pathways, and altered gene expression in the cell (Li and Xu 2000) 
Mechanosensors in VSMC include mtegnns, receptor tyrosine kinases, G proteins and 
G protein-coupled receptors, and ion channels In addition, both the protein kinase C 
(PKC) and MAPK pathways are activated in VSMC in response to mechanical stress
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(Li and Xu 2000, Xu 2000)
Figure 7 M odel for M echanical Stress-induced Signal Transduction in V SM C
Figure 7 M odel for m echanical stress-induced signal transduction in VSM C Mechanical stress 
elongates the cell membrane, resulting in exposure o f  the kinase domain o f  receptors, or altered G 
protein receptor conformation Integnns and ion channels are also involved in the mechanical 
response to stress in VSMC Subsequently, activation o f  Raf, MAPK kmases (MEKs) and PKCs 
results in MAPK activation, which mediates gene expression, protein synthesis and VSMC fate 
decisions In addition, MAPK can mediate MAPK phosphatase-1 (M KP-1) or protem kinase A 
(PKA) activation, which can serve as negative regulators for MAPKs and cyclins (Li and Xu 2000)
1 4.7.1 Integnns
VSMC are surrounded by basement membranes largely consisting of ECM 
Integnns are a family of transmembrane receptors that mediate VSMC attachment to 
ECM proteins at sites called focal attachments (Jockusch et a l , 1995) Integnns are 
heterodimers composed of non-covalently bound transmembrane a  and p subunits A 
diverse family of over twenty different integrin receptors can be formed through the 
heterodimerization of different combinations of the 15 a  and 8 p subunits
Integnns are increasingly recognized as playing an important role as mediators 
of vascular strain Cyclic strain causes the up-regulation of (33 integrin expression in
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human umbilical vein EC (Suzuki et a l , 1997a), and mechanical stretching of human 
saphenous vein grafts results m the up-regulation of av  integrin, a receptor for active 
MMP-2 (Meng et a l , 1999) In addition, the VSMC response to strain was attenuated 
by antibodies to both 03 and av|35 mtegrms (Wilson et a l , 1995) The expression of 
the av|33 integrin appears to be significant in the regulation of vascular remodelling 
This receptor not only acts as a receptor for numerous ECM ligands to mediate cell 
adhesion, it can also transmit extracellular stimuli into intracellular signalling events 
(Ross 1993, Aplin et a l} 1998) These include increases in intracellular calcium and 
tyrosine phosphorylation of a number of cellular proteins, including the adaptor protein 
She This results in a number of downstream events, including cytoskeletal re­
organization leading to VSMC migration, and activation of the MAPK pathways 
resulting in mitogemc responses (Schlaepfer et a l , 1999) Therefore, integnn-mediated 
signal transduction appears to be an important event in response to mechanical stretch
1 4 7 2 Receptor Tyrosine Kmases
A growing number of receptor tyrosine kmases are recognized as being 
regulated by mechanical forces both m EC and VSMC Mechanical stress, for example, 
has been shown to increase both vascular endothelial growth factor (VEGF) expression 
and phosphorylate the VEGF receptor in VSMC (Smith et a l , 2001) This has recently 
been described as being mediated by phosphatidylinositol 3-kinase (PI3K) and an 
atypical PKC, PKC-zeta (Suzuma et a l , 2002) In addition, PDGF receptors a  and 
P are reported to be up-regulated by mechanical stress (Ma et a l , 1999, Li and Xu
2000) Mechanical stress-dependent increases in the endothehn B receptor in VSMC 
have also been identified in venous graft models This mechanically-induced increase 
in gene expression is dependent on PKC, and may contribute to graft failure due to 
endothelm B receptor-mediated SMC hyperplasia and graft occlusion (Riedy et a l , 
1999)
1 4 73  G Proteins and G Protein Coupled Receptors
A family of G proteins, which consist of a , (3 and y subumts, play a central role 
m coupling receptors to a variety of intracellular enzymes and ion channels In the 
cardiovascular system these receptors include those for adrenalin, nor-adrenalin,
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endothelin and angiotensin II, which facilitate the regulation of adenylyl cyclases, 
phosphohpases and ion channels The G protein Gq is thought to be important in the 
process o f remodelling in the cardiovascular system This is due to the fact that 
activators of Gq-coupled receptors, such as angiotensin II and endothelin I, can trigger 
hypertrophy and hyperplasia in cultured VSMC (Bruce and Nixon 1997, Higashita et 
a l , 1997, Touyz et a ! , 1999) In addition, over-expression of Gq proteins and Gq 
coupled receptors in transgenic mouse models result in the development of cardiac 
hypertrophy (Li and Xu 2000) Whilst no reports to date investigate Gq protein 
expression in VSMC following exposure to mechanical stress, an activation of Gq 
proteins in EC due to shear stress has been shown (Gudi et a l , 1998a) The importance 
of G proteins as mechanosensors in VSMC is further highlighted as treatment with the 
G protein inhibitor, pertussis toxin, results in an attenuation of the cyclic strain-induced 
activation of the p38 MAPK pathway (Li et a l , 2000)
1 4 7 4 Ion Channels
Another type of mechanosensor identified on VSMC are cyclic strain-sensitive 
ion channels These include Ca2+ and Na+ channels, which increase their frequency of 
opening following cyclic strain, resulting in a transient increase in intracellular Ca2+, 
Na+ and other divalent cations, and membrane depolarization This can contribute to
vascular remodelling due to subsequent implications on VSMC cell fate decisions
2 +
(Higashita et a l , 1997) The strain-induced increase in Ca primarily results from an 
extra-cellular source due to stram-dependent depolarization o f L-type Ca2+ channels, in 
addition, the existence of a novel strain-sensitive intracellular store o f Ca2+ has been 
suggested, but as yet is not fully investigated (Li and Xu 2000)
1 4  7 5 Mechanical Stress-induced Signal Transduction in VSMC
PKC activation plays a central role in cellular signal processing in many cell 
types, including vascular cells PKC is a large family of serine/threonine kinases, and 
can be divided into three sub-groups, the conventional, the novel and the atypical PKCs, 
denoted cPKC, nPKC and aPKC respectively The PKC family are activated by a large 
number o f extra-cellular signals and, in turn, modify the activity ol numerous targets 
such as cytoskeletal proteins, MAPK and transcription factors (Li and Xu 2000) 
Exposure of VSMC to cyclic strain has been shown to result in a significant increase in
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PKC activity, with a concomitant increase in VSMC proliferation (Mills et a l , 1997) 
In addition, PKC-e 1 and -e 2 expression and activity are increased in cardiac myocyte 
hypertrophy, which occurs, at least partly, as a result o f altered biomechanical stresses 
and can lead to congestive heart failure (Li and Xu 2000) Numerous studies have 
shown that PKC is required for MAPK activation in response to several stimuli, such as 
growth factors, hormones, and environmental stress, leading to cell hypertrophy, 
proliferation, migration, growth inhibition or apoptosis (Leng et a l , 1996, Pukac et a l , 
1998, Bowling et a l , 1999, Martelli et a l , 1999)
In addition to PKC, the MAPK signalling pathway plays a central role in the 
vascular response to altered biomechanical stress The MAPK signalling pathway can 
be divided into three possible sub-families, extracellular-regulated kinase (ERK) 1/2, c- 
Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK), and p38 MAPK 
MAPKs are phosphorylated (activated) by MAPK kmases (MEKs), these are primarily 
dual specific kinases that catalyze the phosphorylation of MAPKs on both tyrosine and 
threonine residues MEKs are subject to phosphorylation by MEK kinases (MEKKs), 
which are serine/threonine kinases, and are themselves subject to regulation by MEKK 
kinases (MEKKKs), many of which have been identified as small G proteins, such as 
Ras and Rac (Xu 2000)
Many studies have documented the up-regulation and activation of components 
of the MAPK signalling pathways due to alteration in biomechanical stress ERK 1/2 
over-expression and activation, for example, has been documented both in vivo and in 
vitro in response to increases in both shear stress and cyclic strain Atherosclerotic 
lesions show increased expression of activated ERK 1/2 (Li et a l , 1999), and ERK 1/2 
is activated by cyclic stretch in VSMC in a time- and strength-dependent manner In 
addition, increased levels o f shear stress activate ERK 1/2 in EC and cardiac myocytes 
(Suzuki et a l , 1997a, Wang et a l , 1999b) Both hypertension and balloon angioplasty 
induce expression and activation of ERK 1/2 and JNKs m rat vascular models (Wilson 
et a l , 1995, Suzuki et a l , 1997a) In addition, cyclic strain can rapidly induce 
activation o f JNKs in VSMC (Gudi et al 1998b, Wang et a l , 1999b), suggesting that 
mechanical forces also influence JNK activation and expression Cyclic strain also 
results in a rapid p38 MAPK phosphorylation in VSMC in a time- and strength- 
dependent manner This is apparently mediated by PKC-Ras/Rac pathways, and results 
in increased cellular proliferation and apoptosis (Gudi et a l , 1997, Mochly-Rosen and 
Gordon 1998, Mayr et a l , 2000, Mayr et a l , 2002) In addition, this group has also 
revealed that inhibition of p38 activation m VSMC results in an attenuated cyclic strain-
induced increase in VSMC migration, presumably as p38 mediates cytoskeletal 
reorganization withm the cell Therefore, biomechanical stress-induced activation of 
the MAPK pathway can have a profound effect on VSMC fate decisions, and 
subsequently on vascular remodelling and cardiovascular disease
1 5 Apoptosis 
1 5  1 Introduction
Apoptosis was first described by Kerr et a l , the term originating from Greek 
meaning falling (ptosis) off (apo) (Kerr et a l , 1972) Apoptosis is described as a 
physiologically relevant and active form of cell death whose control and mediation is 
cell-specific and contextual, and is highly conserved throughout evolution (Hetts 1998, 
Bai et a l , 1999) Apoptosis, or programmed cell death, is recognized as an important 
physiological process, both during development and in the maintenance of homeostasis 
in the adult This mode of cell death allows for the removal of damaged, injured, 
infected and incompetent cells from the body both quickly and efficiently
Cells of multi-cellular organisms generally die in one of two well-characterized 
ways, depending on the context and cause of death These two forms of cell death, 
apoptosis and necrosis, can be defined and contrasted on the basis of their individual 
mechanisms, biochemistry, and altered cellular morphology (Hetts 1998) Necrosis is a 
passive form of cell death, resulting from external noxious stimuli, and is pathologic in 
that localized injury and inflammation is produced A classic example of necrosis is 
ischemic necrosis of the cardiomyocyte during acute myocardial infarction (Yeh 1997) 
The necrotic process is characterized by severe cell swelling, breakdown of the 
membrane barrier and resulting release of the cellular components into the extracellular 
space, and random degradation of nuclear DNAs The release of extracellular 
components such as kimns incites localized inflammation, edema, capillary dilation and 
macrophage aggregation (Yeh 1997, Hetts 1998, Kuan and Passaro 1998) The 
inflammatory response is lengthy and unpredictable in its timecourse, often taking hours 
to days to occur and subside (Kuan and Passaro 1998) Although necrosis may be 
important in acute injury and certain acute inflammatory responses, it is not the 
mechanism whereby cells normally die (Hetts 1998)
In contrast, apoptosis is an active, contained process, resulting from either 
external or internal stimuli (Kuan and Passaro 1998) The morphology of an apoptotic
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cell is clearly distinct to that of a necrotic cell. The apoptotic process is characterized 
by cell shrinkage and subsequent membrane blebbing, chromatin condensation around 
the nuclear membrane, and cleavage of the DNA into regular repeating 180 -  200 base 
pair units (Steller 1995; Yeh 1997). Apoptotic bodies are formed due to cleavage of the 
membrane, these are phagocytosed and digested by macrophages or neighbouring cells, 
or undergo secondary necrosis. As no cytosolic components are released into the 
extracellular space, an inflammatory response is not initiated (Hetts 1998; Kuan and 
Passaro 1998). Unlike necrosis, this process is relatively rapid, reaching completion in 
approximately two hours (Kuan and Passaro 1998).
The genetics and molecular mechanisms of apoptosis were first characterized 
during studies in C. elegans. Programmed cell death during the development of this 
nematode is highly precise and predictable, o f the 1090 cells produced during 
development, 131 are destined to die (Ellis et al., 1991). Such studies have identified 
four sequential steps during the process of apoptosis, commitment to cell death induced 
by extracellular or intracellular triggers, activation of intracellular proteases, engulfment 
of the apoptotic bodies by other cells, and degradation of the apoptotic bodies within the 
lysosomes of the phagoctyotic cells (Steller 1995). Genetic analysis of factors involved 
in apoptosis in C. elegans implicated three main genes, cell death defective 3 (ced 3), 
ced 4 and ced 9. As the genetic control of apoptosis is conserved throughout evolution, 
human homologues of these genes have been identified, these are caspase 8, Apaf-1, 
and Bcl-2 respectively (Hetts 1998).
Figure 8: The Apoptotic Program  is conserved in Evolution
Figure 8: The apoptotic program is conserved in 
evolution. A: Tissue-specific signals activate ced-4, 
which activates ced-3 resulting in apoptosis. If 
activated, ced-9 can inhibit apoptosis by inhibiting 
ced-4-m ediated activation of ced-3. B: A wide array 
of factors com m it a mammalian cell to die, but the 
downstream  apoptotic machinery is conserved (C. 
elegans genes hom ologous to mammalian apoptotic 
genes shown in italics). Arrows indicate positive 
interactions; blunted arrows, negative interactions. 
Adapted from Hetts 1998.
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1.5 2 Triggers of Apoptosis
Apoptosis-mducing stimuli can be either extrinsic or intrinsic, and can cause 
apoptosis through the activation of a number of different pathways In most cases, 
however, these pathways converge on the caspase system of enzymes to execute their 
function Extrinsic triggers of apoptosis include activation of receptor-mediated death- 
signalling pathways, for example Fas ligand activation, exposure to substances that 
cause DNA damage including chemotheraputic agents and ionizing radiation (Hetts 
1998, Rich et a l , 2000) Apoptosis can also be induced due to the removal of death- 
mhibiting (or survival-promoting) ligands, for example, vascular smooth muscle cells 
undergo apoptosis due to the withdrawal of growth factors, such as insulin-like growth 
factor and PDGF (Best et a l , 1999) In addition, intrinsic signals such as increased 
intracellular oxidative stress, can cause the initiation of apoptosis within the cell, in 
which the mitochondria play a pivotal role (Desagher and Martinou 2000)
1.5 2.1 Receptor-Mediated Death Signalling Pathways
Death receptors belong to the tumour necrosis factor (TNF) superfamily, and 
play a central role in instructive apoptosis (Ashkenazi and Dixit 1998) Members of the 
death receptor family contain one to five cysteine-rich repeats in their extracellular 
domain, and a death domain (DD) in their cytoplasmic tail This DD is essential for 
initiation of the apoptotic signal by these receptors TNF receptor 1 and Fas (CD95) are 
two such receptors that initiate apoptosis when activated either by their respective 
ligands, TNF-a andFas-L, or by agonist-like antibodies (MacLellan and Schneider 
1997, Gupta 2003) Following receptor-ligand interaction, the receptor oligomerizes, 
recruits adaptor molecules forming a death inducing signalling complex (DISC), which 
recruits and activates the caspase cascade and can culminate in apoptosis of the cell 
(Yeh 1997, Gupta 2003)
Fas and Fas Ligand
Apoptosis following a cellular immune response is primarily mediated by Fas- 
Fas ligand (Fas-L) interaction (Krammer 2000) Fas is a type I transmembrane receptor, 
that is abundantly expressed in many tissues, including the heart, EC and VSMC 
(Gibbons and Pollman 2000) Fas-L, however, displays a more restricted expression 
Fas-L is a type II membrane protein, but is capable of undergoing cleavage by a
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metalloproteinase to generate a soluble, but less biologically active form of the receptor 
(Tanaka et a l , 1995). Both Fas and Fas-L expression can be upregulated by cytokines 
and stressful stimuli via nuclear factor-KB (NFkB) dependent mechanisms (Nagata 
1999).
Figure 9: Fas-m ediated Signalling Pathway o f Apoptosis.
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Figure 9: Fas-m ediated  signalling pathw ay of apoptosis. Follow ing ligation o f Fas receptor with Fas 
antibody, death dom ains (DD) of Fas receptor are oligom erized and recruit Fas-associated death dom ain 
(FADD) and pro-caspase 8 to form  a DISC. Pro-caspase 8 is autolytically cleaved, activated and released 
from the DISC into the cytoplasm  where it activates caspase 3 to induce apoptosis. Flice inhibitory protein 
(FLIP) with hom ologous death effector dom ain (DED) prevents the association between FADD and pro- 
caspase 8 resulting in an inhibition o f activation of pro-caspase 8, therefore inhibiting apoptosis (Gupta 
2003).
Fas receptor activation results in the trimerization o f the receptor, and the 
formation of a signalling complex of molecules linked to the cytoplasmic portion of the 
receptor, as the cytoplasmic domain of the receptor does not have intrinsic enzymatic 
activity. The adaptor protein FADD is recruited to Fas through interactions between 
their respective death domains. In addition, FADD also contains a DED at its N- 
terminus, which is responsible for binding to pro-caspase 8 (Flice) to form a DISC. 
Subsequently, pro-caspase 8 is auto-proteolytically cleaved, triggering the cellular 
apoptosis cascade (Ashkenazi and Dixit 1998; Gibbons and Pollman 2000; Gupta 
2003). In some cells, the levels of pro-caspase 8 is low, therefore the caspase cascade in 
this case must be amplified by the mitochondria to result in apoptosis (Li et a l, 1998a).
Fas-mediated apoptosis is regulated by FLIP, a protein containing two DEDs.
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FLIP is present within the cell in two alternatively spliced isoforms, the long form 
(FLIPl) and the short form (FLIPs), and stable over-expression of these results in 
resistance to receptor-mediated apoptosis FLIPl resembles caspase 8 and caspase 10, 
but lacks protease activity (Irmler et a l , 1997), therefore effectively functioning as an 
endogenous inhibitor of apoptosis In addition, FLIP also promotes the activation of the 
NFeB and ERK signalling pathways through the recruitment of adaptor proteins 
including RIP and Raf (Kataoka et a l , 2000)
The induction of Fas-mediated apoptosis in VSMC has been the subject of a 
number of conflicting reports Sata et a l , (2000) report that soluble Fas-L and agonistic 
Fas antibodies fail to induce VSMC apoptosis In contrast, however, viral over- 
expression of membrane-tethered Fas-L has been shown to promote VSMC apoptosis 
(Gibbons and Pollman 2000, Sata et a l , 2000) This discrepancy in VSMC response to 
Fas may be a consequence of differing VSMC phenotype Chan et a l , (2000) has 
shown that the Fas-L resistant VSMC exhibit normal levels of receptor expression and 
receptor engagement mechanisms However, these cells display decreased expression 
of FADD, caspase 8 and caspase 3, and increased expression of FLIP when compared to 
Fas-L susceptible VSMC (Chan et a l , 2000) This highlights the fact that the VSMC 
population is heterogenous, and as such, may respond differently to stimuli governing 
cell fate decisions
1 5 2 2 Apoptosis due to DNA Damage
Growth arrest, repair and apoptosis are all legitimate cellular responses to DNA 
damage The choice of cell fate in each instance will depend on cell type, location, 
environment, and extent of damage
p53 is a transcription factor that has been implicated in cell cycle arrest and in 
some, but not all, forms of apoptosis (MacLellan and Schneider 1997) The level of p53 
activity within the cell is maintained at a low level, under normal conditions, due to 
interaction with the Mdm-2 protein, which marks it for ubiquitin-mediated destruction 
(Mayo et a l , 1997) DNA damage-induced phosphorylation of either p53 or Mdm-2 
prevents these two proteins from interacting, thus stabilizing and activating p53 (Evan 
and Littlewood 1998) p53 levels are reported to increase within minutes of DNA
damage, resulting in growth arrest or apoptosis o f the cell (Lundberg and Weinberg 
1999)
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Figure 10 Central Role o f  p53 in C ontrolling Cell G rowth and Apoptosis
Figure 10 Schem atic representation o f  the central role o f  p53 in the regulation o f  cellular growth  
and apoptosis Interm ediate steps have been omitted for sim plicity (Lundberg and W einberg 1999)
Several cell-cycle regulators are induced by p53, including the cyclin-dependent 
kinase inhibitor p21, GADD 45 and members of the 14-3-3 family, resulting in growth 
arrest, followed by either DNA repair or cell death (Rich et a l , 2000) p53 alone will 
not induce apoptosis, but acts as a transcription factor, activating the expression of 
numerous apoptosis-mediatmg genes (Bennett et a l , 1995b) These include Fas 
molecules and members o f the Bcl-2 family of apoptosis regulators, among others 
Increased levels of p53 result in the up-regulation of Fas expressed on cell surfaces, thus 
rendering the cell susceptible to increased levels of Fas-mediated apoptosis In 
addition, p53 induces apoptosis by increasing the expression of a pro-apoptotic member 
of the Bcl-2 family, Bax, whilst limiting the expression of the anti-apoptotic Bcl-2 
protein within the cell p53 also regulates the expression of several proteins that 
regulate the redox state of the cell The up-regulation of these proteins results in 
damage to the mitochondria of the cells, causing leakage of mitochondrial components, 
such as cytochrome c, and subsequent activation o f the caspase cascade (Bennett et a l , 
1995b, Gupta 2003)
The regulation of p53 expression within the cell has been linked to cellular myc 
(c-myc) and E l A proteins, which have both been implicated in the regulation of 
apoptosis and proliferation (Evan and Littlewood 1998) c-Myc, a transcription factor 
of the basic helix-loop-helix-zip family, and El A, a protein encoded by adenovirus has 
been shown to cause transcriptional up-regulation o f p53 (Bennett et a l , 1995b) In 
addition, both o f these proteins are potent inducers of apoptosis (Samuelson and Lowe 
1997)
p53 is also implicated in apoptosis that does not involve obvious DNA damage, 
including metabolite deprivation, physical damage, heat shock and hypoxia (Debbas 
and White 1993, Wagner et a l , 1994, Linke et a l , 1996)
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1 5 2 3 Mitochondrial Pathway of Apoptosis
A number of stimuli, including UV radiation, stress molecules (reactive oxygen 
and reactive nitrogen species), and growth factor withdrawal, mediate apoptosis via the 
mitochondrial pathway (Gupta 2003) During the process of apoptosis the mitochondria 
undergo morphological and cellular re-distribution changes The mitochondria undergo 
a reduction in size and an increase in matrix density (mitochondrial pyknosis) In 
addition, the mitochondria which are normally dispersed throughout the entire cell, 
display perinuclear clustering (Desagher and Martinou 2000)
Mitochondria are organelles comprising of a matrix surrounded by an inner 
membrane (IM), an inter-membrane space, and an outer membrane (OM) The IM 
contains molecules that contribute to the formation of an electrochemical gradient or 
membrane potential, these include adenosine tri-phosphate (ATP) synthase and adenine 
nucleotide translocator The OM contains a voltage-dependent anion channel, whilst 
the inter-membrane space contains proteins that, when activated, contnbute to 
apoptosis, including holocytochrome c, some pro-caspases, and apoptosis-inducing 
factor (A1F) (Gupta 2003) At least three mechanisms contribute to mitochondrial- 
mediated apoptosis These include disruption o f electron transport, oxidative 
phosphorylation and ATP production, alteration of the cellular redox potential, and 
release of proteins, such as cytochrome c, that trigger activation of the caspase family of 
proteases (Green and Reed 1998)
1 5  3 Effectors of Apoptosis
1 5  3 1  The Caspase Cascade
Caspases are an evolutionally conserved family of cysteine proteases, which are 
viewed as the “central executioners” in apoptotic cell death Caspases are synthesized 
as enzymatically inert zymogens, requiring proteolytic cleavage at an internal aspartate 
residue to induce their activation (Gibbons and Pollman 2000, Hengartner 2000) These 
zymogens are composed of three domains, an N-terminal pro-domain, and two domains 
termed plO and p20 The activation of caspases generally results in a serial sequence of 
caspase activation, known as the caspase cascade, which is a common end pathway in 
apoptosis induced by many different stimuli Three general mechanisms of caspase 
activation have been described to date, these are proximity-induced activation,
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processing by an upstream caspase, and association with a regulatory subunit 
(Hengartner 2000)
Proximity-induced activation occurs in the case o f caspases 2 and 8 The 
aggregation of a number of caspase proteins via adaptor proteins renders the caspases 
capable of auto-proteolytic cleavage, and subsequent activation (Hengartner 2000) 
Most caspases are activated by cleavage between the plO and p20 domains, and 
between the p20 and N-terminal pro-domain Activation of caspase 8 and caspase 9, 
known as initiator caspases, results in subsequent cleavage and activation of 
downstream effector caspases, such as caspase 3, caspase 6 and caspase 7 The effector 
caspases are responsible for the induction of the biochemical and morphological 
changes associated with apoptosis, and are usually more abundant and active than the 
initiator caspases (Gibbons and Pollman 2000, Hengartner 2000)
Caspase 9 is activated through association with a regulatory subunit, known as 
an apoptosome The apoptosome consists of cytochrome c, an adapter molecule Apaf-1 
(apoptosis protease-activating factor), and pro-caspase 9 (Hengartner 2000, Gupta 
2003) Cytochrome c is a nuclear DNA encoded protein, its precursor, apocytochrome 
c, is synthesized on free ribosomes within the cytoplasm, and can spontaneously insert 
into the mitochondrial outer membrane (Gonzales and Neupert 1990, Stuart and 
Neupert 1990) This protein then incorporates a heme group, the protein re-folds, and is 
inserted into the inter-membrane space The release of functional cytochrome c is 
reported to be an essential component for the formation of the apoptosome, and 
subsequent activation of caspases 9 and 3 (Liu et a l , 1996a) Apaf-1 is another 
essential component of the apoptosome, and appears to be activated by p53 and 
adenoviral El A (Fearnhead et a l , 1998, Moroni et a l , 2001) Apaf-1 has an N-terminal 
caspase recruitment domain (CARD), adjacent Walker’s A- and B-box sequences, and 
C-terminal to this, twelve WD-40 repeats (Cai et a l , 1998) The binding of cytochrome 
c to the WD-40 repeats allows a conformational change of Apaf-1, thus exposing the 
CARD domain This conformational change is stabilized with the binding of ATP or 
dATP to the Walkers boxes Pro-caspase 9 subsequently binds to the CARD domain, 
resulting in its activation As Apaf-1 does not have caspase activity, it is proposed that 
it facilitates caspase 9 auto-catalysis (Cai et a l , 1998)
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Figure 11 Activation Cascade Initiated by Mitochondrial Cytochrome c Release
Figure 11 Activation cascade initiated by 
m itochondrial cytochrom e c release Release o f 
mitochondrial cytochrom e c (mtCyc c) into the 
cytoplasm (cCyt c) allows interaction with A paf 1 
which, in the presence o f  dATP, results in the 
proteolytic activation o f  pro-caspase 9 Caspase 9 
subsequently activates pro-caspase 3 Caspase 3 
cleaves a variety o f  substrates, resulting in the 
characteristic morphological changes associated 
with apoptosis (Cai ei a l , 1998)
Caspase 9 subsequently cleaves and activates caspase 3, caspase 6, and a 
number of other substrates resulting in the biochemical and morphological 
characteristics o f an apoptotic cell These substrates include caspase-activated DNase 
(CAD), nuclear lamimns, cytoskeletal proteins, and p21 -activated kinase 2, among 
others Activation of CAD within the cell results from the caspase 3-mediated cleavage 
of the CAD inhibitory subunit This active nuclease is subsequently responsible for the 
characteristic “DNA laddering” o f apoptosis Cleavage of cytoskeletal proteins, such as 
fodrin and gelsohn, results in an overall loss of cellular shape (Kothakota et a l , 1997), 
whereas nuclear laminin cleavage is responsible for the characteristic nuclear shrinkage 
and budding seen in apoptosis (Rao et a l , 1996) In addition, caspase-mediated 
cleavage of PAK 2, a member of the p21-activated kinase family, appears to mediate 
the distinctive blebbing of apoptotic cells (Rudel and Bokoch 1997)
Whilst caspase activation undoubtedly plays an important role in the initiation 
and execution of apoptosis, a number of caspase-independent inducers of apoptosis 
have also been identified Reactive oxygen species (ROS), for example, are associated 
with apoptosis (Suzuki et a l , 1997b) The generation of oxidants is involved in changes 
in mitochondrial permeability, and release of molecules, other than cytochrome c, 
involved in the execution of apoptosis AIF, apoptosis inducing factor, is one such 
molecule that is released from the mitochondria, and can induce caspase-independent 
apoptosis AIF is transported to the nucleus where it causes ATP-independent large 
DNA fragmentation and chromatin condensation (Susin et a l , 1996, Gupta 2003) In 
addition, the release of Endo G nuclease trom the mitochondrial inter-membrane space 
is thought to mediate nuclear DNA fragmentation (Li et a l , 2001)
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1 5 3 2 The Bcl-2 Family
Bcl-2 was initially identified as a frequent translocation occurring in human B- 
cell follicular lymphoma, and was found to function by promoting cell survival 
(Kirshenbaum 2000) Bcl-2 is now recognized as being part of a large family of 
homologous proteins that can either promote or suppress apoptosis, known as the Bcl-2 
family The Bcl-2 family are considered the primary regulators of mitochondria- 
mduced apoptosis, controlling mitochondrial membrane permeabilization and 
cytochrome c release (Thompson 1995, Desagher and Martinou 2000, Marsden et a l , 
2002)
At least fifteen members of the Bcl-2 family have been identified, and these can 
be divided into two functional groups, pro-apoptotic and anti-apoptotic Bcl-2 family 
members Examples of family members that prevent apoptosis are Bcl-2, B c 1-xl and 
Bfl-1 among others, whilst Bcl-2 family members that promote apoptosis include Bad, 
Bax, Bid and Bik, (see table l)(Reed 1994, Sedlak et a l , 1995, Green and Reed 1998)
Table 1 Inhibition and Promotion o f Apoptosis by Bcl-2 Family Proteins
Protein Effect on Apoptosis Protein-Protein Interactions
Bcl-2 t B a\ Bak
Bcl-xL* t Bax, Bak
Bcl-W t
B a\ t Bcl-2, Bcl-\j
Bad t Bcl-2 B c l- \L
Bak t Bcl-2, Bcl-x
B cl-\s* t Bax, Bak
* Alternatively spliced
Table 1 Pro- and anti-apoptotic members of the Bcl-2 family of proteins 
Table adapted from Me Lei Ian and Schneider, 1997
Structural analysis of the Bcl-2 family of proteins has identified four conserved 
regions within the family, known as the Bcl-2 homology domains (BH1-BH4) 
(Muchmore et a l , 1996) All members o f the Bcl-2 family contain at least one of these 
domains, which are formed by £ -helices and thus enable different members of the 
family to form either homo- or heterodimers and regulate each other (Oltvai et a l , 
1993, Kelekar and Thompson 1998) The majority of Bcl-2 family members share 
sequence homology at the C-terminal region, with a £20-residue hydrophobic domain, 
which targets the Bcl-2 family of proteins to intracellular membranes The principal 
membrane to which the Bcl-2 family members are directed is the outer mitochondrial 
membrane, therefore this C-terminal region is critical for the function of both the pro- 
and anti-apoptotic Bcl-2 family members (Goping et a l , 1998, Kirshenbaum 2000) 
Variable sequence homology, however, exists between the BH1 to BH4 domains,
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which implies that this variation in homology may determine whether the given Bcl-2 
family member acts to promote or prevent cell death (Kirshenbaum 2000). The anti- 
apoptotic Bcl-2 family members, such as Bcl-2 and Bcl-xL, contain at least three BH 
domains, and all contain the N-terminal BH4 domain. The BH4 domain is restricted to 
Bcl-2 family members with anti-apoptotic properties, therefore it is postulated that this 
domain is critical in preventing apoptosis. This is supported in a number of studies in 
which the deletion of the BH4 domain rendered the anti-apoptotic Bcl-2 protein 
defective in suppressing apoptosis (Hunter et a l, 1996; Huang et al., 1998). Pro- 
apoptotic Bcl-2 family members, such as Bax and Bak, have been identified as closely 
resembling Bcl-2, containing BH 1-BH3 domains. Other pro-apoptotic members of this 
family are described as “BH3 only” as they contain the BH3 domain alone, which is 
therefore sufficient for the anti-apoptotic activity of these proteins (Kelekar and 
Thompson 1998). Cell fate is determined by the ratio of pro- and anti-apoptotic 
members of the Bcl-2 family within any given cell (Sedlak et al., 1995; Reed 1997).
The Bcl-2 family can delay or prevent apoptosis by a diverse number of death 
signals, thus suggesting that it influences a number of signalling factors that can lead to 
cell death. Bcl-2 has been shown, for example, to increase the anti-apoptotic NFeB 
transactivation, which can, in turn, up-regulate anti-apoptotic Bfl-1 and B c 1-Xl 
expression (Lee et al., 1999a; Kirshenbaum 2000).
Figure 12: The M ajor Apoptotie Pathways in M am m alian Cells
Figure 12: The m ajor apoptotie pathways in m amm alian cells. Schem atic diagram showing the 
death-receptor and the m itochondrial pathways o f  apoptosis. Crosstalk between the pathways is 
facilitatied by Bid, as caspase 8-mediated cleavage o f  Bid increases its pro-apoptotic activity, and 
results in its translocation to the m itochondria (Hengartner 2000).
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However, members of the Bcl-2 family primarily exert their pro- or anti- 
apoptotic influence through regulation of mitochondrial membrane potential, and the 
corresponding cytochrome c release Upon stimulation of apoptosis, many members of 
the pro-apoptotic Bcl-2 family translocate from the cytoplasm to the mitochondria 
Following a conformational change, these proteins can insert into the mitochondrial 
membranes, disrupting membrane integrity and increasing mitochondrial membrane 
potential This results in the release o f several mitochondrial proteins involved in 
caspase activation and other apoptotic events (Goping et a l, 1998, Zamzami and 
Kroemer 2001) The pro-apoptotic protein, Bax, for example, is normally present in the 
cell cytoplasm Following stimulation of apoptosis Bax migrates to the mitochondria 
where it inserts into the mitochondrial membrane and forms a homodimer, resulting in 
an increase in mitochondrial membrane potential, thus facilitating apoptosis Similarly, 
the pro-apoptotic protein Bid is cleaved by caspase 8, and the resulting C-termmal 
fragment, tBid, translocates to the mitochondria Bid therefore mediates crosstalk 
between the death receptor and mitochondrial pathways o f apoptosis tBid facilitates 
insertion of other pro-apoptotic proteins into the mitochondrial membrane, and 
promotes Bax dimerization (Eskes et a l , 1998, Jurgensmeier et a l, 1998, Fern and 
Kroemer 2001) Conversely, many of the anti-apoptotic Bcl-2 family proteins are 
associated with the mitochondrial membrane, where they act to inhibit increases in 
mitochondrial membrane potential, and prevent apoptosis by maintaining membrane 
integrity Both the pro- and anti-apoptotic members of the Bcl-2 family appear, at least 
in part, to regulate each other Bcl-2, for example, can form a heterodimer with Bax, 
thus inhibiting the ability of Bax to increase mitochondrial membrane potential 
Similarly, pro-apoptotic members can exert their effect by binding to their anti- 
apoptotic counterparts Bad, for example, binds to B c1-xl thus inhibiting its anti- 
apoptotic function (Desagher and Martinou 2000, Fern and Kroemer 2001, Zamzami 
and Kroemer 2001) In addition, many factors within the cell regulate the level of 
expression of Bcl-2 family o f proteins, increased levels of p53 tumour suppressor 
protein can, for example, increase Bax expression (Miyashita and Reed 1995)
Bcl-2 family members also appear to modulate other cellular processes in 
addition to apoptosis, however, this appears to be restricted to certain family members 
Bfl-1 is an anti-apoptotic member of the Bcl-2 family that also exhibits proliferative and 
potent oncogene transforming activities (D'Sa-Eipper and Chinnadurai 1998) Bfl-1, 
therefore, communicates with both the apoptotic and proliferation cell machineries, 
suggesting a link between these two cellular processes
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The importance of the Bcl-2 family of proteins in normal physiology is 
highlighted by the fact that Bcl-2- and Bcl-XL-deficient mice die either at an embryonic 
stage or immediately post-natal due to increased apoptosis in multiple organs and 
tissues of the body (Veis et a l , 1993, Motoyama e ta l, 1995)
1.5 3 3 NFkB
NFkB is a family of transcription factors that was originally identified in B cells, 
and is now recognized as being ubiquitously expressed in mammals Family members 
include p65 (RelA), p50 (NFkB 1), p52 (NFkB 2), RelB and c-Rel, and the inhibitory 
subunits IkBcc, IkBP and IkBs NFkB subunits form either homo- or heterodimers, 
with the most predominant form of NFkB being the p50/p65 heterodimer (De Martin et 
a l , 2000, Gupta 2003) In un-stimulated cells, NFkB i s  sequestered in the cytoplasm 
through interactions with inhibitor kB (IkB) proteins, however, NFkB can be rapidly 
activated in response to a variety of inflammatory and other stimuli, such as TNF-a, 
interleukin (IL)-l, oxidized lipids, shear stress, and hypoxia/reperfusion (Pahl 1999) 
Cell stimulations result in rapid phosphorylation of IkB at serme 32 and serine 36, 
which is mediated by IkB kinases Phosphorylated IkB dissociates from NFkB, and is
i
targeted for ubiquitinylation and proteolytic degradation (Kirshenbaum 2000) Free 
NFkB dimers then translocate to the nucleus where they activate transcription of target 
genes Activation of NFkB is generally transient, as NFkB stimulates the transcription 
of the IkB gene, resulting in a rapid replenishment of the inhibitor The newly 
synthesized IkB molecules then enter the nucleus, where they bind to the NFkB dimers 
resulting in their dissociation from the DNA and return to the cytoplasm Perturbation 
of IkB control of NFkB has been associated with many pathological conditions, 
including chronic inflammatory conditions and cancer (Oakley et a l , 2003)
NFkB generally mediates cell survival signals and opposes apoptotic processes 
by regulating the expression of anti-apoptotic proteins This is supported by the 
embryonic lethality of p65 negative mice due to excessive apoptosis, suggesting that 
NFkB i s  crucial for regulating apoptosis during embryonic development (Beg et a l ,
1995) In addition, NFkB has repeatedly been shown to inhibit apoptosis in adult cells 
(Baldwin 1996, Liu et a l , 1996b, Ghosh et al 1998) NFkB activation results in the 
up-regulation of a number of anti-apoptotic proteins, including the regulator of Fas- 
mediated apoptosis, FLIP, and also inhibitors of apoptosis proteins (IAP), which results
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in inhibition of caspase activity (Nicotera et a l , 1999) In addition, NFkB also up- 
regulates the expression of the anti-apoptotic members of the Bcl-2 family of proteins,
a *
such as Bcl-2, Bc1-xl, and Bfl-1 (Nicotera et a l , 1999, Benedict et a l , 2000), however 
the pro-apoptotic protein Bax also appears to be regulated by NFkB (Bentires-Alj et a l ,
2001) NFkB activity is typically transient, its activity can be down-regulated by 
removal of the activation stimulus, or due to NFicB-dependent transcriptional activation 
and re-synthesis of IkB, resulting in the re-sequestration of NFkB m the cytoplasm (De 
Martin et a l , 2000)
1 5.4 Role of Apoptosis in the Vasculature
Apoptosis is a normal physiological process, playing important roles in both 
development and maintenance of a wide variety of tissues, including the vasculature It 
also is an essential component in the vascular response to tissue insult or injury The 
critical role of apoptosis is evident throughout life, and consequently dysfunctions in 
apoptosis manifest themselves not only in developmental abnormalities, but also in a 
wide range of adult pathologies
Apoptosis plays a critical role in normal vasculogenesis, and aberrations in this 
process can result in embryonic lethality Decreased apoptosis can, for example, result 
in increased development of endocardial cushions, and subsequently increased cardiac 
valve formation, whilst overabundance of apoptosis in the heart of developing mice has 
been shown to result in emybryomc lethality (White et a l , 2004) Apoptosis is also one 
of the mechanisms of neonatal vascular remodelling during the transition from foetal to 
neonatal circulation Apoptosis is involved in the regression of the human umbilical 
vessels and the ductus arteriosus, and in the remodelling of the branching great arteries 
during the neonatal period (Kim et a l , 2000) In addition, apoptosis has been shown to 
be involved m the post-natal morphogenesis of the atrioventricular node and Bundle of 
His, and aberrations in this process could predispose to tachyarrhythmias or 
bradyarrythmias in adulthood (James 1994)
The pathogenesis of various forms of vascular diseases involves dysregulation 
of both apoptosis and proliferation within the cells of the vasculature Many vascular 
diseases involve an accumulation of cells within the mtimal space This was initially 
accredited to perturbations in cellular proliferation, however, the importance of 
apoptosis in vascular remodelling and lesion formation is now recognized (Bai et a l ,
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1999, Pollman et al y 1999)
Apoptosis can contribute to the pathogenesis o f vascular disease through several 
potential mechanisms The transition of a fatty streak to an atherosclerotic plaque, for 
example, is characterized by the appearance of focal and diffuse regions of cell death 
The SMC of these fatty acid streaks express increased levels of the pro-apoptotic 
protein Bax, which increases the susceptibility o f the cells to undergo apoptosis (Kockx 
et a l , 1998) Apoptosis also occurs in advanced atherosclerotic lesions resulting in the 
formation of hypocellular fibrous zones and a lipid-rich core (Geng et a l , 1996) It has 
also been extensively documented that SMC isolated from atherosclerotic arteries 
undergo apoptosis more frequently than their counterparts isolated from healthy vessels 
(Bennett et a l , 1995a) Apoptosis can influence the structure of the atherosclerotic 
plaque, causing thinning of the fibrous cap, rendering the plaque more prone to rupture 
(Walsh et a l , 2000) In addition, increased apoptosis can also cause activation of tissue 
factor, which may increase the thrombogenicity of the lesion (Mallat et a l , 1999) It is 
postulated that the development of atherosclerotic lesions are regulated by forces 
governing cellular proliferation and migration, in addition to plaque remodelling due to 
apoptotic cell death Similarly, the development o f restenotic lesions following balloon 
angioplasty or atherectomy of diseased arteries is thought to be due, at least in part, to 
impaired apoptotic signalling (Kraemer 2002) Many studies have documented 
increased VSMC apoptosis following balloon injury This increase in apoptosis occurs 
both early after injury, with a 70% increase in apoptosis evident 30 minutes post-injury, 
and can also occur in the neointima from 7 - 3 0  days post-injury (Han et a l , 1995, 
Bochaton-Piallat et a l , 1996, Perlman et a l , 1997) It is postulated that apoptosis plays 
an important role in the development of vascular lesions, as exuberant balloon injury- 
induced apoptosis has been found to result in enhanced neointimal formation (Rivard et 
a l , 1999) However, the mechanisms that regulate neointimal SMC apoptosis remain 
incompletely understood
Cardiac myocyte apoptosis is a feature o f many pathological disorders, 
including myocardial infarction and congestive heart failure (Cook et a l , 1999, Kang 
and Izumo 2000) The Bcl-2 family of proteins are becoming increasingly recognized 
as important modulators of cardiac myocyte apoptosis Bcl-2, for example, which is 
expressed in both the developing and adult hearts, is up-regulated following coronary 
occlusion in rat hearts and myocardial infarction in human hearts (Kajstura et a l , 1995, 
Misao et a l , 1996, Liu et a l , 1998) The pro-apoptotic protein Bax is also up-regulated 
following coronary occlusion and is over-expressed in spontaneously hypertensive rats,
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which may contribute to increased apotosis (Fortuno et a l , 1998, Liu et a l , 1998) 
Therefore, the possibility of limiting cardiac myocyte loss by inhibiting apoptosis, 
possibly through interference with the level of expression of members of the Bcl-2 
family, may have important therapeutic implications m the treatment of heart failure
1 6 Notch Signalling Pathway 
1 6.1 Introduction to the Notch Signalling Pathway
The Notch gene of Drosophila melanogaster (Drosophila) was first described by 
Morgan m 1916 (Simpson 1998), and was so named as haploinsufficiencies of the gene 
causes “notches” at the wing margin in these flies Further studies in Drosophila, C 
elegans, and subsequently in mammals and humans, have identified and characterized a 
super-family of Notch receptors that show a high degree of evolutionary conservation 
Notch was originally identified in humans as a gene involved in the chromosomal 
translocations in T-cell leukaemias (Kojika and Griffin 2001) The receptors exhibit a 
high degree of structural conservation both within, and across, species as diverse as flies 
and humans The Notch receptor family includes Notch in Drosophila, LIN-12 and 
GLP-1 in C elegans, mNotch 1 and mNotch 2 in mouse, and Notch 1-4 in humans 
(Wemmaster 1997)
1.6 2 Biological Consequences and Methods of Notch Signalling
Further analysis of Notch signalling pathway mutants revealed that Notch 
function is important for the proper development of many tissues during embryogenesis 
(Miele and Osborne 1999) In Drosophila, for example, Notch is required for normal 
neurogenesis, myogenesis, wing formation, eye development, oogenesis, leg formation 
and heart formation (Park et a l , 1998) The importance of this signalling pathway is 
highlighted as targeted disruption of components of the pathway can lead to embryonic 
lethality Targeted disruption of the notch-1 gene, for example, leads to embryonic 
lethality at 11 5 days post-conception (Swiatek et a l , 1994, Conlon et a l , 1995) A 
number of studies present evidence that Notch signalling acts as an important “switch” 
controlling cell fate decisions dunng embryogenesis (Greenwald et a l , 1998) Indeed, 
Artavams-Tsakonas et a l , (1995) aptly described Notch as a “gatekeeper of cell fate”, 
as Notch signalling critically influences cell proliferation, differentiation and apoptosis
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Notch signalling has, for example, been shown to affect cellular differentiation 
programs in many experimental models The classic paradigm for this is Drosophila 
neurogenesis, in which activation of the Notch signalling pathway prevents neuronal 
precursors from differentiating towards the neuronal lineage (Artavanis-Tsakonas et a l , 
1991, Artavanis-Tsakonas and Simpson 1991)
There are two types o f signalling primarily employed by the Notch pathway, 
termed lateral signalling and inductive signalling (Simpson 1998) Lateral signalling 
causes two initially equivalent cells to adopt different fates or differentiate to different 
tissues This occurs when one cell expressing Notch receptor is stimulated by another 
cell expressing a Notch ligand Activation of the receptor in the first cell causes it to 
adopt a specific developmental fate and, through a negative feedback loop, suppresses 
its own Notch ligand expression The adjacent cell is then exposed to less Notch ligand 
and adopts an alternative differentiation program This allows a single cell or group of 
cells to be singled out from the surrounding cells, and it is this mode of signalling that is 
involved in preventing neuronal precursors from differentiating towards the neuronal 
lineage (Artavanis-Tsakonas et a l , 1995, Simpson 1998, Kojika and Griffin 2001) 
Inductive signalling occurs between non-equivalent cells, and can lead to a specific 
response at the interface between the two, leading to the formation of sharply defined 
boundaries of gene expression In this case, activation of the Notch receptor promotes 
production of Notch ligand, thus causing increased Notch activation in the adjacent cell 
(Artavanis-Tsakonas et a l , 1995, Lewis 1998, Simpson 1998) This occurs, for 
example, along the wing margin in Drosophila, where cells on one side o f the margin 
signal via Notch to cells on the other side Notch is only activated in each group by the 
signal coming from cells on the other side This is possible as the two populations 
produce a different ligand, and the cells are rendered insensitive to the ligand produced 
by equivalent cells (Simpson 1998)
In addition to its role as an arbiter of cell fate decisions in the developing 
organism, a growing body of evidence has implicated the Notch signalling pathway in 
determining cell fate decisions in the mature organism (Kojika and Griffin 2001, Wang 
et a l , 2002b), which may be due to the fact that most tissues are renewed throughout 
life from reserves of uncommitted stem cells (Artavanis-Tsakonas et a l , 1995) Notch, 
for example, is involved in the control of cell fate decisions during haematopoiesis 
(Bigas et a l , 1998) and inhibits the differentiation of murine myoblast cells (Bush et a l ,
2001) In addition, the Notch signalling pathway has been shown to affect other cell 
fate decisions, such as proliferation and apoptosis in the mature organism Notch has
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been shown to promote proliferation in certain cell types, for example, activation o f the 
receptor and transfection of a constitutively active form of the receptor in bone marrow 
stem cells and promyelocytic leukaemia cells, respectively, cause accelerated 
progression through Gi (Carlesso et a l , 1999)
Notch is reported to have anti-apoptotic properties in many cell types The anti- 
apoptotic properties o f Notch in T-cell systems has, for example, been documented by 
Deftos et a l , (1998) and Jehn et a l , (1999) showing that Notch 1 activation inhibits 
glucocorticoid- and Nur-77-dependent apoptosis respectively As human malignant 
cells display a resistance to both physiologically- and therapeutically-induced apoptosis, 
and Notch has been implicated in the control of cell fate decisions, it was postulated that 
alterations in Notch signalling or expression may contribute to tumorigenesis (Miele 
and Osborne 1999) Several lines of evidence support this Increased expression of 
Notch receptor and ligands is apparent in many malignancies, including cervical 
carcinomas, leukaemias, neuroblastomas, and pleural mesotheliomas, among others 
(Zagouras et a l , 1995, Daniel et a l , 1997) Notch over-expression is, for example, 
evident m 100% of the cervical cancer specimens studied (Zagouras et a l , 1995) 
Notch receptor and ligands were both found to be over-expressed, and the sub-cellular 
distribution o f Notch 1 changed in cervical cancer cells, with strong nuclear 
immunoreactivity observed only in carcinomas (Daniel et a l , 1997) Constitutively 
active forms of the Notch receptor cause transforming activity in many animal models, 
over-expression of the active form of Notch 4 for instance, causes breast cancer in mice 
(Jhappan et a l , 1992, Robbins et a l , 1992, Smith et a l , 1995, Gallahan et a l , 1996) 
In addition, Notch 3 signalling has been shown to promote vascular smooth muscle cell 
survival in response to the pro-apoptotic Fas ligand (Wang et a l , 2002b)
The importance of the Notch signalling pathway in the vasculature is highlighted 
due to the fact that it is involved in multiple aspects of vascular development Recent 
studies have implicated the Notch signalling pathway in the regulation of 
vasculogenesis and angiogenesis (Tallquist et a l , 1999, Gndley 2001, Luttun et a l ,
2002) It is postulated that the Notch pathway contributes to the establishment o f two 
distinct sub-populations at different stages of vasculogenesis and angiogenesis These 
could include EC versus SMC, artery versus vein, pulmonary versus systemic vessels, 
and large vessels versus capillaries (Iso et a l , 2003a) In addition, mutations of Notch 
receptors and ligands lead to abnormalities in many tissues, including in the vascular 
system Similar vascular phenotypes are observed in mice with both increased and 
decreased Notch signalling, suggesting that the level of signalling is critical for proper
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blood vessel development Alterations in Notch signalling produces abnormalities in 
vessel structure, branching and patterning of the vasculature, suggesting that Notch 
signalling does not function early in vasculogenesis, but regulates subsequent events 
that pattern the vascular network (Villa et a l , 2001) Mutations in components of the 
Notch signalling pathway are often embryonically lethal This is the case, for example, 
with deletion of notch 1 and jagged 1 in mice, which causes defects in angiogenic 
vascular remodelling and defects in vascular morphogenesis respectively (Kojika and 
Griffin 2001)
The distribution of components of the Notch signalling pathway in the 
developing vasculature is primarily restricted to arterial blood vessels Villa et a l , 
(2001) have reported that Notch 1, Notch 3, Notch 4, Delta 4, Jagged 1 and Jagged 2 are 
all expressed in arteries and not in veins However, other groups have noted a few 
exceptions, for example expression of Jagged 1 in portal and hepatic veins (Nijjar et a l ,
2002), Notch 3 in cerebral veins (Joutel et a l , 2000), and Notch 4 in the cardinal vein 
(Uyttendaele et a l , 1996) This suggests that the Notch signalling pathway may also 
play a role in venous development
A growing body of evidence has indicated that the Notch signalling pathway 
plays a role in the maintenance of vessel homeostasis m the adult (Gndley 2001) In 
addition, components o f the Notch signalling pathway are present primarily in the adult 
arterial vasculature Notch 3 expression is, for example, localized specifically to smooth 
muscle cell, and is absent from endothelial cells (Joutel et a l , 2000), similarly, the 
expression of Notch 4 is reported to be endothelial cell-specific (Uyttendaele et a l ,
1996) It is postulated that the Notch signalling pathway plays a role m determining cell 
fate decisions following vascular injury Two independent studies have shown changes 
in the expression of the components o f this pathway following balloon catheter 
denudation of the rat carotid artery Lindner et a l , (2001) demonstrated that the 
expression of Notch receptors (Notch 1-4) and ligands (Jagged 1-2) in both endothelial 
cells and smooth muscle cells of the vasculature was increased following injury This 
report also suggests that the level o f Notch receptor expression may be related to 
endothelial cell/smooth muscle cell interaction In contrast, Wang et a l , (2002a) 
reported that Notch 1, Notch 2, Notch 3, and the effector genes HRT 1, HRT 2 and HRT 
3 were coordinately down-regulated following balloon injury The discrepancies 
between these reports may be accounted for as Lindner et a l , used in situ hybridization 
thus limiting the study to the inner face of the artery Wang et a l , however, extracted 
RNA from the artery following removal of the mtimal and adventitial layers,
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representing the smooth muscle layer of the artery While further work is needed to 
elucidate the specific role of the Notch signalling pathway in maintaining vascular 
homeostasis, the importance of this pathway, and its potential for therapeutic 
intervention is not disputed
16  3 Components of the Notch Signalling Pathway
The Notch signalling pathway is an evolutionary preserved mechanism that 
serves to regulate cell fate decisions (Fleming 1998, Baron et a l , 2002) The main 
components o f the Notch signalling pathway include the Notch receptors (Notch 1-4 in 
vertebrates) and ligands (Delta 1 -4, Jagged 1 and 2 in vertebrates) among others, which 
are detailed in table 2 The Notch receptor and its ligands were first identified in 
Drosophila, and the Notch gene was first cloned by Wharton et a l , m 1985 (Baron et 
al, 2002)
The components o f the Notch signalling pathway are expressed in a variety of 
cells and tissues (Saxena et a l , 2001), including cells of the immune system, the 
nervous system, and the vasculature Vascular expression of Notch receptors and 
ligands has, to date, been described as being restricted to arterial vessels (Villa et a l ,
2001) Villa et a l , report that Notch 1, Notch 3, Notch 4, Delta 4, Jagged 1 and Jagged 
2 are all expressed in arteries and not in veins In addition, vascular expression of 
Notch 3 has been localized specifically to smooth muscle cells (Joutel et a l , 2000), 
while Notch 4 (Uyttendaele et a l , 1996) and Delta 4 (Shutter et a l , 2000) have been 
described as endothelial cell specific Components of the Notch signalling pathway are 
upregulated in injured arteries This was first described in 2001 by Lindner et a l , who 
observed increased expression of Notch signalling pathway genes, in both SMC and 
EC, following balloon catheter denudation of rat carotid arteries Analysis of Notch 
receptor expression within the cell reveals that although Notch is a cell surface protein, 
the majority of Notch within the cell is found intracellularly (Fehon et a l , 1991, Aster 
et a l , 1994), and that a significant portion of Notch is retained in the endoplasmic 
reticulum (Aster et a l , 1994, Weinmaster 1997)
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1 6 3.1 Structure of Notch Signalling Pathway Receptors and Ligands
The structure and spatial arrangement of Notch Signalling Pathway receptors 
and ligands are highly conserved from Drosophila to humans However, although the 
general architecture is conserved, large variations in specific domain size can be 
observed both withm and among species, as illustrated in figure 13
Figure 13 Schem atic Representation o f the Notch Family o f Receptors
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Figure 13 Schem atic representation o f  the Notch fam ily o f receptors The family members have the same 
overall arrangement o f  structural motifs The extra-cellular domains contain multiple epidermal growth factor 
(EGF)-like repeats, in addition to LIN12/Notch-related region (LNR) and two conserved cysteines The sub­
transmembrane domain (ST) lies between the transmembrane domain (TM) and the 6 ankyrin repeats (ANK) 
A region rich in prohne, glutamine, serine and threonine (PEST) lies at the C terminal (Wemmaster 1997)
The Notch receptor family includes Notch in Drosophila, LIN-12 and GLP-1 m 
C elegans, mNotch 1 and mNotch 2 in mouse, and Notch 1-4 in humans (Wemmaster 
1997) Notch receptors are single-pass transmembrane proteins, and as such have an
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extracellular (ExC), transmembrane (TM), and intracellular (IC) domains (Baron et a l ,
2002) Notch receptors are synthesized as single (300 kDa) polypeptides, and are 
proteolytically processed into heterodimeric (180 kDa and 120 kDa) forms presented on 
the cell surface (Blaumueller et a l , 1997, Pan and Rubin 1997, Logeat et a l , 1998)
The predominant features of the Notch ExC domain are a number of tandem ly 
arranged EGF-like repeats, a cysteine-rich region termed the LNR (LIN-12/Notch- 
related region) and a pair of conserved cysteines between the LNR and TM regions 
(Weinmaster 1997, Fleming 1998, Baron et a l , 2002) Notch 1 and Notch 2 proteins 
contain 36 tandemly arranged EGF-like repeats, while Notch 3 and Notch 4 contain 34 
and 29 respectively While the number of these EGF-like repeats is not conserved, their 
spatial arrangement is, suggesting that this spatial arrangement is important to the 
function of the receptor (Weinmaster 1997) A number o f studies in Drosophila have 
elucidated the function of specific EGF-like repeats, EGF-like repeats 11 and 12, for 
example, are both necessary and sufficient for binding of Notch to its ligands on 
adjacent cells (Rebay et a l , 1991, Baron et a l , 2002) Additional regions between 
EGF-like repeats 17-20 and 24-26 have been implicated in modulating the ligand 
receptor interactions (de Celis et a l , 1993), with the later region shown to be critical for 
Serrate-dependent signalling through Notch (Lawrence et a l , 2000) The LNR region is 
located immediately downstream of the EGF-like repeat domain, and appears to 
negatively regulate receptor activation In support o f this, studies show that either 
deletion of the LNR region, or missense mutations in this region produce a 
constitutively active receptor (Greenwald and Seydoux 1990, Lyman and Young 1993) 
The pair of conserved cysteines located between the LNR and TM regions have been 
postulated to function in receptor dimerization (Greenwald and Seydoux 1990, Lieber et 
a l , 1993) In addition, a conserved valine residue has been identified within the TM 
domain, and sequencing studies have established this as a cleavage site of Notch during 
receptor activation (Schroeter et a l , 1998)
Four functionally important regions have been identified within the 
Notch IC domain These are the RAM domain located in the subtransmembrane region, 
the ANK repeat domain, a transcriptional activator domain (TAD), and a PEST (proline, 
glutamate, serine, thronme-rich) sequence In addition, two nuclear localization 
sequences are present in the Notch IC domain, located either side o f the ANK repeat 
domain (Stifani et a l , 1992, Fortini et a l , 1993) Following translocation o f Notch IC 
to the nucleus, it exerts its effects by binding to DNA by forming a complex with CSL 
(CBF-1, Suppressor of Hairless, Lag-1) family of transcription factors The RAM
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domain is the mam site o f CSL interaction (Tamura et a l , 1995) The ANK repeat 
region also provides a lower affinity binding site to the CSL proteins, which facilitates 
the RAM/CSL interaction (Tamura et a l , 1995, Roehl et a l , 1996, M atsuno et a l , 
1997) These regions are essential to the function o f Notch IC, studies show that 
expression o f the RAM and ANK domains produce a similar phenotype to that of the 
activated Notch receptor (Roehl et a l , 1996), and proteins lacking these regions 
produce dominant-negative effects (Lieber et a l , 1993, Rebay et a l , 1993) In addition, 
the ANK repeat domain is known to be a binding site for a number o f positive 
regulators o f the Notch signalling pathway, including the deltex protein (Matsuno et a l , 
1995) Therefore, this region is an essential to Notch signalling, and may mediate 
multiple elements o f this pathway The PEST region of the Notch receptor is thought to 
be involved in Notch protein turnover (Rogers et a l , 1986, Greenwald and Seydoux 
1990) Deletion o f the PEST domain inactivates Notch but does not produce a 
dominant-negative form of the receptor (Lieber et a l , 1993, Lyman and Young 1993) 
The number and sequence conservation of amino acids between the ANK and PEST 
regions vary between the Notch proteins, accounting for the different sizes o f the Notch 
IC domains, and may account for some of the functional differences between the Notch 
proteins Deletion o f this amino acid sequence and the PEST region produces a 
dominant gain-of-function phenotype, which suggests that this region contains a 
negative regulatory domain (Mango et a l , 1991, Lyman and Young 1993)
Figure 14 Schem atic Representation o f the DSL Fam ily o f Notch Ligands
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Figure 14 Schem atic R epresentation o f the DSL Fam ily o f N otch L igands The family members 
contain the same arrangements o f  conserved structural m otifs The extra-cellular domains contain 
multiple EGF-like repeats, however, some o f  the serrate-like ligands have inserts on some o f  their repeats, 
and contain additional cysteine-rich (CR) regions between the EGF-hke repeats and the single TM 
domain The cytoplasmic domains do not share significant amino acid identities (Wemmaster 1997)
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The Notch ligand family includes Delta and Serrate in Drosophia, LAG-2 in C 
elegans, and Delta 1-3 and Jagged 1-2 in vertebrates, known as the DSL family of 
ligands (Dunwoodie et a l , 1997, Weinmaster 1997, Appel and Eisen 1998, Haddon et 
a l , 1998) Similar in structure to the Notch receptors, the Notch ligands are also single- 
pass transmembrane proteins, and as such, have ExC, TM and IC domains (Artavams- 
Tsakonas et a l , 1995) Although the general architecture of the ligands is conserved, 
large variations in specific domain size and composition can be seen both within and 
among species (Fleming 1998)
The ExC domain of the Notch ligands consists of a DSL domain, multiple EGF- 
like repeats, and a CR region, which is present m Jagged but absent m Delta and their 
respective homologues All Notch ligands possess a characteristic DSL domain, located 
N-terminal to the EGF-like repeats (Weinmaster 1997) The DSL domain is described 
as a modified EGF-like repeat domain, and is believed to be the portion o f the ligand 
that activates the receptor, point mutations that affect conserved cysteines in this 
domain have resulted in strong loss-of-function phenotypes (Henderson et a l , 1994) 
Experiments conducted in C elegans suggest that these DSL domains may be 
functionally interchangeable (Rebay et a l , 1991) Whilst both Jagged and Delta, and 
their homologues, possess an EGF-like repeat region, the structural differences between 
the two families are highlighted due to the difference in the number o f these repeats 
(Fleming 1998) The importance, if any, of the number of EGF-like repeats to the 
function of the receptor is unknown Evidence presented to date, however, indicates 
that this is not an important factor, as studies in Drosophila have shown that Delta and 
Serrate are capable of activating Notch receptors interchangeably (Henderson et a l ,
1997) Both the DSL and EGF-like domains appear to be necessary for ligand function 
(Weinmaster 1997) The CR domain, located between the EGF-like domain and the 
TM domain is approx 100 ammo acids in length, and is reputed to be involved in 
selecting specific Notch receptors (Fleming 1998) The CR region may also modulate 
binding of the ligand to the receptor, as Delta/Notch interactions have been shown to be 
more stable that those of Serrate/Notch (Fehon et a l , 1991, Rebay et a l , 1991)
The IC domain of the Notch ligands are relatively short, approximately 70-215 
ammo acids in length, and do not display significant sequence homology either within 
or among species (Fleming 1998) However, both the TM and IC domains are required 
by most ligands for proper Notch activation (Chitms et al 1995, Sun and Artavams- 
Tsakonas 1996, 1997), although the mechanisms remain unclear
Although Notch ligands are primarily transmembrane proteins, proteolytically
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cleaved, secreted forms of the proteins have been identified (Klueg et a l , 1998, Qi et 
a l , 1999) Initial reports indicated that the secreted soluble ligands act as dominant- 
negative molecules, competing with membrane bound ligands and blocking Notch 
activation (Sun and Artavanis-Tsakonas 1997) Conflicting reports, however, have been 
published, describing the soluble ligands as agonists o f the Notch signalling pathway 
(Wang et a l , 1998, Qi et a l , 1999, Han et a l , 2000) A secreted form of Jagged 1, for 
example, can activate Notch 1 in hematopoietic cells to inhibit differentiation (Li et a l , 
1998b) The factors controlling whether the soluble form o f the ligand is an agonist or 
antagonist on the Notch signalling pathway remain unclear
1 6*4 Molecular Aspects of Notch Signaling 
1.6 4 1 Processing of the Notch Receptor
Mature Notch receptors are heterodimers derived from the cleavage of the full 
length Notch protein (300 kDa) into two fragments, an N-terminal fragment, Notch 
ExC, that contains most o f the ExC domain (180 kDa), and a C-termmal fragment, 
cleaved N-terminal to the TM domain (120 kDa), and therefore contains the TM and IC 
regions (Blaumueiler et a l , 1997) The formation of this heterodimer, and subsequent 
activation o f the Notch receptor requires at least three proteolytic cleavage events, 
designated S I, S2, and S3 (Mumm and Kopan 2000, Baron et a l , 2002) Cleavage at 
SI does not require ligand binding of the Notch receptor, whereas both S2 and S3 
cleavage require such binding (Weinmaster 2000)
Figure 15 Proteolytic C leavage o f a Notch Receptor
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Notch R eceptor Schematic representation 
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Notch 1, putative proteases involved, and 
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Cleavage at SI is performed by a calcium-dependent serine protease known as 
furin (Bush et a l , 2001) This cleavage event occurs within the secretory pathway, such 
that a processed heterodimeric form of the Notch receptor is transported to the cell 
surface The two subunits of the heterodimer are held together at the plasma membrane 
by non-covalent interactions requiring calcium (Rand et a l , 2000) Jarnault et a l , 
(1998) has shown that inhibition of furin activity interferes with heterodimer formation, 
and antagonizes the ability o f Notch to activate its signalling intermediate, the CSL 
transcription factors Interaction of the heterodimeric receptor with a Notch ligand 
triggers two additional cleavage events, S2 and S3, adjacent to the plasma membrane 
(Kopan et a l , 1996, Brou et a l , 2000) Ligand binding to Notch induces a 
conformational change in the receptor that facilitates cleavage at S2 (Weinmaster 1998, 
Hardy and Israel 1999) The S2 cleavage site has been identified as a conserved valine 
located twelve ammo acids N-terminal of the TM region (Brou et a l , 2000, Mumm et 
a l , 2000) Two proteins have emerged as cleavage enzymes at S2, these are TACE 
(TNF-s converting enzyme) and Kuzbaman (Kuz), both members of the ADAM (a 
disintegrin and metalloproteinase) family (Blobel 1997), although it may emerge that 
other proteins are also involved in this cleavage event TACE has been shown to cleave 
at an S2 site m both vertebrates and Drosophila (Brou et a l , 2000), suggesting that the 
site of action of Kuz may be distinct to that of TACE Conflicting reports surround the 
identification of Kuz as an S2 cleavage enzyme, however, a role for Kuz in the Notch 
signalling pathway is not disputed, as transgenic mice deficient in either Kuz or Notch 1 
have been shown to display the same phenotype (Mumm et a l , 2000) Drosophila 
Notch has been shown to physically interact with Kuz, and removal of Kuz activity by 
RNAi inhibited an S2-like cleavage in vitro (Lieber et a l , 2002) However, proteolytic 
S2 processing has been shown in cells deficient m Kuz (Mumm et a l , 2000), and the 
expression of a dominant negative form of Kuz was shown to have no effect on Notch 
processing (Qi et a l , 1999), suggesting that this enzyme is not required for S2 cleavage 
Lieber et a l , suggest that the subsequent S3 cleavage step may have a different 
efficiency depending on whether the S2 cleavage was performed by TACE or Kuz, 
which could have implications on the strength and duration of the Notch signal The 
membrane tethered Notch product produced by S2 cleavage is a substrate for the 
proteolytic cleavage at the S3 site, resulting in an active form of the Notch receptor, 
Notch IC (5-39) Presemlins, E-secretases that play a crucial role in familial 
Alzheimer’s disease, have been implicated in the S3 cleavage event (Levitan and 
Greenwald 1998, Struhl and Greenwald 1999, Ye et a l , 1999) Two mammalian forms
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of presemlms (PS) have been identified, PS 1 and PS 2 (Kojika and Griffin 2001) 
Several studies have shown PS 1 to be a requirement for S3 cleavage of Notch, 
dominant-negative mutagenesis of PS 1, for example, reduces the extent o f S3 cleavage 
(De Strooper et a l , 1998) In addition, Notch 1 and PS have been shown to physically 
interact in both Drosophila and mammalian cells (Ray et a l , 1999a, Ray et a l , 1999b), 
and murine Notch homologues have all been shown to undergo presemlin-dependent 
proteolysis (Saxena et a l , 2001) However, Berechid et a l , (2002) have recently 
documented presemlm-independent Notch signalling, suggesting that a novel 
mechanism supports Notch signal transduction when presemhn proteins are absent The 
cleavage events described appear to be mutually dependent in that cleavage at S2 
requires prior cleavage at SI, similarly cleavage at S3 requires prior cleavage at S2 
(Kadesch 2000)
1 6 4 2 Processing of the Notch Ligand
Notch ligand processing also plays an important role in the activation of the 
Notch receptor Parks et a l , (2000) present evidence that endocytosis o f the Delta 
ligand, complexed with the Notch ExC domain, into the signal-generating cell is 
required for the activation of Notch in Drosophila This endocytosis of the ligand and 
trans-endocytosis o f the receptor is mediated by a Dynamin homologue, a GTP-ase 
required for the formation of clathrin-coated vesicles derived from the plasma 
membrane during endocytosis This study suggests that endocytosis may play a role in 
Notch activation, inducing cleavage of the receptor at the S2 site The removal of the 
Notch ExC domain relieves the LNR-mediated repression of S3 cleavage, thus 
promoting the release of the Notch IC domain
1 6 4 3 Receptor-Ligand Interactions
Ligand-dependent proteolysis generates the active form of the Notch receptor, 
the Notch IC domain (Kadesch 2000) Several studies have indicated that receptor- 
ligand interactions within the Notch signalling pathway are interchangeable (Fehon et 
a l , 1990, Rebay et a l , 1991) This suggests that the specificity o f function of 
components of this pathway may be downstream of the receptor-ligand interaction In 
C elegans, for example, all three known ligands, LAG-2, APX-1 and ARG-1, have 
been shown to activate the two receptors of the Notch signalling pathway, LIN-12 and
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GLP-1 (Bray 1998). However, an increasing number of studies are reporting intrinsic 
specificity of receptor-ligand interactions. Mammalian Jagged-1 is reported to activate 
both Notch 1 and Notch 2 expressed in myoblasts, whereas Delta-1 can only activate 
Notch 1 efficiently in the same cells (Weinmaster 1997). However, introduction of the 
Jagged specific CR region into Delta creates a ligand capable of activating both Notch 1 
and Notch 2. Similarly, removal of the CR region from the Jagged ligand results in 
ligand activation comparable to that of Delta. This suggests that receptor-ligand 
specificity can be affected by the presence or absence of the Jagged CR region 
(Weinmaster 1998).
Interactions between Notch ligands and receptors are predominantly intercellular 
(Alton et a l, 1989; Fehon et a l, 1990), however Sakamoto et a/.,(2002) have reported 
that these interactions can be cell autonomous and occur predominantly in the Golgi 
apparatus or endoplasmic reticulum, with only full length Notch participating in their 
formation. The resulting dominant-negative effect on the Notch signalling pathway may 
be that these complexes inhibit the formation of a heterodimeric Notch receptor, or due 
to competition between the different forms of the Notch receptor for ligand binding.
1.6.4.4 Modulation of the Notch Signalling Pathway 
Figure 16: M odulators o f the Notch Signalling Pathway
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Figure 16: M odulators o f the Notch signalling pathway. Schem atic representation of sites o f action of 
some modulators of the Notch signalling pathway (Panin and Irvine 1998).
A number of proteins have been identified that exert either a positive or negative 
effect on the Notch signalling pathway. These include both intracellular and 
extracellular modulators, such as Numb, Fringe, Scabrous and Wingless among others.
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Numb, a negative regulator of Notch signalling, is a phosphotyrosine-binding 
(PTB) domain protein that binds via its PTB domain to two regions o f Notch, the RAM 
domain and at the C-terminus (Baron et a l , 2002) Numb blocks CSL protein 
translocation to the nucleus in response to Notch activation, but does not interfere with 
CSL cellular localization in the absence of Notch receptor-ligand interactions (Fnse et 
a l , 1996) Fringe is a glycoslytransferase that acts within the Golgi apparatus to 
potentiate the activating effects of Delta and impede those of Jagged (Fleming et a l , 
1997, Panin et a l , 1997) It exerts its effects by binding to and modifying the EGF-like 
repeats o f the Notch receptor in a cell autonomous manner (Moloney et a l , 2000) 
Three vertebrate homologues of Drosophila fringe have been identified, Lunatic fringe, 
Manic fnnge and Radical fringe The Wingless signalling pathway also acts as a 
negative regulator o f Notch signalling It exerts this effect primarily through activation 
of Dishevelled, a cytoplasmic protein that binds to the carboxy terminus of the Notch 
receptor (Axelrod et a l , 1996) Scabrous, a secreted fibrinogen-related protein, acts 
also acts as a negative regulator of the Notch signalling pathway by binding to the EGF- 
like repeats and modulating receptor-hgand binding (Lee et a l , 2000, Powell et a l ,
2001) In addition, the Notch Signalling Pathway is regulated by a number of ubiquitin 
pathway associated proteins, including Sel-10, Nrarp, Neurahzed and Deltex (Baron et 
a l, 2002)
The modulation o f the Notch signalling pathway is a complex issue, with the 
above list o f modulators being by no means exhaustive Miele and Osborne (1999) 
propose that the intracellular concentrations, subcellular localization, timecourse of 
expression, and post-translational modifications o f Notch receptors, ligands, mediators, 
targets, and modulators may all contribute to the biological effects of Notch activation 
in a specific cell type
1 6  5 Notch Signal Transduction
Notch signalling activates at least two different pathways, one of which involves 
members o f the CSL family o f transcription factors as an intermediary (CSL/CBF-1- 
dependent), and one of which does not (CSL/CBF-1 -independent) (Baron 2003) These 
mechanisms of Notch signal transduction are widely conserved from Drosophila to 
humans (Miele and Osborne 1999) Bush et al ? (2001) suggest that the full length 
(300kDa), uncleaved form of Notch is the mediator of the CBF-1-independent pathway, 
whereas the processed form of the receptor (120 and 180 kDa subunits) mediates the
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CBF-1 dependent pathway Therefore, two isoforms of the same cell-surface receptor 
can mediate two distinct signalling pathways in response to ligand binding
1.6.5 1 CBF-l-dependent Pathway
The CBF-1 type transcription factors are the primary effectors of the Notch 
signalling pathway (Struhl and Adachi 1998, Lai 2002), and require presenelhn- 
dependent proteolysis of Notch IC for normal signal transduction (Miele and Osborne
1999) Notch 1C then translocates to the nucleus (Struhl and Adachi 1998), where it 
acts to regulate transcription of Notch-responsive genes (Artavams-Tsakonas et a l , 
1995, Bray 1998, Weinmaster 2000) In support of this model of Notch signalling, two 
nuclear localization signals have been identified in the Notch IC domain (Weinmaster 
2000, Gndley 2003), and several studies have shown nuclear access and action of Notch 
IC both in vivo (Struhl and Adachi 1998) and in vitro (Kimble et a l , 1998, Singh et a l , 
2000, Berechid et a l , 2002) Additionally, Schroeter et al (1998) demonstrated that 
very low levels of Notch in the nucleus are sufficient to produce a significant response 
This study shows transfection of Notch IC in mammalian cells at concentrations that 
activate gene transcription, but that do not allow detection of nuclear Notch by 
immunocytochemistry Similar studies have also shown this to be the case in 
Drosophila (Weinmaster 1997, Lewis 1998, Weinmaster 2000)
Notch IC, upon nuclear localization, cannot bind directly to DNA (Goodbourn
1995) but forms a tertiary complex with a CBF-1 complex (CSL proteins) and DNA 
The mam CBF-1 interaction site has been mapped to the RAM23 region of Notch IC 
(Tamura et a l , 1995), with a lower-affimty binding site in the ankyrin repeat region 
(Aster et a l , 1994) Therefore CBF-1 acts as a “docking protein” that directs activated 
Notch to promoter targets, and regulates the transcription of downstream genes (Struhl 
and Adachi 1998)
Involvement of a CSL protein in the Notch signalling pathway was first 
demonstrated in Drosophila The Drosophila CBF-1 orthologue, Suppressor of 
Hairless (Su(H)), was shown to display both genetic and physical interactions with 
Notch (Fortini et a l , 1993), and to activate gene expression upon Notch activation by 
binding to the regulatory DNA of target genes (Bailey and Posakony 1995) However, 
the significance of the Notch IC-Su(H) interaction remained controversial for many 
years, and as a result, the vertebrate CSL protein was identified by multiple groups 
without recognition of its connection to the Notch signalling pathway As a
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consequence of this, many names exist to describe the vertebrate CSL protein, including 
CBF-1 (Epstein Barr Virus (EBV) latency Ç  promoter binding factor, (Henkel et a l,
1994)), and RBP-Js (recombination signal binding protein of the ^imm unoglobulin 
gene,(Matsunami et al., 1989)). CBF-1 is a transcriptional regulator that binds to the 
DNA sequence GTGGGAA (Zhou et al., 2000; Kimberly et al., 2003). Initially, CBF-1 
was described as a transcriptional repressor in vitro (Dou et al., 1994). However, Hsieh 
and Hayward (1995) demonstrated that, during EBV-mediated cell immortalization, the 
viral protein EBV nuclear antigen-2 (EBNA-2) subverts the CBF-1 repressor function 
by binding to it, and converting it to a transcriptional activator. Notch IC was 
subsequently shown to exert a similar effect on CBF-1 (Hsieh et al., 1996). At present, 
accumulated data of both in vivo (Barolo et a l, 2002) and in vitro (Zhou et al., 2000) 
analysis of CBF-1 supports the model in which CBF-1 is a dual function transcription 
factor, repressing target gene expression in the absence of Notch/EBNA-2 signalling, 
and activating transcription in their presence.
1.6.5.1.1 CBF-1 Transcriptional Repression
CBF-1-mediated transcriptional repression involves destabilization of the 
transcription factor IID (TFIID)- transcription factor IIA (TFIIA) interactions (Brulin et 
al., 2002; Campos et a l, 2002), rendering TFIID unable to interact with TFIIA and 
form a functional complex (Loomes et al., 1999; Kadesch 2000). Repression also 
involves recruitment of a histone deacetylase (HDAC) co-repressor complex to the 
promoter (Zhou et a l, 2000). Reduction of histone acétylation by HDACs is linked to 
repressed, transcriptionally inactive chromatin, rendering the chromatin less accessible 
to the transcription machinery (Kadesch 2000). Kao et al., (1998) has shown that 
treatment of cells with the HDAC inhibitor, tricostatin A, causes a potentiation of the 
expression of a CBF-1 target gene in Xenopus.
Figure 17: Schem atic diagram o f the 
vertebrate CBF-1 co-repressor com plex.
CBF-1 binds to prom oter sequence within 
the nucleus, and also binds a HDAC- 
containing co-repressor com plex resulting in 
a repression o f  transcription (Lai 2002).
Figure 17: CBF-1 Co-R epressor Complex
V ertebrate C BF-1 C o-R ep ressor C om plex
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Several co-repressors make up the HDAC co-repressor complex, which binds to 
CBF-1 and mediates, at least partially, its transcriptional repressor activity These 
include SKIP (Ski-interacting protein (Kuroda et a l , 1999, Kadesch 2000)), SMRT 
(silencing mediator for retinoid and thyroid receptor, 78,54), N-CoR (nuclear receptor 
co-repressor (Lindner et a l , 2001)) and CIR (CBF-mteracting repressor (Hsieh et a l ,
1999)) SKIP is an adaptor protein which acts as both a tethering point for the CBF-1 
co-repressor complex to mediate repression, and as a tethering point for the ankyrin 
repeat domain of Notch IC during activation (Zhou et a l , 2000) Therefore, this protein 
facilitates the switching of the transcriptional regulation role of CBF-1 from that of 
repression to activation (Lai 2002) SMRT and N-CoR were originally identified as 
transcriptional repressors for unliganded nuclear hormone receptors (Chen and Evans 
1995, Horlein et a l , 1995) and have both since been shown to act as co-repressors for a 
variety of other transcription factors, including CBF-1 (Lindner et a l , 2001, Lai 2002) 
Both proteins have been shown to bind directly to CBF-1 and antagonize the ability of 
Notch IC to stimulate gene expression via CBF-1 (Kao et a l , 1998) Additionally, both 
SMRT and N-CoR bind directly to SKIP, to other co-repressor proteins designated Sin 
3A and SAP 30, and also to HDAC (Lai 2002) Besides acting as bridging proteins in 
the HDAC co-repressor complex, SMRT and N-CoR have been shown to directly 
activate the deacetylase activity o f the class I enzyme HDAC3 through the SANT DNA 
binding domain that both proteins possess (Guenther et a l , 2001, Zhang et a l , 2001) 
CIR has also been shown to directly bind to CBF-1 (Goodbourn 1995, Zhou et a l ,
2000), SKIP (Lai 2002) and other members of the co-repressor complex, including 
HDAC 1/2 and SAP-30 (Kadesch 2000, Oberg et a l , 2001) SMRT, N-CoR and CIR 
all fail to bind repression-defective CBF-1 mutants, further highlighting their inclusion 
and importance in the CBF-1 co-repressor complex (Kadesch 2000, Lai 2002)
1 6  5 1 2  CBF-1 Transcriptional Activation
Activation of CBF-1 by Notch IC involves a two-part mechanism, firstly, the 
loss of CBF-1 mediated transcriptional repression, and secondly, activation of gene 
expression mediated through the endogenous Notch IC activation domain (Apelqvist et 
a l , 1999, Zhou et a l , 2000)
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Figure 18 Model for activation of CBF-1 repressed promoters. CBF-1 binds promoter sequence within 
the nucleus SKIP interacts with CBF-1 The SMRT/HDAC co-repressor complex binds to both SKIP and 
CBF-1 mediating transcriptional repression Notch IC competes with SMRT for contacts on both SKIP and 
CBF-1 Displacement o f the co-repressor complex relieves repression and Notch IC further actuates 
promoter through its transactivational domain (Zhou el al 2000)
Evidence supporting the fact that Notch IC acts to displace the co-repressor 
complex from the CBF-1-SKIP complex has been demonstrated in a number of studies 
CBF-1 has been shown to bind both SMRT and Notch IC, however, CBF-1 cannot bind 
these proteins simultaneously (Kadesch 2000, Lindner et a l , 2001) Additionally, 
protein-protein interactions assays have demonstrated that SKIP can interact with both 
SMRT and Notch IC, however, it has been shown that these interactions are mutually 
exclusive (Zhou et a l , 2000) SMRT and Notch IC therefore compete for binding to 
the CBF-1 complex (Kimble et a l , 1998, Zhou et a l , 2000), and similar competition 
has been demonstrated between SMRT and EBNA-2 (Zecchini et a l , 1999, Zhou et a l ,
2000) Thus, the conversion of CBF-1 from transcriptional repression to activation 
involves, at least in part, both CBF-1 and SKIP exchanging the SMRT containing co- 
repressor complex for the Notch 1C activation complex (Zhou et a l , 2000) Notch IC 
binds to CBF-1 via its RAM23 region, and binds to SKIP via its ankynn repeat domain 
Both of these binding sites are necessary for the biological activity of Notch IC Zhou 
et a l , (2000) has shown that a mutation in the fourth ankynn repeat of Notch IC 
abolished its interaction with SKIP but not CBF-1, and eliminated biological activity in 
this study Similarly, the ability of Notch IC to block muscle cell differentiation was 
blocked with the expression of antisense SKIP in these cells
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Figure 19: CBF-1 Co-Activator Com plex
V ertebrate C BF-1 C o-A ctivator C om p lex
Figure 19: CBF-1 C o-A ctivator Com plex. Notch IC recruits a co-activator complex to facilitate 
transactivation at the CBF-1 prom oter (Lai 2002).
Notch IC subsequently activates gene expression through the presence o f its 
endogenous activation domain (Apelqvist et al., 1999; Zhou et a l, 2000). In addition, 
Notch IC recruits a co-activator complex, which includes the nuclear protein 
Mastermind and histone acetyltransferases (HATS) (Baron 2003). Mastermind was first 
identified as a modulator of Notch signalling in Drosophila, and loss-of-function 
mutations of Drosophila Mastermind generates a similar phenotype to that of loss-of- 
function Notch (Kojika and Griffin 2001; Iso et a l, 2003b). Mastermind is therefore an 
essential component of the Notch signalling pathway, it does not bind to the DNA 
directly, but forms a complex with Notch IC and CBF-1, and acts to stabilize this 
complex (Nakagawa et a l, 2000; Kojika and Griffin 2001). Mastermind acts as a 
positive regulator of Notch signalling as it contains transcriptional activator domains 
(Baron et a l, 2002) and acts to recruit HATS to the co-activator complex (Fryer et a l,
2002). These HATS include p300/CBP (Oswald et a l, 2001) and PCAF/GCN5 
(Kurooka and Honjo 2000) which may act catalytically to produce an open chromatin 
conformation, thus promoting transcription (Baron 2003). Therefore, repression and 
activation by CBF-1 proteins are linked to histone hypo- and hyper-acetylation 
respectively (Lai 2002).
1.6.5.2 CBF-l-independent Pathway
The first evidence of the existence of the CBF-l-independent pathway was 
obtained through analysis of Notch and Su(H) mutant phenotypes in Drosophila. The 
Notch mutant phenotype was seen to be slightly stronger than that of the Su(H) mutant, 
which suggested that Su(H)-dependent signalling does not mediate all functions of
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Notch (Shawber et a l , 1996, Martinez Anas et a l , 2002) Further experiments in 
Drosophila highlight the existence and importance o f the Su(FI)-independent pathway, 
Notch, for example, has been shown to regulate dorsal closure in Drosophila, however, 
this effect is independent of Su(H), as Su(H) mutant embryos undergo dorsal closure 
normally (Zecchmi et a l , 1999) Several in vitro and in vivo experiments also point 
towards the existence of CBF-1-independent Notch signalling in vertebrates In 1996, 
Shawber et a l , provided the first in vitro evidence of a Notch-activated CBF-1 - 
mdependent pathway in vertebrates This study shows that Notch 1 over-expression 
prevents the differentiation of muscle cells (C2C12) upon serum withdrawal, but does 
not interact with CBF-1 or up-regulate endogenous Hes-1 expression Additionally, 
incubation of C2C12 myoblasts with Jagged expressing cells prevented their 
differentiation into myoblasts, but failed to activate a CBF-1-dependent reporter gene 
(Bush et a l , 2001) Endo et a l , provided the first in vivo evidence for the existence of 
CBF-1-independent Notch signalling This study shows that a Delta 1-activated Notch 
signal is required for the expression of Slug, which is involved in epithelial to 
mesenchyme cell transition in the developing neural crest during avian ectodermal 
development However, the expression of Slug is not affected by the expression of a 
dominant negative CBF-1 protein in the ectoderm
1 6 5 2 1 Molecular Mechanisms of CBF-l-independent Signalling
A growing repertoire of CBF-l-independent Notch signalling mediators is 
emerging In some cases the CBF-l-independent signals represent interactions of Notch 
IC with transcription factors other than members of the CBF-1 family, for example, 
with Mef 2C in mouse fibroblasts (Wilson-Rawls et a l , 1999) and LEF1 in human T- 
cells (Ross and Kadesch 2001) Alternatively, CBF-1-independent signals may involve 
a direct interaction of Notch IC with other proteins within the cytoplasm that directly 
alters their function without any change in gene expression Notch signalling, for 
example, can directly alter the function of the translational regulator Musashi in the 
cytoplasm of Drosophila (Okabe et a l , 2001)
The most commonly described mediator o f CBF-l-independent Notch signalling 
is deltex The first links between the Notch signalling pathway and deltex were 
described in Drosophila Firstly, over-expression of deltex produces a similar dominant 
phenotype to that produced with over-expression of Notch IC, in addition, Notch IC has 
been shown to rescue the deltex negative (dx-) phenotype (Matsuno et a l , 1995) This
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data suggests that deltex acts genetically upstream of Notch, and that deltex acts as a 
positive regulator o f the Notch signalling pathway Deltex encodes a cytoplasmic 
protein containing three domains, domain I, an SH3 binding domain (domain II) and a 
zmc-fmger domain (domain III)(Matsuno et a l , 1998), and in Drosophila, is expressed 
ubiquitously throughout development (Busseau et a l , 1994) Further evidence linking 
deltex to the Notch signalling pathway are the protein-protein interactions observed 
between Notch and deltex both in Drosphila  (M atsuno et a l , 1995) and humans 
(U yttendaele et a l , 1996, Panin and Irvine 1998) Deltex binds to the conserved 
ankyrin repeats within Notch via domain I, only the most carboxyl (sixth) ankynn 
repeat has been shown to be non-essential for this binding activity (Matsuno et a l ,
1995)
Figure 20 M odel o f  Physical Interactions between Notch and Deltex
Figure 20 M odel o f  Physical Interactions between Notch and Deltex Deltex associates with the first 
five ankyrin repeats o f  Notch via its domain I (Matsuno et a l , 1995)
The function o f domain III of deltex, the zinc finger domain is unknown, but it is 
thought to be involved in protein-protein interactions (Matsuno et a l , 1995) Both 
drosophila and human deltex have been shown to bind to the SH3-domain containing 
protein Grb2 via domain II o f deltex (Matsuno et a l , 1998) This study also provides 
the first link between deltex and Notch-dependent transcriptional events, with deltex 
exerting a two-fold stimulation o f Notch target gene expression in cultured cell assays 
Whilst transformation experiments demonstrate that only deltex domain I is sufficient to 
rescue a dx- mutation, they also suggest that domains II and III are also important for 
deltex function For example, the over-expression o f full-length deltex induces 
dominant phenotypes much more efficiently than over-expression o f domain I alone 
(Matsuno et a l } 1995)
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Notch IC has been shown to antagonize signalling through a JNK MAP kinase 
pathway (Ordentlich et a l , 1998, Zecchini et a l , 1999), and that this effect is mediated 
through deltex (Ordentlich et a l , 1998) Through deltex-mediated effects on JNK, 
Notch signalling has been shown to crosstalk with Ras signalling (Miele and Osborne 
1999) Studies in Drosophila have identified an antagonist o f deltex, Suppressor of 
Deltex (Fostier et a l , 1998), however, no mammalian homologue of this gene has, to 
date, been identified Suppressor of Deltex is an E3 ubiquitin ligase (Cornell et a l , 
1999), rendering it capable of binding to specific target proteins and adding ubiquitin 
Although its target protein is unknown, Notch is known to be ubiquitinated and 
degraded through the proteasome pathway (Qiu et a l , 2000)
Other proteins that are involved in CBF-1 -independent Notch signalling include 
p50-NFeB (Guan et a l , 1996), the Abl-accessory protein Disabled (Giniger 1998), and 
the orphan nuclear receptor, nur 77 (Jehn et a l , 1999) A human Notch 1 construct 
(delta RAM) has been shown to interact with the inhibitory p50-NFeB homodimers, 
and that this may be the method of Notch activation of NFeB seen in vivo (Guan et a l ,
1996) The Drosophila abl gene, and its vertebrate homologue, the protooncogene, c- 
abl encode cytoplasmic tyrosine kinases with a role in Notch signalling in neurons 
This effect is mediated by the abl accessory protein, disabled, which binds directly to 
Notch IC, and exerts an effect on axon guidance (Giniger 1998) Additionally, Notch 1 
IC has been shown to directly interact with nur 77, resulting in an inhibition of nur 77- 
dependent transcription (Jehn et a l , 1999)
The interaction o f Notch with these proteins clearly demonstrates that not all of 
the effects o f Notch are mediated through a CBF-1-dependent mechanism, but rather 
that several other proteins, in addition to the CBF-1 family o f transcriptional regulators, 
can act as putative regulators o f Notch signalling Whether some or all of these proteins 
regulate different functions of the Notch signalling pathway, or whether they represent 
different mediators used in differing cell types remains to be fully established
1 6  6 Effectors of the Notch Signalling Pathway (Notch Target Genes)
Notch IC activates expression of primary target genes of Notch signalling, such 
as Hairy/Enhancer o f  Split (Hes) and Hairy Related Transcription Factor (HRT) genes 
(Bailey and Posakony 1995, Lecourtois and Schweisguth 1995), which are activated by 
Notch IC in a CBF-1 dependent manner (Chen et a l , 1997, Beatus et a l , 1999, Lee et 
a l , 1999b, Ohtsuka et a l , 1999, Wang et a l , 2002a) These genes are part of a family
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of basic helix-loop-helix (bHLH) type transcriptional repressors that act as Notch 
effectors by negatively regulating expression of downstream target genes such as tissue- 
specific transcription factors (Iso et a l , 2001a, Iso et a l , 2003b) The Hes family was 
the first described primary effector o f Notch signalling It should be noted that, due to 
the independent identification of the second family of effectors of Notch signalling by 
different groups, many different names exist for the HRT family, including HERP (Hes- 
related repressor protein, (Apelqvist et a l , 1999, Iso et a l , 2001b)), CHF 
(Cardiovascular helix-loop-helix factor, (Chin et a l , 2000)) and Hey genes (Maier and 
Gessler 2000)
1 6  61  bHLH Proteins
bHLH proteins have been implicated in the control of lineage commitment and 
differentiation in several organs and cell types, such as the heart, nervous system and 
skeletal muscle cells (Beatus et a l , 1999) bHLH proteins bind DNA as a dimer, with 
the basic and HLH domains having distinct functions in this process, the basic domain 
is a major determinant of DNA binding, while the HLH domains contain hydrophobic 
residues that allow them to form either homo- or hetero-dimers (Murre et a l , 1994) 
These proteins can be grouped into three different classes according to their structural 
features and biochemical characteristics, class A and B proteins such as Mashl and Myc 
respectively are transcriptional activators, whereas class C proteins such as the Hes and 
HRT families act primarily as transcriptional repressors (Iso et a l , 2003b)
There are several similarities and differences that render the Hes and HRT 
families related to, yet distinct from, each other These are evident both in their similar 
but distinct structures, and their mechanism of transcriptional repression
Consistent with their classification as bHLH proteins, both the Hes and HRT 
proteins contain three functional domains, a basic domain containing a conserved 
proline m the case of the Hes family and a conserved glycine at a corresponding 
position in the case of the HRT family (Iso et a l , 2003b) Both families contain another 
domain, the Orange domain, located carboxy to the bHLH region In addition, Hes 
family members contain a highly conserved tetrapeptide (WRPW) motif at or adjacent 
to the carboxy terminus, whereas this motif is replaced m HRT proteins by either a 
YRPW or YQPW motif (Iso et al 2001b)
Both the Hes and HRT families have been described as transcriptional 
repressors, with the exception of Hes-6, which antagonizes the function of Hes-1
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resulting in de-repression (Bae et a l , 2000) However, another differing characteristic 
between these two families is that they achieve transcriptional repression of target genes 
using different mechanisms
1 6  6 2 The Hes Family
Three mechanisms of transcriptional repression have been described as 
repression mechanisms utilized by the Hes family, active repression, passive repression 
and repression mediated by the Orange domain
Active repression involves binding of a Hes protein homodimer to an N box 
(CACNAG) consensus DNA site (Matsuno et a l , 1995, Chen et a l , 1997, Panin and 
Irvine 1998) and recruitment of the co-repressor Transducin-hke Enhancer of Split 
(TLE) in mammals via the C-terminal WRPW motif (Kojika and Griffin 2001, Prakash 
et a l , 2002) Chen et a l , 1999 have shown that the Drosophila homologue of TLE, 
Groucho, can recruit a histone deacetylase Rpd3, an orthologue of mammalian HD AC 
Reduction of histone acetylation by HDACs is linked to repressed, transcriptionally 
inactive chromatin, rendering the chromatm less accessible to the transcription 
machinery (Kadesch 2000), however, whether this mechanism of repression is 
employed by mammalian TLE remains to be determined Active repression appears to 
be primary mode of repression employed by the Hes family, however, repression can be 
achieved in the absence of the C-terminal WRPW domain (Dawson et a l , 1995, Takke 
e ta l, 1999)
Passive repression involves protein sequestration in which the Hes protein form 
a non-function heterodimer with another bHLH protein, such as E47 (Sasai et a l , 1992, 
Hirata et a l , 2000) MyoD and MASH1 are two transcription factors, important in 
myogenesis and neurogenesis respectively, interact with E47 and activate transcription 
This is inhibited by Hes-1, probably by disrupting the formation of functional MyoD- 
E47 and MASH1-E47 complexes
A third mechanism of repression by the Hes family has been shown to involve 
the Orange domain (Castella et a l , 2000), either through the direct recruitment of an 
unidentified co-repressor, or by the stabilization of the TLE co-repressor function, or 
both
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1 6 6 3 The HRT Family
In contrast to the Hes family, the primary mechanism of HRT mediated 
transcriptional repression involves its bHLH domain rather than its C-terminal 
tetrapeptide motif (Iso et a l , 2001a) The method of repression employed is similar to 
the active repression employed by the Hes family, in that, following DNA binding, the 
HRT protein homodimer recruits a co-repressor complex including HDAC and/or 
Sin3 A/N-Co-R to cause transcriptional repression (Iso et a l , 2003b)
Therefore, although the Hes and HRT families have similar structures and 
functions, it is clear that they utilize distinct domains to achieve this transcriptional 
repression However, it has been suggested that Hes and HRT proteins may co-operate 
with one another within the cell to achieve transcriptional repression Hes and HRT 
proteins are co-expressed in many cells and organs, including the embryonic heart, and 
they have both been shown to bind to the same DNA sequences in vitro (Iso et a l , 
2003b) Leinmaster et a l , (1999) demonstrated that Hes and HRT proteins associate 
with each other both in vitro and m intact cells m the absence of DNA In addition, 
Hes-HRT heterodimers have been shown to bind more efficiently to target DNA 
sequences than the respective homodimers (Iso et a l , 2001b) Therefore, it is suggested 
that in cells co-expressing Hes and HRT proteins, such heterodimers are likely to form 
and act in preference to homodimers o f the respective proteins (Iso et a l , 2001b, Iso et 
al, 2003b)
Figure 21 M odel for HES and HRT Cooperation m Notch Signalling
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Figure 21 M odel for HES and HRT cooperation in Notch signalling Refer to text (iso et a l 2001b)
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Upon Notch stimulation, HES and HRT expression might both be induced In 
tissues where only HES or HRT is expressed, the respective homodimer binds 
promoters of target genes The HES homodimers recruit TLE via their WRPW motif, 
whereas the HRT homodimers recruit the mSin3A-HDAC-N-CoR complex via their 
bHLH domain In tissues where both HES and HRT are co-expressed, the HES-HRT 
heterodimers become the predominant complex that binds a specific DNA site newly 
defined by the basic domains of HES and HRT Because o f the higher DNA binding 
affinity of the heterodimers, a lower concentration of them may be sufficient to achieve 
repression Repression by HES-HRT heterodimers may be reinforced by their ability to 
recruit a more diverse set of repressors (Iso et a l , 2001b)
1 6 6 4 Primary Effectors of the Notch Signalling Pathway
Currently, there are seven described members m the mammalian Hes family, 
however, only two of these, Hes-1 and Hes-5, are known to be involved in Notch 
signalling (Gndley 1997, Kojika and Griffin 2001, Iso et a l , 2003b) Similarly, a 
number of studies have described the HRT family as downstream targets of the Notch 
signalling pathway (Maier and Gessler 2000, Iso et a l , 2001b) In addition, many 
studies have proven that Notch IC activation of both the Hes and HRT promoters occurs 
in a CBF-1 dependent manner In cultured mammalian cells, for example, the 
transactivation of Hes-1 and HRT-2 promoters by Notch IC was reduced in the presence 
of the CBF-1 mutants, R218H-RPB-Js and RY227GS (Iso et a l , 2001a) In addition, 
this study also demonstrated that over-expression of Notch IC failed to induce HRT-2 
and Hes-1 mRNA expression in CBF-1 deficient cells Therefore, CBF-1 is essential 
for both Hes and HRT expression in response to Notch signalling
Recent studies have indicated that a single Notch ligand or receptor can 
participate in the up-regulation o f multiple members of the Hes and HRT families, for 
example, Notch 1 deficient mice have been shown to exhibit a decreased expression of 
Hes-5 and HRT-1-3, but not Hes-1 (de la Pompa et a l , 1997, Leimeister et a l , 2000a, 
Leimeister et a l , 2000b) In addition, activation of different Notch receptors can result 
in different levels o f transactivation of the target gene Beatus et a l , (1999) have shown 
that Notch 3 IC, in contrast to Notch 1 IC, to be a poor transactivator of the Hes-1 and -  
5 promoters, and that Notch 3 IC can act as a repressor of Notch 1 IC mediated Hes 
activation The Hes and HRT families act as Notch effectors by negatively regulating 
expression of downstream target genes such as tissue-specific transcription factors, for
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example, MASH-1 (Ishibashi et a l , 1994, Chen et a l , 1997, Hirata et a l , 2000) and 
Cbfa-1, a Drosophila Runt related protein involved in the regulation o f a variety o f cell 
differentiation events (McLarren et a l, 2000), and thus are involved in the Notch 
signalling pathway regulation o f cell fate decisions In addition, the Hes and HRT 
families have been shown to repress the expression of bHLH transcriptional activators 
that drive the expression of Notch ligands (Kimble et a l , 1998, Weinmaster 1998, 
Martinez Arias et a l , 2002) Therefore, Notch signalling in a cell can lead to a decrease 
in the expression of its ligand
The importance of these Hes and HRT proteins as Notch effectors in the 
vasculature is increasingly being recognized The HRT family, for example, is 
expressed in specific regions o f the developing heart, vasculature, pharyngeal arches 
and somites, and the periodicity of their expression in somatic precursors mirrors that of 
Notch signalling related molecules (Iso et a l, 2003a) In addition, members of the 
Hes/HRT families have been shown to play an important role in vasculogenesis, for 
example, gridlock, the Zebrafish HRT-2 homologue, has been shown to be required for 
assembly of the aorta in Zebrafish Both HRT and Hes proteins have also been 
described as being present and active within adult vascular smooth muscle cells 
(Campos et a l , 2002), however, their roles remain to be fully elucidated
1 6  7 Notch Signalling within the Vasculature
Dysfunctions o f the Notch signalling pathway are associated with human 
pathologies involving cardiovascular abnormalities CADASIL (cerebral autosomal 
dominant arteriopathy with sub-cortical infarcts and ¡eukoencephalopathy) and Alagille 
syndrome are two such disorders (Gridley 2003) These, coupled with the increased 
expression of Notch signalling pathway genes in both vascular smooth muscle and 
endothelial cells in vivo, highlight both the presence and the importance of the Notch 
signalling pathway in both the adult and developing cardiovascular system (Lindner et 
al, 2001)
1 6  71  CADASIL
The importance of Notch 3 in vascular smooth muscle cells was highlighted in 
1996 when Joutel et a l , (1996), through positional cloning, found the genetic cause of 
CADASIL to be point mutations in the human Notch 3 gene CADASIL is a cerebral
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autosomal-dominant adult onset arteriopathy, with the mean onset age being 
approximately 45 years (Gndley 1997, Joutel et a l , 2000) Affected individuals exhibit 
a variety of symptoms including recurrent subcortical ischemic strokes, usually in the 
absence of any vascular risk factors, leading to progressive cognitive decline, dementia 
and premature death (Joutel and Toumier-Lasserve 1998, Gndley 2003) Other 
symptoms include migraine with aura (approx 30% o f patients), mood disorders and 
psychiatric disturbances (approx 20% of patients) (Brulin et a l , 2002) The prevalence 
o f this disorder is difficult to estimate, as it is believed that the condition is under- or 
mis-diagnosed due to its variable mode of presentation (Tournier-Lasserve et a l , 1993) 
In support of this theory, of the 300 affected families that have been described 
worldwide, more than one third o f these are found in regions where systematic DNA- 
based screening and diagnosis are employed (Prakash et a l , 2002)
The vascular lesions underlying CADASIL are non-atherosclerotic, non-amyloid 
angiopathies preferentially affecting the small arteries and arterioles of the brain (Rubio 
et a l , 1997) However, vascular pathological changes in CADASIL patients are not 
only confined to the brain, but are also observed in systemic arteries and some veins, as 
well as in muscle, nerve vessels and skin (Brulin et a l , 2002) CADASIL is therefore a 
systemic vasculopathy Ultrastructural analysis of affected arteries have revealed 
alterations and eventual loss of vascular smooth muscle cells, and the accumulation of 
granular osmophihc material within the smooth muscle cell basement membrane and 
the surrounding extracellular matrix (Gndley 2003) In addition, endothelial cells 
appear to shrink, detach from the basal lamina, and the tight and gap junctions appear to 
be disrupted (Prakash et a l , 2002)
All of the mutations associated with CADASIL result m the gam or loss of a 
cysteine residue m one of the 34 EGF-hke repeats o f the ExC domain of the Notch 3 
protein Most of these mutations are mis-sense mutations and tend to be found within 
the first five EGF-hke repeats (Gndley 2003, Liu et a l , 2003) The resulting odd 
number of cysteine residues within the EGF-hke repeats is likely to alter the overall 
conformation of the Notch 3 protein (Joutel and Tournier-Lasserve 1998) Studies have 
shown that although this mutation does not affect the cell surface expression or ligand 
binding ability of the protein (Loomes et a l , 1999, Gndley 2003), the clearance of the 
Notch 3 ExC domain from the cell surface is greatly impaired (Luo et a l , 1997, Gndley
2003) This was first recognized by Joutel et a l , (1996) upon observing that the ExC 
domain of the Notch 3 protein accumulates in the cerebral microvasculature of 
CADASIL patients It has been suggested that the mutant Notch 3 molecules present on
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the cell surface compete with non-mutant Notch proteins for ligand binding, thus 
dominantly inhibiting the normal signalling pathway (Spinner 2000)
1 6 7 2 Alagille Syndrome
Alagille Syndrome (AGS) is an autosomal dominant disorder characterized by 
developmental abnormalities o f the heart, liver eye, skeleton and kidneys (Loomes et 
a l , 1999) The incidence of this disorder is 1 70,000 live births (Joutel and Tourmer- 
Lasserve 1998), however it is likely to be a cause of death in utero, as is evident with 
homozygous mouse models of AGS (Xue et a l , 1999) Congenital heart defects, the 
majority of which affect the pulmonary circulation, significantly contribute to mortality 
in AGS patients Most patients (97%) have a heart murmur, and 67% of these have 
peripheral pulmonary stenosis (Loomes et a l , 1999) Two groups independently 
identified Jagged 1 as the defective gene m AGS (Henderson et a l , 1994, Joutel and 
Tourmer-Lasserve 1998), further highlighting the importance of the Notch signalling 
pathway in the cardiovascular system
The majority of mutations (90%) identified to date are frame-shift, non-sense 
and splice mutations, resulting in a truncated protein product (Joutel and Tourmer- 
Lasserve 1998, Iso et a l , 2002) Mis-sense mutations have also been identified, and 
have resulted in the defective mtra-cellular transport and processing of the mutant 
protein (Morrissette et a l , 2001) However, Jagged 1 mutations have only been found 
in 70% of AGS patients (Spinner et a l , 2001), and these patients (90%) typically 
present with cardiovascular abmormalities in the absence of other characteristic defects 
(McElhinney et a l , 2002) This suggests that other genes, perhaps those encoding other 
components of the Notch signalling pathway, are also responsible for AGS
The two aforementioned disorders highlight the importance of the Notch 
signalling pathway in the cardiovascular system In addition, a study by Linder et a l , 
(2001) demonstrated that component o f the Notch signalling pathway were up-regulated 
in a rat carotid artery model following balloon catheter denudation Therefore, the 
Notch signalling pathway may also play a role in the cardiovascular response to injury
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EBV is a human oncogenic herpes virus, which causes lymphoprohferative 
diseases, such as Burkitt’s lymphoma, in immunodeficient individuals (Le Roux et a l , 
1994) The regulation of cell fate decisions (apoptosis, proliferation and differentiation) 
by EBV is central to the establishment of latent infection and the long-term survival of 
the infected cell EBV infects primary resting B cells and has been shown to induce 
unlimited proliferation o f virus-infected cells in vitro (Hofelmayr et a l , 2001) In 
addition, a central component in the overall EBV strategy o f infection is the ability of 
the viral latent proteins to suppress the cellular apoptotic program (Allday 1996) 
Several viral genes are required for the initiation and maintenance of cell growth, these 
include genes encoding the nuclear proteins EBNA-1, EBNA-2, EBNA-LP, EBNA-3A 
and EBNA-3C, and the plasmid membrane protein, Latent Membrane Protein-1 (LMP- 
1) (Spender et a l , 1999) EBNA-2 and EBNA-LP are the first viral genes expressed 
following EBV infection, and are essential for both the initiation and maintenance of 
immortalization (Hammerschmidt and Sugden 1989)
The overlap between EBV and the Notch signalling pathway is evident as many 
of the EBV latent proteins, including EBNA-2, EBNA-3 A and other viral gene products 
such as RPMS-I, have been shown to interact with the Notch signalling pathway (Smith 
et a l , 2000) In addition, EBV infection and activation of the Notch signalling pathway 
achieve similar functions phenotypically, by virtue o f their ability to modulate cell fate 
decisions Several studies have highlighted this, including Hofelmayr et a l , (2001), 
demonstrating that activated Notch 1 can transiently substitute for EBNA-2 in the 
maintenance of proliferation of immortalized B cells
16  81  EBNA-2
EBNA-2 is essential for B-cell immortalization by EBV, and is also necessary 
for the maintenance of the transformed state of the cell (Hofelmayr et a l , 1999) 
EBNA-2 activates a number of cellular and viral genes, including CD21 (B cell 
differentiation marker), CD23 (B cell activation marker) and the oncogene c-fgr In 
addition, EBNA-2 activates transcription of the viral RNAs coding for the various EBV 
nuclear and membrane proteins expressed in transformed cells (Kieff 1996) EBNA-2 
does not bind to DNA directly, but is recruited to EBNA-2 responsive elements by 
interacting with the transcription factor, CBF-1, in a manner reminiscent to that of
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1 6  8 O verlap between the Notch Signalling Pathw ay and E pstein-B arr Virus
Notch IC (Schlee et a l, 2004). CBF-1 binding sites are present in all of the EBNA-2- 
regulated promoters identified to date, and this binding site is essential but not sufficient 
to mediate EBNA-2 responsiveness (Hofelmayr et a l, 1999). As with Notch IC, 
activation of CBF-1 by EBNA-2 involves a two-part mechanism, as shown in figure 22. 
Firstly, EBNA-2 acts to displace the co-repressor complex from the CBF-1-SKIP 
complex and, upon binding to this CBF-1 complex, EBNA-2 activates gene 
transcription through the presence of its endogenous activation domain (Hsieh et al.,
1996). Therefore, EBNA-2 can be regarded as a functional homologue of activated 
Notch, and as such can provide insight into the Notch signalling pathway. In addition, 
other protein products o f EBV can provide tools for manipulating the Notch signalling 
pathway, as is the case with EBNA-3 A and RPMS.
Figure 22: Model for EBNA-2 Activation o f CBF-1 Repressed Promoters
Figure 22: M odel for EB N A -2 activation  o f CBF-1 repressed prom oters. CBF-1 binds prom oter 
sequence within the nucleus, SKIP interacts with CBF-1. The SM RT/HDAC co-repressor com plex binds 
to both SKIP and CBF-1, mediating transcriptional repression. EBNA-2 com petes with SMRT for contacts 
on both SKIP and CBF-1. D isplacem ent o f the co-repressor com plex relieves repression, and EBNA-2 
further activates promoter through its transactivational domain (Hsieh et al., 1996).
1.6.8.2 EBNA-3A
EBNA-3 A is essential for EBV transformation of B cells (Cludts and Farrell
1998). Two regions o f EBNA-3A have been shown to bind to CBF-1 (Robertson et al., 
1995; Robertson et al., 1996; Zhao et a l, 1996). EBNA-3 A has been shown to repress 
EBNA-2 mediated transactivation by binding directly and exclusively to CBF-1, thus 
preventing it binding to its target DNA sequence (Robertson et al., 1995; Robertson et 
al., 1996). Therefore EBNA-3 A negatively modulates transcriptional activity mediated
PROM OTER
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by EBNA-2, and consequently may also be antagonistic to the Notch signalling 
pathway
1 6 8 3 RPMS-I
The EBV Bam U bA  rightward transcripts (BART’s) are expressed in all EBV- 
associated tumours, in addition to latently infected B cells both in vivo and in vitro 
One of the EBV BART’s contains an open reading frame RPMS-I, encoding the nuclear 
protein, RPMS-I Smith et a l , (2000) demonstrated that RPMS-I antagonized both 
Notch IC and EBNA-2 mediated activation at promoters with CBF-1 binding sites, in 
addition Zhang et a l , (2001) have shown that RPMS-I reversed Notch IC-mediated 
inhibition of differentiation in myoblasts, again highlighting the central role o f the 
Notch signalling pathway m EBV biology RPMS-I interacts with both CBF-1 and 
components of the CBF-1 co-repressor complex RPMS-I has been shown to bind to 
the co-repressor component CIR with the highest affinity (Zhang et a l , 2001) As 
illustrated in figure 23, RPMS-I acts to stabilize the CBF-1-HDAC co-repressor 
complex, thus preventing effective displacement of the co-repressor complex by Notch 
IC or EBNA-2 (Zhang et al ,2001)
Figure 23 Stabilization of CBF-1 mediated repression
F igure  23 S tab iliza tion  o f CBF-1 m ediated  rep ression  RPMS-1 mediates repression o f  CBF-1 
through binding to CIR, thus precluding the effective displacem ent o f  the co-repressor complex by 
EBNA-2 and Notch IC (Zhang et al 2001)
Thus, several areas o f overlap between the Notch and EBNA-2 signalling 
pathways are evident, and consequently, if both are present and active within a cell, 
there exists a potential for mutual modification of the activity and function of the 
pathway
6 4
1 7 Relevance and Objectives of this Study
Apoptosis is an essential physiological process, important in both vascular 
development, and maintenance of homeostasis within the adult vasculature 
Dysregulation of apoptosis, however, is a common response to vascular injury, 
contributing to the progression and ultimate clinical outcome of vascular disease states, 
such as hypertension, transplant artenopathy, and atherosclerosis (Best et a l , 1999) 
Despite its clinical importance, regulation of apoptosis within the adult vasculature is 
poorly understood Therefore, better knowledge of the control of this process could 
identify potentially important therapeutic targets, and could have significant therapeutic 
implications
Numerous studies have implicated the Notch signalling pathway in the 
regulation of cell fate decisions, including apoptosis, in many cell types (Artavams- 
Tsakonas et a l , 1995, Greenwald 1998, Artavams-Tsakonas et a l , 1999) Whilst the 
presence and function of the Notch signalling pathway was not established in adult 
VSMC, until recently, several lines of evidence indicated that components of this 
pathway could be present, and act to regulate apoptosis in adult VSMC The Notch 
signalling pathway has previously been implicated in several aspects of vascular 
development, including arterio-venous differentiation, angiogenic processes, and in the 
regulation of developmental VSMC fate decisions (Artavams-Tsakonas et a l , 1999, 
Gndley 2001, Iso et a l , 2003a) Moreover, mutations in Notch receptors result in 
embryonic lethality due to defects in both vasculogenesis and angiogenesis (Xue et a l , 
1999, Singh et a l , 2000) In addition, the fact that dysregulation of the Notch signalling 
pathway is involved with human pathologies involving cardiovascular abnormalities, 
such as CADASIL and AGS, highlights the importance o f the Notch signalling pathway 
in the adult vasculature
Therefore, the principal aims of this study are to establish the presence and 
activity of the Notch signalling pathway within VSMC, and determine the effect, if any, 
of this pathway on VSMC apoptosis, induced by both serum-deprivation and exposure 
to cyclic strain In addition, we aim (i) to determine whether Notch signalling and 
function within these cells is executed in a CBF-1-dependent or -independent manner, 
and (11) to begin to elucidate potential cellular targets of the Notch signalling pathway in 
the regulation of VSMC apoptosis In addition, in vivo models of altered biomechanical 
force are used as an in vivo correlation of the in vitro findings of alterations in Notch 
signalling pathway expression and apoptosis due to changes in cyclic strain
This study aims to provide increased understanding into the regulation of
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apoptosis in VSMC, both under physiological and pathological conditions, and 
additionally aims to direct future research, with the ultimate aim of the eventual 
development of diagnostic, prognostic and therapeutic tools in an attempt to decrease 
mortality due to cardiovascular disease
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Chapter 2
Materials & Methods
2 1  Introduction
All general purpose chemicals and reagents used in experimental work were of 
analytical grade, and were purchased from the companies indicated in section 2 2 All 
cell culture plastic-ware was purchased from Sarstedt (Drinagh, Wexford, Ireland)
2 2 Materials
2 2 1 Biological Materials 
2 2 11 Antibodies
The anti-Notch 1 and -Notch 3 were purchased from Upstate Cell 
Signalling Solutions (Milton Keynes, UK) The anti- HRT-1, -HRT-2, -HRT-3, -Hes-1, 
-Hes-5, -Jagged and an additional -Notch 3 antibody were purchased from Santa Cruz 
Biotechnology (CA, USA) The HRP conjugated anti-mouse, anti-goat and anti-rabbit 
antibodies were purchased from Amersham Biosciences (Buckinghamshire, UK) The 
Alexa-fluor conjugated secondary antibodies were purchased from Molecular Probes 
(Leiden, The Netherlands)
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2 2 1 2  Expression and Reporter Constructs 
Table 3 P lasm ids used in this study 68
Plasm id Gift from D escription
pC M V -E D l-H A Dr Bettina K em pkes, pED l expresses N otch 1 1C pED4 expresses Notch 1 IC w ithout it’s RAM  dom ain, rendering it
pCM V-ED 4 G SF-Institute o f  Clinical unable to interact with CBF-1 pH A C S -1 is the HA vector into which N otch 1 IC and Notch 1
pHACS I M olecular Biology, N euherberg, 
Germ any
IC-delta RAM w ere cloned
pCM X -N otch 3 IC-HA D r Urban Lendahl, N otch 3 IC cD N A  was cloned in pCM X -polylinker 2 The Notch 3 IC cD N A  is follow ed by a
K arolinska Institute, DNA sequence encoding a HA im m unotag
Stockholm ,
Sweden
pG a50-7 D r Bettina K em pkes, The pG a9 8 -l-6  reporter construct was generated using a 50-bp oligonucleotide harboring both
pG a9 8 -l-6 G SF-Institute o f  Clinical CBF-1 binding sites o f  the EBV TP1 prom oter, which was then ligated as a hexam er into plasm id
M olecular Biology, N euherberg, pG a50-7 (M m oguchi e t a l , 1997)
G erm any
pGL3 P rof Eric Olson, Plasm id expression constructs for HRT-1 and HRT-3 were prepared by inserting partial digestion
pG L 3-m H R Tl University o f  Texas, fragm ents o f  mHRT-1 and - 3  repsectively into pGL3 basic luciferase vector (Prom ega)
pG L3-m H R T3 Southwestern M edical Centre,
Dallas,
Texas,
USA
pTK -H es 1 -lue Dr Urban Lendahl, Hes-1 and - 5  prom oter fragm ents w ere inserted into pTK-luc vector
pTK H es-5-luc K arolinska Institute,
Stockholm ,
Sweden
pcD N A 3RPM S-I Dr Paul J Farrell, Contains the full length RPM S-I cDNA O RF cloned into the pcD N A 3H A  vector (Invitrogen)
Ludwig Institute for Cancer (Sm ith, 2000)
Research,
Imperial College School o f
M edicine,
London, 
U K
pC M X -R 21 8H -R B P-Jk
pSG5
pSG5EBMA2
pCM V
pC M V -EB N A 3A
p-1374/+81 Bfl-1 Luc
pPG K puro
3 x enh k B-1uc 
pSG5 Ik B
P ro f Diane H ayw ard,
Johns H opkins School o f  
M edicine,
Baltim ore,
M aryland 21231,
USA
Lindsey Spender,
Ludwig Institute for Cancer 
Research,
Im perial C ollege School o f 
M edicine,
London,
U K
Dr C eline G elinas,
U niversity o f  M edicine and 
Dentistry o f  N ew  Jersey,
N ew  Jersey,
USA
D r B rendan D ’Souza, 
Laboratory for M olecular and 
C ellular Biology,
Dublin City University,
Dublin,
Ireland
D r Peter Laird,
University o f  Southern 
California,
Kerk School o f  M edicine,
Los A ngeles,
California,
USA
P ro f M artin Rowe,
University o f  W ales,
Cardiff,
U K
pCM X -R218H -RBP-jK  is a dom inant-negative CBF-1 contstruct, with an arginine to histidine 
m utation at position 218
PSG 5EBN A 2 (pPD L151) expresses the wild type B95-8 EBNA2 gene which has been cloned 
into pSG5 (Stratagene)
Contains the EBN A 3A  cD N A  inserted into the pCM V vector (Stratagene) (le Roux, 1994)
Consists o f  the B am H l-X ba l fragm ent o f -1 3  74/+81 Bfl-1 CAT inserted into the B am H l- 
HinDIII portion o f  the pGL2 basic vector w hich contains the luciferase reporter (D ’Souza, 2000)
Purom ycin plasm id (Tucker e t a l , 1996)
3 x enh kB -)uc contains three kB  elem ents upstream  o f a minimal conalbum in prom oter driving 
the expression o f  the firefly luciferase gene (Floettmann a n d  Rowe 1997) pSG5 IkB contains 
IkB cloned into the pSG5 vector
T able 4 G eneric  nam e assigned to p lasm ids used in th is  stu d y
P lasm id (G eneric  nam e) G eneric  nam e assigned  to p lasm ids used in this s tudy
pC M V -ED l-H A Notch I IC
pCM V-ED4 mut Notch 1 IC
pCM X-Notch 3 IC-HA Notch 3 IC
pG a98-l-6 C B F -H u c
PGa50-7 C B F-l-luc Con
pcDNA3RPM S-I (RPM S-I) RPMS-I
pC M X -R 21 8H-RBP-Jk R218H
pSG5EBNA2 EBNA-2
pCM V-EBNA3A EBNA-3A
3 x enh k B-1uc N Fk B
pSG5 IkB Ik B
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2 2 1 3  C om m ercial K its and O ligonucleotides
Oligonucleotides (see section 2 3 8 3 ) MWG Biotech
BCA Protein Assay Kit Pierce
High Sensitivity Mgalactosidase Assay Kit Stratagene
Luciferase Reporter Reagents Promega
WizardR Plus Midipreps DNA purification kit Promega
Super Signal West Pico Chemiluminescent Reagent Pierce
2 2 2 Chemical Materials
AGB Scientific (Dublin, Ireland)
Whatmann Chromatography paper
Amersham Pharmacia Biotech (Buckinghamshire, UK)
ECL Hybond nitrocellulose membrane 
ECL Hyperfilm
Rainbow molecular weight marker, broad range (6-175kDa)
BioRad (Alpha Technologies, Dublin)
Bio-Dot SF Micro filtration apparatus
Bio Sciences Ltd (Dun Laoghaire, Ireland)
DMEM
dNTP’s
DEPC-treated water 
Trizol® reagent
Calbiochem (Bad Soden, Germany)
Hygromycin
Gibco (Dun Laoghaire, Ireland)
G418
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Oxoid (Hampshire, U K )
Tryptone
Skim Milk Powder 
Yeast Extract
PALL Corporation (Dun Laoghaire, Ireland) 
Biotrace nitrocellulose membrane
Promeea (UK)
Taq DNA Polymerase 
MLV-RT 
RNase H 
Oligo dT
Siema Chemical Company (Poole, Dorset, England)
Mglycerophosphate Methanol
Mmercaptoethanol Mineral oil (molecular grade)
Acetic Acid Pemcillin-Streptomycin (lOOx)
Acetone Ponceau S
Agarose Potassium Chloride
Ammonium Persulphate Potassium Iodide
Acrylamide/bis-Acrylamide Potassium Phosphate (Dibasic)
Bovine Serum Albumin p-Nitroanihne
Brefeldin A RPMI-1640
Bnghthne Haemocytometer Sodium Acetate
Bromophenol blue Sodium Chloride
Calcium Chloride Sodium Doecly Sulphate
CHAPSO Sodium Hydroxide
Chloroform Sodium Nitrite
DMEM Sodium Orthovanadate
DMSO Sodium Phosphate
DTT Sodium Pyrophosphate
EDTA Sulphuric Acid
EGTA Tetracycline
Ethidium Bromide TEMED
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Foetal Calf Serum 
Glycerol 
Glycine
Hanks Balanced Salt Solution 
Hydrochloric acid 
Isopropanol 
Lauryl Sulphate 
Leupeptin 
Monensin
N-Acetyl-Asp-Glu-Val-Asp-pNitroanihde
Oiagen (West Sussex, U K )
SYBR Green® PCR Kit
2 3 Methods 
2 3 1 Cell Culture 
2 3 11 Introduction
All cell culture procedures were performed using aseptic technique in a 
sterile environment created by an Aura 2000 m a c  laminar airflow cabinet, Bioair 
Instruments Cells were visualised using an Oylmpus CK30 phase contrast microscope
2 3 12  Culture of Rat Vascular Smooth Muscle Cells (RVSMC)
The cell line used in this study were RVSMC, purchased from Cell 
Applications Inc (CA, USA) cat no R-354-05 RVSMC were maintained in RPMI- 
1640, supplemented with 10% foetal calf serum (FCS), and 1% penicillin/streptomycin 
(P/S), and were maintained in a 37°C humidified atmosphere of 5% C (V  95% air in a 
Hera water jacketed cell culture incubator Cells were cultured in 175 cm2 or 75 cm2 
tissue culture flasks, or in 6-well plates Only cells of passage number 3 to 20 were 
used in this study Cells were passed using a trypsimsation method This method 
involved removal of the RPM1-1640 growth media from the cells, and two subsequent 
washes of the cells with Hanks Balanced Salt Solultion (HBSS) The cells were then 
incubated with lx  Trypsin/Ethlyenediamine Tetracetic Acid (EDTA), diluted from the 
lOx stock solultion with HBSS Typically 1 ml of lx  Trysin/EDTA was used per 25 
cm2 tissue culture flask area The cells were then incubated at 37°C for 5 min, or until
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Tns Acetate 
Tns Base 
Tns Chloride 
Triton X-100
Trypsin-EDTA solution (lOx) 
Tween 20
the cells had detached from the flask RPMI-1640 growth media was then added to the 
flask to neutralize the trypsin/EDTA (an equal volume of RPMI-1640 growth media to 
trypsin/EDTA was typically added) The cell suspension was then removed from the 
flask, and centrifuged at 3,500 rpm for 5 min The supernatant was subsequently 
removed, and the cells were re-suspended in fresh growth medium For routine sub- 
culturing, a 1 2 to 1 4 dilution of cells was typically made
2 3 13  Maintenance of RVSMC
Cells were fed every 3-4 days with RPMI-1640 growth media, and 
routinely sub-cultured at 90-100% confluency, as described in 2 3 1 2
2 3 14  Cell Counting
Cell counts were carried out using a Sigma bright line haemocytometer 
In brief, a drop of cell suspension was used to fill the haemocytometer counting 
chamber Following visualization under 10X magnification, the number o f cells were 
counted in each of the four outer quadrants of the haemocytometer The average of 
these four counts was equal to the number of cells x 104/ml o f cell suspension
2 3 15  Cell Storage and Recovery
For longterm storage of cells, freshly trypsmised and pelleted cells, as 
described in section 2 3 12, were re-suspended in freezing down media (RPMI-1640, 
20% FCS, 1% P/S and 10% DMSO) and transferred to sterile cryovials Typically cells 
from a 175 cm2 tissue culture flask were re-suspended in 3 ml freezing down media, and 
stored in 1 ml aliquots The cryovials were then placed in a Nalgene cryofreezing 
container, and placed in the -80°C freezer overnight This allows for gradual freezing of 
the cells at a rate of -1 °C/min Cells were then transferred to the Thermoylen locater jr 
cryostorage system for longterm storage in liquid nitrogen, the levels of which were 
monitored regularly
Recovery o f cells from liquid nitrogen storage involves gradual thawing 
of a 1 ml aliquot, and the immediate addition o f the aliquot to 9 ml o f RPMI growth 
medium when thawing occurs Cells were then centrifuged at 3,500 rpm for 5 min, 
resuspended in 1 ml of RPMI growth medium, and added to 14 ml of medium in a 75 
cm tissue culture flask Media was changed the following day, and cells were routinely 
sub-cultured twice before being used in an experiment to ensure complete recovery
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2 3 1,6 Exposure of RVSMC to Cyclic Strain
RVSMC were seeded into 6-well Bioflex® plates (Dunn Labortechnik 
GmBH - Asbach, Germany) at a density of lx l0 5 cells/well Bioflex® plates contain a 
pronectin-coated silicon membrane bottom which enables precise deformation of 
cultured cells by microprocessor controlled vacuum (Banes et a l , 1995) When cells 
had reached approximately 80-90% confluency, a Flexercell® Tension Plus™ FX- 
4000T™ system (Flexcell International Corporation, Hillsborough, NC, USA) was 
subsequently employed to apply cyclic strain, typically 10% cyclic strain, 60 
cycles/mm, 24 h was applied unless otherwise stated Control cells remained 
unstrained Following strain, the cells were washed twice m lx  PBS, and either protein 
or RNA samples isolated as described in sections 2 3 2 or 2 3 8 1 respectively 
Alternatively, cells were assayed for apoptosis using Acridine Orange/Ethidium 
Bromide or Annexm V/Propidium Iodide dual stains as described m sections 2 3 9 2 and 
2 3 9 3 respectively
2 3 1 7  Culture and Maintenance of HeLa Cells
A HeLa-denved cell line, HtTA-jag 10 cells, expressing human Jagged 1 
under tetracycline control was also used in this study, and were obtained as a kind gift 
from Prof Celine Gelinas, Centre for Advanced Biotechnology and Medicine, NJ, 
USA Cells were maintained m DMEM, supplemented with 10% FCS, 1% P/S, 
hygromycin (225 U/ml), G418 (125 fxg/ml) and tetracycline (2 ^g/ml), and routinely 
sub-cultured To induce jagged expression, cells were cultured onto 6-well plates at a 
density of 1 x 105 cells/well Following overnight recovery, cells were maintained in 
media in the absence of tetracycline for a period of 48 h To facilitate jagged 
expression, cells were washed three times in growth media (- tetracycline) at 0 and 24 h 
following initiation of jagged induction
2 3 2 Preparation of Whole Cell Lysates
The preparation of whole cell lysates involved the trypsimsation and 
centrifugation of cells, as described in section 2 3 12 The cell pellet was then re­
suspended in an appropriate volume of lx  Lysis Buffer (20 mM Tns, 150 mM NaCl, 1 
mM Na2EDTA, 1 mM EGTA, 1% Triton, 2 5 mM sodium pyrophosphate, 1 mM M 
glycerophosphate, 1 mM sodium orthovanadate and 1 ug/ml leupeptin), typically cells 
from a 175 cm2 tissue culture flask were re-suspended in 300 -  500 ^1 lx  Lysis Buffer
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The lysates were then subjected to freeze-thawing three times, and stored at -80°C prior 
to use
2 3 3 Bicinchomnic Acid (BCA) Protein Microassay
The bicinchomnic acid protein microassay utilizes the biuret reaction, the 
reduction of Cu++ to Cu+ by protein under alkaline conditions, with the selective 
colounmetric detection of the cuprous cation (Cu+) using a reagent containing 
bicinchomnic acid This water-soluble complex exhibits a strong absorbance at 562 nm 
that is linear with increasing protein concentrations over a broad working range of 20- 
2000 |JLg/ml The two separate reagents used were supplied m the commercially 
available assay kit (Pierce Chemicals) A, an alkaline bicarbonate solution and B, a 
copper sulphate solution A working solution was prepared by mixing 1 part reagent B 
with 50 parts reagent A On a microtitre plate 200 \i\ of the working solution was added 
to 10 \x\ of the whole cell lysate or Bovine serum albumin (BSA) protein standard The 
plate was then incubated at 37°C for 30 mm The absorbance of each well was then read 
at 560 nm using a Tecan Spectra plate reader All samples and standards were tested in 
triplicate Quantitation was carried out by interpolation from a BSA standard curve (0 -  
2 mg/ml)
2 3 4 DNA Manipulations
2 3 4 1 Preparation of Competent Cells
Competent JM109 cells were used during this study for transformation of 
DNA A modified Rhubidium chloride (RbC^) method was employed to prepare 
competent cells This method gives better transformation efficiencies than the Calcium 
chloride (CaCh) procedure for most strains This procedure is an adaptation of one 
described by (Hanahan 1983) An E coh strain was streaked from a glycerol stock onto 
an LB agar plate and incubated at 37°C overnight An isolated colony was then picked 
using a sterile inoculating loop, and used to inoculate 5 ml of LB broth (1 0% tryptone, 
0 5% yeast extract, 1 0% NaCl) This culture was incubated in a shaking incubator at 
200 rpm overnight The resulting culture (2 5 ml) was then used to inoculate 250 ml of 
LB broth, supplemented with 20 mM MgS04, and incubated in a 1 L flask at 37°C until 
the O D of the culture at 640 nm was between 0 4 and 0 8 (approximately 4-5 h) The 
cells were then transferred to two sterile 250 ml centrifuge tubes and pel letted by 
centrifugation at 4,500 x g, 4°C for 5 min The resulting pellets were re-suspended in 
0 4 original volume ice-cold TFB1 (30 mM Potassium Acetate, 10 mM CaCl2, 50 mM
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MgCh, 100 mM RbCl, 15% glycerol, pH 5 8 and filter sterilize 100 ml for 250 ml 
culture -  50 ml per centrifuge tube) and the two pellets combined Cells were kept on 
ice for all subsequent steps, and pipettes, tubes and flasks were chilled The re­
suspended cells were then incubated on ice at 4°C for 5 min, and pelleted by 
centrifugation at 4,500 x g, 4°C for 5 mm Cells were then gently re-suspended in 1/25 
of the onginal volume of ice-cold TFB2 (100 mM MOPS, 75 mM CaCh, 10 mM RbCl, 
15% glycerol, pH 6 5 and filter sterilize for 250 ml culure use 10 ml) Cells were then 
incubated on ice for 1 h, ahquoted at 100 i^l per tube for storage at -80°C Prior to
storage the ahquoted cells were snap frozen in a dry ice/isopropanol bath JM 109
compenent cells prepared using this method are stable for 1 year
2 3 4 2 Transformation of DNA into JM 109
Frozen JM 109 competant cells were removed from -80°C environment 
and placed on ice for 5 mm, or until just thawed The cells were mixed gently, by 
flicking the tube, and 100 \x\ o f cells per transformation were transferred to pre-chilled 
culture tubes Plasmid DNA (10 ng) was added to the 100 i^l of JM 109 cells, ensuring 
even addition of DNA to the cells by trituration and by gently flicking the tube several 
times The tube was immediately placed on ice for 30 mm, after which time the cells 
were heat-shocked for 45-50 sec at exactly 42°C, without shaking The tube was then 
immediately placed on ice for 2 mm After this time, 900 i^l of SOC medium (0 5% 
Yeast Extract, 2 0% Tryptone, 10 mM NaCl, 2 5 mM KC1, 10 mM MgCh, 20 
mMMgS04, 20 mM glucose, pH 7 0) was added to the transformation reaction tube and 
incubated for 60 mm at 37°C, shaking at approximately 225 rpm The tube was then 
centrifuged at 3000 rpm for 1 mm, 900 ¡ml of the supernatant was removed, and the 
pellet resuspended in the remaining 100 fxl The resuspended cells (20 \i\ and 80 i^l) 
were plated out, with the appropriate controls, on LB plates (1 0% Tryptone, 0 5% 
Yeast Extract, 0 5% NaCl, 1 5% Agar) containing the appropriate selective medium (LB 
+ 125 ^ig/ml ampicillin) and incubated at 37°C for 12-16 h If the cells are transformed 
they become ampicillan resistant, thus only the transformed cells will yield colonies 
After this incubation period, a single cell colony is picked under aseptic conditions, and 
introduced into a starter culture as described in section 2 3 4 4 for eventual plasmid 
preparation
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2 3 4 3 Glycerol Stock Preparation
Following the transformation procedure (section 2 3 6 2), glycerol stocks 
of the plasmid of interest were made by aseptically removing 800 j^ l of the starter 
culture and mixing it with 200 \x\ glycerol in a sterile eppendorf The glycerol stock 
was then stored at -80°C
2 3 4 4 Preparation of Plasmid DNA
All procedures were earned out under aseptic conditions A glycerol 
stock of the plasmid of bacteria o f interest was streaked out onto LB ampicillm agar 
(1 0% tryptone, 0 5% yeast extract, 0 5% NaCl, 1 5% Agar, 125 [ig/ml ampicillm) and 
incubated overnight at 37°C An isolated colony from this plate was used to inoculate a 
3 ml starter culture o f LB broth (1 0% tryptone, 0 5% yeast extract, 1 0% NaCl) with 
the appropriate antibiotic (ampicillm 100 ^xg/ml), which was incubated at 37°C with 
gentle agitation at approximately 225 rpm 200 \i\ of the starter culture was then used to 
inoculate 25 ml o f LB broth (secondary culture) with the appropriate antibiotic in a 250 
ml sterile flask The secondary culture was then incubated overnight at 37°C with 
gentle agitation at approximately 225 rpm, with the appropriate controls The O D of 
the culture should read 1-1 5 at 600 nm The secondary culture was then transferred to a 
sterile centrifuge tube and centrifuged, using a T533 rotor in an ALC PK 131R 
centrifuge, at 6,000 x g for 15 mm at 4°C The supernatant was then removed and the 
pellet was dried by inverting the tube on tissue paper and allowing the remaining 
supernatant to dram off
Plasmids were prepared using the WizardR Plus Midipreps DNA 
purification kit (Promega) according to the manufacturers instructions Briefly, the cell 
pellet prepared was completely re-suspended in 3 ml o f Cell Resuspension Solution, 
complete re-suspension being critical for optimal yields Cell Lysis Solution (3 ml) was 
then added, and the mixture inverted four times, after which time 3 ml o f Neutralization 
Solution was added and again mixed by inversion The mixture was centrifuged at
14,000 x g for 15 mm at 4°C, and the supernatant then decanted to a new centrifuge tube 
(DNA solution) Ten ml of DNA purification resin was added to the DNA solution, and 
swirled for 30 sec The resin/DNA mixture was then transferred to a midicolumn that 
was attached to a vacuum port A vacuum of at least 15 inches of Hg was applied to 
pull the sample through the column, after which time the vacuum was disconnected 
Column wash solution (15 ml) was added to column and vacuum reapplied, this 
washing procedure was repeated twice The column was allowed dry for 30 sec after
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the second wash. The midicolumn reservoir was then removed, placed in a micro­
centrifuge tube and centrifuged at 10,000 x g for 2 min. The reservoir was then placed 
in a new microcentrifuge tube, 300 ¡il of preheated (65-70°C) nuclease-free water was 
added to the reservoir, incubated for 1 min, and the reservoir was then centrifuged at
10.000 x g for 20 sec. The reservoir was then discarded and eluate was centrifuged at
10.000 x g for 5 min. The DNA containing supernatant was then transferred to a new 
microcentrifuge tube and stored at -20°C in lx  Tris EDTA (TE) buffer (10 mM TrisCl,
1 mM EDTA, made up in DNase/RNase free water, pH 7.4), for example add 30 ¡ml of 
lOx TE buffer to 300 [i\ of eluted DNA.
2.3.4.5 DNA Quantitation and Storage
To determine the amount of DNA in sample obtained from the plasmid 
midi kit, the sample was diluted 1:100 in sterile TE (lx) buffer and spectrophotometric 
analysis carried out using the Shimadzu UV-160A dual spectrophotometer, blanked 
with TE. The sample was measured, using a quartz cuvette, at wavelengths of 260 and 
280 nm, and the concentration of the DNA in the sample was carried out as follows;
Abs260nm x dilution factor x 50 = concentration o f  DNA (|xg/ml)
The purity of the DNA was determined by calculating the ratio of absorbance at 
260 nm to 280 nm, the value of which should be greater than 1.6. All samples were 
tested in triplicate and were kept on ice at all times during the experiment. DNA 
samples were then stored at -20°C, ready for use in transient transfections.
2.3.5 Transient Transfections
2.3.5.1 LipofectAMINE ™ (LFA) Mediated Transfection
Transient transfection was carried out in RVSMC using 
Lipofect AMINE™ (Invitrogen), according to the manufacturers instructions. For 
transfection in a 6-well plate, cells were seeded at a density of 1.0 x 105 cells/well, and 
transfected at 70% confluency 2 days later. Per well of a 6-well plate (10 cm2), the cells 
were transfected with a luciferase reporter construct, and various expression constructs, 
with the addition of a total of 2.0 \ig DNA/well. The pCMV-LacZ expression construct 
(0.5 (ig/well) was co-transfected for normalization. Briefly, the appropriate volumes of 
DNA, mixed before use, were added to 500 \i\ of DMEM/well not containing serum or 
antibiotics as these can decrease transfection efficiency. Per well of a 6 well plate, 4 \i\ 
o f LFA was made up to 100 \x\ in DMEM, mixed and added to the DNA/DMEM
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mixture, and incubated for 30 min at room temperature to allow DNA-liposome 
complexes to form During this incubation period, each well to be transfected was 
washed twice with HBSS, and 400 \il DMEM was added to each well Following 
completion o f the incubation period, 600 \i\ DNA/DMEM/LFA mixture was placed on 
each well, and incubated for 3 h at 37°C in a humidified atmosphere Following 
incubation, transfection medium was aspirated from well and replaced with RPMI-1640 
growth medium, and the cells were allowed to recover for 18-24 h following 
transfection Each transfection on 6-well plates was performed in triplicate For 
transfections m flasks o f a larger surface area, the amount o f DNA and reagents were 
calculated up in the same proportion as was used in transfecting each well o f a 6-well 
plate which is 2 \ig DNA/10 cm2
2.3 5 2 Luciferase Assay
To analyse transactivation of luciferase tagged reporter genes, cells were 
harvested 18-24 h post transfection Cells were washed twice in lx  PBS, and incubated 
with lx  Reporter Lysis Buffer (Promega) for 10 min at 37°C in a humidified 
atmosphere, 500 [xl/well Cells were then scraped, transferred to eppendorfs, and lysed 
by freeze-thawing once The lysates were clarified by centrifugation at 3,000 rpm for 2 
mm, and the supernatants were saved in a fresh tube for analysis Transactivation of the 
luciferase tagged reporter genes was then analysed by luciferase assay, using 40 |la1 
sample, and 50^ x1 luciferase assay buffer at room temperature (Promega) Light 
emission was measured over a period of 60 sec, after a lag period o f 10 sec Briefly, the 
enzyme firefly luciferase, generated due to promoter activation on a luciferase tagged 
plasmid, catalyses the conversion of D-luciferin to oxyluciferin, with a concominant 
production o f a photon of light, with is measured by the lummometer (Labsystems 
Luminoskan)
2 3.5 3 P-Galactosidase Assay
A P-Galactosidase assay (High Sensitivity (3-Galactosidase Assay,
Stratagene) was carried out according to the manufacturers instructions to normalise for
differing transfection efficiencies p-Galactosidase, which is expressed due to
transfection with pCMV-LacZ, catalyzes the hydrolysis o f chlorophenol red-|3-D-
galactopyranoside (CRPG) into galactose and the chromophore chlorophenol red,
yielding a dark red solution, which can be quantified using a spectrophotometer at 570
nm In brief, per sample, 20 |la1 of cell lysate was analysed in triplicate in a 96 well
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plate 130 \i\ o f lx CRPG substrate was added per well and the time recorded The plate 
was then covered and incubated at 37°C for 30 min -  72 h, until the sample turned a 
dark red The incubation time should be recorded and the reactions terminated by the 
addition of 80 jil Stop solution (0 5 M Na2C03) to each well The absorbance was then 
analysed at 570 nm using a microplate spectrophotometer A blank was set up for each 
experiment by substituting the 20 \x\ of sample for 20 \xl of lysis buffer
2 3 5 4 Calculations
Luciferase activity was corrected for both MGalactosidase activity and 
differing protein concentrations, and expressed as fold activation over the empty vector
2 3 5 5 Puromycin Selection
Alternative to transfection with luciferase tagged reporter genes, cells 
were transfected with Notch 1 IC, Notch 3 IC or the Notch 1 IC mutant, and co­
transfected with pPGK-puromycin plasmid, which offers puromycin resistance to any 
transfected cells Following overnight recovery untransfected cells were selected out 
with treatment of cells in RPMI-1640 supplemented with 10% FCS, 100 U/ml penicillin 
and 100 ug streptomycin, and 0 8 ^g/ml puromycin for 48 h
2 3 6 Dot Blot Immunoassay
The dot blot immunoassay technique was used to optimize both primary 
and secondary antibody dilutions prior to western blot analysis A Bio-Dot SF 
Microfiltration apparatus (170-6542) from Bio-Rad was used for all dot blots The dot 
blot apparatus was used to immobilize protein from whole cell lysates directly onto a 
nitrocellulose membrane The dot blot procedure was carried out as follows, the dot 
blot apparatus was cleaned and dried prior to use, and subsequently assembled as per 
manufacturers instructions (Bio Rad) In brief, this involved the soaking of three sheets 
of Whatman chromotography paper in phosphate buffered saline (PBS) Nitrocellulose 
membrane (PALL BioTrace) was pre-soaked in distilled water, and also soaked in PBS 
The dot blot apparatus was then assembled with the filter paper and membrane as per 
instruction manual The vacuum was then applied to the apparatus, and the four corner 
screws of the apparatus tightened in a diagonal crossing pattern under vacuum to ensure 
no cross well contamination The membrane was then re-hydrated with 100 i^l PBS per 
well The flow valve was then adjusted so that the vacuum chamber was open to the 
atmosphere A volume of 200 i^l protein solution containing 10 jig RVSMC total
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protein lysate was then added to each well, and the samples were allowed to filter 
through the membrane by gentle vacuum Each well was then washed with 200 ¡ml PBS, 
and the wash solution allowed filter through membrane by gentle vacuum After the 
wells were completely drained, the membrane was removed from the apparatus The 
membrane was then blocked in a 5% skim milk solultion in PBS-Tween20 (PBS-T20) 
(10 mM Tns, 100 mM NaCl, 0 1% Tween-20), for 2 h at room temperature, whilst 
being rocked gently on an orbital shaker The membrane was then incubated in primary 
and secondary antibodies, and developed as described in sections 2 3 5 5-2 3 5 7 In 
this procedure, however, the blocked membrane was cut and incubated in varying 
primary or secondary antibody concentrations Following development the blots were 
analyzed, and the optimum concentration for the antibody of interest was determined 
prior to use in Western Blot analysis
2 3 7 SDS-PAGE and Western Blot Analysis
2 3 71  Preparation of SDS-PAGE Gel
An Atto AE-6450 Dual Mini Slab Kit was used for all protein 
electrophoresis carried out during this study Pnor to preparation of the SDS-PAGE 
gel, all gel cast parts were cleaned with ethanol and assembled as per manufacturers 
instructions (AHO, Tokyo, Japan) Stock solutions o f 5% (stacking gel) and the 
7 5/12% (resolving gel, depending on antibody used) un-polymenzed bis-acrylamide 
were made up and stored at 2-8°C for no longer than 3 months As an example, 500 ml 
of 7 5% stacking gel solution was made up as follows,
Resolving Gel Buffer (1 5 M Tris/HCL, pH 8 8) -125 ml
Acrlyamide/Bis Acrlyarmde (40%  solution, 29 1 ratio) -93 5 ml
10% w/v Sodium Dodecyl Sulphate -5 ml
Ultra-pure water -276 5 ml
An aliquot of resolving gel solution (10 ml per gel) was mixed with 50 ¡ill 
o f freshly prepared 10% ammonium persulphate, and 15 \i\ TEMED This solution was 
then immediately poured in to gel cast, overlaid with a film of ethanol to remove any 
air-bubbles, and allowed to polymerize undisturbed for 5 to 15 min When gel 
polymerized, the ethanol was poured off, and traces o f ethanol washed away with 
stacking gel buffer The stacking gel (5 ml per gel) was then prepared in the same 
manner as the resolving gel This was then poured onto the resolving gel, the 12-well
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comb put in place, and the gel allowed to polymerize for 5 to 15 mm The 
electrophoresis chamber was then half filled with reservoir buffer (25 mM Tris, 192 
mM Glycine, 0 1% Sodium Doecyl Sulphate (SDS), 2-8°C) When the gel had set, the 
comb, clips and gaskets were removed, and the gel cast placed in to the chamber and 
secured in place, care was taken to avoid any airlocks as gel was placed in chamber 
The chamber was then filled with reservoir buffer, and the wells flushed out to remove 
any un-polymerized bis-acrlyamide
2 3 7 2 Preparation and Addition of Samples
Ten i^g of whole protein lysate was added per lane used in the 
experiment Samples were prepared as follows, a volume of the total protein lysate 
giving a concentration of 10 \ig protein was mixed 1 4 with 5 [i\ of 4x Sample 
Solubilisation Buffer (SSB) (4 g SDS, 20 ml glycerol, 2 ml Mmarcaptoethanol, 0 04 g 
Bromophenol blue, 24 ml 0 25M TnsCl, made up to 50 ml, pH 6 8), and made up to a 
total volume of 20 [xl with lysis buffer per sample required The sample was made up in 
a screw-cap eppendorf, boiled at 100°C for 3 mm, and immediately placed on ice prior 
to loading on to gel The 20 |jil sample were then slowly loaded into required well, and 
2 fxl Rainbow molecular weight marker (Amersham) was also loaded into first lane 
The loading arrangement was recorded
2 3 7 3 Electrophoresis
The proteins and markers were then electrophoretically separated at 200 
V, 90 mA and 150 W until the dye front had migrated to the end of the gel
2 3 7 4 Semi-Dry Transfer, Ponceau S Staining, and Blocking of 
Membrane
An Atto AE-6675 semi-dry blotting apparatus was used for all transfer 
procedures during this study The transfer procedure was carried out as follows, when 
the gel had finished running, the gel was removed from the gel cast, and the stacking gel 
cut away The resolving gel was soaked in semi-dry transfer buffer (25 mM Tris, 192 
mM Glycine, 20% Methanol) for 5 mm Two stacks of 15 sheets of Whatman 
chromotography were cut to the size of the resolving gel (9x6 cm2), and were also 
soaked in semi-dry transfer buffer for 5 min In addition, a piece of nitrocellulose 
membrane (PALL BioTrace) was cut to the size o f the resolving gel, pre-soaked in ultra 
pure water for 5 mm, and subsequently soaked in semi-dry transfer buffer for 5 mm
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The transfer stack was then assembled as follows, 1 stack of Whatman chromotography 
paper was placed on the semi-dry transfer apparatus, and over-laid with the 
nitrocellulose membrane, resolving gel, and the second stack of Whatman 
chromatography paper A pen was then rolled over the entire stack to expel any air- 
bubbles that may have been trapped The apparatus was then closed, and run at 90 V, 
500 mA and 150 W for 45 mm
Upon completion of the semi-dry transfer, the nitrocellulose membrane 
was removed and stained in Ponceau S solution for 5 mm The membrane was then 
rinsed briefly in ultra pure water to remove any background staining, placed between 
two clear acetates, and the image scanned using an Epson perfection 1200S scanner 
The image was saved and subsequently used to assess equality of protein loading onto 
gel, and quality of protein transfer onto nitrocellulose membrane The membrane was 
then de-stained using distilled water, until all ponceau stain was removed
The membrane was then blocked in a 5% skim milk solultion in PBS- 
T20, for 2 h at room temperature The membrane was rocked gently on an orbital 
shaker whilst blocking
2 3 7 5 Incubation with Primary and Secondary Antibodies
Following blocking, the membrane was washed vigorously with PBS- 
T20, for two mm, twice The membrane was then incubated with the primary antibody 
of interest diluted in 2 5% skim milk in PBS-T20 Both the primary and secondary 
antibody dilutions were determined by dot blot immunoassay, as described in section 
2 3 4, or according to manufacturers recommendations The membranes were typically 
incubated in the primary antibody overnight at 2-8°C, and then 1 h at room temperature, 
whilst being gently rocked on an orbital shaker
Following incubation with the primary antibody, the membrane was 
rinsed twice, and washed vigorously for 2 x 15 mm in PBS-T20 The membrane was 
then incubated in the appropriate secondary antibody diluted in PBS-T20, for 2 h at 
room temperature, whilst being gently rocked on an orbital shaker Prior to 
development o f membrane, the membrane was again washed vigorously for 2 x 15 min 
in PBS-T20
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Table 5 Incubation conditions for antibodies used in W estern Blot Analysis
Primary Antibody Dilution Secondary Antibody Dilution
Anti Notch 1 
(Upstate)
1 1000 HRP-Conjugated A nti-rabbit IgG 
(Am ersham Biosciences)
1 1000
Anti Notch 3 
(Upstate)
1 1000 HRP-Conjugated A nti-rabbit IgG 
(Am ersham Biosciences)
1 1000
Anti Notch 3 
(Santa Cruz)
1 800 HRP-Conjugated A nti-goat IgG 
(Am ersham  Biosciences)
1 1000
Anti Jagged 
(Santa Cruz)
1 800 HRP-Conjugated Anti-rabbit IgG 
(Am ersham Biosciences)
1 1000
Anti HRT-1 
(Santa Cruz)
1 500 HRP-Conjugated Anti-goat IgG 
(Am ersham Biosciences)
1 1000
Anti HRT-2 
(Santa Cruz)
1 500 HRP-Conjugated Anti-goat IgG 
(Am ersham Btosciences)
1 1000
Anti HRT-3 
(Santa Cruz)
1 800 HRP-Conjugated Anti-goat IgG 
(Am ersham Btosciences)
1 1000
Anti Hes-I 
(Santa Cruz)
1 800 HRP-Conjugated Anti-goat IgG 
(Am ersham Biosciences)
1 1000
Anti Hes-5 
(Santa Cruz)
1 800 HRP-Conjugated Anti-goat IgG 
(Am ersham  Biosciences)
1 1000
Anti Bcl-2 
(Santa Cruz)
1 500 HRP-Conjugated Anti-rabbit IgG 
(Am ersham Biosciences)
1 2000
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2 3 7 6 Detection and Development of Blot
Supersignal west ehemiluminescent substrate (Pierce) was the detection 
reagent used in developing all blots during this study Briefly, the substrate was 
prepared according to manufacturers instructions, and allowed to equilibrate to room 
temperature in a dark environment Following the last wash, any excess fluid was 
removed from membrane by a gentle capillary action, and the membrane was placed on 
chng-film, protein side-up The detection reagent was then placed on the membrane for 
5 min, ensuring that the whole membrane was covered After this incubation period, 
any excess detection reagent was removed by a gentle capillary action, and the 
membrane was placed on a fresh piece of cling-film, protein side down, and covered, 
ensuring any air bubbles were removed Development o f the blot was carried out in a 
dark room, where the covered membrane was placed protein side up in an x-ray film 
cassette A piece o f Amersham Hyperfilm autoradiography film was then placed on the 
membrane for the desired amount of time, usually between 10 sec and 5 mm depending 
on the strength of the chemiluminescent signal The film was then removed and 
developed in an Amersham hyperprocessor automatic developer
2 3 7 7 Densitometnc Analysis of Blot
Bands on a developed film were photographed using a Kodak DC290 
digital camera The image generated was then analysed using Kodak 1D (version 3 5 4) 
densitometry imaging software Briefly, a mean densitometnc value was generated for 
each band, these values were then corrected using ponceau controls for each lane The 
corrected values were then expressed as fold increase over negative control (where 
applicable), and graphically expressed using Microsoft ExcelIM
2 3 8 Polymerase Cham Reaction (PCR) 
2 3 8 1 Preparation of Total RNA
Total RNA was isolated from RVSMC’s using Trizol® reagent according 
to the method of Chomczynski and Sacchi (1987) The reagent, a mono-phasic solution 
of phenol and guanidine isothiocyanate, is a modification on the isolation method 
developed by Chomcznski and Sacchi Trizol reagent maintains the integrity of RNA 
while disrupting cells and dissolving cell components Growth media was removed and 
cells were washed with HBSS twice Cells were then lysed directly by adding trizol 
reagent to the flask, 1 ml per 10 cm2 The lysate was transferred to a falcone tube and
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incubated tor 5 min at 15°C to 30°C to permit the complete dissociation of 
nucleoprotein complexes 0 2 ml of chloroform per 1 ml of trizol was then added, the 
tube was then shaken vigorously for 15 sec and then spun down at 12,000 x g for 15 
min at 2 to 8°C The resulting aqueous phase was then transferred to a fresh tube RNA 
was then precipitated by mixing with isopropyl alcohol, 0 5 ml per 1 ml of tnzol The 
samples were then incubated at 15°C to 30 °C for 10 min and spun down at 12,000 x g 
for 10 mm at 2 to 8 °C The RNA was then visible as a gel like pellet on the side and 
bottom of the tube The supernatant was then removed and the pellet washed with at 
least 1ml of 75% ethanol per 1 ml of trizol used The sample was then mixed by 
vortexing and spun down at 7,500 x g for 5 minutes at 2 to 8°C The supernatant was 
removed and the pellet washed again in ethanol After washing the pellet was air-dried 
and the RNA re-suspended in 30-50 [xl of RNase free water All total RNA preparations 
were stored at -80 °C
2 3 8 2 Quantification of Total RNA in Samples
To determine the amount o f total RNA in samples obtained in section
2 3 8 1, the sample was diluted 1 500 in sterile water and spectrophotometric analysis 
carried out using the Shimadzu UV-160A dual spectrophotometer, blanked with RNase 
free water The sample was measured, using a quartz cuvette, at wavelengths of 260 
and 280 nm, and the concentration of the RNA in the sample was carried out as follows,
A bs260nm * dilution factor x 40 = concentration o f  RNA (|xg/ml)
The purity of the RNA was determined by calculating the ratio of 
absorbance at 260nm to 280nm A ratio of 1 9 to 2 0 was indicative of a highly purified 
preparation of RNA A ratio lower than this was indicative of protein contamination 
Absorbance at 230 nm reflected contamination of the sample by phenol, while 
absorbance at 325 nm suggests contamination by particulates or a dirty cuvette All 
samples were tested in triplicate and were kept on ice at all times during the experiment 
RNA samples were then stored at -80 °C
2 3 8 3 Design of PCR Primer Sets
A number of web based programs, “Primer 3 Output” and 
“NCBI/BLAST” were utilized to design the primer sets used in this study The Primer
3 program picks primers from the given sequence, and the BLAST program allowb 
multiple sequence alignment, which allows primers to be designed from highly
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conserved areas Primers were designed with -50%  GC content so the annealing 
temperature for all sets was ~55°C
Notch 1 Primer Set (designed from rat sequence) Fragment size 550 bp 
Forward primer 5’-GAG TCA CCC CAT GGC TAC-3’
Reverse primer 5’-GTG GCT GCA CCT GCT GGG-3’
Notch 3 Primer Set (designed from rat sequence) Fragment size 390 bp 
Forward primer 5’-GAC CGT GTG GCC TCT TTC TAT TGT-3’
Reverse primer 5’-GCA GCT GAA GCC ATT GAC TCT ATC CT-3’
HRT-1 Primer Set (designed from rat sequence) Fragment size 290 bp 
Forward pnmer 5’-GAA GCG CCG ACG AGA CCG AAT CAA-3’ 
Reverse primer 5’-CAG GGC GTG CGC GTC AAA ATA ACC-3’
HRT-2 Pnmer Set (designed from rat sequence) Fragment size 330 bp 
Forward pnmer 5’-CAT CAG AGT CAA CGC CAT GT-3’
Reverse primer 5’-GAC ACT GAT AAC GGT GGG CT-3’
HRT-3 Pnmer Set (designed from rat sequence) Fragment size 340 bp 
Forward pnmer 5’-GTG GCA CAG GGT TCT TTG AT-3’
Reverse primer 5’-GCT GAG ATA GGG TAA GGG GG-3’
Hes-1 Primer Set (designed from rat sequence) Fragment size 280 bp
Forward primer 5’-TCA ACA CGA CAC CGG ACA AAC-3’
Reverse primer 5’-GGT ACT TCC CCA ACA CGC TCG-3’
Hes-5 Primer Set (designed from rat sequence) Fragment size 380 bp
Forward pnmer 55-GCT CAG TCC CAA GGA GAA AA-3’
Reverse primer 5’-GTC GGG GTC TCC TTG ACA G-3’
Jagged Primer Set (designed from rat sequence) Fragment size 147 bp 
Forward pnmer 5’-AAC AGA ACA CAG GGA TTG CC-3’
Reverse primer 5’-AGG TTT TGT TGC CAT TCT GG-3’
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GAPDH Primer Set (designed from rat sequence) Fragment size 186 bp 
Forward primer 5’-TGC TGA GTA TGT CGT GGA GT-3’
Reverse primer 5’-GCA TTG CTG ACA ACT TTG AG-3’
Bad Primer Set (designed from rat sequence) Fragment size 175 bp 
Forward primer 5’-TGT TCC AGA TCC CAG AGT TT-3’
Reverse primer 3’-TGA TGA CTG TTA TTG GCT GC-3’
Bax Primer Set (designed from rat sequence) Fragment size 207 bp 
Forward primer 5’-TTG CCC TCT TCT ACT TTG CT-3’
Reverse primer 5’-CAA AGA TGG TCA CTG TCT GC-3’
Bel-2 Primer Set (designed from rat sequence) Fragment size 256 bp
Forward pnmer 5’-CCA GAA TCA AGT GTT CGT CA-35 
Reverse primer 5’-AGG TAC CAA TAG CAC TTC GC-3’
Bcl-xi_ Primer Set (designed from rat sequence) Fragment size 170 bp
Forward primer 5’-AAT GAC CAC CTA GAG CCT TG-3’
Reverse primer 5’-AGT GAG CCC AGC AGA ACT AC-3’
2 3 8 4 Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) 
2 3 8 4 1 Reverse-Transcnptase
All total RNA samples were prepared by the Trizol® method as 
previously described in section 2 3 8 1 RNA preparations were then quantified by 
absorbance spectroscopy as described in section 2 3 8 2 Reverse transcriptase was 
carried out using Promega Murine Leukemia Virus Reverse Transcnpase (MLV RT) as 
follows The initial amount of RNA used for each primer set was determined 
empirically to ensure a semi quantitative analysis section For the purpose of this 
protocol 2 ^g of RNA was transferred to an RNase free microcentrifuge tube To this 1 
^1 of Promega Oligo dT primer was added This ratio of amount of RNA to Oligo dT 
remained constant for each primer set used The volume was then made up 12 ¡ml with 
RNase free water The tube was heated to 70°C for 5 minutes to melt secondary 
structure within the template The tube was cooled immediately to prevent secondary 
structure from reforming The following cocktail was made up and added to each 
reaction
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MLV 5x Reaction buffer 5 111
dATP, 10 mM 1 25 til
dCTP, 10 mM 1 25 1
dGTP, 10 mM 1 25 \i\
dTTP, 10 mM 1 25 \i\
M LV-RT 1 |il
RNase free water 2 \jl\
The components were mixed by gently flicking the tube The mix was 
then spun down in a microfuge and incubated for 60 minutes at 42°C, followed by a 15 
mm incubation at 70°C 1 \i\ of RNaseH (2 units/jul) was then added per reaction, and 
was incubated for 20 minutes at 37°C A negative control was also carried out with 
every RT reaction The control contained no reverse transcriptase, any amplification by 
RT PCR from the negative control was indicative of genomic DNA contamination All 
RT samples were stored at -80°C until needed for PCR
2 3.8 4.2 Polymerase Chain Reaction (PCR)
PCR was carried out using Promega Taq DNA Polymerase A 
PCR mix was made up for each sample to be amplified The mix was made up as 
follows
RNase free water 36 5 ¿ii
Buffer lOx 5 0 (xl
dNTP lOmM 1 0 |Al
MgCl2 25mM 3 0 \ i \
Forward primer 10 (liM 1 0 \i\
Reverse primer 10 ^iM 1 0 \i\
Taq Polym erase 2-5u/[il 0 5 (il
RT sample 2 0 |xl
Mineral oil 50 0 ¿ii
When the reaction mixture was made up it was placed in the PCR thermocycler 
All PCR was intiallly carried out in a Hybaid PCR thermocycler (SPRT 001), used to 
optimize conditions for PCR The program used was optimised for each primer set, 
with the annealing phase being 55°C for the Notch signalling pathway primers, and
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57°C for the apoptosis primers For the purpose o f this protocol the program was as 
follows
D enaturing Phase 94°C -  4  minutes 
A nnealing Phase 55°C/57°C -  2 minutes 
E longation Phase 72°C -  3 minutes  40 cycles
4 C -  Hold
When finished the samples were stored at -80°C until needed for agarose gel 
electrophoresis
2.3.8 5 Agarose gel electrophoresis
All DNA gel electrophoresis was carried out using a GibcoBRL Horizon 
20 25 Gel Electrophoresis Apparatus Before use the gel box was cleaned with ethanol 
and the gel cast was set up as described in the manufacturers instruction manual A 
2 5% agarose gel stock was made up by dissolving 12 5 g o f agarose in 500 ml of lx  
Tns Acetate EDTA (TAE) (40 mM Tris-Acetate, 1 mM EDTA) The agarose was 
dissolved by heating in a microwave (700 mHz) at full power for 5 mm 100 ml o f the 
liquid agarose was then transferred to a fresh glass beaker To this 250 jul o f 200 jutg/ml 
o f Ethidium Bromide (EtBr) solution was added and mixed thoroughly to give a final 
concentration of 0 5 \ig/m\ EtBr The agarose was then poured into the cast, the comb 
put into place and the gel allowed to set Once set the comb was removed and the 
apparatus filled with lx  TAE buffer The samples were prepared as follows 13 |j l 1 of 
PCR product + 5 \x\ o f 4x loading dye 8 i^l was loaded each well in duplicate The gel 
was run at 80 V, 110 mA and 150 W until the dye front had migrated the length of the 
gel When finished the gel was placed on an Ultra Violet Products UV transilluminator 
for visualization A picture was taken using a Kodak DC290 digital camera for 
documentation The gel was then disposed of in the appropriate EtBr waste container
2 3 8 6 Real Time PCR
Quantitative PCR was also carried out using a Real time Rotor-GeneRG- 
3000™ lightcycler (Corbett Research) The principle o f real time amplification 
detection is that the amount o f fluorescence is proportional to the concentration o f 
product in a reaction Higher fluorescence indicates a higher concentration o f a product 
Each PCR reaction was set up as follows,
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SYBR-Green 12 5^1
RNAse free w ater 8 5 \i\
cDNA 2 0 \i\
Forward prim er 10 1 0 \i\
Reverse prim er 10 1 0 t^l
Each sample was assayed in triplicate, and the program used for the 
different primer sets was as follows,
D enaturing Phase 95°C - 20 s —
A nnealing Phase 55°C - 30s (Notch prim ers)   55 cycles
57°C - 45 s (Apoptosis primers)
E longation Phase 72°C - 30 s __
2 3.9 Acid Phosphatase Assay
The Acid Phosphatase (AP) cell viability assay was carried out to 
determine the concentration o f Brefeldin A and Monensin with which to treat the 
RVSMC’s Brefeldm A and Monensin were used as pharmacological inhibitors o f the 
Notch signalling pathway, and a concentration which rendered the cells 70% viable 
post-24 h treatment was determined by AP cell viability assay In brief, cells were 
plated onto 6-well plates at 1 5 x 105 and treated 2 days later or when 80% confluent 
The wells were washed twice with lx  PBS, and 100 (Jtl of freshly prepared phosphatase 
substrate (10 mM p-mtrophenolphosphate, 0 1 M sodium acetate, 0 1% Triton-X-100, 
pH 5 5) was added per well Plates were then wrapped in aluminium foil and incubated 
in the dark at 37°C for 2 h The enzyme reaction was stopped after the appropriate 
incubation time with the addition o f 50 \xl o f 1 0 M NaOH The samples were then 
analysed at 405 nm using a microplate spectrophotometer
2 3 10 Apoptosis Assays
2 3.10 1 Caspase Assay
A colourimetric caspase 3 assay was carried out on cell lysates (prepared 
as described in section 2 3 2) to determine the level o f caspase 3 activation in the 
sample, and therefore the level o f apoptosis Briefly, 10 \il caspase 3 substrate (2 mM
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Ac-DEVD-pNA containing 10% DMSO in 20 mM HEPES, 0 1% CHAPSO, 5 mM 
DTT and 2 mM EDTA) was added to 50 ¡ml cell lysate, and diluted in assay buffer (20 
mM HEPES, 0 1% CHAPS, 5 mM DTT and 2 mM EDTA) to a final volume of 100 \il 
Samples were incubated for 90 min and the absorbance measured at 405 nm using a 
Tecan Spectra plate reader Appropriate negative controls and blanks were included A 
pNA standard curve (0-200 jig/jAl) allowed for the specific activity of caspase 3 to be 
calculated for each sample
2 3 10 2 Acndine Orange/Ethidium Bromide Cell Staining
The staining of RVSMC’s with the Acndme Orange/Ethidium Bromide 
(AO/EtBr) dual stain (10 fxg/ml, Sigma) allows determination of viable, apoptotic and 
necrotic cells concurrently Acndme Orange is a metachromatic dye which 
differentially stains double stranded (ds) and single stranded (ss) nucleic acids When 
acndme orange intercalates into the dsDNA of healthy cells it emits a green 
fluorescence upon excitation at 480-490 nm However, this stain emits an orange 
fluorescence when intercalated with the ssDNA of apoptotic cells Ethidium bromide is 
a nucleic acid stain which does not permeate viable or apoptotic cells It does, however, 
penetrate necrotic cells due to plasma membrane disruption and stains the nucleus red 
Therefore, viable cells appear to have a bright green nucleus with intact structure, while 
apoptotic cells exhibit a bright green nucleus showing condensation of chromatin as 
dense green areas Late apoptotic cells have an orange nucleus showing condensation 
of chromatin, while necrotic cells display a red nucleus with intact structure Briefly, 
cells were washed twice in lx PBS, and fixed in ice-cold isopropanol for 5 min Cells 
are then rehydrated in lx  PBS for 7-8 min, and stained with the AO/EtBr dual nuclear 
stain for 5 min, rinsed with PBS, and visualized using an Olympus DP-50 fluorescent 
microscope (excitation 460-490 nm, emission 515-565 nm)
2 3 10 3Annexin V/Propidium Iodide Cell Staining
Staining of RVSMC’s with Annexin V (AV, Roche)/Propidium Iodide 
(PI, Sigma) dual stain allows for the simultaneous detection of viable, apoptotic and 
necrotic cells In the early stages of apoptosis, changes occur at the cell surface, one 
such change is the translocation of phosphatidlyserine from the inner part of the plasma 
membrane to the outer layer, by which phosphatidly serine becomes exposed at the 
external surface o f the cell Annexin V is a Ca2+-dependent phospholipid-binding 
protein with high affinity for phosphatidlysenne (Schmid et a l , 1992) However, as
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necrotic cells also expose phosphatidlyserine due to the loss o f membrane integrity, the 
simultaneous application o f a DNA stain, which is used for dye exclusion tests is 
necessary to distinguish apoptotic from necrotic cells Propidium Iodide (50 fxg/ml) was 
the DNA stain used in this case The Annexin V-Fluos labeling solution was prepared 
according to manufacters instructions Per 1 ml of labeling solution, 20 ¡al of AV 
reagent was pre-diluted in 1 ml of incubation buffer (10 mM Hepes/NaOH, 140 mM 
NaCl, 5mM CaCh, pH 7 4), and 20 \x\ PI (50 ¡ng/ml) was subsequently added Briefly, 
media was removed and cells were washed twice in lx  PBS, 150 ¡ill of labeling solution 
was added per well of a 6-well plate and incubated for 10 min at room temperature, 
before being aspirated off cells The cells were then analyzed immediately using an 
Olympus DP-50 fluorescent microscope (excitation 450-500 nm, emission 515-565 
nm) With this assay, viable cells (AV negative, PI negative) do not fluoresce, 
apoptotic cells (AV positive, PI negative) appear green, and necrotic cells (AV positive, 
PI positive) appear green and orange/red
2 3 11 In Vivo Studies 
2 3 111 Carotid Artery Ligation
The left carotid arteries of male Sprague-Dawley rats (Charles River 
Laboratories, Massachusetts, USA) were ligated, with the right carotid artery acting as a 
high flow control Anesthesia was induced in animals pre-medicated with atropine 
sulphate (0 04 mg/kg, intra-muscular) through administration of pentobarbital sodium 
(50 mg/kg, mtra-pentoneal) and halothane (inhalational) Following induction of 
anesthesia, the animal was positioned on a clean operating table, with a body pad to 
maintain body temperature The animal was clipped and the surgical site prepped using 
betadine solution and alcohol A midline cervical incision was made, and, with the aid 
of a dissecting microscope, the right and left common carotid arteries were isolated A 
Transonic flowprobe was used to measure carotid blood flow in both the left and right 
arteries The left common carotid artery was ligated near the carotid bifurcation using a 
6-0 silk suture The incision was then closed using 4-0 coated Vicryl, running suture 
pattern The animal was then allowed to recover, whilst being momtered Sham 
operated animals were subjected to the same surgical techniques, with the exception of 
the carotid artery ligation Vessels were harvested from sham operated and ligated 
animals at 3 days and 28 days post-ligation for RNA isolation (4 vessels per 
preparation) and protein isolation (2 vessels required per preparation) Terminal surgery
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was carried out by halothane inhalation and cervical dislocation, followed by harvesting 
of the carotid arteries
2 3 112 Portal Vein Ligation
This procedure involved the ligation o f the portal vein of male Sprague- 
Dawley rats (Charles River Laboratories, Massachusetts, USA) Anesthesia was 
induced in animals pre-medicated with atropine sulphate (0 04 mg/kg, intra-muscular) 
through administration of pentobarbital sodium (50 mg/kg, intra-peritoneal) and 
halothane (mhalational) Following induction of anesthesia, the animal was positioned 
on a clean operating table, with a body pad to maintain body temperature The animal 
was clipped and the surgical site prepped using betadine solution and alcohol An 
appropriate incision was made, and, with the aid o f a dissecting microscope, the portal 
vein was isolated, and a stenosis was created by means o f a single ligature placed 
around the portal vein using a blunt-edged 20-gauge needle The immediate removal of 
the needle allowed for the portal vein to expand to the limit imposed by the ligature 
(PVL) The incision was then closed using 4-0 coated Vicryl, running suture pattern 
The animal was then allowed to recover, whilst being momtered Sham operated 
animals were subjected to the same surgical techniques, with the exception o f the portal 
vein ligation Vessels were harvested from sham operated and ligated animals at 2, 4, 6, 
9 and 15 days post-ligation for RNA isolation (4 vessels per preparation) and protein 
isolation (2 vessels required per preparation) Terminal surgery was carried out by 
halothane inhalation and cervical dislocation, followed by harvesting of the portal vein 
(Hou et a l , 1998)
2 3 12 Data Analysis
Results are expressed as mean±SEM Comparison between control versus 
treated cells were made by i) Student’s unpaired t test and 11) Wilcoxon matched-pairs 
signed-rank test, with statistical significance established at p<0 05
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Chapter 3
Results
The Notch Signalling Pathway
in
Adult VSMC
3.1 Introduction
The initial aim of this study was to identify the presence of Notch signalling 
pathway components in adult VSMC, and to determine the ability o f this pathway to be 
activated in a CBF-1 -dependent manner in these cells. Pathway activation was analyzed 
through transient over expression of the active form of the Notch receptor (Notch IC), 
serum stimulation, and exposure of the cells to the endogenous ligand, Jagged. In 
addition, we analyzed the ability of the EBV nuclear protein, EBNA-2, to mimic 
activation of the Notch signalling pathway in VSMC.
Several studies have reported the importance of the Notch signalling pathway in 
the development of many tissues and organs in the body (Artavanis-Tsakonas et a l, 
1999; Miele and Osborne 1999). Formation of the vascular system is one of the earliest 
and most important events during embryogenesis in mammals. During the early stages 
of vascular development, the de novo formation of blood vessels occurs from 
mesodermally-derived endothelial cell precursors, angioblasts. Angioblasts 
differentiate and subsequently assemble into primitive blood vessels, termed the 
primary vascular plexus, in a process known as vasculogenesis. The primary vascular 
plexus is subsequently modified by angiogenesis to generate the small and large vessels 
of the mature vascular system. During angiogenesis, the endothelial cell layer of large 
vessels is covered by multiple layers of SMC, providing structural support and stability 
for the vessel wall. A number of signalling pathways have been implicated in the 
control of vasculogenesis and angiogenesis, these include the VEGF, PDGF, and 
ephrin/Eph receptor pathways (Kojika and Griffin 2001). Recent studies have added the 
Notch signalling pathway to this list. Mutation of many components of the Notch 
signalling pathway in mice, for example, results in embryonic lethality due to defects in 
the formation of the vascular system. Mice homozygous for null mutations in Jagged 1 
and Notch 1 die in utero due to defects in vascular morphogenesis and angiogenic 
vascular remodelling respectively (Han et a l, 2000; Singh et a l, 2000). In addition, 
mice with mutations in both Delta-like 1 and Notch 2 show embryonic haemorrhage, 
possibly resulting from poor development of vascular structures (Kojika and Griffin
2001). Mutations in Notch target genes also highlight the importance of the Notch 
signalling pathway in vascular development. Zebrafish embryos harbouring a mutation 
in Gridlock, a IIRT-2 orthologue, show impairment of vascular formation in the form of 
aortic coarctation (Zhong et a l, 2000). In contrast, HRT-2 null mice do not present 
with aortic coarctation, suggesting a level of redundancy between mammalian Notch
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target genes, however, they present with massive post-natal cardiac hypertrophy, and 
a resulting high rate of lethality in the first 10 days of life (Gessler et a l , 2002) The 
importance of the CBF-1 -dependent pathway of Notch signalling in vascular 
development is supported by the fact that mutations in the presenihn 1 gene results in 
embryonic blood vessel haemorrhage (Shen et a l , 1997, Wong et a l , 1997) In 
addition, Notch 4 gain-of-function mutations result in embryonic lethality due to 
abnormal vessel structure and patterning of the vascular network (Uyttendaele et a l ,
2001) The fact that both gain-of-function and loss-of-function mutations result in 
altered vascular phenotype suggests that the appropriate levels of Notch signalling 
pathway activation are critical in vascular formation
Whilst the role o f the Notch signalling pathway in development is reasonably 
well established, there is increasing recognition of the importance of the Notch 
signalling pathway in adult cells Throughout life multi-cellular organisms produce and 
replenish mature functional cells from immature non-functional cells One of the well 
recognized functions of the Notch signalling pathway is to delay the differentiation of 
immature cells The Notch signalling pathway has been documented in both 
physiological and pathological roles in mammals, for example, T cell development and 
maturation, and cancer development respectively (Kojika and Griffin 2001) The 
“synthetic” adult SMC phenotype are not terminally differentiated, and are similar both 
in morphology and gene expression to foetal or embryonic SMC (Gittenberger-de Groot 
et a l , 1999) Therefore, it is conceivable that components of the Notch signalling 
pathway could be present and play an important functional role in adult VSMC Whilst 
several studies reveal the presence of some of the components of the Notch signalling 
pathway in VSMC (Leimeister et a l , 2000, Lindner et a l , 2001, Campos et a l , 2002), 
this study aims to provide a more comprehensive analysis of the presence, activation, 
and function of components o f the Notch signalling pathway, both in vivo and in vitro
The human disorders CADASIL and AGS provide additional evidence of the 
importance of the Notch signalling pathway in the adult vasculature These disorders 
involve dysregulation of components of the Notch signalling pathway, and resulting 
cardiovascular abnormalities CADASIL, which is caused by mutations in Notch 3, is 
characterized by degeneration of SMC, primarily in cerebral arteries, but also in 
systemic arteries and some veins CADASIL patients present with an abnormal 
accumulation of Notch 3 in VSMC, impaired Jagged 1/Notch 3 binding and defective 
CBF-1-dependent Notch 3 signalling (Brulin et a l , 2002, Prakash et a l , 2002, Joutel et 
a l , 2004) AGS also highlights the importance of the Notch signalling pathway, and in
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particular Jagged 1, in the development and maintenance of the cardiovascular 
system AGS patients typically present with congenital heart defects, heart murmurs 
and/or peripheral pulmonary stenosis (Joutel and Tourmer-Lasserve 1998, Loomes et 
al, 1999)
The importance of Jagged as a Notch ligand is further highlighted as Jagged has 
been shown to bind and activate all four Notch receptors (Shimizu et a l , 1999) The 
presence of Jagged has been shown in VSMC, and Jagged is reported to influence cell 
matrix and cell-cell interactions in VSMC (Lindner et a l , 2001) However, it remains 
to be established which Notch receptor Jagged activates in VSMC, and whether it 
activates the Notch receptor in a CBF-1-dependent or -independent pathway Several 
studies have revealed the presence of Notch 1, Notch 2 and Notch 3 in VSMC, both in 
vivo and in vitro (Leimeister et a l , 2000, Lindner et a l , 2001, Campos et a l , 2002) 
However, it is only Notch 3 expression that is SMC specific (Joutel et a l , 2000), which 
could be indicative of a significant role for this receptor in VSMC To date, vascular 
expression of Notch 4 has not been documented in VSMC, which is reported to be 
endothelial cell specific (Uyttendaele et a l , 1996) Therefore, whilst significant 
advances have been made in recent years in detailing the regulation, expression and role 
of the Notch signalling pathway in the adult vasculature, the pathway remains poorly 
characterized
This study further characterizes the Notch signalling pathway in adult VSMC 
The effect of Notch 1 and Notch 3 activation on VSMC was performed through 
transient transfection of the respective IC portion, which is the active form of the 
receptor (Weinmaster 1998) Activation of the CBF-1-dependent pathway and Notch 
target gene activation was analyzed using reporter plasmids, with luciferase constructs 
upstream of the promoter of interest, as detailed in Chapter 2, table 3 The CBF-1 
plamid, pGA98-l-6, contains an enhancer consisting o f 12 CBF-1 binding sites linked 
to the K-globin promoter driving a luciferase gene pGA50-7 is the corresponding 
control vector lacking the CBF-1 enhancer (Minoguchi et a l , 1997) The reporter 
plasmids for the Notch target genes contain promoter fragments o f the relevant target 
gene inserted into a basic luciferase vector The activity of both endogenous and 
transfected Notch was inhibited using documented pharmacological and molecular 
inhibitors of the Notch signalling pathway The pharmacological inhibitors, Brefeldin 
A and Monensin have been shown to inhibit Notch 1 IC activity in fibroblasts 
(Schroeter et al s 1998) Whilst neither are specific inhibitors o f the Notch signalling 
pathway, Brefeldin A and Monensin are chemically distinct inhibitors of protein
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translocation to the golgi apparatus, thus inhibiting Notch IC translocation to the 
nucleus In addition to the pharmacological inhibitors, specific inhibitors o f the Notch 
signalling pathway were utilized in this study, these include pCMV-ED4, RPMS-I, 
R218H-RBP-Jk and EBNA-3A pCMV-ED4 is a mutant form of Notch 1 IC, generated 
without the RAM domain Mutant Notch 1 IC can compete with endogenous and 
transfected Notch IC for both CBF-1 binding at the ANK domain, and for co-activator 
binding RPMS-I has previously been shown to prevent Notch IC-mediated activation 
at promoters with CBF-1 binding sites by stabilizing the CBF-1/HDAC co-repressor 
complex This prevents effective displacement o f the co-repressor complex by Notch 
IC (Smith et a l , 2000) The R218H-RBP-Jk plasmid is a mutant CBF-1 plasmid that 
competes with CBF-1 for Notch IC binding, but cannot bind effectively to DNA (Sakai 
et a l , 1998) EBNA-2 has been shown to signal in a CBF-1-dependent manner in B 
cells, in a manner reminiscent to that of the Notch signalling pathway (Hsieh et a l , 
1996, Zhang et a l , 2001) EBNA-3A has been shown to modulate EBNA-2-mediated 
CBF-1 activity (Robertson et a l , 1995, Robertson et a l , 1996), therefore the effect of 
EBNA-3A as a Notch signalling pathway inhibitor was also investigated The activity 
of EBNA-2 in VSMC has not previously been documented, and was also investigated
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3 2 Results
Analysis of RVSMC has revealed the presence o f components of the Notch 
signalling pathway in adult vascular smooth muscle cells (Figures 3 1 -  3 8) The 
Notch receptors, Notch 1 (Figure 3 1) and Notch 3 (Figure 3 2) are present in RVSMC 
The antibodies used in this study are directed against the active IC portion of the Notch 
receptors Therefore, these antibodies detect both the cleaved 1C portion of the Notch 
receptor, in addition to the full-length receptor This is clearly illustrated in Figure 3 2D, 
using the Notch 3 receptor as an example The detection of Notch 3 IC with antibodies 
from two different commercial sources (Figure 3 2A - Upstate Cell Signaling Solutions 
and Figure 3 2D Santa Cruz Biotechnology), coupled with the competing away of 
Notch 3 expression with an appropriate blocking peptide confirms the rigour of the 
antibodies used As expression of the active IC form of Notch is of interest in this 
study, expression changes in Notch 1 IC and Notch 3 IC will hereafter be presented 
The specificity of the antibodies used in detecting Notch 1 IC and Notch 3 IC was 
further confirmed by over-expression of Notch 1 IC or Notch 3 IC in RVSMC using 
HA-tagged plasmids The molecular weight of the tagged Notch IC detected with an 
anti-HA antibody corresponded to that o f Notch 1 IC (Figure 3 2E) and Notch 3 IC 
respectively Expression of the Notch ligand, Jagged, was also evident in RVSMC 
(Figure 3 3) Additionally, the presence of the Notch target genes, HRT-1 (Figure 3 4), 
HRT-2 (Figure 3 5), HRT-3 (Figure 3 6), Hes-1 (Figure 3 7) and Hes-5 (Figure 3 8) was 
also established The presence of protein was confirmed by western blot and 
immunocytochemical analysis, and the presence of mRNA was verified through semi- 
quantitative PCR analysis
Immunocytochemical analysis revealed the sub-cellular localization of the 
components of the Notch signalling pathway Figure 3 1C illustrates that Notch 1 is 
predominately located in the nuclei of RVSMC, however, it is present both in the cell 
cytoplasm and on the plasma membrane Nuclear Notch 1 does not appear to be present 
in the nucleoli of the cell, and the distribution o f Notch 1 in the cytoplasm appears to be 
clustered around the nucleus Membrane-tethered Notch 1 appears to constitute a small 
proportion of the overall cellular distribution of Notch 1 Similarly, Notch 3 appears to 
be primarily located in the nuclei of RVSMC (Figure 3 2C), however, in this case, a 
discrete localization of the receptor around the nuclear envelope is also in evidence
3 2 1 C om ponents o f the Notch Signalling Pathw ay are present in RVSM C
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Notch 3 is also present in the cytoplasm of the cell, however, nuclear clustering as 
seen with Notch 1 is not apparent The presence of the Notch ligand, Jagged, has also 
clearly been shown in RVSMC (Figure 3 3C) Similar to the Notch receptors, the sub- 
cellular localization of Jagged is predominately cytoplasmic and nuclear
Immunocytochemical analysis also revealed the presence of Notch target genes 
of the HRT and Hes families in RVSMC HRT-1 (Figure 3 4C), HRT-2 (Figure 3 5C) 
and HRT-3 (Figure 3 6C) all exhibit a strong nuclear localization pattern within the cell, 
as is evident with Notch receptors and ligands The HRT family members examined 
however, appear to be absent from the nucleoli of the cells Cytoplasmic HRT-1 
appears to exhibit nuclear clustering, which does not appear to be the case with 
cytoplasmic HRT-2 and HRT-3 Both Hes-1 (Figure 3 7C) and Hes-5 (Figure 3 8C) 
exhibit significant nuclear localization within RVSMC Hes-1 appears to be absent 
from the nucleoli of the cells, and distinct clusters or areas of high concentration of Hes- 
1 are also in evidence within the nucleus Both Hes-1 and Hes-5 are present within the 
cytoplasm, Hes-1 appears to be evenly distributed throughout the cytoplasm whilst Hes- 
5 exhibits a low level of nuclear clustering In the case of all of the components o f the 
Notch signalling pathway examined, the cytoplasmic proportions appear to be contained 
in discrete vesicles
In all cases the appropriate primary and secondary controls were performed in 
parallel with each experiment
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Figure 3.1 The Presence o f N otch 1 in A dult RVSM C
A: Notch 1 protein expression B: notch I mRNA expression
120 kDa
550 bp
C: Notch 1 protein expression
20x 40x
Nuclear c==> Cytoplasmic Membrane c=> Cytoplasmic clustering t—>
lOOx Secondary Control
Figure 3.1 The presence o f Notch 1 in adult VSMC
A & B) Notch 1 protein (A) and mRNA (B) is expressed in RVSMC, as determ ined by western blot 
analysis and semi-quantitative PCR respectively. C) Im m unocytochem istry showing Notch 1 expression 
at 20x, 40x, and lOOx magnifications, and a secondary control. Arrows indicate sub-cellular localization 
of Notch 1. n=3.
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Figure 3.2 The Presence o f N otch 3 in A dult RVSM C
A: Notch 3 protein expression B: notch 3 mRNA expression
90 kDa
390 bp
I
C: Notch 3 protein expression
Nuclear c=i> Cytoplasmic c=i> Nuclear envelope [=> 
lOOx Secondary Control
1
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Figure 3.2 continued: The Presence o f N otch 3 in Adult R V SM C
D: Notch 3 Protein Up-regulation
Notch 3
300 kDa and 90 kDa (cytoplasmic fraction) 
Blocking peptide ^
Notch 3
200 kDa
105 kDa
Notch 3 IC h
M i '«ft»
V - .
f
f  -  ‘
.
Notch 3 
IC
Notch 3 IC
(cytoplasmic fraction)
Blocking peptide 
(-) (+)
E: Anti-HA detection of Notch IC
mock transfected Notch 1 IC transfected
120 kDa
Figure 3.2 The presence o f Notch 3 in adult VSM C. A & B) Notch 3 protein (A) and 
mRNA (B) is expressed in RVSM C, as determ ined by western blot analysis and semi- 
quantitative PCR respectively. Q  Im m unocytochem istry showing Notch 3 expression at 
20x, 40x, and lOOx m agnifications, and a secondary control. A rrow s indicate sub- 
cellular localization of Notch 3. D) Additional analysis o f Notch 3 expression in VSM C 
showing full length un-cleaved Notch 3 (300 kDa) and Notch 3 IC expression. C o­
expression with the Notch 3 blocking peptide proves Notch 3 detection. E) Detection of 
Notch 1 IC using an anti-HA antibody. n=3.
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Figure 3.3 The Presence o f Jagged in Adult RVSM C
A: Jagged protein expression B: jagged mRNA expression
160 kDa
147 bp
C: Jagged protein expression
20x 40x
\
/
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Figure 3.3 The presence o f Jagged in adult VSMC
A & B) Jagged protein (A) and mRNA (B) is expressed in RVSMC, as determ ined by western blot 
analysis and semi-quantitative PCR respectively. C) Im m unocytochemistry showing Jagged expression at 
20x, 40x, and lOOx magnifications, and a secondary control. Arrows indicate the sub-cellular localization 
of Jagged in VSMC. n=3.
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Figure 3.4 The Presence o f HRT-1 in Adult RVSM C
A: HRT-1 protein expression B: hrt-1 mRNA expression
42 kD
290 bp
C: HRT-1 protein expression
40x
Nuclear i=t> Cytoplasmic Cytoplasmic clustering
lOOx Secondary Control
Figure 3.4 The presence o f HRT-1 in adult VSM C
A & B) HRT-1 protein (A) and mRNA (B) is expressed in RVSMC, as determ ined by western blot 
analysis and semi-quantitative PCR respectively. C) Immunocytochemistry showing HRT-1 expression at 
20x, 40x, and 100\ magnifications, and a secondary control. Arrows indicate sub-cellular localization of 
HRT-1. n=3.
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Figure 3.5 The Presence o f HRT-2 in Adult RVSM C
A: HRT-2 protein expression
42 kDa
B: hrt-2 mRNA expression
330 bp
C: HRT-2 protein expression 
20x 40x
Nuclear i= >  Cytoplasmic Nuclear Vesicles «=>
lOOx Secondary Control
Figure 3.5 The presence o f HRT-2 in adult VSMC
A & B) HRT-2 protein (A) and mRNA (B) is expressed in RVSMC, as determ ined by western blot 
analysis and semi-quantitative PCR respectively. C) Immunocytochemistry showing HRT-2 expression at 
20x, 40x, and lOOx magnifications. n=3.
107
Figure 3.6 The Presence o f HRT-3 in Adult RVSM C
A: HRT-3 protein expression B: hrt-3 mRNA expression
42 kDa
340 bp
C: HRT-3 protein expression
Nuclear Cytoplasmic c=>
lOOx Secondary Control
Figure 3.6 The presence o f HRT-3 in adult VSMC
A & B) HRT-3 protein (A) and mRNA (B) is expressed in RVSMC, as determ ined by western blot 
analysis and semi-quantitative PCR respectively. C) Im m unocytochemistry showing HRT-3 expression at 
20x, 40x, and lOOx magnifications. n=3.
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Figure 3.7 The Presence o f Hes-1 in A dult RVSM C
A: Hes-1 protein expression B: hes-1 mRNA expression
35 kDa — ► W M
280 bp
C: Hes-1 protein expression
20x 40x
Nuclear i= >  Cytoplasmic «=> Nuclear Vesicles i= >  
lOOx Secondary Control
Figure 3.7 The presence o f Hes-1 in adult VSM C
A & B) Hes-1 protein (A) and mRNA (B) is expressed in RVSMC, as determined by western blot analysis 
and sem i-quantitative PCR respectively. C) Im m unocytochem istry show ing Hes-1 expression at 20x, 
40x, and lOOx magnifications. n=3.
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Figure 3.8 The Presence o f  H es-5 in A dult RVSM C
A: Hes-5 protein expression B: hes-5 mRNA expression
19 kDa 380 bp
C: Hes-5 protein expression
40x
Nuclear i= >  Cytoplasmic i=>
lOOx Secondary Control
Figure 3.8 The presence o f Hes-5 in adult VSMC
A & B) Hes-5 protein (A) and mRNA (B) is expressed in RVSMC, as determined by western blot analysis 
and sem i-quantitative PCR respectively. C) Im m unocytochem istry showing Hes-5 expression at 20x, 
4 0 \, and lOOx magnifications. n=3.
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3 2 2 A ctivation o f the N otch Signalling Pathway in RV SM C
This study has successfully detected components of the Notch signalling 
pathway in cycling RVSMC In addition, we investigated whether the Notch signalling 
pathway could be activated in these cells This was examined through the transient 
transfection of RVSMC with the active (IC) portion of either the Notch 1 or Notch 3 
receptor, co-transfected with either a CBF-1- or Notch target gene-1 uciferase-tagged 
reporter plasmid Activation of the reporter plasmid results in generation of the firefly 
luciferase enzyme, which catalyzes the conversion of D-luciferin to oxyluciferin, with 
the concomitant production of a photon of light, which is measured by a luminometer 
In addition, CBF-1-dependent activation of the Notch signalling pathway was 
confirmed through analysis of Notch target gene mRNA levels in VSMC following 
over-expression of the active form of the Notch 1 and Notch 3 receptors
Up-regulation o f Notch 1 IC and Notch 3 IC through transient transfection was 
verified at the protein and mRNA level (Figure 3 9) Over-expression of the active 
forms of both Notch 1 and Notch 3 clearly activates both CBF-1-dependent promoter 
activity (Figure 3 10) and Notch target gene promoter activity (Figure 3 11) in RVSMC
The co-transfection of Notch 1 IC and the CBF-1 luciferase-tagged promoter 
(CBF-1-luc) resulted in a significant fold increase (19 29±3 09) in luciferase activity 
over control cells lacking transfected Notch 1 IC (Figure 3 10A) Co-transfection of 
Notch 1 IC and CBF-1-luc with inhibitors of the Notch signalling pathway resulted in 
an attenuation of the Notch 1 IC-induced increase in luciferase activity Mutant Notch 1 
IC (pCMV-ED4) co-transfection, for example, resulted in a 71 0±2 0% decrease in 
luciferase activity as compared to Notch 1 IC transactivation of CBF-1-luc, whereas 
RPMS-I, and EBNA-3A co-transfection resulted in 71 38±4 1% and 87 46±4 48% 
decreases in luciferase activity respectively Notch 1 IC and CBF-1-luc transfected 
cells were also exposed to the pharmacological inhibitors Brefeldin A and Monensin, 
which resulted in a 57 86±4 56% and 75 12±2 85% decrease in luciferase activity 
respectively, as compared to Notch 1 IC transactivation of CBF-1-luc The attenuation 
of the Notch 1 IC-induced increase in luciferase activity was shown to be statistically 
significant as compared to Notch 1 IC transactivation o f CBF-1-luc for all of the co­
transfected inhibitors, and for the pharmacological inhibitors, Brefeldin A and 
Monensin
Co-transfection of Notch 3 IC and CBF-1-luc resulted »n a significant fold
increase (15 72±3 80) in luciferase activity over control cells lacking transfected 
Notch 3 IC (Figure 3 10B) Similarly, co-transfection with inhibitors of the Notch 
signalling pathway resulted in an attenuated fold increase in luciferase activity with 
respect to that due to Notch 3 IC alone Mutant Notch 1 IC co-transfection, resulted in a 
52 29±19 1% decrease in luciferase activity as compared to Notch 3 IC transactivation 
of CBF-l-luc, whereas RPMS-I, and R218H-RBP-Jk co-transfection resulted in
79 95±8 27% and 69 78±3 75% decrease in luciferase activity respectively Exposure 
to the pharmacological inhibitors Brefeldin A and Monensin resulted 78 75±3 75% and
80 98±4 77% decrease in luciferase activity respectively as compared to Notch 3 IC 
transactivation of CBF-l-luc, with a significant attenuation being shown for RPMS-I, 
Brefeldin A and Monensin
Over-expression of Notch 1 IC and Notch 3 IC in RVSMC also resulted in the 
transactivation of Notch target gene luciferase-tagged promoters (Figure 3 11) Co- 
transfection of both Notch 1 IC and Notch 3 IC resulted in a significant fold increase 
(3 25±1 04 and 8 16± 1 73 respectively) in hes-5 luciferase activity over control cells 
lacking transfected Notch Notch 1 IC and Notch 3 IC, however, was found to have a 
lesser effect on hes-J promoter activity, resulting in 1 54±0 32 and 1 3±0 17 fold 
increase in luciferase activity respectively The effect of Notch 1 IC and Notch 3 IC on 
the hrt-1 luciferase-tagged promoter was also investigated Notch 1 IC resulted m a 
19 51 ±4 17 fold increase in luciferase activity over control cells lacking transfected 
Notch, whereas Notch 3 IC over-expression resulted in a 4 96±1 22 fold increase 
(Figure 3 11C), however, both receptors caused a significant increase with respect to 
control As was evident with the CBF-1 luciferase-tagged promoter, co-transfection of 
the Notch 1 mutant with Notch 1 IC resulted in a significant attenuation (77 25±7 89%) 
of the Notch 1 IC-induced increase in hrt-1 luciferase activity (Figure 3 1 ID)
The effect of Notch 1 IC and Notch 3 IC over expression on the Notch signalling 
pathway was confirmed using quantitative real time-PCR analysis The effect of Notch 
1 IC (Figure 3 12A) and Notch 3 IC (Figure 3 12B) on Notch target gene mRNA 
expression levels was investigated Notch 1 IC over expression resulted in a 2 98±0 81 
fold increase in hrt-1 mRNA expression levels over mock transfected control cells (data 
not shown, assigned a value of 1), an increase in hrt-2 (1 51 ±0 52) and hes-5 
(2 19±0 05) was also observed (Figure 3 12 A) Co-transfection of Notch 1 IC with the 
Notch signalling pathway inhibitor, RPMS-I, significantly attenuated the Notch 1- 
mediated increase in hrt-1, hrt-2 and hes-5 mRNA expression by 71 48±0 33%,
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79 48±3 31%, and 90 42±1 14% respectively (Figure 3 12A) Similarly, Notch 3 IC 
over expression resulted in increased mRNA expression levels o f Notch target genes 
over mock transfected control cells, exhibiting a 3 55±0 5, 1 62±0 41 and 1 52±0 39 
fold increase for hrt-l, hrt-2 and hes-5 respectively (Figure 3 12B) Co-transfection of 
Notch 3 IC with the Notch signalling pathway inhibitor, RPMS-I, significantly 
attenuated the Notch 3-mediated increase in hrt-l, hrt-2 and hes-5 mRNA expression by 
80 0±0 28%, 53 1±4 3%, and 53 95±3 2% respectively (Figure 3 12B)
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Figure 3 9 Up-regulation of Notch 1 IC and Notch 3 IC in transfected 
VSMC
A Notch 1 Protein Up-regulation
< -------120 kDa
Mock transfected Notch I IC transfected
B Notch 1 mRNA Up-regulation
550 bp
T M T  M T M T M  (-)RT
C Notch 3 Protein Up-regulation
< ------- 90 kDa
Mock transfected Notch 3 IC transfected
D Notch 3 mRNA Up-regulation
390 bp
T M T M T M (-)RT
Figure 3 9 Up-regulation of Notch 1 IC and Notch 3 IC in transfected VSMC Up-
regulation of Notch I protein (A) and mRNA (B) expression following transfection with 
Notch J IC Up-regulation of Notch 3 protein (C) and mRNA (D) expression following 
transfection with Notch 3 IC M -m ock  translected, l= N o tc h  1 IC/Notch 3 IC 
transfected
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Figure 3 10 A ctivation o f the N otch S ignalling Pathw ay in RV SM C
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Figure 3 10 Notch 1 and Notch 3 activate CBF-1 activity in adult VSMC RVSMC 
were transiently transfected with the CBF-1 luciferase-tagged reporter plasmid, and co­
transfected with either Notch I IC (A) or Notch 3 IC (B) Additionally, cells were co ­
transfected with inhibitors of the Notch signalling pathway, mut Notch 1 IC, RPM S-I, 
R218H, or EBNA-3A, and treated with the pharmacological inhibitors Brefeldin A 
(0 l^g /m l, 24 h) and M onensin (0 25 ^ig/ml, 24 h) Luciferase assays were normalized 
to o-galactosidase activities and protein levels, n= at least 3, and expressed as fold 
increase over control (= the value obtained with pG A 98-l-6  transfected cells arbitrarily 
assigned a value o f 1) * p<0 05 ** p<0 005 (rank test) as com pared to mock
transfected co n tro l,$ p<0 05 as com pared to N otch transfected cells (b tud tn t’s i-tesi)
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Figure 3 11 A ctivation o f N otch T arget G enes in  RV SM C
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Figure 3 11 O ver-expression o f  Notch 1 and Notch 3 activates notch target genes in 
RVSM C A & B) RVSM C were transiently transfected with the Hes-5 and Hes-1 
reporter plasmids and co-transfected with either Notch 1 -IC (A) or Notch 3-IC (B) 
Luciferase assays were norm alized to ogalac to sidase  activities and protein levels, n=3, 
and expressed as fold increase over control (= the value obtained with Hes-5 or Hes-1 
reporter plasmid transfected cells arbitrarily assigned a value of 1) C) RVSM C were 
transiently transfected with the HR 1 -1 reporter plasmid and co-transfected with either 
Notch 1 IC or Notch 3 IC D) RVSM C were transiently transfected with the HRT-1 
reporter plasmid and co-transfected with Notch 1 IC in the presence and absence of the 
mutant Notch 1 1C plasmid Luciferase assays were norm alized to ogalac tosidase  
activities and protein levels, n=3, and expressed as fold increase over control (= the 
value obtained with HRT-1 reporter plasmid transfectcd cells arbitrarily assigned a value 
of 1) ° p<0 05 as com pared to mock transfected control c e l ls ,$ p<0 05 as com pared to 
Notch transfected cells (student s t test)
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Figure 3 12 N otch T arget G ene m R N A  L evels in RV SM C
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Figure 3 12 N otch 1 and Notch 3 up-regulate Notch Target G ene m RNA expression, 
this is inhibited by the Notch inhibitor, RPM S-I RVSM C were transiently 
transfected with Notch 1 IC (A) and Notch 3 IC (B) in the presence and absence of the 
Notch inhibitor, RPMS-I mRNA levels were m easured using quantitative RT-PCR, and 
expressed as fold increase over control (= the levels of target gene present in 
untransfected cells (not shown)), n=3 ° p<0 05, on p<0 0 0 5 ,<im p<0 005 as com pared to 
mock transfected control (student’s t test)
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3 2 3 Serum -dependent A ctivation o f the Notch Signalling Pathw ay in RVSM C
The Notch signalling pathway in RVSMC can be activated through over 
expression of either Notch 1 IC or Notch 3 1C in these cells It was also of interest to 
examine whether the Notch signalling pathway could be activated in RVSMC by less 
artificial means, therefore the effect of serum stimulation the Notch signalling pathway 
in RVSMC was studied This was achieved through the transient transfection of 
RVSMC with a luciferase-tagged reporter plasmid, followed by serum deprivation for 
48 h, and serum stimulation over a period of 24 h The results obtained clearly 
demonstrate that serum activates the Notch signalling pathway in RVSMC (Figure 3 13 
and 3 14) Serum stimulated CBF-1 promoter activity over a period of 24 h (Figure 
3 13 A and B), with a significant fold increase over the 0 h timepoint control (arbitrarily 
assigned a value o f 1) evident at 8 h post-serum addition (26 1±7 9) This fold increase 
in luciferase activity was also present at 10 h post-serum addition (13 9±4 2), with the 
24 h timepoint almost returning to control level (1 5±0 2) The effect of serum 
stimulation on the CBF-1-luc control vector, pGA50-7, was also investigated (Figure 
3 13A) pGA50-7 exhibited an increase in luciferase activity over its 0 h control at 8 h 
(8 1±2 3) and 10 h (3 9±0 3) However, the fold increase in CBF-1 luciferase activity 
was significantly increased over its control vector at the 8 h and 10 h timepoints The 
effect of co transfection of mutant Notch 1 IC, and the pharmacological inhibitors, 
Brefeldin A and Monensin, on serum-stimulated increases in CBF-1 luciferase activity 
was investigated (Figure 3 13B) All three inhibitors resulted in a significant 
attenuation of the serum-induced increase in CBF-1 luciferase activity at 8 h post-serum 
stimulation Cells treated with Brefeldin A and Monensin exhibited a 69 73±10 72% 
and a 81 61 ±7 85% decrease in luciferase activity respectively, and cells co-transfected 
with mutant Notch 1 IC exhibited a 83 91 ± 11 87% decrease in CBF-1 luciferase 
activity, as compared to that at 8 h post-serum stimulation An attenuation in the serum 
stimulated increase in CBF-1 luciferase activity was also seen at 10 h post-serum 
addition, with decreases of 61 6±16 54%, 69 07±10 79%, and 84 9±3 59% due to 
Brefeldin A, Monensin and mutant Notch 1 IC respectively An additional experiment 
was performed to examine the effect of co-transfecting the Notch inhibitors, RPMS-I or 
R218H-RBP-Jk, on serum-stimulated CBF-1 luciferase activitation In this case, the 
fold increase in luciferase activity was examined at 4 h, 8 h, and 24 h post-serum
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addition (Figure 3 13C) The 4 h timepoint post-serum addition resulted in a 
17 9±5 4 fold increase in CBF-1 luciferase activity, whereas the 8 h and 24 h timepoints 
exhibited a significant increase of 26 6±2 3 and 11 0±0 32 respectively Co-transfection 
o f RPMS-I resulted in an attenuation of the serum-induced increase in luciferase 
activity by 47 21 ±1 9%, 56 43±18 34% and 28 82±8 0% at 4 h, 8 h, and 24 h post­
serum stimulation respectively R218H-RBP-Jk co-transfection also resulted in an 
attenuation of the serum-stimulated increase in CBF-1 luciferase activity at 4 h by 
41 57±12 34%, and a significant attenuation at 8 h and 24 h by 76 32±3 64% and 
70 37±2 36% respectively, as compared to serum stimulated CBF-1 luciferase activity 
at each timepoint (Figure 3 13C)
Serum stimulation also resulted in the transactivation of Notch target gene 
luciferase-tagged promoters (Figure 3 14) Serum stimulation resulted in an increase in 
hes-5 luciferase activity over a period of 24 h, with significant increases of 2 9±0 6 and 
6 4±1 0 evident at 4 h and 8 h post-serum addition respectively, and an increase of 
3 2±1 2 evident at 24 h post-serum addition (Figure 3 14A) In contrast, serum 
stimulation did not significantly increase hes-1 luciferase activity, with 1 2±0 I, 1 5±0 2 
and 1 3±0 1 fold increases in luciferase activity evident at 4 h, 8 h and 24 h post-serum 
addition respectively The effect of serum stimulation on hrt-I promoter activity was 
also investigated over a period of 24 h (Figure 3 14B) Serum stimulation resulted in a 
significant fold increase (24 6±6 4) in hrt-I luciferase activity at 8 h post-serum 
addition Similarly, fold increases in hrt-1 luciferase activity of 13 6±4 8 and 6 0±2 2 
were evident at 10 h and 24 h post-serum addition Co-transfection of the Notch 
inhibitor, RPMS-I, resulted in an attenuated fold increase in luciferase activity due to 
serum stimulation (Figure 3 14B) The fold increase was significantly attenuated by 
82 65±10 97% and 81 62±6 6% at 8 h and 10 h post-serum addition respectively, and by 
56 5±21 6% at 24 h post-serum addition, as compared to serum stimulated CBF-1 
luciferase activity at each timepoint
As serum stimulation activates CBF-1-dependent Notch signalling, the effect of 
serum on Notch receptor and target gene expression was investigated The effect of 
serum on the Notch signalling pathway was confirmed using western blot analysis and 
both semi-quantitative PCR and quantitative real time-PCR analysis Serum stimulation 
significantly increases expression of the activated portion of the Notch 1 receptor, 
Notch 1 1C, by 1 4±0 1 fold over the non-serum stimulated control cells (Figure 3 15A) 
Analysis of mRNA expression levels of Notch 1 and Notch 3 at 8 h post-serum
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stimulation (Figure 3 I5B) revealed that serum causes a significant fold increase in 
notch I (1 78± 27) and notch 3 (1 81 ±0 1) mRNA levels over the non-serum stimulated
0 h control
The effect of serum stimulation on hrt-I (Figure 3 16A) and hrt-2 (Figure 
3 I6B) mRNA expression levels was investigated over a period of 24 h Semi- 
quantitative PCR revealed a temporal increase in both hrt-I and hrt-2 mRNA 
expression levels, which were maximal at 4 - 10 h post serum addition Similarly, serum 
stimulation for 8 h resulted in significant increases in Notch target gene mRNA as 
compared to un-stimulated control cells (Figure 3 16C) The fold increases for hrt-l, 
hrt-2, hrt-3, hes-I and hes-5 being 1 65±0 17, 1 67±0 1, 1 55±0 29, 2 12± 31, and
1 75±0 01 respectively
To further verify the involvement of the CBF-1 dependent Notch signalling 
pathway in serum-stimulated increases in Notch target gene mRNA expression, cells 
were mock-transfected, or transfected with the CBF-1-dependent Notch signalling 
pathway inhibitor, RPMS-I (Figure 3 17) Quiesced cells were serum stimulated for 8 
h, and assayed for Notch target gene mRNA expression Control levels of the Notch 
target genes in mock-transfected cells were arbitrarily assigned a value of 1 Hrt-2 and 
hrt-3 mRNA expression levels were significantly decreased due to the presence of 
RPMS-I by 58 0±1 0% and 65 0±5 0% respecitvely Similarly, hrt-I and hes-5 mRNA 
expression levels were also decreased by 58 0± 12 0% and 67 0± 13 0% respectively
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Figure 3 13 Serum Stimulation of the Notch Signalling Pathway 
in RVSMC
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Figure 3 13 Serum  stim ulates CBF-1 activity in adult VSM C in a tim e-dependent 
m anner, which can be inhibited by inhibitors o f  the Notch signaling pathway A)
RVSM C were transiently transfected with the CBF-1 reporter plasmid, pG A 98-I-6 , or 
the CBF-1 mutant, pGA50-7 Following overnight recovery from transfection, cells 
were quiesced for 48 h, and stim ulated with m edia containing 10% FBS at 0 h B) 
RV SM C were transiently transfected with the CBF-1 reporter plasm id, pG A 98-l-6 , and 
co-transfected with the Notch 1 mutant plasmid, mut Notch 1 IC Following overnight 
recovery from transfection, cells w ere quiesced for 48 h, and stim ulated with media 
containing 10% FBS at 0 h, in either the presence or absence of the pharm acological 
inhibitors Brefeldin A (0 l^g /m l) or M onensin (0 25 fig/ml) as indicated C) RVSM C 
were transiently transfected with the CBF-1 reporter plasmid, pG A 98-l-6 , and co­
transfected with the Notch pathway inhibitors, RPMS-I and R218H as indicated 
Following overnight recovery from  transfection, cells w ere quiesced for 48 h, and 
stim ulated with m edia containing 10% FBS at 0 h Samples were taken over a period 
of 0 -2 4  h, and assayed for luciferase activity Luciferase assays were norm alized to o- 
galactosidase activities and protein levels, n=3, and expressed as fold increase over 
control (= the value obtained with relevant reporter plasmid transfected cells at 0 h 
arbitrarily assigned a value o f  1) °  p<0 05 , aa p<0 05 as com pared to 0 h serum  control, 
$ p<0 05 as com pared to  serum  control at that tim epoint (student’s t test)
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Figure 3 14 Serum  Stim ulation  o f  N otch T arget G enes in  R V SM C
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Figure 3 14 Serum  stim ulates N otch target gene activity in adult V SM C  in a 
tim e-dependent m anner, w hich can be inhibited by inhibitors o f  the Notch  
signaling pathway A) RVSM C were transiently transfected with the hes- 5  or hes 1 
reporter plasm id B) RVSM C were transiently transfected with the HRT-1 reporter 
plasmid, and co-transfected with the Notch inhibitor RPMS-I In both cases, 
follow ing overnight recovery from  transfection, cells were quiesced for 48 h, and 
stim ulated with m edia containing 10% FBS at 0 h Samples w ere taken over a period 
of 0 -2 4  h, and assayed for luciferase activity Luciferase assays were norm alized to 
o g a lac to sid ase  activities and protein levels, n=3, and expressed as fold increase over 
control (= the value obtained with relevant reporter plasmid transfected cells at 0 h 
arbitrarily assigned a value o f 1) n p<0 05, no p<0 005 as com pared to 0 h serum 
co n tro l,$$ p<0 005 as com pared to serum control at that tim epoint (student’s t test)
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Figure 3 15 Serum Stimulation of Notch Receptor Expression 
RVSMC
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Figure 3 15 Serum  increases N otch protein expression in RVSM C A) RVSM C 
were quiesced for 48 h, and stim ulated with media containing 10% FBS at 0 h as 
indicated Samples were taken at 6 h post-serum  addition in serum containing and 
non-serum  containing samples, and subsequently assayed using for Notch 1 protein 
expression Samples are expressed as fold increase over non-serum  stim ulated 
control (arbitrarily assigned a value of 1) B) RVSM C were quiesced for 48 h, and 
stim ulated with m edia containing 10% FBS at 0 h Sam ples were isolated at 8 h post­
serum  addition and subsequently assayed using quantitative PCR All values were 
norm alized to GAPDH levels, and expressed as fold increase over control (= the 
value obtained with serum depleted mRNA levels at 8 h arbitrarily assigned a value 
o f 1), n=3 ° p<0 0 5 ,00 p<0 005 as com pared to 0 h serum control (student’s t test)
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Figure 3 1 6  Serum  Stim ulation  o f N otch T arget G ene m RNA
Expression in RV SM C
B
5 10 15 20 25
Time post serum addition (h)
5 10 15 20 25
Time post serum addition (h)
x  ^  3  “ i
% -C 
> oa> w
<  -  
z  >
2 -\
s i
c «
C3 
u
O¡Jh
1
a
x
a aX
h Post-serum Addition 
1------ '8 h Post-serum Addition
X
G O
hrt-1 hrt-2 hrt-3 hes-1 hes-5
Figure 3 16 Serum  stim ulates Notch target gene activity in adult VSM C in a 
tim e-dependent m anner A & B) RVSM C were qu icsctd  for 48 h, and stimulated 
with media containing 10% FBS at 0 h Samples were taken over a period of 0 -2 4  h, 
and subsequently assayed using sem i-quantitative PCR C) RVSM C were quiesced 
lo r 48 h, and stimulated with media containing 10% FBS at 0 h Samples were 
isolated at 8 h post-serum addition and subsequently assayed using quantitative PCR 
All values were norm alized toG A P D H  levels, and expressed as a ratio ol GAPDH (A 
& B) or as fold increase over control (= the value obtained with serum depleted 
mRNA levels at 8 h arbitrarily assigned a value of 1)(C), n=3 ° p<0 0 5 , tK1 p<0 005 
as com pared to 0 h serum  control (student s t test)
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Figure 3 17 Inhibition o f Serum  Stim ulated N otch T arget G ene m RNA
E xpression in  RV SM C
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Figure 3 17 Inhibition o f serum  stim ulated Notch target gene m RNA expression  
in RVSM C A) RVSM C were transfected with and em pty vector (-RPM S-I) or with 
the a Notch signalling pathway inhibitor (+RPM S-I) Following recovery overnight 
cells were quiesccd for 48 h, and stimulated with media containing 10% FBS at 0 h 
Samples were isolated at 8 h post-serum addition and subsequently assayed using 
quantitative PCR for Notch target gene mRNA expression All values were 
normalized to GAPDH levels, and expressed as a fold decrease over control (= the 
value obtained with serum stim ulated mRNA levels at 8 h in the absence o f the Notch 
inhibitor, arbitrarily assigned a value o f I), n=3 B) Representative exam ple of semi- 
quantitative PCR gel for the Notch target gene, hes-5, and GAPDH in both the 
presence and absence of RPMS-I ° p<f) 05, (Ta p<0 005 as com pared to mock 
transfccted control (student’s t test)
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3 2 4 Endogenous ligand activation o f the N otch Signalling Pathw ay in RVSM C
This study has demonstrated the activation of the Notch signalling pathway 
through over expression of Notch 1 IC and Notch 3 IC, and through serum stimulation 
o f quiesced cells In addition, we investigated the effect o f exposure of RVSMC 
transfected with a CBF-1 luciferase-tagged promoter to the endogenous ligand, Jagged, 
on the Notch signalling pathway (Figure 3 18) Jagged expression was induced in HeLa 
cells through removal of tetracycline from the growth media for 48 h, and Jagged 
induction was confirmed by western blot analysis (S Loughran personal 
communication) Exposure of RVSMC to Jagged expressing HeLa cells resulted m a 
significant 2 51 ±0 53 fold increase in CBF-1 luciferase activity over control (RVSMC 
exposed to non-Jagged expressing HeLa cells, arbitrarily assigned a value of 1)
3 2 5 EBNA-2 Activates the Notch Signalling Pathway in RVSMC
The overlap between EBV and the Notch signalling pathway is evident as many 
of the EBV latent proteins, including EBNA-2, EBNA-3A and other viral gene products 
such as RPMS-I, have been shown to interact with the Notch signalling pathway (Zhang 
et a l , 2001) We have previously shown that RPMS-I and EBNA-3A attenuate a Notch 
IC mediated-, and also serum stimulated- (in the case of RPMS-I), increase in Notch 
signaling pathway activity in RVSMC This study investigated whether EBNA-2 could 
mimic the activation of the Notch signalling pathway in RVSMC The co-transfection 
of EBNA-2 and the CBF-1 luciferase-tagged promoter resulted in a significant fold 
increase (12 3±3 21) in luciferase activity over control cells lacking transfected EBNA- 
2, arbitrarily assigned a value of 1 (Figure 3 19) Co-transfection with the viral gene 
products EBNA-3A, RPMS-I and the CBF-1 mutant R218H-RBP-JK, resulted in an 
attenuation of the EBNA-2 induced fold increase in luciferase activity by 88 54±4 87%, 
78 54±11 95% and 56 1±27 72% respectively This attenuation was significant in the 
case of EBNA-3A and RPMS-I Exposure of the EBNA-2 and CBF-1-luc co­
transfected cells to the pharmacological inhibitors, Brefeldin A and Monensin, resulted 
in a very slight attenuation of the EBNA-2 induced fold increase in luciferase activity, 
by 7 32±39 83% and 17 89±24 87% respectively
128
Figure 3 18 Stim ulation o f the N otch S ignalling Pathw ay in RV SM C
due to exposure to the N otch Ligand, Jagged
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Figure 3 18 Stim ulation of the N otch Signalling Pathway in RVSM C due to exposure 
to the Notch Ligand, Jagged H e La cells were plated onto 6-well plates and Jagged 
expression was induced as indicated through the removal of tetracycline from the growth 
media over a period of 48 h In parallel, RVSM C were transiently transfected with the 
CBF-1 lucilerase-tagged reporter plasmid, and co-transfected with the puromycin 
resistance plasmid, pG K -puro Following overnight recovery, transfected cells were 
selected out with exposure of the cells to puromycin containing media (0 8 ^ig/ml) for 48 
h RVSM C were seeded onto the non-induced and induced HeLa cells at equal densities 
Samples were isolated after 24 h, and assayed for luciferase activity Luciferase assays 
were normalized to o-galactosidase activities and protein levels, n=3, and expressed as 
fold increase over control (= the value obtained with non-induced HeLa cells co-cultured 
with the CBF-1 reporter plasmid, pG A 98-l-6 , expressing RVSM C, arbitrarily assigned a 
value o f I ) ° p<0 05, as com pared to mock transfected control (student s t test)
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Figure 3 1 9  Stim ulation o f the Notch Signalling Pathw ay in
R V SM C  w ith the E B V  protein , EBN A -2
e = i  + EBNA-3A 
i= j + RPMS-I 
asm  + R218H
mock --------------------------------------
transfected + EBNA-2
Fig 3 19 EBNA-2 activates CBF-1 activity in adult VSM C RVSM C were transiently 
transfected with the CBF-1 luciferase-taggcd reporter plasmid, pG A 98-l-6 , and co­
transfected with the EBV nuclear antigen, EBNA-2 plasmid Additionally, cells were co ­
transfected with inhibitors of the Notch signalling pathway EBNA-3A, RPM S-I, or R218H, 
and treated with the pharmacological inhibitors Brefeldin A (0 l^ig/ml, 24 h) and Monensin 
(0 25 }ig/ml, 24 h) Luciferase assays were normalized to cr-galactosidase activities and 
protein levels, n=S, and expressed as fold increase o \e r  control (= the value obtained with 
pG A 98-l-6  transfected cells arbitrarily assigned a value of 1) * p<0 05 (rank test) as 
com pared to mock transfected control, s p<0 05 as com pared to EBNA-2 over-expressing 
cells (student s t test)
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3 3 D iscussion
This study comprehensively documents the presence of many components of the 
Notch signalling pathway in RVSMC This is largely in agreement with several recent 
studies (Campos et a l , 2002, Iso et a l , 2002), and provides additional evidence of the 
presence o f the Notch signalling pathway in VSMC Campos et a l , for example, 
documented the presence of Jagged 1, Notch 3, HRT-1, HRT-2 and HRT-3 protein and 
mRNA expression in RVSMC in vitro Contrary to the present study, however, 
Campos et a l , could detect Notch 1 mRNA but not protein expression, and could not 
detect any evidence of Hes-1 or Hes-5 in RVSMC, the presence of which is 
unequivocally proven in this study The Notch receptor antibodies used in this study are 
directed against the IC portion of the Notch receptor and, as such, detect both the IC and 
full-length forms of the Notch receptor This study focused on the presence and the 
over-expression of the IC portion o f the Notch receptor, as this is the active form of the 
receptor involved in CBF-1-dependent signalling (Weinmaster 1998) In addition, 
several studies have revealed the predominance of the IC portion of the Notch receptor, 
both in vascular cells (Campos et a l , 2002, Wang et a l , 2002a, Wang et a l , 2002b) and 
other cell types (Fehon et a l , 1991, Aster et a l , 1994) This study also investigated the 
sub-cellular localization of the components of the Notch signalling pathway using 
immunocytochermcal analysis The components of the Notch signalling pathway 
appear to localize predominately in the nucleus, which is in agreement with several 
other reports, which document the predominant sub-cellular localization of Notch IC in 
the nucleus (Fortini et a l , 1993, Lieber et a l , 1993, Kopan et a l , 1996)
This study presents the novel finding that both Notch 1 IC and Notch 3 IC signal 
via a CBF-1-dependent pathway in adult RVSMC This method of signalling is likely 
to be conserved from development, as CBF-1-dependent signalling of Notch 1 and 
Notch 3 has recently been observed in rat embryonic VSMC (Campos et a l , 2002) 
Over-expression of Notch 1 IC and Notch 3 IC resulted in increased CBF-1-dependent 
promoter activity, and Notch target gene mRNA levels In most cell types Notch 1 IC 
expression results in increased CBF-1-dependent activity, however, the role of Notch 3 
IC appears to be cell-type specific In 1999, Beatus et a l , suggested that Notch 3 IC 
acts as an antagonist o f the CBF-1-dependent Notch signalling pathway, as Notch 3 IC 
expression inhibited the Notch 1 IC CBF-1-dependent increase in Hes-1 activity Our 
study, and others, establishes Notch 3 as an agonist of the CBF-1-dependent pathway,
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and in addition, Wang et a l , have shown that co-expression of Notch 1 and Notch 3 
IC in VSMC results in a potentiation o f the Notch 1 IC response (Wang et a l , 2002a) 
The CBF-1-dependent nature of Notch 1C signalling in VSMC was further confirmed 
with the attenuation of the Notch IC-mediated response on CBF-1 promoter activity and 
Notch target gene mRNA levels due to co-transfection with CBF-1-specific inhibitors 
Intracellular Notch IC transport is also likely to be an important factor in Notch activity 
in VSMC, as pharmacological inhibitors of protein transport inhibited the observed 
effects of Notch IC, a phenomenon that is also reported in fibroblasts (Schroeter et a l , 
1998) Notch 3 IC and Notch 1 IC activates CBF-1 promoter activity to a similar extent 
in adult VSMC This contradicts the finding in embryonic VSMC, that the activation of 
Notch 3 IC on the CBF-1 promoter is considerably more potent (2 5 fold) than that of 
Notch 1 IC (Campos et a l , 2002) The reason for this discrepancy is not clear, but 
perhaps points to a more important role for Notch 3 signalling developmentally, or 
indeed, a more significant role for Notch 1 in adult VSMC
Further analysis o f the effect of Notch 1 IC and Notch 3 IC over-expression 
revealed that both receptors activate hrt-l and hes-5 > but not hes-1, promoter activity in 
adult VSMC This is achieved through CBF-1-dependent signalling This establishes 
both HRT-1 and Hes-5, but not Hes-1, as a direct downstream target gene of Notch 1 
and Notch 3 in adult RVSMC This is in agreement with several studies that have 
documented the HRT-1, -2 and -3 as direct downstream targets of all Notch receptors in 
myoblasts and fibroblasts (Maier and Gessler 2000, Nakagawa et a l , 2000, Iso et a l , 
2002) In addition, Wang et a l , have shown that both HRT-1 and HRT-2 are direct 
downstream targets of Notch 3 IC in adult VSMC (Wang et a l , 2002a) Whilst Notch 3 
IC evokes a similar level of activation at both the hes-5 and hrt-l promoters, the effect 
of Notch 1 on the hrt-l promoter is considerably greater than that on the hes-5 
promoter This could indicate a significant role for Notch 1-mediated activation of 
HRT-1 in adult VSMC This is consistent with the preferential expression of HRT-1 in 
the cardiovascular system (Chin et a l , 2000), furthermore, Notch 3 IC significantly 
increases hrt-l over hrt-2 promoter activity in VSMC (Wang et a l , 2002a) Consistent 
with this, we have documented that both Notch 1 IC and Notch 3 IC cause a greater 
increase in hrt-l as opposed to hrt-2 mRNA levels The activation of Notch target 
genes is likely to be cell context specific, as although Notch 1 and Notch 3 IC over- 
expression did not activate hes-1 promoter activity in VSMC, Hes-1 has been shown to 
be a direct downstream target o f Notch 1 in endothelial cells (Liu et a l , 2003) In 
addition, Notch 1 has also been reported to increase Hes-1 expression in T lymphoma
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cell lines (Lee et a l , 1999), however, expression of Hes-5, HRT-1, HRT-2 and HRT- 
3, but not Hes-1, was greatly diminished in Notch 1 deficient mice in various tissues (de 
la Pompa et a l , 1997, Leimeister et a l , 1999, Leimeister et a l , 2000) Hes-1 and Hes-5 
have been shown to functionally compensate each other, for example, in Notch- 
mediated neuronal degeneration (Ohtsuka et a l , 1999), therefore whether Hes-1 activity 
in VSMC could be induced by disruption of Hes-5 remains to be investigated
Further evaluation of Notch signalling pathway activation in vitro revealed the 
novel finding that serum temporally promotes Notch signalling in VSMC in a CBF-1 - 
dependent manner Interestingly, although hes-1 promoter activity was not activated as 
a result o f serum addition, an increase in hes-1 mRNA expression was observed The 
reason for this discrepancy is not clear, put points to the fact that Hes-1 could 
potentially play a role m modulating the effects of the Notch signalling pathway in adult 
VSMC
This study has, however, clearly shown that serum stimulation results in an 
increase in Notch receptor protein and mRNA expression, in addition to Notch target 
gene mRNA expression Using a robust antibody directed against the IC portion of the 
Notch receptor, we demonstrate that serum significantly increases the active IC 
component of the Notch 1 receptor We have previously shown that Notch IC over- 
expression increases activation of the artificial CBF-1 luciferase-tagged promoter, and 
also the natural CBF-1 promoter within VSMC, as evidenced by Notch target gene 
promoter activation and up-regulation in a CBF-1-dependent manner Therefore, we 
propose that the serum-mediated up-regulation of Notch signalling pathway activity is 
due to a serum-regulated increase in the IC portion of the Notch receptor within VSMC 
The explanation of the serum-induced activation of the Notch signalling pathway is not 
immediately apparent, however, several studies have revealed that serum mitogens 
influence Notch receptor expression and Notch signalling in several cell types VEGF, 
for example, has recently been shown to induce Notch 1 and Delta-like 4 expression in 
arterial endothelial cells via the PI3K/Akt pathway (Liu et a l , 2003) Additionally, 
serum components have been shown to stimulate Jagged expression via NFkB 
activation in non-vascular cells (Artavams-Tsakonas et a l , 1999, Nickoloff et a l , 
2002) Serum mitogens are also reported to result in decreased Notch signalling 
pathway expression Angiotensin II and PDGF cause a time-dependent decrease in 
Notch 3, Jagged 1, HRT-1 and HRF-2, mediated, at least in part, by ERK-dependent 
signalling mechanisms (Campos et a l , 2002, Wang et a l , 2002a) Notwithstanding, 
our study has clearly demonstrated that serum activates the Notch signalling pathway in
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RVSMC, and that this is achieved in a CBF-1-dependent manner
This study also demonstrates that the expression of the endogenous ligand, 
Jagged, induces CBF-1-dependent activation of the Notch signalling pathway in VSMC 
Whilst the level of CBF-1 activation is markedly lower than that induced by either 
Notch IC over-expression or serum stimulation, the mode of activation is the same 
Many authors claim that Notch IC over-expression produces differing results compared 
with endogenous ligand activation (Iso et a l , 2002), however, others claim that 
constitutively activated Notch produces a phenotype identical to that produced by ligand 
activation (Uyttendaele et a l , 2000) We observed similar levels oi CBF-1 activation m 
Notch IC- and serum-stimulated cells, indicating that either the level of activation 
produced by Notch IC over-expression is physiological, or that the level of Notch 
signalling following serum stimlation of quiesced cells might represent a response 
similar to that seen in vascular insult or injury
It is widely accepted that EBNA-2 activates the Notch signalling pathway in 
many cell types (Hsieh et a l , 1996), and this study adds VSMC to that list Increased 
understanding of the activities of EBNA-2 may increase understanding of EBV-related 
pathologies, in addition, it is possible that EBNA-2, or other EBV components, could be 
used to manipulate the level of Notch pathway activation in VSMC
3 4 Conclusion
This study demonstrates the presence o f many components of the Notch 
signalling pathway in RVSMC, and illustrates that Notch 1 IC, Notch 3 IC, EBNA-2 
and serum stimulation result in a CBF-1-dependent activation of the Notch signalling 
pathway in these cells In conjunction with this, we have clearly shown that HRT-1 and 
Hes-5, but not Hes-1, are among the primary target genes of the Notch signalling 
pathway in RVSMC
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Chapter 4
Results
The Notch Signalling Pathway
and
VSMC Apoptosis
4 1  Introduction
Components o f the Notch signalling pathway are present m both embryonic and 
adult VSMC, therefore it is conceivable that the functional role o f this pathway in 
development is also conserved in adult cells However, the functional role o f the Notch 
signalling pathway in adult VSMC remains poorly characterized Therefore, this study 
attempts to further elucidate the role o f Notch signalling in adult VSMC As the Notch 
signalling pathway has previously been implicated m the regulation of apoptosis in both 
the developing vasculature and other non-vascular adult cells, this study mvestigated the 
role of this pathway m regulating VSMC apoptosis In addition, we investigate whether 
Notch regulation o f apoptosis occurs in a CBF-1-dependent manner, and attempt to 
determine some of the mechanisms whereby the Notch signalling pathway acts to 
regulate apoptosis This was achieved through investigating Notch interaction with 
members o f the BcI-2 and NFkB families
In recent years numerous studies have identified the Notch signalling pathway as 
an important factor in controlling cell fate decisions in many tissues (Artavanis- 
Tsakonas et a l , 1995, Greenwald 1998, Artavams-Tsakonas et a l , 1999) This role is 
conserved from Drosophila  to humans, and many examples o f Notch signalling 
pathway control o f  cell fate decisions abound W hilst accumulated data from 
Drosophila, C Elegans and vertebrates suggest that the Notch signalling pathway plays 
a fundamental role in the differentiaton o f uncommitted cells, it is now emerging that 
N otch has m ultiple developm ental roles, including the regulation o f other 
developmental cell fate decisions Notch has been shown to restrict neural 
differentiation in Drosophila (P arks et a l , 1997), and similarly represses both 
neurogenesis and myogenesis in vertebrates (Lai 2004) Aberrant regulation o f the 
Notch signalling pathway during development can result in embryonic lethality Studies 
using notch 1 knockout mice documented that the mice did not survive beyond the 
second stage o f gestation, and the embryos exhibited widespread apoptotic cell death 
(Swiatek et a l , 1994, Conlon et a l , 1995) Recent studies have implicated the Notch 
signalling pathway in multiple aspects o f vascular development, including control o f 
VSMC fate decisions, angiogeneic processes, and arterial-venous differentiation 
(Artavams-Tsakonas et a l , 1999, Gndley 2001, Iso et a l , 2003) Dysregulation of the 
Notch signalling pathway in embryogenesis can result in embryonic lethality due to 
defects in vasculogenesis (Xue et a l , 1999) and angiogenesis (Singh et a l , 2000), 
postulated to be as a result o f aberrant regulation o f cell fate decisions in the developing
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decisions in the developing vasculature Although the role o f the Notch signalling 
pathway in vasculogenesis and organogenesis is well established, the role of this 
pathway in the adult vasculature remains to be fully defined
A growing body of evidence also implicates the Notch signalling pathway in the 
control o f cell fate decisions m adult cells Notch has been widely implicated in the 
control of cell fate decisions in haematopoieisis (Bigas et a l , 1998, Jehn et a l , 1999), 
and is increasingly recognized as an important arbiter of cell fate in other tissues and 
organs Notch, for example, inhibits munne pancreatic cell (Apelqvist et a l , 1999) and 
myoblast differentiation (Bush et a l , 2001) Notch has also been shown to implicate 
other cell fate decisions in mature organisms Increased Notch receptor and ligand 
expression in carotid arteries decreases cellular migration through regulation of cell-cell 
and cell-matnx interactions (Lindner et a l , 2001) In addition, Notch signalling 
pathway activation results in increased proliferation in bone marrow stem cells and 
promyelotic leukaemia cells (Carlesso et a l , 1999) As many signalling pathways 
involved in the control of proliferation also regulate apoptosis, it is not surprising that 
the Notch signalling pathway has also been shown to regulate cellular apoptosis Whilst 
Notch is generally considered to exert an anti-apoptotic effect, some reports indicate 
that Notch can promote apoptosis, suggesting that the effect of Notch is cell type 
specific Notch 1 inhibits glucocorticoid-induced and T-cell receptor-mediated
apoptosis in thymocytes (Deftos et a l , 1998, Kaneta et a l , 2000), and Notch 4 has 
recently been shown to inhibit endothelial cell apoptosis (MacKenzie et a l , 2004) In 
contrast, Notch 1 activation has been reported to promote apoptosis in chicken B 
lymphocytes and human monocytes (Morimura et a l , 2000, Ohishi et a l , 2000) Notch 
regulation of cell fate decisions occurs both in a CBF-1-dependent and -independent 
manner Notch regulation of cell fate determination of marginal zone B cells is CBF-1 - 
dependent (Tanigaki et a l , 2002), whereas inhibition of munne muscle cell 
differentiation occurs in a CBF-1-independent manner (Shawber et a l , 1996) In 
addition, inhibition of apoptosis in endothelial cells is mediated via both CBF-1- 
dependent and -independent pathways (MacKenzie et a l , 2004)
Dysregulation o f cell fate decisions is associated with a wide variety of diseases, 
including cancer, neurodegeneration and heart disease As Notch is intimately involved 
in the regulation of cell fate decisions it was postulated and proven that aberrant 
regulation o f the Notch signalling pathway contributes to tumoungenesis This was first 
demonstrated in a recurrent translocation that is associated with many types o f T-cell 
acute lymphoblastic leukaemias, resulting in a constitutively active form of Notch 1 in
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the cells (Ellisen et a l , 1991) Increased expression of Notch receptors and ligands has 
since been identified in several cancers, including epithelial malignancies, colon 
adenocarcinomas and lung squamous carcinomas (Zagouras et a l , 1995, Daniel et a l , 
1997) Expression of the Notch ligands, Jagged 1 and Delta 1 are markedly increased in 
cervical carcinomas, with a concomitant increase m Notch 1 and Notch 2 receptor 
expression (Gray et a l , 1999)
Dysregulation of cellular proliferation and apoptosis are evident in multiple 
forms of vascular disease, including hypertension, transplant artenopathy and 
atherosclerosis (Best et a l , 1999) Clinically, the most common and important 
manifestation of excessive and progressive apoptosis is the loss of tissue from 
myocardial infarction and strokes In both instances, although there is a loss of tissue 
from ischemic necrosis, the larger loss of tissue results from the extension of the 
original vascular insult by apoptosis (Misao et a l , 1996) Therefore, a better 
understanding of the regulation of these processes in vascular cells could identify 
important therapeutic targets, and have potentially important clinical implications 
Dysregulation of the Notch signalling pathway underlies a number of adult disorders 
with associated vascular pathologies, such as CADASIL and AGS (Loomes et a l , 1999, 
Brulin et a l , 2002) Therefore, it is conceivable that the Notch signalling pathway 
plays a role in the regulation of cell fate decisions within the vasculature Recent 
reports have provided initial evidence that this is the case Mac Kenzie et a l , (2004) 
has shown that Notch 4 inhibits EC apoptosis triggered by lipopolysaccharide In 
addition, Wang et a l , (2002b) demonstrate that Notch 3 inhibits Fas-mediated apoptosis 
in VSMC through of induction of c-FLIP
Apoptosis is a normal physiological process required for the maintenance of 
homoestasis in all tissues and organs o f the body, including the vasculature Therefore, 
this study initially investigated the effect of manipulation of the Notch signalling 
pathway on VSMC apoptosis in cycling cells Serum deprivation is a well-documented 
trigger for apoptosis in many cells types, including vascular cells (Yao and Cooper 
1995, Kono et a l , 2002) The effect o f manipulation of the Notch signalling pathway 
was also investigated on serum deprivation-induced apoptosis in VSMC Mac Kenzie 
et a l , (2004) have documented that Notch 4 inhibits EC apoptosis in both a CBF-1 - 
dependent and -independent manner, in addition, Wang et a l , revealed that Notch 3 
protects VSMC from apoptosis in a CBF-1-independent manner Therefore, this study 
investigated whether Notch signalling pathway activation in VSMC could affect 
apoptosis in a CBF-1-dependent manner This was achieved through transfection of
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CBF-1 specific inhibitors, including mutant Notch 1 IC, RPMS-I, and R218H-RBPJk
The process o f apoptosis is tightly regulated through a number o f gene products 
that promote or inhibit cell death at different stages o f apoptosis The most extensively 
studied, and perhaps the most important, are the Bcl-2 family (Gupta 2003) The net 
influence o f the Bcl-2 family on apoptosis appears to be the ratio between the pro- and 
anti-apoptotic molecules in a cell at any given time A number of signalling pathways, 
such as the MAPK and NFkB pathways, can influence the relative concentration of Bel- 
2 family o f proteins in mammalian cells (Gupta 2003), this study investigates whether 
the Notch signalling pathway should be added to this list EBNA-2, which mimics and 
subverts the Notch signalling pathway, has been shown to up-regulate bfl-1 mRNA 
levels in a Burkitts lymphoma (BL) cell line, and regulate bfl-1 promoter activity in a 
CBF-1-dependent manner (P Pegman personal commumication) Therefore, the effect 
o f Notch over-expression on bfl-1 promoter activity in VSMC was examined In 
addition, Notch 1 has been shown to physically interact with the NFkB signalling 
pathway in T cells (Guan et a l , 1996) Notch exhibits an IicB-like activity, physically 
interacting with the p50 NFkB subumt, sequestering it in the cytoplasm, thus inhibiting 
NFkB activity It is currently not documented whether Notch IC, or indeed EBNA-2, 
exerts the same effect on NFkB activity in VSMC This study, therefore, examined the 
effect o f Notch 1 IC, Notch 3 IC and EBNA-2 on NFkB activity in VSMC using a 
luciferase-tagged promoter upstream of NFkB binding sites, and an IkB control 
plasmid It is conceivable, and indeed likely, that the Notch signalling pathway could 
be part o f a complex multi-signalling network that exerts an influence over VSMC fate 
decisions, including apoptosis This, however, remains largely undefined An mcreased 
understanding into the regulation of apoptosis in the vasculature, in particular in VSMC, 
has the potential to translate into future therapeutic benefits
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4 2 Results
4 2 1 Inhibition of Endogenous Notch-mediated CBF-l-dependent Signalling in 
RVSMC Results in Increased Apoptosis
To determine the effects of the Notch signalling pathway on RVSMC apoptosis 
in vitro, the effect of inhibition of endogenous Notch signalling on RVSMC apoptosis 
was initially investigated This was achieved either through transfection of cycling 
RVSMC with inhibitors of the Notch signalling pathway, RPMS-I, R218H-RBP-Ja, or 
mutant Notch 1 IC, or treatment of cells with the pharmacological inhibitors Brefeldin 
A or Monensin Cells were co-transfected with the puromycin resistance plasmid, and 
exposed to puromycin-containmg media, to ensure a high level of plasmid expression
Apoptosis was measured using histochemical analysis and caspase 3 activity 
assays, as described in section 2 3 10 Briefly, the annexin V/propidium iodide and the 
acndine orange/ethidium bromide dual stains, which allow simultaneous detection of 
viable, apoptotic and necrotic cells, were used in this study Using the annexin 
V/propidium iodide dual stain, viable cells (AV negative, PI negative) do not fluoresce, 
apoptotic cells (AV positive, PI negative) appear green, and necrotic cells (AV positive, 
PI positive) appear orange/red The acndine orange/ethidium bromide dual stain causes 
viable cells to appear to have a bright green nucleus with intact structure, while early 
apoptotic cells exhibit a bright green nucleus showing condensation of chromatin as 
dense green areas Late apoptotic cells have an orange nucleus showing condensation 
of chromatin, while necrotic cells display a red nucleus with intact structure The 
reliability of all assays was confirmed using a number of ubiquitous activators of 
apoptosis, such as hydrogen peroxide and serum deprivation (data not shown)
Transfection of RVSMC with RPMS-1 and mutant Notch 1 IC, and treatment of 
the cells with Brefeldin A all resulted in significantly increased apoptosis, as measured 
by the annexin V/propidium iodide dual stain Inhibition of Notch with RPMS-I, 
mutant Notch 1 IC or Brefeldin A resulted in significantly increased apoptotic (annexin 
V positive/green) cells with respect to mock transfected control, which exhibited 
predominately viable (annexin V negative/propidium iodide negative) cells (Figure 4 1) 
Representative histochemical analysis are shown in Figure 4 1A, and cumulative data 
on the percentage of apoptotic (annexin V positive/propidium iodide negative cells) are 
also presented (Figure 4 IB) Mock transfected cycling RVSMC exhibited a low level 
of apoptosis (4 3±2 72%), whereas inhibition of endogenous CBF-1 -dependent Notch
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signalling with RPMS-I, mutant Notch 1 IC and Brefeldin A resulted in an increase in 
the percentage of apoptotic cells to 16 18±1 4%, 16 5±1 5% and 14 5±0 5% 
respectively This increase in apoptosis in RVSMC due to endogenous Notch inhibition 
was further confirmed using the acndine orange/ethidium bromide dual stain 
Transfection of cycling RVSMC with the Notch inhibitor RPMS-I resulted in a 
significant increase in apoptotic cells, as compared to mock transfected control cells 
(Figure 4 2A) Cumulative data on the percentage of apoptotic cells again revealed a 
low level of apoptosis in control cells (5 3±0 3%), which is significantly increased due 
to Notch inhibition to 31 0±8 32% (Figure 4 2B) In addition, analysis of caspase 3 
activity m RVSMC revealed an increase in the activity of this marker of apoptosis due 
to endogenous CBF-1-dependent Notch inhibition Transfection with the Notch 
signalling inhibitor, RPMS-I, resulted in a significant fold increase in caspase 3 activity 
(1 44±0 07) with respect to mock transfected control cells (Figure 4 3A) Furthermore, 
transfection of cells with mutant Notch 1 IC, R218H-RBP-Ja, or treated with the 
pharmacological inhibitor Brefeldin A resulted in a fold increase of caspase 3 activity 
over control to 1 59±0 07, 1 55±0 05 and 1 2±0 15 respectively, with significant 
increases being observed due to mutant Notch 1 IC- and R218H-RBP-Jcunduced 
inhibition o f the Notch signalling pathway (Figure 4 3B)
The effect o f endogenous CBF-1-dependent Notch pathway inhibition on the 
bcl-2 family o f apoptotic genes was also investigated (Figure 4 4) RPMS-I transfection 
resulted in an increase in the pro-apoptotic bad and box gene expression to 1 52±0 24 
and 1 3±0 3 over mock transfected control cells respectively A significant fold 
increase in the anti-apoptotic bcl-2 gene expression was also seen in RPMS-I 
transfected cells to 1 83±0 33 over the mock transfected control In contrast, a decrease 
of 27 0±10% in anti-apoptotic bcl-Xi mRNA expression was evident in RPMS-I 
transfected cells (to 0 73±0 1) as compared to mock transfected control cells (Figure 
4 4A) To further investigate whether these genes were under the control of the Notch 
signalling pathway, or whether the change in gene expression observed following CBF- 
1 -dependent Notch inhibition was compensatory, we over-expressed Notch 3 IC in the 
cells and examined bcl-2 family gene expression Notch 3 over-expression increased 
bad expression to 1 35±0 45 over mock transfected control cells, and a significantly 
deceased box expression by 34 0± 10 0% (to 0 66±0 1) as compared to mock transfected 
cells In addition, an increase in both bcl-2, and bcl-Xi expression to 1 5±0 29 and 
1 6±0 21 over mock transfected control cells was also observed, with the increase in
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b c l - X L  proving to be significant (Figure 4 4B) Therefore a reciprocal change in bax and 
bcl-x i, but not bad  and bcl-2 , was evident following CBF-1 -dependent stimulation and 
inhibition of the Notch signalling pathway This was confirmed by simultaneous over- 
expression and inhibition of the Notch signalling pathway, which decreases any change 
exerted by individual manipulation of the Notch signalling pathway on both bax and 
bcl-XL expression to 1 08±0 07 and 0 9±0 09 as compared to mock transfected control 
(Figure 4 4C)
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Figure 4.1 Inhibition of Notch in Cycling RVSMC causes increased 
Apoptosis, as measured by the Annexin V/Propidium Iodide Dual 
Stain
a
mock RPMS-I 
transfected
a
Brefeldin A mut Notch 1 IC
Figure 4.1 Inhibition o f Notch in cycling RVSM C results in increased apoptosis.
RVSM C were transiently transfected with the puromycin resistance plasmid, 
pGK3puro, and co-transfected with the em pty vector p7pCM V or the Notch 
inhibitors, RPMS-I or mut Notch 1 IC. Following overnight recovery, cells were 
incubated in puromycin containing growth medium (0.8 jxg/ml, 48 h). Additionally, 
indicated cells were treated with the pharmacological inhibitor Brefeldin A 
(0.1 ng/ml, 24 h). Cells were stained with the Annexin V/Propidium Iodide dual stain 
and viewed under a fluorescent microscope. A) Representative images. Apoptotic 
cells, blue arrow; N ecrotic cells, red arrow. B) G raph showing percentage increase in 
the num ber of apoptotic cells due to Notch inhibition. Each experim ent was 
perform ed in duplicate, with the graph representative o f n=3. K p<0.05 as com pared to 
mock transfected control (student’s t test).
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Figure 4.2 Inhibition of Notch in Cycling RVSMC causes increased 
Apoptosis, as measured by the Acridine Orange/Ethidium Bromide 
Dual Stain
A
mock transfected RPMS-I
B
mock transfected RPMS-I
Figure 4.2 Inhibition o f Notch in cycling RVSM C results in increased apoptosis.
RVSM C were transiently transfected with the puromycin resistance plasmid, 
pGK3puro, and co-transfected with the empty vector p7pCMV or the Notch inhibitor, 
RPMS-I. Following overnight recovery, cells were incubated in puromycin 
containing growth medium (0.8 (ng/ml, 48 h). Cells were stained with the Acridine 
O range/Ethidium  Bromide dual stain and viewed under a fluorescent microscope. A) 
Representative images. Viable cell, white arrow; Early apoptotic cell, yellow arrow ; 
Late apoptotic cell, blue arrow. B) Graph showing percentage increase in the num ber 
of apoptotic cells due to Notch inhibition. Each experim ent was perform ed in 
duplicate, with the graph representative of n=2. K p<0.05 as com pared to mock 
transfected control (student’s t test).
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Figure 4 3 Inhibition of Notch in Cycling RVSMC causes increased 
Apoptosis, as measured by Caspase 3 Activity
A
mock transfected RPMS-I
Figure 4  3 Inhibition o f  Notch in cycling RVSM C results in increased apoptosis
RVSM C w ere transiently transfected with the purom ycin resistance plasmid, 
pGK3puro, and co-transfected with the empty vector p7pCM V or the Notch 
inhibitors, RPM S-I, m ut Notch 1 IC or R218H as indicated Follow ing overnight 
recovery, cells were incubated in purom ycm  containing growth m edium (0 8 fig/ml, 
48 h) A dditionally, indicated cells were treated with the pharm acological inhibitor 
Brefeldin A (0 l^ig/ml, 24  h) Protein was isolated and assayed for caspase 3 activity 
Caspase assays were norm alized to protein levels, and expressed as fold increase over 
control (= the value obtained with mock transfected cells arbitrarily  assigned a value 
o f 1) A) n=6, * p<0 05 as com pared to m ock transfected control (rank test) B) 
R epresentative experim ent perform ed in triplicate °  p<0 05, 00 p<0 005 as com pared 
to m ock transfected control (student’s t test)
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Figure 4 4 The Effect of Endogenous Inhibition or Over-expression 
of Notch 3 IC on Bcl-2 Family mRNA Expression
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C Notch 3 IC + RPMS-I
mock transfected 
Notch 3 IC 
RPMS-I
Notch 3 IC + RPMS I
box
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Notch 3 IC 
RPMS-I
Notch 3 1C + RPMS-
bcl- xL
Figure 4 4 Inhibition o f Notch in cycling RVSM C results in increased apoptosis
RVSM C w ere transiently transfected with the purom ycin resistance plasmid, 
pG K 3puro, and co-transfected with the em pty vector p7pCM V, the Notch inhibitor, 
RPM S-I (A) or Notch 3 IC (B), or both (C) as indicated Following overnight 
recovery, cells were incubated in purom ycin containing growth m edium  (0 8 tig/m l, 48 
h) RNA w as isolated and assayed for bad , bax, bcl-2  and bcl-xL expression as 
indicated using quantitative real time PCR analysis Expression was norm alized to 
GA PD H  levels, and expressed as fold increase over control (= the value obtained with 
m ock transfected cells arbitrarily assigned a  value of 1) n=3, a p < 0 0 5  as com pared to 
m ock transfected control
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4 2 2 1 Serum Deprivation-induced Apoptosis in RVSMC
Several studies have established the fact that serum deprivation induces VSMC 
apoptosis (Bennett et a l , 1995, Kono et a l , 2002) This is confirmed in the present 
study through analysis of the apoptotic profile o f serum deprived RVSMC, again 
utilizing histochemical analysis and caspase 3 activity assays
Apoptosis was measured during a serum deprivation timecourse over 96 h (data 
not shown) A period of 72 h serum deprivation was necessary to induce apoptosis, as 
measured with the annexin V/propidium iodide and the acndine orange/ethidium 
bromide dual stains (Figure 4 5 A and 4 5B respectively) Serum deprivation resulted in 
a significant increase in the percentage of apoptotic cells, as measured using the annexin 
V/propidium iodide dual stain, with control cells exhibiting 2 5±0 6% apoptosis 
compared to 67 75±4 5% in serum deprived cells (Figure 4 5 A) Similarly, 
measurement of apoptosis using the acridine orange/ethidium bromide dual stain 
revealed a significant increase in the percentage of apoptotic cells in serum deprived 
(71 1±7 0%) versus control cells (2 0±0 5%) (Figure 4 5B) Using increase in caspase 3 
activity as a measure of apoptosis, 6 h serum deprivation was shown to be optimal to 
induce apoptosis (data not shown) Serum deprivation resulted in a significant fold 
increase in caspase 3 activity (1 4±0 06) over serum control cells (Figure 4 5C)
The anti-apoptotic effect o f the Notch signalling pathway revealed in section 
4 2 1 was further analyzed through over-expression of either Notch 1 IC or Notch 3 IC 
in RVSMC The effect o f this over-expression on serum deprivation induced apoptosis 
was investigated
4 2 2 2 Effect of Notch 3 IC Over-expression on Serum Deprivation-induced 
Apoptosis in RVSMC
RVSMC were transfected with an empty vector or Notch 3 IC, and co­
transfected with the Notch signalling pathway inhibitors, RPMS-I or mutant Notch 1 IC 
Apoptosis was induced by serum deprivation and apoptosis measured using the annexin 
V/propidium iodide dual stain (Figure 4 6) Transfection of Notch 3 IC significantly
attenuated the serum depnvation-mduced percentage increase in apoptotic cells
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4 2 2 Effect o f Notch S ignalling Pathw ay O ver-expression on Serum  D eprivation-
induced A poptosis in RV SM C
from 67 75±4 5% in mock transfected control cells to 38 53±2 0% Co-transfection of 
the Notch inhibitors, RPMS-I and mutant Notch 1 IC, decreased this attenuation to 
50 53±3 85% and 60 91 ±6 12% respectively (Figure 4 6B) Similarly, transfection of 
Notch 3 IC proved to be anti-apoptotic in cells analyzed using the acridine 
orange/ethidium bromide dual stain (Figure 4 7) Serum deprived cells exhibited 
71 0±7 0 percentage apoptosis (Figure 4 7B) Transfection of Notch 3 IC significantly 
attenuated the serum deprivation-induced increase in apoptosis to 39 2±3 8% 
Histochemical analysis suggests that although Notch 3 1C demonstrated an anti- 
apoptotic effect on serum deprivation-induced apoptosis, the presence of apoptotic 
bodies in the Notch 3 IC transfected cells suggests that Notch retards but not completely 
inhibits apoptosis The anti-apoptotic effect o f Notch 3 IC was further confirmed by 
caspase 3 activity assays on mock and Notch 3 IC transfected cells (Figure 4 8) Notch 
3 IC transfection resulted m a small but significant attenuation of the fold increase in 
caspase 3 activity to 0 76±0 04 over control (serum deprived mock transfected cells, 
arbitrarily assigned a value of 1), which represents a 24 0±4 0% decrease in caspase 3 
activity Co-transfection of Notch 3 IC with the Notch inhibitor, RPSM-I, restored 
caspase 3 activity to 1 29±0 21 fold over control, which is significantly increased over 
the level of caspase 3 activity in cells transfected with Notch 3 IC alone
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Figure 4.5 Serum Deprivation Induces Apoptosis in RVSMC 
A Annexin V/Propidium Iodide
25-
Serum Serum Deprived
B Acridine Orange/Ethidium Bromide
Serum Serum Deprived
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B Acndine Orange/Ethidium Bromide (continued)
C Caspase 3 Activity
Serum Serum Deprived
Figure 4 5 Serum  deprivation induces apoptosis in RV SM C  A and B) RVSM C were 
serum  deprived for 72 h Cells were stained with the annexin V /propidium  iodide dual 
stam  (A) or the acnd ine orange/ethidium  bromide dual stain (B) and viewed under a 
fluorescent m icroscope Representative im ages, viable cells, white arrow , apoptotic 
cells, blue arrow  Histogram s represent cum ulative data for the annexin V/propidium  
iodide dual stain  (A) or the acndine orange/ethidium  brom ide dual stain (B), n=3, 00 
p<0 005 as com pared to serum control (student’s t test) C) RVSM C w ere serum 
deprived for 6  h Protein was isolated and assayed for caspase 3 activity Caspase 
assays w ere norm alized to protein levels, and expressed as fold increase over control (= 
the value obtained with cells exposed to 10% FCS, arbitrarily assigned a value of 1), 
n=6, * p<0 05 as com pared to serum  control (rank test)
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Figure 4.6 Effect o f N otch 3 O ver-expression on Serum  Deprivation-
induced A poptosis in R V SM C
mock transfected Notch 3 IC+ RPMS-I
Notch 3 IC Notch 3 IC + mut Notch 1 IC
B
+ RPMS-I 
+ mut Notch 1 IC
mock transfected Notch 3 IC
Figure 4.6 Effect o f Notch 3 on serum  deprivation-induced apoptosis in RVSM C.
RVSM C were transiently transfected with the puromycin resistance plasmid, pGK3puro, 
and co-transfected with the em pty vector p7pCM V, Notch 3 IC or the Notch inhibitors, 
RPMS-I or mut Notch 1 IC as indicated. Following overnight recovery, cells were 
incubated in puromycin containing growth medium (0.8 fig/ml, 48 h). RVSM C were 
serum deprived for 72 h. Cells were stained with the Annexin V/Propidium  Iodide dual 
stain and viewed under a fluorescent microscope, n=3. A) Representative images; 
apoptotic cells, blue arrow. B) Graph showing percentage apoptotic cells. K p<0.05 as 
com pared to mock transfected control, s p<0.05 as com pared to cells over-expressing 
Notch 3 IC (student’s t test).
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Figure 4.7 Effect o f N otch 3 O ver-expression on Serum  Deprivation-
induced Apoptosis in RV SM C
mock transfected mock transfected Notch 3 IC
B
100 - mock transfected 
mock transfected 
Notch 3 IC
Serum Serum Deprived
Figure 4.7 Effect o f Notch 3 on serum  deprivation induced apoptosis in RVSM C.
RVSM C were transiently transfected with the puromycin resistance plasmid, 
pGK3puro, and co-transfected with the empty vector p7pCMV or Notch 3 IC as 
indicated. Following overnight recovery, cells were incubated in puromycin containing 
growth medium (0.8 fig/ml, 48 h). RVSM C were serum deprived as indicated for 72 h. 
Cells were stained with the Acridine Orange/Ethidium  Bromide dual stain and viewed 
under a fluorescent m icroscope, n=3. A) Representative images; V iable cell, white 
arrow; Early apoptotic cell, yellow arrow; Late apoptotic cell, blue arrow. B) Graph 
showing percentage apoptotic cells. KK p<0.005 as com pared to mock transfected 
control, $ p<i).05 as com pared to cells over-expressing Notch 3 IC (student’s t test).
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Figure 4 8 E ffect o f  N otch  3 O ver-expression  on  Serum  D eprivation-
induced A poptosis in  RV SM C
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Figure 4 8 Effect o f  Notch 3 on serum  deprivation-induced apoptosis m RVSM C
RVSM C were transiently transfected with the purom ycin resistance plasmid, 
pG K3puro, and co-transfected with the em pty vector p7pCM V, Notch 3 IC or the 
Notch inhibitor RPM S-I, as indicated Following overnight recovery, cells were 
incubated m purom ycin containing growth m edium  (0 8 fig/ml, 48 h) RVSM C were 
serum  deprived for 6 h Protein was isolated and assayed for caspase 3 activity 
Caspase assays w ere norm alized to protein levels, and expressed as fold increase over 
control (= the value obtained with mock (p7pCM V) transfected cells, arbitrarily 
assigned a value o f 1), n=3 °p < 0  05 as com pared to m ock transfected co n tro l,$ p<0 05 
as com pared to cells over-expressing Notch 3 IC (student’s t test)
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In addition to Notch 3 IC, the effect of Notch 1 IC on serum deprivation-induced 
apoptosis was also investigated RVSMC were transfected with an empty vector or 
Notch 1 IC, and co-transfected with the Notch inhibitor RPMS-I Apoptosis was 
induced through serum deprivation, and analyzed using the annexin V/propidium iodide 
dual stain (Figure 4 9) Results obtained clearly demonstrate the anti-apoptotic effect of 
Notch 1 IC against serum deprivation-induced apoptosis Notch 1 IC significantly 
attenuated the serum deprivation-induced increase in apoptotic cells from 68 0±4 7% to 
40 0±2 88% Co-transfection of Notch 1 IC with RPMS-I resulted in a restoration of 
the level of apoptosis over control level, to 78 0±7 2%, which was significantly 
increased over the level of apoptosis apparent in Notch 1 IC transfected cells alone 
The anti-apoptotic effect of Notch 1 IC was further confirmed through analysis o f serum 
deprivation-induced apoptosis with the acridine orange/ethidium bromide dual stain 
(Figure 4 10) Serum-deprivation significantly increased the percentage of apoptotic 
cells from 3 2±0 7% to 73 2±5 9% This increase in apoptosis was significantly 
attenuated with the transfection o f Notch 1 IC to 41 3±4 5% (Figure 4 10B) Caspase 3 
activity analysis also established the anti-apoptotic effect o f Notch 1 IC on serum 
deprivation-induced apoptosis Similar to the effect of Notch 3 IC, Notch 1 IC 
transfection resulted in a small but significant attenuation of the fold increase in caspase 
3 activity to 0 80±0 045 to control (serum deprived mock transfected cells, arbitrarily 
assigned a value of 1), which represents a 20 0±4 5% decrease in caspase 3 activity 
Over-expression of the Notch inhibitors, RPMS-I and R218H-RBP-Ja, resulted in 
caspase 3 activities o f 1 11±0 08 and 1 27±0 11 respectively over control
4 2 2 3 Effect o f N otch 1 IC O ver-expression on Serum  D eprivation-induced
A poptosis in RVSM C
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Figure 4.9 Effect of Notch 1 Over-expression on Serum Deprivation- 
induced Apoptosis in RVSMC
A
mock transfected Notch 1 IC Notch 1 IC + RPMS-1
Serum Deprived
100 + RPMS-I
mock
transfected Notch 1 IC
Figure 4.9 Effect o f Notch 1 on serum  deprivation-induced apoptosis in RVSM C.
RVSMC were transiently transfected with the puromycin resistance plasmid, pGK3puro, 
and co-transfected with the em pty vector p7pCM V, Notch 1 IC or the Notch inhibitor, 
RPMS-I. Following overnight recovery, cells were incubated in puromycin containing 
growth medium (0.8 fxg/ml, 48 h). RVSM C were serum deprived for 72 h. Cells were 
stained with the Annexin V/Propidium Iodide dual stain and viewed under a fluorescent 
microscope, n=3. A) Representative images; Blue arrows, apoptotic cells. B) Graph 
showing percentage apoptotic cells. K p<0.05 as com pared to m ock transfected c o n tro l,$ 
p<0.05 as com pared to cells over-expressing Notch 1 IC (student’s t test).
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Figure 4.10 Effect o f N otch 1 on Serum  D eprivation-induced
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Figure 4.10 Effect o f Notch 1 on serum  deprivation-induced apoptosis in RVSM C.
RVSM C were transiently transfected with the purom ycin resistance plasmid, pGK3puro, 
and co-transfected with the em pty vector p7pCM V or Notch 1 IC as indicated. Following 
overnight recovery, cells were incubated in puromycin containing growth medium (0.8 
fxg/ml, 48 h). RVSMC were serum deprived as indicated for 72 h. Cells were stained 
with the A cridine O range/Ethidium  Brom ide dual stain and viewed under a fluorescent 
m icroscope, n=3. A) Representative images; W hite arrows, viable cell; Blue arrow, 
apoptotic cell. B) Graph showing percentage apoptotic cells. K p<0.05 as com pared to 
mock transfected serum control, $ p<0.05 as com pared to m ock transfected serum 
deprived cells (student’s t test).
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Figure 4 1 1  E ffect o f  N otch 1 on serum  deprivation-induced apoptosis in RVSM C
RVSM C w ere transiently transfected w ith the purom ycin resistance plasmid, pGK3puro, 
and co-transfected w ith the em pty vector p7pCM V, Notch 1 IC or the N otch inhibitors 
RPM S-I or R218H, as indicated Following overnight recovery, cells were incubated in 
purom ycin containing growth medium (0 8 n-g/ml, 48 h) RVSM C were serum deprived 
for 6 h Protein w as isolated and assayed for caspase 3 activity Caspase assays were 
norm alized to protein levels, and expressed as fold increase over control (= the value 
obtained with m ock transfected cells, arbitrarily assigned a value o f 1), n=3 °  p<0 05 as 
com pared to m ock transfected control, $ p<0 05 as com pared to  cells over-expressing 
Notch 1 IC (student’s t test)
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4 2 3 Effect o f Serum  D eprivation on the N otch Signalling Pathw ay in RVSM C
To elucidate an explanation for serum deprivation-induced apoptosis in 
RVSMC, and to further confirm the anti-apoptotic effect of the Notch signalling 
pathway on such apoptosis, the effect o f serum deprivation on components of the Notch 
signalling pathway was examined
Expression of notch 3 was determined using quantitative real time PCR 
analysis at 6 h, 24 h, and 72 h post-serum deprivation, and compared to cycling control 
cells at each timepoint (Figure 4 12A) Serum deprivation resulted in a decrease in 
notch 3 mRNA expression levels at 6 h, 24 h, and 72 h post-serum deprivation by 
48 0±3 0%, 46 0±2 0% and 37 0±7 0% respectively as compared to control cycling 
cells The decrease evident at 6 h and 24 h post-serum deprivation was significant with 
respect to cycling control cells A corresponding serum deprivation-induced decrease in 
Notch 3 IC expression was also observed in RVSMC (Figure 4 12B) Serum 
deprivation significantly decreased Notch 3 IC protein expression by 48 0± 11 0% as 
compared to control cycling cells In addition, serum deprivation resulted in a decrease 
in Notch target gene and Notch ligand mRNA expression (Figure 4 12C) Serum 
deprivation for 6 h resulted in a significant decrease in both notch 1 (41 0±5 0%) and 
hrt-2 (40 0±14 0%) mRNA expression compared to serum control mRNA expression 
levels Similar significant decreases in hes-5 (31 0±19 0%) and jagged  (35 0±13 0%) 
expression levels was also noted
The effect of serum deprivation on CBF-1 -dependent promoter activity m 
RVSMC was also investigated RVSMC were co-transfected with a CBF-1 luciferase- 
tagged reporter plasmid and Notch 1 IC, and, following overnight recovery from 
transfection, cells were maintained in either serum containing or serum deprived media 
as indicated (Figure 4 13) A pattern of CBF-1 activity reminiscent of that due to serum 
stimulation (Figure 3 13) was evident in cycling cells, and can perhaps be attributable to 
exposure of the cells to fresh serum Serum deprivation resulted in a decrease in CBF-1 
activity at each timepoint, with respect to its serum-containing counterpart A 
significant decrease o f 34 3±4 5% was evident 4 h post serum deprivation, with similar 
levels of inhibition of 37 0±20 6% and 22 3±39 0% seen due to serum deprivation at 8 h 
and 24 h (Figure 4 13)
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Interactions between the Notch signalling pathway, EBV-related proteins, and 
the NFkB pathway have been demonstrated (Wang et a l , 2001, D'Souza et a l , 2004) in 
many cell types, but not VSMC Therefore, we investigated whether the components of 
the Notch signalling pathway or EBNA-2 could transactivate a luciferase tagged NFkB 
reporter plasmid in VSMC
RVSMC were transfected with the luciferase-tagged N F kB reporter plasmid, and 
co-transfected with either p7pCMV, the known NFkB inhibitor, IkB, Notch 1 IC, Notch
3 IC or EBNA-2 (Figure 4 14) The baseline level o f transactivation of the NFkB 
plasmid in the presence o f serum was high, and arbitrarily assigned a value of 1 Co- 
transfection of IkB resulted in a significant attenuation o f 79 0±2 0% in basal NFkB 
activity in VSMC Similarly, both Notch 1 IC and Notch 3 IC resulted in a significant 
attenuation of 69 0±14 0% and 72 0±7 0% respectively in basal N FkB activity 
Transfection of EBNA-2 however, did not affect the level of NFkB activity in VSMC
4 2.5 Effect of the Notch Signalling Pathway on bfl-1 Promoter Activity in
RVSMC
It has previously been shown that ectopic expression of the anti-apoptotic Bfl-1 
protein can protect a Burkitts lymphoma cell line from serum deprivation-induced 
apoptosis in vitro (D’ Souza et a l , 2000) Additionally it has been shown that EBNA-2 
can up-regulate bfl-1 mRNA expression levels, and regulate bfl-1 promoter activity in a 
Burkitts lymphoma cell line through interaction with components o f the cellular Notch 
signalling pathway (D’Souza et a l , 2004) Therefore, this study addressed the question 
whether components of the Notch signalling pathway activated the bfl-1 promoter in 
RVSMC
RVSMC were transfected with the luciferase-tagged bfl-1 promoter, and co­
transfected with either p7pCMV, Notch 1 IC, Notch 3 IC or EBNA-2 (Figure 4 15) 
Neither Notch 1 IC (0 99±0 26) nor Notch 3 IC (0 97±0 34) transfected cells showed 
any fold change in bfl-1 luciferase activity with respect to mock transfected cells 
(arbitrarily assigned a value o f 1) EBNA-2 transfection, however, resulted in a 
3 13±1 2 fold increase in bfl-1 luciferase activity compared to mock transfected control
4 .2 .4  E ffect o f  the N otch  S ignalling  P athw ay on N F kB  Prom oter A ctiv ity  in
RV SM C
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Figure 4 12 Effect o f Serum  D eprivation on the N otch Signalling
Pathw ay in RV SM C
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Figure 4 12 E ffect o f serum  deprivation on the N otch signalling pathway in 
RVSM C A ) RVSMC were maintained in serum containing media (10% FCS) or serum 
deprived media (0% FCS) for 6 h, 24 h or 72 h as indicated mRNA levels were 
measured using quantitative RT-PCR for Notch 3, and expressed as fold increase over 
control (= the levels o f target gene present in cells exposed to serum containing media at 
each timepoint, arbitrarily assigned a value of 1) Representative experiment, assayed in 
triplicate B) RVSMC were maintained in serum containing media (10% FCS) or serum 
deprived media (0% FCS) for 6  h, assayed for Notch 3 protein expression, and expressed 
as fold increase over control 0= the level Notch 3 protein in cells exposed to serum 
containing media, arbitrarily assigned a value o f 1), n=2 C) RVSMC were maintained 
in serum containing or serum deprived media for 6 h as indicated mRNA levels were 
measured using quantitative RT-PCR for Notch 1, Notch 3, HRT-2, Hes-5 and Jagged, 
and expressed as fold increase over control (= the levels o f target gene present in cells 
exposed to serum containing media, arbitrarily assigned a value of 1), n=3 ° p<0 05, 00 
p<0 005 as compared to serum control (student’s t test)
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Figure 4 13 E ffect o f  Serum  D eprivation on  the N otch  Signalling
Pathw ay A ctivity  in RV SM C
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Figure 4 1 3  E ffect o f serum  depnvation  on the Notch signalling pathway activity m 
R VSM C RVSMC were transiently transfected with the CBF-1 luciferase-tagged 
reporter plasmid and Notch 1 IC (B) Following overnight recovery from transfection, 
cells were maintained in serum containing or serum deprived media as indicated (0 h) 
Luciferase assays were normalized to p-galactosidase activities and protein levels, n=2, 
and expressed as fold increase over control (= the value obtained with transfected cells at 
0 h arbitrarily assigned a value of 1) °  p<0 05, 00 p<0 005 as compared to 0 h serum 
control,$ p,0 05 as compared to serum control at that timepoint (student’s t test)
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Figure 4 1 4  E ffect o f N otch S ignalling Pathw ay A ctivation  on NFkB
Prom oter A ctivity in  R V SM C
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+  IkB  
+ Notch 1 IC 
+ Notch 3 IC 
+ EBNA-2
N F k B-Iuc
Figure 4 14 Effect o f  Notch signalling pathway activation on N F k B  prom oter 
activity in RV SM C  RVSMC were transiently transfected with the N F k B  reporter 
plasmid and co-transfected with either Notch 1 IC, Notch 3 IC or EBNA-2 Following 
overnight recovery from transfection, protein samples were isolated and assayed for 
luciferase activity Luciferase assays were normalized to (3-galactosidase activities and 
protein levels, n=2, and expressed as fold increase over control (= the value obtained 
with N F kB  reporter plasmid transfected cells arbitrarily assigned a value of 1), ° 
p<0 0 5 ,00 p<0 005 as compared to N F kB  reporter plasmid transfected cells (student’s t 
test)
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Figure 4 15 Effect o f N otch S ignalling Pathw ay A ctivation on bfl-1
Prom oter A ctivity in R V SM C
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Figure 4 15 Effect o f Notch signalling pathway activation on bfl-1 prom oter 
activity in RVSM C RVSMC were transitntly transfected with the bfl / reporter 
plasmid and co-transfected with either Notch I IC, Notch 3 IC or EBNA-2 Following 
overnight recovery from transfection, protein samples were isolated and assayed for 
luciferase activity Luciferase assays were normalized to K-galactosidase activities and 
protein levels, n=3, and expressed as fold increase over control (= the value obtained 
with bfl I reporter plasmid transfected cells arbitrarily assigned a value o f 1)
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4 3 Discussion
This study clearly establishes the anti-apoptotic effect of the Notch signalling 
pathway in VSMC, and proves that this anti-apoptotic effect is, at least in part, CBF-1 - 
dependent
Inhibition of the Notch signalling pathway clearly increases apoptosis in cycling 
VSMC, suggesting that Notch exerts a net anti-apoptotic effect in these cells This 
concurs with the anti-apoptotic role o f the Notch signalling pathway established in 
many other cell types (Kaneta et a l , 2000, MaeKenzie et a l , 2004), and confirms the 
addition of VSMC to this list In concurrence with this study, Wang et a l , (2002b) 
recently published a report citing that Notch 3 IC promotes VMSC survival in response 
to the pro-apoptotic FasL, through induction of cFLIP Contrary to this study however, 
they find that Notch 3 inhibits VSMC apoptosis in a CBF-1 -independent manner, 
whereas we have established a CBF-1-dependent anti-apoptotic effect of the Notch 
signalling pathway It is likely, therefore, that Notch can inhibit apoptosis in both a 
CBF-1-dependent and -independent manner in VSMC To concur with this theory, a 
recent report details that Notch 4 inhibits apoptosis in both a CBF-1-dependent and - 
independent manner in EC (MaeKenzie et a l , 2004) The method of execution of 
Notch signalling pathway-mediated events in VMSC is, to date, largely undefined 
Several reports suggest that Notch, in other cell types, may interact with several 
signalling pathways, some of which are involved in the regulation of apoptosis (Jang et 
a l , 2004) Wang et a l , for example, established the involvement o f the ERK/MAPK 
pathway in Notch-mediated cell survival in VSMC, as the induction of cFLIP occurred 
in an ERK/MAPK-dependent manner This suggests methods through which the anti- 
apoptotic effect of the Notch signalling pathway in VMSC could be mediated, and will 
be discussed in further detail later
This study also demonstrates that serum deprivation induces apoptosis in 
VSMC This has been widely demonstrated in many cell types (Pollman et a l , 1999b, 
Shichiri et a l , 2000), including VSMC (Wang et a l , 2002b) In addition, we also 
present the novel finding that both Notch 1 IC and Notch 3 IC act to protect VSMC 
against serum deprivation-induced apoptosis A similar anti-apoptotic effect o f Notch 1 
has been recently demonstrated in serum deprived arterial EC (Liu et a l , 2003) This 
report found that both Notch 1 IC and Hes-1 conferred a strong resistance to serum 
deprivation-induced apoptosis in EC, indicating that these components o f the Notch 
signalling pathway play a role in regulating EC survival The function of the Notch
165
signalling pathway has oftentimes been demonstrated as being cell type specific (Yang 
et a l , 2004) We have demonstrated that Hes-1 is not a primary Notch target gene in 
VSMC, therefore it is unlikely that this target gene plays a major role in the Notch- 
mediated anti-apoptotic effect in VSMC
Notch 1 IC and Notch 3 IC appear to exert a similar level o f resistance to 
apoptosis in all assays It is interesting to note that the attenuation o f serum 
deprivation-induced apoptosis by Notch 3 IC, measured by the annexin V/propidium 
iodide dual stain, is only partially reversed with the CBF-1 inhibitors, RPMS-I and 
mutant Notch 1 IC (Figure 4 6) This suggests that the anti-apoptotic eifect of Notch 3 
IC may occur in both a CBF-1-dependent and -independent manner, perhaps due to 
interaction with the ERK/MAPK pathway, as shown by Wang et a l , (2002b) However, 
the Notch 3 IC-induced decrease in caspase 3 activity is completely reversed by RPMS- 
I, suggesting that (i) the caspase 3-mediated aspect o f serum deprivation-induced 
apoptosis is CBF-1-dependent, and (11) that any anti-apoptotic effect mediated m a CBF- 
1-independent manner is also caspase 3-independent In contrast, the anti-apoptotic 
effect mediated by Notch 1 is completely reversed using CBF-1 inhibitors in all assays 
studied, suggesting that Notch 1 regulates apoptosis in a CBF-1-dependent, and not - 
independent, manner
The mechanisms o f serum deprivation-induced apoptosis are complex and are, 
to date, poorly defined As we have reported that both inhibition of the Notch signalling 
pathway and serum deprivation induce apoptosis in VSMC, we investigated the effect 
of serum deprivation on Notch signalling pathway component expression This study 
reports the novel finding that serum deprivation results in a decrease in expression of 
Notch signalling pathway components, and also causes a decrease in CBF-1 reporter 
activity The mechanism o f this serum deprivation-induced decrease in Notch 
signalling pathway components and activity in VSMC remain to be defined, however, 
as mentioned previously, several serum mitogens have been shown to influence 
expression of Notch signalling pathway components in both vascular and non-vascular 
cells (Artavams-Tsakonas et a l , 1999, Nickoloff et a l , 2002, Liu et a l , 2003)
Whilst the mechanism of Notch-mediated cell survival is not immediately 
apparent, there are numerous possible anti-apoptotic pathways whereby Notch could 
regulate apoptosis in VSMC These include interaction with, or regulation of 
expression o f the Bcl-2 family, the NFkB family, c-myc, p53, or regulation of JNK, 
PI3K or MAPK activity It is possible that Notch interacts with one or all o f these 
components, and interaction may depend on cellular context, for example, the method
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of apoptosis induction Whilst in-depth investigation into the interaction of the Notch 
signalling pathway with all o f these anti-apoptotic mechanisms is beyond the scope of 
this project, this study investigates the interaction o f the Notch signalling pathway with 
the members o f the Bcl-2 and NFkB families in VSMC In addition, this study presents 
evidence from current literature that could rationalize further investigative work within 
the laboratory into Notch signalling pathway interactions with other known anti- 
apoptotic pathways, and will be discussed further in Chapter 7
The NFkB signalling pathway plays a central role in many vascular diseases, 
including arteriosclerosis, restenosis, and reperfusion injury The beneficial and usually 
transient effect o f this pathway may be exaggerated in pathological situations within the 
vasculature, resulting in damage to the vessel wall and impaired vascular cell function 
(De Martin et a l, 2000) NFkB generally mediates cell survival signals and opposes 
apoptotic processes by regulating the expression of anti-apoptotic proteins Interactions 
between the Notch signalling pathway, EBV-related proteins, and the NFkB pathway 
have been demonstrated (Wang et a l , 2001, D'Souza et a l , 2004) Wang et a l , have 
shown that Notch 1 inhibits NFkB activity in T-cells through physically interacting with 
the p50 subunit o f N FkB  and exerting the same effect as an IkB molecule 
Additionally, a recent paper by Oakley et a l , (2003) reports that expression of the 
NFkB inhibitor, IkBcx, is under the control of CBF-1 and subsequently Notch 1 in both 
liver and kidney cells CBF-1 is reported to interact with a dual NFkB/CBF-1 binding 
site (kB2 site) m the IkBcx promoter, repressing IkBcx expression resulting in increased 
levels o f NFkB activity Over-expression of Notch 1 1C is reported to reverse the 
repressive effects o f CBF-1 on IkBcx expression, thus decreasing NFkB activity within 
the cell The effect o f Notch 1 is CBF-1-dependent, as over-expression of Notch 1 IC 
without the CBF-1 binding RAM domain, or Notch 1 IC in the presence of the CBF-1 
inhibitor, R218H-RBPJk, does not result in increased IkBoi expression As this 
mechanism is conserved across kidney and liver cells, it is likely that Notch interacts 
with the NFkB pathway in VSMC in a similar manner
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Figure 24 Model for the Regulation of NFkB Activity by CBF-1 and Notch
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Figure 24 Top p a n el U nder conditions o f  low CBF-1 expression the Ik B cx gene is transcribed in a de­
repressed state, resulting in excess IicBa protein, and low levels o f  N F kB  activity M iddle panel Under 
conditions o f  high CBF-1 expression, CBF-1 binds to the kB 2  site o f  the IicBa promoter, recruits co­
repressor com plexes, resulting in repression o f  k B a  transcription, and increased N FkB  activity Bottom  
panel A ctivated N otch 1 1C stim ulates release o f  the co-repressor com plex, activates CBF-1, and recruits 
the transcriptional co-activator CBP/p300, resulting in activation o f  Ik B cx gene transcription, and reduced 
NFkB activity (Oakley et a l , 2003)
We provide previously unreported evidence that both Notch 1 IC and Notch 3 
IC inhibit NFkB activity in VSMC, whereas EBNA-2 does not affect the activity of the 
NFkB signalling pathway in these cells This is supported by the observations that both 
Notch expression is decreased, and NFkB expression increased in arterial VSMC 
following balloon injury (De Martin et a l , 2000, Wang et a l , 2002a) Whilst our 
results concur with the effect o f Notch expression on NFkB expression in T-cells, it is 
somewhat surprising as the Notch signalling pathway has been implicated m cell 
survival in VSMC However, whilst the NFkB is generally considered to exert an anti- 
apoptotic effect in VSMC, inhibition of this pathway by IkB resulted in apoptosis in 
low- but not high-density cultures (De Martin et a l , 2000) It is interesting to note that 
a similar bi-functional effect was documented on the regulation of VSMC growth due to 
Notch 3 IC over-expression (Campos et a l , 2002) This study revealed a decrease in 
cell accumulation in low-density cultures, and a lack o f growth arrest in high-density 
cultures As Notch exerts a differential effect on the proliferation pathway in VSMC, it 
is possible that a similar differential effect is also exerted on the NFkB pathway Jagged
¡YF-XB
*
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2 expression results in a rapid and transient activation o f the NFkB family in murine 
erythroleukaemia cells, followed by an inhibition of the pathway (Jang et a l , 2004) 
The activation of the NFkB pathway occurred 30 min following Notch signalling 
pathway activation, however this effect was reversed, and NFkB activity dramatically 
down-regulated 4 h post-Notch activation The crosstalk between the Notch and NFkB 
pathways appears to be bi-directional, as NFkB up-regulates Jagged 1 expression in T- 
cells (Robey 1999) The interaction between the Notch and NFkB pathways in VSMC, 
and the resulting effects on apoptosis, remain incompletely defined This study 
confirms an interaction between these two pathways in VSMC, thus providing a basis 
upon which further research can be established
In an attempt to elucidate the mechanisms through which the Notch signalling 
pathway exerts its anti-apoptotic effect in VSMC we examined the effect o f the Notch 
signalling pathway on the Bcl-2 family o f apoptotic genes The Notch signalling 
pathway and EBNA-2 have been shown to regulate members o f the Bcl-2 family in both 
vascular and non-vascular cells Notch 1 and Notch 4 up-regulate Bcl-2 expression in 
T-cells and EC respectively, whereas EBNA-2 has been shown to up-regulate Bid in B 
cells (Deftos et a l , 1998, MacKenzie et a l , 2004, Schlee et a l , 2004) In addition, 
EBNA-2 up-regulates bfl-1 mRNA expression and promoter activity in a BL cell line in 
a CBF-1-dependent m anner (PPegman personal communication) This study 
established that EBNA-2, but neither Notch 1 IC nor Notch 3 IC, activated the bfl-1 
promoter in VSMC, suggesting that the anti-apoptotic o f Notch is not mediated through 
Bfl-1 in VSMC
As the Bcl-2 family is central to the regulation o f apoptosis in many cell types, 
and changes in Bcl-2 family expression are oftentimes observed during the pathogenesis 
o f vascular disease, it is likely that the Notch signalling pathway regulates at least some 
members o f the Bcl-2 family Therefore, this study examined the effect of the Notch 
signalling pathway on mRNA expression of both pro- and anti-apoptotic members of 
the Bcl-2 family Following inhibition o f the Notch signalling pathway, we observed 
increased pro-apoptotic bad  and bax expression, decreased anti-apoptotic bcl-xi 
expression but also increased anti-apoptotic bcl-2 expression Conversely, following 
Notch 3 IC-mediated stimulation of the Notch signalling pathway increased bad  and 
bcl-2  expression was maintained, whereas decreased bax  and increased b cl-x i 
expression was observed The opposing effects of stimulation and CBF-1-dependent 
inhibition of the Notch signalling pathway on bax and bcl-x¿ suggest that these genes,
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but not bad or bcl-2, are regulated by the Notch signalling pathway in a CBF-1 - 
dependent manner This study has shown that serum-deprivation results in decreased 
expression of both Notch 1 IC and Notch 3 IC In addition, recent studies within the 
laboratory have revealed a serum deprivation-induced decrease in BcI-xl expression, 
further suggesting a Notch-mediated regulation of BcI-xl expression in VSMC This 
regulation o f bax and bcl-xi was confirmed in a preliminary experiment examining gene 
expression in cells in which the Notch signalling pathway was simultaneously activated 
and inhibited, and compared to control cells The level of both bax and bcl-xi 
expression in both sets of cells was very similar, thus confirming CBF-1-dependent 
Notch 3 regulation of these apoptotic proteins in VSMC In addition, using 
bioinformatics, this study examined whether any Notch target gene promoter sites are 
present on either the bax or bcl-xi genes Nakagawa et a l , (2000) have determined that 
the HRT family of Notch target genes preferentially bind to an E box motif, CACGTG, 
but also bind to other E box motifs (CAACTG, CACCTG, CACTTG, and CATCTG) to 
regulate transcription of other genes Therefore, through sequence alignment of cloned 
bax and bcl-xL promoters (Grillot et a l , 1997, Igata et a l , 1999), we have determined 
that the Notch family HRT target genes can bind to, and therefore possibly directly 
regulate, both the bax and bcl-xL genes (using MultAlin) The HRT family can bind to 
the CACGTG or CATCTG sequences o f bax, and the CACCTG or CACTTG sequences 
of bcl-Xi, however, this would have to be further confirmed with mutational analysis 
Therefore, it is likely that the HRT family of Notch target genes act as effectors of the 
Notch signalling pathway, at least in part, by repressing bax expression and promoting 
bcl-xi expression, which has been confirmed in additional experiments within the 
laboratory
This study has provided the basis for further analysis of the mechanism of Notch 
signalling pathway regulation o f bax and bcl-XL Using siRNA knockdown technology 
preliminary results indicate that the down-regulation of hrt-1, hrt-2 and hrt-3 results in 
increased bax expression, with the most significant effect being mediated by hrt-3 In 
contrast, down-regulation of hes-1 results in decreased bax expression In addition, 
targeted inhibition of hrt-1, hrt-2 and hrt-3 results in a decrease in bcl-xL expression in 
VSMC, whereas hes-1 down-regulation results in a slight increase in bcl-xi expression 
(D Morrow personal communication) This suggests a differential role for members of 
the HRT and Hes families in mediating VSMC apoptosis, and may partially account for 
the relatively small fold changes observed m this study, as RPMS-I inhibits both the 
HRT and Hes families Therefore, this study has provided a solid basis for the
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identification of both bax and bcl-xL as important Notch target genes in the regulation of 
VSMC apoptosis, which has been confirmed by ongoing research within the laboratory 
It is also interesting to note that both bax and bcl-xL are transcriptional targets for 
N FkB NFkB meditates up-regulation o f bcl-xL expression (Lee et a l , 1999) and 
inhibition o f NFkB results in decreased bax expression (de Martin et a l , 2000) 
Therefore, activation o f the NFkB and Notch signalling pathways both result in a 
decrease in bax and an increase m bcl-XL expression However, we have demonstrated 
that Notch inhibits NFkB activity in VSMC Therefore, we must consider the 
possibility o f an NFKB-independent Notch-mediated regulation o f these genes, or the 
bi-phasic regulation o f Notch on the NFkB signalling pathway
The importance of bax and bcl-xi in regulating VSMC apoptosis is unsurprising 
as these genes have been implicated in both physiological apoptosis and the 
pathogenesis o f vascular disease, and in some instances their regulation has been 
coupled to the Notch signalling pathway in other cell types Numerous papers, for 
example, indicate a specific role for both Bax and Bcl-xL during both neo-natal and 
post-injury vascular remodelling (Pollman et a l , 1999a, Gibbons and Pollman 2000, 
Kim et a l , 2000)
Bc1-xl is an important modulator o f mtimal and medial VSMC apoptosis, and is 
a critical determinant o f vascular lesion formation Vascular lesion formation is 
associated with an up-regulation of Bcl-xt within mtimal VSMC, resulting in decreased 
cellular apoptosis Bai et a l , (1999), and others (Pollman et a l , 1998) have 
dem onstrated that dow n-regulation o f Bc1-xl expression  using anti-sense 
oligonucleotides results in increased mtimal VSMC apoptosis and regression o f 
vascular lesions Therefore, it is conceivable that proposed future anti-apoptotic gene- 
based therapies targeting Bc1-xl could utilize the demonstrated Notch signalling 
pathway regulation of this gene Interestingly, Bai et a l , (1999) also reports increased 
medial VSMC apoptosis following injury, whilst Perlm an et a l , (1997) reports 
decreased Bcl-xL expression in the media o f injured arteries To concur with our finding 
that Notch pathway stimulation up-regulates Bcl-xL expression, Wang et a l , (2002a) 
reports a balloon injury-induced decrease in Notch signalling pathway expression in the 
same cells In addition, Notch 1 over-expression has recently been shown to 
preferentially up-regulate Bcl-xL expression in T-cells (Jang et a l , 2004)
In addition, a recent study has demonstrated that up-regulation of Bcl-xL by 
serum is critical in protecting cells from serum deprivation-induced apoptosis in a
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prostate cancer cell line (Yang et a l , 2003) As we have demonstrated both that serum 
deprivation decreases and serum stimulation increases Notch expression, it is probable 
that BcI-xl plays a similar anti-apoptotic role in Notch-mediated protection against 
serum deprivation-induced apoptosis
Bax is also increasingly recognized as an important mediator of apoptosis within 
the vasculature Physiological apoptosis that occurs in human umbilical vein EC during 
delivery is associated both with a strong expression of Bax and caspase 3 activation 
(Kim et a l , 2000) Bax is also up-regulated in SMC within human fatty streaks, and is 
up-regulated following coronary occlusion in the rat heart and following myocardial 
infarction in the human heart (Misao et a l , 1996, Kockx et a l , 1998) In addition, it is 
postulated that Bax over-expression m ventricles of spontaneously hypertensive rats 
may contribute to apoptosis (Fortuno et a l , 1998)
In this study, the observed increase in bcl-2 expression due to Notch inhibition 
was somewhat surprising, as we have clearly established that inhibition of the Notch 
signalling pathway results in YSMC apoptosis However, the rationale for this could be 
that Bcl-2 has been shown to have variable anti-apoptotic effects within a cell, and that 
this is determined by the ratio of other apoptotic factors within a cell Bcl-2, for 
example, protects against Fas-mduced apoptosis in some ceils but not in others (Yeh 
1997) and increased Bcl-2 expression observed in failing hearts is insufficient to 
overcome death-promoting signals (Hetts 1998) The question of Notch signalling 
pathway regulation of Bcl-2 expression is complex, and may be cell type specific 
Notch 1 increases Bcl-2 expression in a thymic lymphoma cell line (AKR1010) but not 
in a T-cell hybndroma line (2B4 11), however Notch 1 confers resistance to 
glucocorticoid-induced apoptosis in both cell types Interestingly, a number of recent 
papers suggest that Notch promotes Bcl-2 expression, and that this is achieved in a 
CBF-1-independent manner Notch 1 and Notch 4 up-regulate Bcl-2 expression in T- 
cells and EC respectively (Jang et a l , 2004, MacKenzie et a l , 2004) and inhibit 
induction of apoptosis in the respective cells Notch may therefore up-regulate Bcl-2 
expression in VSMC in a CBF-1-independent manner, thus explaining the sustained 
increase in Bcl-2 expression following inhibition with RPMS-I
4 4 Conclusion
This study establishes some of the mechanisms of Notch-mediated cell survival 
m VSMC It is clear that the Notch signalling pathway can regulate apoptosis, and
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indeed other cell fate decisions, through interactions with multiple signalling pathways, 
which will be discussed in further detail m Chapter 7 Understanding the process of 
VSMC apoptosis at a molecular level affords insights into cardiovascular pathogenesis, 
and also opens new avenues for the development of diagnostic, prognostic and 
therapeutic tools
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Chapter 5
Results
Effect of Cyclic Strain on the 
Notch Signalling Pathway and 
Apoptosis i n  v i t r o
5 1  Introduction
An important aspect o f this study was to investigate the effect of cyclic strain on 
both the Notch signalling pathway and apoptosis in VSMC, and additionally determine 
whether the Notch signalling pathway regulates cyclic strain-mediated apoptosis in 
these cells
Cells of the vasculature are exposed to two principal haemodynamic forces, 
shear stress and cyclic strain, generated as a result o f blood flow Shear stress is 
described as the dragging frictional force created due to blood flow, and primarily 
affects EC under normal conditions Arterial blood vessels are additionally exposed to 
an oscillating transmural pressure due to the pulsatile nature of arterial blood flow 
Therefore, arterial blood vessels are exposed to a pulse pressure-induced cyclic strain 
event, resulting in the “stretching” of the vascular cells in multiple planes VSMC, 
which constitute the major component of the blood vessel wall, absorb most of the 
pressure-induced cyclic strain Therefore, this study focuses on the effect of alterations 
in cyclic strain on VSMC As arterial SMC reside in a mechanically active environment 
and are subjected to variable mechanical loads, the response of these cells to 
deformation may represent an important defense mechanism against excess mechanical 
load
Mechanical forces associated with blood flow play an important role in the 
regulation o f vascular tone, vascular remodelling and the maintenance of vascular 
homeostasis Blood vessels are continuously exposed to mechanical forces which is 
necessary, for example, to develop and maintain a differentiated and functional VSMC 
phenotype (Birukov et a l , 1998) Altered or elevated biomechamcal stress is a 
common feature of vascular disease (Bennett 1999, Xu 2000) Spontaneous 
atherosclerotic lesions, for example, are prone to form in arterial branching regions 
where cyclic strain is elevated In addition, many studies have demonstrated that 
venous vessels do not develop atherosclerosis in their normal low-pressure 
environment However, accelerated atherosclerosis is observed when veins are grafted 
to arteries, and the vessels are exposed to increased mechanical forces (Bennett 1999, 
Mayr et a l , 2000)
The pathogenic role of VSMC apoptosis is increasingly recognized in 
cardiovascular disease SMC apoptosis is described as an early event in vein by-pass 
graft arteriosclerosis, suggesting that biomechamcal forces play a key role in the 
regulation of apoptosis (Mayr et a l , 2000) This has repeatedly been demonstrated by
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many studies, both in vivo and in vitro (Pollman et a l , 1999, Wermg et a l } 2003), and 
this study further establishes this fact However, despite the recognized importance of 
apoptosis in vascular disease, and potential therapeutic implications for the modulation 
o f VSMC apoptosis, relatively little is known about the regulation of VSMC apoptosis 
by alterations in biomechamcal forces This study has clearly established the anti- 
apoptotic role o f the Notch signalling pathway both in cycling VSMC and against serum 
deprivation-induced apoptosis It is conceivable, therefore, that the Notch signalling 
pathway regulates apoptosis induced by other means, for example, due to alterations in 
biomechamcal force
M echanical forces are an important regulator o f structure and function in 
mammalian cells, and have been implicated in phenotypic changes, including alteration 
of gene expression m VSMC Cyclic strain, for example, has been shown to increase 
expression o f PD G F-a and Integrm fo, whilst concomitantly decreasing MMP-1 
expression A study by Feng et a l , (1999) suggests however, that cyclic strain is a 
highly specific stimulus both in vivo and in vitro, with response restricted to a small 
number of genes O f five thousand genes analyzed in this report, for example, only 
eleven exhibited changes m expression due to cyclic stress Our study investigates 
whether components o f the Notch signalling pathway should be added to the 
continuously increasing list of cellular components regulated by cyclic strain
VSMC can sense and transduce mechanical stress signals to cellular responses 
via receptor-dependent and -independent G protein-dependent pathways, as previously 
discussed in Chapter 1 A recent report by Wermg et a l , (2003) indicates that cyclic 
strain-induced apoptosis in VSMC m mediated by pi-integnn-rac-p38-p53 signalling 
pathways However, as is the case with apoptosis induced by other stimuli, it is possible 
that additional signalling pathways mediate cyclic strain-induced VSMC apoptosis As 
we have previously identified bax and bcl-xi as targets o f the Notch signalling pathway, 
we investigated members o f the bcl-2 family o f genes as possible mediators of apoptosis 
in mechanically stimulated VSMC
A Flexercell Tension Plus™ strain unit was used in this study to regulate 
pressure to flexible bottomed pronectin-coated BioFlex® plates, thus allowing VSMC to 
be exposed to defined levels of cyclic strain in vitro Unless otherwise stated, cells in 
this study were exposed to 10% cyclic strain using a heart pulse pressure waveform 
This is generally accepted as a level o f cyclic strain that VSMC are subjected to under 
normal physiological conditions in vivo Cardiovascular disease states, such as 
hypertension, can increase the level o f cyclic strain exerted on arterial VSMC up
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to 30% (Li and Xu 2000). Large deformations in vitro (>15%) result in transient VSMC 
injury, similar to observations following experimental balloon injury in vivo (Feng et 
al., 1999).
Figure 25: Flexercell Tension Plus™  Strain Unit
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Figure 25: A: F lexercell Tension Plus™  Strain U nit is a m icroprocessor-driven instrum ent that 
regulates pressure to BioFlex® culture plates. B: Cartoon detailing the mechanical stretch exerted on 
cells in vitro due to the Flexercell Tension Plus™  strain unit.
This study provides evidence for a role o f the Notch signalling pathway in 
modulating cyclic strain-induced apoptosis in VSMC. As aberrant regulation o f cyclic 
strain-induced apoptosis plays a pivotal role in many forms o f cardiovascular disease 
states, this has the potential to translate into future therapeutic benefits.
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5 2 Results
The effect of cyclic strain on RVSMC apoptosis in vitro was determined using 
histochemical analysis and caspase 3 activity assays Cyclic strain (10%, 24 h) resulted 
in a significant increase m annexin V positive (green /apoptotic) cells with respect to 
static control Representative histochemical analysis are shown in Figure 5 1A, and 
cumulative data on the percentage of apoptotic (annexin V positive/propidium iodide 
negative cells) are also presented (Figure 5 IB) Static cells exhibit a low level of 
apoptotic cells (6 1±1 22%), which is significantly increased, as result of exposure to 
cyclic strain, to 15 6±2 6% This increase in apoptosis in RVSMC due to cyclic strain 
was further demonstrated using the acridine orange/ethidium bromide dual stain (Figure 
5 2) Cyclic strain significantly increased the percentage of apoptotic cells from 
8 25±1 25% in the static control sample to 30 75=1=8 98% (Figure 5 2B) In addition, 
cyclic strain-induced apoptosis was confirmed through caspase 3 activity assays (Figure 
5 3) Cyclic strain resulted m a significant fold increase in caspase 3 activity to 
1 66±0 15 with respect to static control (arbitrarily assigned a value o f 1), which 
corresponds to a 66 0±15% increase The effect o f cyclic strain on the bcl-2 family of 
apoptotic genes was also investigated (Figure 5 4) Cyclic strain increased the 
expression of the pro-apoptotic bad and box genes by 41 0±28 0% and 31 0±8 0% 
respectively over unstrained control cells An increase of 68 0±41 0% in bcl-2 gene 
expression was also observed in VSMC following cyclic strain, as compared to static 
control cells In contrast, cyclic strain resulted in a decrease of 29 0±17 0% in 
expression of the anti-apoptotic bcl-xi gene The pattern of bcl-2 family gene 
expression is in agreement with our finding that cyclic strain induces apoptosis in 
VSMC, as the progression of apoptosis is determined by the relative concentration of 
both pro- and anti-apoptotic mediators withm a cell These results suggest that the 
balance of bcl-2 family gene expression favours apoptosis following cyclic strain
5 2 1  Cyclic Strain Induces A poptosis in RVSM C in vitro
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Figure 5.1 C yclic Strain Increases A poptosis in R V SM C , as
m easured by the A nnexin  V /Propidium  Iodide D ual Stain
10 x
magnification
Fig 5.1 Cyclic strain induces apoptosis in RVSM C. RVSMC were seeded onto 
F lexercell™  plates at 1 x 105 cells/well. Following a 48 h growth period, cells were 
subjected to cyclic strain (10%, 24 h). Cells were stained with the Annexin V/Propidium 
Iodide dual stain and viewed under a fluorescent microscope. A) Representative images; 
Apoptotic cell, blue arrow. B) Graph showing percentage increase in the num ber of 
apoptotic cells due to cyclic strain. Each experim ent was perform ed in duplicate, with 
the graph representative of n=2. p p<0.05 as com pared to static control (student’s t test).
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Figure 5.2 C yclic Strain Increases A poptosis in R V SM C , as
m easured by the A cridine O range/ Ethidium  Brom ide D ual Stain
Static Strain
B
Fig 5.2 Cyclic s tra in  induces apop tosis  in R V SM C . RVSM C were seeded onto 
Flexercell™  plates at 1 x 105 cells/well. Following a 48 h growth period, cells were 
subjected to cyclic strain (10% , 24 h). Cells were stained with the Acridine Orange/ 
Ethidium Bromide dual stain and viewed under a fluorescent microscope. A) 
Representative images; V iable cell, white arrow; Apoptotic cell, blue arrow. B) Graph 
showing percentage increase in the num ber of apoptotic cells due to cyclic strain. Each 
experim ent was perform ed in duplicate, with the graph representative of n=3. P p<0.05 as 
com pared to static control (student’s t test).
179
Figure 5 3 C yclic Strain Increases A poptosis in R V SM C , as
m easured by Caspase 3 A ctivity
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Fig 5 3 Cyclic strain induces apoptosis in RVSMC RVSM C were seeded onto 
Flexercell™  plates at 1 x 10s cells/well Following a 48 h growth period, cells were 
subjected to cyclic strain (10% , 24 h) Protein was isolated and assayed for caspase 3 
activity Caspase assays were norm alized to protein levels, and expressed as fold 
increase over control (= the value obtained with static cells arbitrarily assigned a value 
of 1), n=6, * p< 0 05 (rank test) as com pared to static control
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Figure 5 4 Effect o f C yclic Strain  on Bcl-2 Fam ily m RNA
Expression
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Fig 5 4 Effect o f cyclic strain on Bcl-2 fam ily m RNA expression in RVSM C
RVSM C were seeded onto Flexercell™  plates at 1 x 10s cells/w ell Following a 48 h 
growth period, cells were subjected to cyclic strain (10% , 24 h) as indicated Samples 
were isolated at 24 h post-cyclic strain and subsequently assayed using quantitative PCR 
for b a d , b a x , bcl-2  and bcl x L mRNA expression as indicated All values were 
normalized to GAPDFI levels, and expressed as a fold change over static control (= the 
value obtained with static RV SM C mRNA levels, arbitrarily assigned a value of 1), n=3
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5 2 2 The Effect o f C yclic Strain on C om ponents o f the N otch  Signalling Pathw ay
in RVSM C
The effect of cyclic strain on components o f the Notch signalling pathway was 
determined in this study by western blot analysis, lmmunocytochemistry, and 
quantitative real time PCR analysis Cells were exposed to 10% pulsatile cyclic strain, 
using the Flexercell™ Strain Unit, for 24 h, unless otherwise stated, and compared to 
non-strained, static control
Exposure of RVSMC to cyclic strain resulted in a decrease in the level of Notch 
receptor, ligand and target gene protein expression Notch 1 IC and Notch 3 IC protein 
expression levels were significantly reduced by 17 0±2 0% (Figure 5 5A) and 
25 0±3 0% (Figure 5 5B) respectively as compared to static control expression levels 
Similarly, exposure to cyclic strain resulted in a significant decrease of 30 0±6 0% in 
Jagged protein (Figure 5 5C) as compared to static control expression levels The effect 
of cyclic strain on HRT-1 and HRT-3 protein expression levels in RVSMC was also 
determined (Figure 5 6) Cyclic strain induced a small but significant decrease in HRT- 
1 protein expression levels (12 0±1 0%), with a similar decrease in protein expression in 
evidence for HRT-3 (11 0±2 0%) as compared to static control cells Immunochemical 
analysis further confirmed the cyclic strain-induced decrease in HRT-1 protein 
expression (Figure 5 7)
The effect of cyclic strain on the components of the Notch signalling pathway 
was further confirmed by quantitative real time PCR analysis Cyclic strain caused 
significant decreases in notch 1 and notch 3 mRNA expression levels of 57 0± 11 0% 
and 50 0±2 9% with respect to static control (Figure 5 8A) Similarly, a significant 
decrease of 35 0±4 0% in jagged  mRNA levels was also observed due to cyclic strain 
(Figure 5 8B) The cyclic strain-induced decrease in Notch signalling pathway mRNA 
expression levels was also evident in analysis of Notch target gene mRNA expression 
(Figure 5 9) Hrt mRNA expression levels were significantly reduced by 39 0±1 0%, 
47 0±17 0% and 42 0±12 0% with respect to static control for hrt-1, hrt-2 and hrt-3 
respectively (Figure 5 9A) Similarly, exposure of the cells to cyclic strain resulted in a 
significant decrease in hes 1 (42 0±12 0%) and hes-5 (57 0±11 0%) mRNA expression 
levels as compared to static control (Figure 5 9B)
In order to determine whether the effect of cyclic strain on the Notch signalling 
pathway was force-dependent, RVSMC were subjected to 0, 5, 10 and 15% cyclic strain
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and assayed for Notch receptor and Notch target gene mRNA expression (Figure 5 10) 
Both notch 3 and hes-5 exhibit a significant force-dependent decrease in mRNA 
expression The percentage decrease in notch 3 mRNA levels was 26 0±1 0, 50 0±3 0 
and 64 0±0 8 at 5%, 10%, and 15% cyclic strain, as compared to the static control 
(Figure 5 10A) Hes-5 mRNA expression was similarly decreased with increasing 
levels of cyclic strain, with a decrease of 38 0±13 0% at 5% cyclic strain, 57 0±11 0% 
at 10% cyclic strain, and 61 0±14 0% at 15% cyclic strain, as compared to static control 
(Figure 5 10B)
A similar experiment was carried out to determine the effect of time on the 
cyclic strain-induced changes in the Notch signalling pathway (Figure 5 11) RVSMC 
were exposed to 10% cyclic strain over a period of 24 h, with timepoints taken at 0 h, 4 
h, 8 h, and 24 h post-cyclic strain Quantitative real time PCR analysis revealed a 
significant time-dependent decrease in hes-5 mRNA expression, of 27 0±4 0%, 
55 0±6 0% and 25 0±3 0% at 4 h, 8 h, and 24 h post-cyclic strain respectively, as 
compared to static control (0 h timepoint)
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Figure 5 5 E ffect o f Cyclic Strain  on N otch R eceptor and Notch
Ligand Protein  E xpression  in RV SM C
A Notch 1
Static Strain____
U  120 kDa
B Notch 3
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Static Strain
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Fig 5 5 C yclic strain decreases Notch receptor and ligand protein expression in 
RV SM C  RV SM C w ere seeded onto Flexercell™  plates at 1 x 105 cells/well Following 
a 48 h growth period, cells were subjected to cyclic strain (10% , 24 h) as indicated 
Protein extracted from  both static and strained RVSM C was assayed for Notch 1 (A ), 
Notch 3 (B) and Jagged(C) expression using W estern blot analysis Values are 
expressed as fold change over static (arbitrarily assigned a  value o f 1), n=3 °  p<0 05 as 
com pared to static control (student’s t test)
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Figure 5 6  E ffect o f  C yclic Strain  on  N otch  T arget G ene Protein
E xpression  in  R V SM C
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Static Strain
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Fig 5 6 Cyclic strain causes a decrease in Notch target gene protein  expression in 
RVSM C RVSMC were seeded onto Flexercell™  plates at 1 x 105 cells/w ell Following 
a 48 h growth period, cells were subjected to cyclic strain (10%, 24  h) as indicated 
Protein extracted from both static and strained RVSMC was assayed for HRT-I (A) or 
HRT-2 (B) expression using Western blot analysis Values are expressed as fold change 
over static (arbitrarily assigned a value o f 1), n=3 °  p<0 05 as compared to static control 
(student’s t test)
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Figure 5.7 E ffect o f C yclic Strain on N otch T arget G ene Protein
Expression in  RVSM C
Fig 5.7 Cyclic s tra in  causes a decrease  in N otch ta rg e t gene p ro te in  expression  in 
R V SM C . RVSMC were seeded onto Flexercell™  plates at 1 x 105 cells/well. Following 
a 48 h growth period, cells were subjected to cyclic strain (10%, 24 h) as indicated. Cells 
were fixed and probed for HRT-1 expression using im m unocytochem istry, and viewed 
under a fluorescent microscope, with equal exposure tim es used for both static and strain 
images.
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Figure 5 8 E ffect o f  C yclic Strain  on  N otch  R ecep tor and N otch
L igand m R N A  E xpression  in  RV SM C
B Jagged
Fig 5 8 C yclic s tra in  causes a  d ecrease  in  N otch  re c e p to r  a n d  ligand  m R N A  
expression  m  R V S M C  RVSM C were seeded onto Flexercell™  plates at 1 x 105 
cells/w ell Following a  48 h growth period, cells w ere subjected to cyclic strain (10% , 
24 h) as indicated Samples were isolated at 24 h post-strain and subsequently assayed 
using quantitative PCR for Notch receptor (A) and N otch ligand (B) mRNA 
expression All values were norm alized to GAPDH levels, and expressed as a fold 
change over static control (= the value obtained with static RVSM C m RNA levels, 
arbitrarily assigned a  value o f 1), n=3 00 p<0 005, ooa p<0 005 as com pared to static 
control (student’s t test)
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Figure 5 9  E ffect o f  C yclic Strain  on  N otch  T arget G ene m R N A
E xpression  in  R V SM C
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Fig 5 9 C yclic s tra in  causes a  d ecrease  in N otch ta rg e t  gene m R N A  expression  in 
R V S M C  RVSM C were seeded onto F lexercell™  plates at 1 x 105 cells/well Following 
a 48 h growth period, cells were subjected to cyclic strain (10% , 24  h) as indicated 
Samples w ere isolated at 24 h post-strain and subsequently assayed using quantitative 
PCR for hrt-1, hrt-2 , hrt-3  (A), hes-1  and hes-5  (B) mRNA expression All values were 
norm alized to G APDH levels, and expressed as a fold change over static control (= the 
value obtained w ith static RVSM C mRNA levels, arbitrarily assigned a value o f 1), n=3 
°  p<0 0 5 ,ao p<0 0 0 5 ,000 p<0 0005 as com pared to static control (student’s t test)
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Figure 5 10 Force D ependent E ffect o f  C yclic Strain-induced
D ecrease in N otch  Signalling Pathw ay m R N A  E xpression m
R V SM C
5% 10%
Level of Cyclic Strain
15%
B hes-5 mRNA Expression
Fig 5 10 F o rc e -d ep e n d en t effect o f  cyclic s tra in  in d u ced  d ec rease  in  N otch  S ignalling  
P a th w ay  m R N A  exp ression  in R V SM C  RVSM C were seeded onto Flexercell™  plates 
at 1 x 105 cells/w ell Following a 48 h growth period, cells w ere subjected to differing 
levels o f cyclic strain, 0% , 5% , 10% or 15% for 24  h as indicated Sam ples were isolated 
at 24  h post-strain and subsequently assayed using quantitative PCR for notch 3 (A), and 
hes-5  (B) m RNA expression All values were norm alized to GAPDH levels, and 
expressed as a  fold change over static (0%) control (= the value obtained with static 
RVSM C m RNA levels, arbitrarily assigned a value o f 1), representative experim ent, mean 
of 6 w ells, experim ent perform ed in triplicate °  p<0 05, 00 p<0 005, 000 p<0 0005 as 
com pared to static control (student’s t test)
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F igure 5.11 E ffect o f  T im e on C yclic Strain-induced  D ecrease in
N otch S ignalling Pathw ay m RNA E xpression in R V SM C
hes-5 mRNA Expression
Fig 5 11 T im e-dependent effect o f cyclic strain induced decrease in Notch Signalling  
Pathw ay m RN A  expression in RVSM C RVSM C were seeded onto Flexercell™  plates 
at 1 x 105 cells/w ell Following a 48 h growth period, cells were subjected to cyclic strain 
over a period o f 24 h, as indicated Samples were isolated at 0 h, 4  h, 8 h, and 24 h post- 
strain and subsequently assayed using quantitative PCR for and hes-5  mRNA expression 
All values were norm alized to GAPDH levels, and expressed as a  fold change over static 
(0%) control (= the value obtained with static RVSM C m RNA levels, arbitrarily assigned 
a value o f 1), representative experim ent, m ean of 6 wells, experim ent perform ed in 
triplicate °°  p<0 0 0 5 ,000 p<0 0005 as com pared to static control (student’s t test)
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5 2 3 Effect o f Cyclic Strain on Notch Signalling Pathw ay A ctivation in RVSM C
The effect o f cyclic strain on Notch signalling pathway activation was 
investigated over a 24 h period This was determined through transient transfection of 
RVSMC with luciferase-tagged reporter plasmids, the CBF-1 reporter plasmid, or 
Notch target gene reporter plasmids, and comparing transactivation in static versus 
strained cells
Cyclic strain resulted in a decrease in CBF-1 luciferase activity as compared to 
static control cells at 6 h, 10 h and 24 h post-cyclic strain (Figure 5 12) Static cells 
analyzed over a 24 h time period exhibited a temporal increase in CBF-1 luciferase 
activity, reminiscent o f the effect o f serum stimulation on luciferase activity (Figure 
3 13) This can be attributable to the replacement o f the cell media at the 0 h timepoint 
Cyclic strain significantly decreases CBF-1 luciferase activity by 82 36±1 96% 6 h 
following the onset of cyclic strain (Figure 5 12) Similarly, a decrease of 38 9±22 2% 
and 26 9±13 0% in CBF-1 luciferase activity was evident at 10 h and 24 h post-cyclic 
strain respectively, as compared to static control at each timepoint
Exposure of RVSMC to cyclic strain also resulted m a decrease in Notch target 
gene reporter activity Cells were transfected with the hrt-1 luciferase tagged reporter, 
subjected to cyclic strain over a 24 h period, and compared to static controls (Figure 
5 13A) A representative experiment revealed a marked decrease in hrt-1 luciferase 
activity between static and strained cells at all timepoints analyzed As with the CBF-1 
reporter experiment, a temporal increase in hrt-1 luciferase activity was evident in static 
but not strained cells Cyclic strain significantly decreased hrt-1 luciferase activity by 
50 0±2 7% and 65 8±0 5% at 8 h and 10 h post-cyclic strain respectively, as compared 
to static control at each timepoint A similar decrease of 33 4±7 0% was apparent at 24 
h post-cyclic strain, as compared to static control cells A more in depth analysis of the 
effect of cyclic strain on hrt-1 luciferase activity revealed a similar trend (Figure 
5 13B) RVSMC were analyzed at 8 h post-cyclic strain and a significant decrease of 
62 0± 12 0% in hrt-1 luciferase activity was evident in strained cells at this timepoint, as 
compared to static control cells
Similarly, the effect of cyclic strain on hes-5 luciferase activity in RVSMC was 
also investigated (Figure 5 14) A representative timecourse revealed a decrease in hes- 
5 luciferase activity at all timepoints, reminiscent o f the effect o f cyclic strain on the 
CBF-1 and hrt-1 luciferase reporter plasmids Cyclic strain significantly decreased hes-
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5 luciferase activity at 8 h and 24 h post-cyclic strain by 45 84±12 5% and 65 38±3 84% 
respectively, as compared to appropriate static controls, and decreased hes-5 luciferase 
activity at 10 h post cyclic strain by 6 25±18 75% as compared to static control Further 
analysis o f the effect of cyclic strain at 8 h post-onset confirmed this trend (Figure 
5 14B) In this case, a significant decrease of 47 0±4 0% in hes-5 luciferase activity 
was evident, as compared to static control cells
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Figure 5 .12 E ffect o f Cyclic Strain on C B F-1 A ctivation  in RV SM C
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Fig 5 1 2  Cyclic strain causes a decrease in Notch S ignalling Pathw ay activation  
in RV SM C  RVSM C w ere seeded onto Flexercell™  plates at 1 x 105 cells/weil 
RVSM C were transiently transfected with the CBF-1 luciferase-tagged reporter 
plasm id Following overnight recovery, cells were subjected to cyclic strain (10%, 24 
h) as indicated Sam ples were isolated at 0, 6 ,1 0  and 24 h post-strain and assayed for 
luciferase activity Luciferase assays were norm alized to (5-galactosidase activities 
and protein levels, n=4, and expressed as fold increase over control (= the value 
obtained with CBF-1 reporter plasmid transfected cells at 0 h arbitrarily assigned a 
value o f 1) °  p<0 05 as com pared to 0 h static c o n tro l,$ p<0 05 as com pared to static 
control at that tim epoint (student’s t test)
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F igure 5 1 3  E ffect o f  C yclic Strain  on  H R T -1 A ctivation  in
R V SM C
5-,
8 10 24
Time post cyclic strain (h)
B Cyclic Strain (8 h)
8 h post cyclic strain
Fig 5 13 C yclic s tra in  causes a  d ecrease  m  H R T -1 ac tiv a tio n  in  R V S M C  RVSMC 
were seeded onto Flexercell™  plates at 1 x 105 cells/well RVSM C w ere transiently 
transfected with the hrt-1 reporter plasmid Following overnight recovery, cells were 
subjected to cyclic strain (10% , 24 h) as indicated A) Sam ples w ere isolated at 0, 8, 10 
and 24 h post-strain and assayed for luciferase activity Representative tim ecourse, 
perform ed in triplicate B) Samples were isolated 8 h post cyclic strain and assayed for 
luciferase activity, n=3 Luciferase assays were norm alized to  p-galactosidase activities 
and protein levels, and expressed as fold increase over control (= the value obtained with 
hrt-1 reporter plasm id transfected cells at 0 h arbitrarily assigned a value of 1 (A), or = 
the value obtained with static hrt-1  reporter plasmid transfected cells at 8 h arbitrarily 
assigned a value o f 1 (B) ) °  p<0 05 as com pared to 0 h static control, $ p,0 05 as 
com pared to static control at that tim epoint (A), ° p<0 05 as com pared to static control 
(B) (student’s t test)
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Figure 5 .14 E ffect o f  C yclic Strain on H es-5 A ctivation  in RV SM C
A Representative Timecourse
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Fig 5 14 C yclic s tra in  causes a  d ecrease  in  H es-5 ac tiv a tio n  in  R V S M C  RVSM C were 
seeded onto Flexercell™  plates at 1 x 105 cells/well RVSM C were transiently 
transfected with the hes-5  reporter plasm id Following overnight recovery, cells were 
subjected to cyclic strain (10%, 24 h) as indicated A) Sam ples were isolated at 0, 8, 10 
and 24 h post-strain and assayed for luciferase activity Representative tim ecourse, 
perform ed in triplicate B) Samples were isolated 8 h post cyclic strain and assayed for 
luciferase activity, n=3 Luciferase assays w ere norm alized to p-galactosidase activities 
and protein levels, and expressed as fold increase over control (= the value obtained with 
hes-5  reporter plasm id transfected cells at 0 h arbitrarily assigned a value o f 1 (A), o r = 
the value obtained with static hes-5  reporter plasm id transfected cells at 8 h arbitrarily 
assigned a  value o f 1 (B) ) °  p<0 05 as com pared to 0 h static control, $ p,0 05 as 
com pared to  static control at that tim epoint (A), 00 p<0 005 as com pared to  static control 
(B) (student’s t test)
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This study has previously demonstrated that over-expression of Notch 1 IC and 
Notch 3 IC attenuates serum deprivation-induced apoptosis (Figure 4 6 - Figure 4 11), 
and that inhibition of CBF-1-dependent Notch signalling promotes apoptosis in VSMC 
(Figure 4 1 - Figure 4 4) In addition, this study has also revealed that cyclic strain 
decreases Notch signalling pathway component expression in RVSMC, whilst 
concomitantly increasing apoptosis Therefore, the effect of Notch 3 IC over- 
expression on cyclic strain-induced apoptosis was investigated, in an attempt to 
counteract the functional repercussions o f cyclic strain on VSMC apoptosis RVSMC 
were transfected with either an empty vector (mock transfected) or Notch 3 IC, and co­
transfected with the puromycin resistance plasmid Following overnight recovery from 
transfection, cells were exposed to puromycin-containmg media, to ensure a high degree 
of plasmid expression in the cells subsequently exposed to cyclic strain (10%, 24 h) 
Apoptosis was examined using histochemical analysis, caspase 3 activity assays, and 
measurement of both bax and bcl-xi expression levels
The effect of Notch 3 IC on cyclic strain-induced apoptosis was initially 
examined using the acndine orange/ethidium bromide dual stain (Figure 5 15) 
Representative histochemical analysis are shown in Figure 5 15A, and cumulative data 
on the percentage of apoptotic cells are also presented (Figure 5 15B) Cyclic strain 
resulted in a significant increase in apoptotic cells The percentage of apoptotic cells 
present in the mock transfected static control sample was 8 25±1 25%, which was 
increased to 30 75±8 98% following exposure o f the cells to cyclic strain Over- 
expression of Notch 3 IC significantly attenuated this increase in percentage apoptotic 
cells by 50 15±8 4%
The anti-apoptotic effect o f Notch 3 IC was further confirmed following analysis 
of caspase 3 activity (Figure 5 16) Cyclic strain resulted in a 30 0±1 0% increase in 
caspase 3 activity in strained cells, as compared to mock transfected static control cells 
Over expression of Notch 3 IC resulted in a significant decrease in caspase 3 activity in 
static cells of 34 0±4 0%, as compared to mock transfected static control cells Cyclic 
strain also resulted in an increase in capsase 3 activity of 33 0±4 0% in Notch 3 IC 
transfected cells Therefore, the level of caspase 3 activity in Notch 3 IC transfected 
cells exposed to cyclic strain is equivalent to that of mock transfected static control
5 2 4 Effect o f the N otch Signalling Pathw ay on Cyclic Strain-induced RVSM C
A poptosis m vitro
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cells, suggesting comparable levels o f apoptosis in these cells, and functional recovery 
against cyclic strain-induced apoptosis due to Notch 3 IC
The effect o f Notch 3 IC over-expression on cyclic strain-induced changes in 
bcl-2 family mRNA levels was also investigated using quantitative real time PCR 
analysis (Figure 5 17) Exposure of RVSMC to cyclic strain resulted in a decrease in 
bcl-xj expression by 29 0±17 0%, as compared to static mock transfected control cells 
(Figure 5 17A) Over expression of Notch 3 IC in static cells resulted in a significant 
increase in bcl-xi expression by 60 0±21 0% as compared to static mock transfected 
control This was attenuated by exposure of the Notch 3 IC transfected cells to cyclic 
strain, such that the level of bcl-xi expression in Notch 3 IC transfected cells exposed to 
cyclic strain is similar to that in mock transfected static control cells Expression of bcl- 
xl in Notch 3 IC transfected strained cells is increased by only 12 0±3 0% over static 
mock transfected control cells, showing recovery of the cyclic strain-induced decrease 
in bcl-xi expression
The effect o f Notch 3 IC over-expression on cyclic strain-induced changes in 
bax was also examined Cyclic strain increased box expression in RVSMC by 
30 0±8 0% over static mock transfected control cells, whereas the level o f bax 
expression in Notch 3 IC transfected static cells was significantly decreased by 
34 0±1 0% over mock transfected static control cells Notch 3 IC transfected cells 
exposed to cyclic strain, however, exhibited an increase in bax expression to 
149 0±120 0% over mock transfected static control cells
5 2 5 Effect of Notch Over-expression on hrt-2 mRNA levels in RVSMC exposed
to Cyclic Strain
Notch 3 IC over-expression protects against cyclic strain-induced apoptosis 
Notch 3 IC also increases Notch target gene mRNA levels in RVSMC (Figure 3 12B) 
Therefore, it was decided to investigate the mRNA levels o f a Notch target gene in 
mock and Notch 3 IC transfected cells exposed to cyclic strain Exposure to cyclic 
strain resulted in a significant decrease o f 33 0±7 0% in hrt-2 mRNA expression levels, 
as compared to static control in mock transfected cells (Figure 5 18) Notch 3 IC over- 
expression resulted in a significant fold increase (2 81±0 4) in hrt-2 mRNA expression 
levels, and exposure of these cells to cyclic strain reduced this fold increase to 
1 99±0 46 over mock transfected static control
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Figure 5.15 Effect of Notch Over-expression on Cyclic Strain-induced 
Apoptosis, as measured by Acridine Orange/Ethdidum Bromide Dual 
Stain
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Fig 5.15 O ver-expression  o f N otch 3 decreases cyclic s tra in -in d u ced  apop tosis  in 
R V S M C . RVSMC were seeded onto Flexercell™  plates at 1 x 105 cells/w ell, and were 
transiently transfected with the puromycin resistance plasmid, pGK3puro, and co­
transfected with the empty vector p7pCM V or Notch 3 IC 2 days later. Following 
overnight recovery, cells were incubated in purom ycin containing growth medium (0.8 
fxg/ml, 48 h), and subsequently exposed to cyclic strain (10% , 24 h) as indicated. Cells 
were stained with the Acridine O range/ Ethidium Bromide dual stain and viewed under a 
fluorescent microscope. A) Representative images; V iable cell, white arrow ; Apoptotic 
cell, blue arrow. B) Graph showing percentage change in the num ber of apoptotic cells, 
n=2. P p<0.05 as com pared to static control, $ p<0.05 as com pared to m ock-transfected 
strained cells (student’s t test).
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Figure 5.16 Effect of Notch Over-expression on Cyclic Strain-induced 
Apoptosis, as measured by Caspase 3 Activity
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Fig 5 16 Over-expression of Notch 3 decreases cyclic strain-induced apoptosis in 
RVSMC RVSM C were seeded onto Flexercell™  plates at 1 x 105 cells/well, and 
were transiently transfected with the puromycin resistance plasmid, pGK3puro, and co ­
transfected with the em pty vector p7pCM V or Notch 3 1C 2 days later Following 
overnight recovery, cells were incubated in purom ycin containing grow th m edium (0 8 
Hg/ml, 48 h), and subsequently exposed to cyclic strain (10% , 24  h) Protein was 
isolated and assayed for caspase 3 activity Caspase assays w ere norm alized to protein 
levels, and expressed as fold increase over control (= the value obtained with static 
cells arbitrarily assigned a value o f 1), representative experim ent perform ed in 
triplicate ° p<0 05 as com pared to static c o n tro l ,$ p<0 05 as com pared to Notch 3 IC 
transfected static cells (student’s t test)
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F ig 5 17 E ffec t o f  cyclic s tra in  a n d  N otch  3 over-exp ress ion  on box  a n d  bcl-xL 
exp ression  in  R V S M C  RVSM C were seeded onto Flexercell™  plates at 1 x 10* 
cells/w ell, and were transiently transfected with the purom ycin resistance plasmid, 
pGK3puro, and co-transfected with the em pty vector p7pCM V or Notch 3 IC 2 days later 
Follow ing overnight recovery, cells were incubated in purom ycin containing growth 
m edium (0 8 (jig/ml, 48 h), and subsequently exposed to cyclic strain (10% , 24  h) mRNA 
levels were m easured using quantitative RT-PCR, and expressed as fold increase over 
control (= the levels o f target gene present in static m ock transfected cells) n=3 °  p<0 05 
as com pared to static control (student’s t test)
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Figure 5.18 Effect of Notch Over-expression on hrt-2 mRNA 
Expression in RVSMC exposed to Cyclic Strain
4-,
mock transfected Notch 3 1C
Fig 5 18 E ffect o f  N otch  over expression  on hrt-2  m R N A  expression  in R V SM C  
exposed to  cyclic s tra in  RVSM C were seeded onto F lexercell™  plates at 1 x 105 
cells/w ell, and were transiently transfected with the purom ycin resistance plasmid, 
pG K3puro, and co-transfected with the em pty vector p7pCM V or Notch 3 IC 2 days later 
Follow ing overnight recovery, cells w ere incubated in purom ycin containing growth 
m edium (0 8 fxg/ml, 48 h), and subsequently exposed to cyclic strain (10% , 24 h) mRNA 
levels w ere m easured using quantitative RT-PCR, and expressed as fold increase over 
control (= the levels o f target gene present in static m ock transfected cells) n=3, °  p<0 05 
as com pared to static control (student’s t test)
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5 3 Discussion
This study clearly establishes that cyclic strain induces apoptosis in VSMC 
This concurs with other studies, which report increased VSMC apoptosis both in vivo 
and in vitro The level of cyclic strain-induced apoptosis observed in this study is 
comparable to that reported in other in vitro studies, which describe a 2- to 4-fold 
increase in apoptosis due to increased cyclic strain (Mayr et a l , 2002, Wermg et a l , 
2003) The fact that cyclic strain-induced apoptosis is, at least in part, caspase 3- 
dependent is unsurprising, as activation of caspase 3 has been observed in 
atherosclerotic plaques at sites o f VSMC apoptosis (Mallat et a l , 1997) In addition, 
caspase 3 activation was observed in human umbilical arteries, which are exposed to 
dramatic increases in haemodynamic forces during delivery (Kim et a l , 2000)
The importance of the Bcl-2 family in the regulation of apoptosis in a variety of 
cells is well established, and changes in Bcl-2 family expression are often observed 
during the pathogenesis of vascular disease (Bai et a l , 1999, Cook et a l , 1999) 
Therefore, this study investigated the effect of cyclic strain on the pro-apoptotic genes, 
bad and bax, and the anti-apoptotic genes, bcl-2 and bcl-xi This study shows that 
cyclic strain changes the bcl-2 family profile in favour o f apoptosis, with an increase in 
both bad and bax, and a concomitant decrease in bcl-xi expression However, an 
increase in the anti-apoptotic bcl-2 gene expression was also observed This is 
somewhat surprising as we, and others, have clearly demonstrated that cyclic strain 
induces apoptosis in VSMC in vitro However, this finding concurs with a recent study 
by Mayr et a l , (2002) which demonstrates an increase in Bcl-2 following cyclic strain 
The anti-apoptotic activity o f Bcl-2, however, may be cell type or context specific, as 
Bcl-2 has been shown to have variable anti-apoptotic effects in different cell types ( Yeh 
1997) In addition, despite a 1 8-fold increase in Bcl-2 expression observed in failing 
hearts, the normal anti-apoptotic action of Bcl-2 in these cells is insufficient to 
overcome the pro-apoptotic stimuli, such as mechanical stretch, that is present in the 
failing heart (Hetts 1998) Therefore, the up-regulation of bcl-2 in VSMC exposed to 
cyclic strain may be a compensatory up-regulation in response to the increased pro- 
apoptotic bcl-2 family gene expression, but is ineffective in protecting against 
apoptosis
The regulation of both bax and bcl-xi by cyclic strain is somewhat unsurprising 
as both have been implicated in neonatal vascular remodelling and the pathogenesis of 
vascular disease (Pollman et a l , 1999, Gibbons and Pollman 2000, Kim et a l , 2000)
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The stimulus for the observed increase in bax gene expression due to cyclic strain is 
likely due to increased p53 activity as bax is a direct transcriptional target for p53, and 
two recent studies have shown increases in both p53 activity and Bax expression due to 
cyclic strain (Mayr et a l , 2002, Wermg et a l , 2003) Bax expression is up-regulated in 
the rat heart following coronary occlusion (Liu et a l , 1998), and its over-expression in 
the ventricles of spontaneously hypertensive rats is said to contribute to myocyte 
apoptosis (Fortuno et a l , 1998) In addition, an increased level of Bax expression was 
observed in the human umbilical vessel during delivery, which coincided with an 
increase in apoptosis in the vessel (Kim et a l , 2000) The umbilical vessel is exposed 
to increased haemodynamic forces during delivery, therefore it is possible that the 
observed Bax up-regulation is a result of increased mechanical forces Similarly, Bax- 
associated apoptosis was also observed at other sites undergoing dramatic 
haemodynamic changes during the perinatal period, such as the ductus arteriosus and 
the branching point of large arteries (Kim et a l , 2000) These observations indicate that 
Bax may play a key role in both neonatal and pathological vascular remodelling, and 
that the stimulus for Bax up-regulation may be exposure to increased haemodynamic 
forces
The observed decrease in bcl-xi expression in this study is in contradiction with 
Mayr et a l , (2002), who reports an increase in Bcl-xL following cyclic strain This 
discrepancy could perhaps be attributed to differences in VSMC phenotype, as this has 
previously been shown to determine the growth response of VSMC to mechanical 
forces in vitro (Cappadona et a l , 1999) However, the decrease in bcl-xL observed in 
this study following cyclic strain is consistent with the observed increase in cyclic 
strain-induced VSMC apoptosis In addition, a down-regulation of bcl-xl in vivo is 
repeatedly associated with VSMC apoptosis (Yeh 1997, Bai et a l , 1999) B c1-xl 
protein expression is dramatically decreased in medial VSMC following balloon injury 
(Yeh 1997), presumably as a result of the distention injury to the SMC due to balloon 
inflation This is also associated with an increase in medial VSMC apoptosis, and acute 
medial cell loss As we have previously established a relationship between the Notch 
signalling pathway and bcl-xL expression, it is interesting to note that Wang et a l , 
(2002a) report a decrease in expression of Notch signalling pathway components in 
medial SMC following balloon injury Therefore, it is tempting to speculate that Notch 
regulates the cyclic strain-induced decrease in btl-xi expression, further suggesting that 
cyclic strain may affect expression of Notch signalling pathway components In 
contrast to medial cells, neointimal cells are relatively resistant to apoptosis, and exhibit
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an increased expression of Bcl-Xj Vascular lesion formation is associated with an up- 
regulation of B c1-xl within intimal VSMC in both animal models and human specimens 
of vascular disease (Bai et a l , 1999) In addition, down-regulation of B c1-xl using anti­
sense oligonucleotides induces VSMC apoptosis and regression of vascular disease 
(Pollman et a l , 1998) These findings indicate that increased Bcl-xL expression is a 
critical determinant of intimal VSMC viability and vascular lesion formation, and could 
be an attractive target for future therapeutic interventions
This study has clearly established that cyclic strain induces apoptosis in VMSC 
In addition, a functional coupling between the Notch signalling pathway and VSMC 
apoptosis was also established, in that the Notch signalling pathway exerts a protective 
effect against serum deprivation-induced apoptosis, and CBF-1-dependent inhibition of 
this pathway results in increased apoptosis in VSMC Therefore it was postulated that 
changes m Notch signalling pathway activity could contribute to cyclic strain-induced 
apoptosis in VSMC Cyclic strain has previously been shown to affect the level of 
expression of a number o f VSMC components (Feng et a l , 1999), therefore, the effect 
of cyclic strain on the Notch signalling pathway was investigated Additionally, the 
effect of Notch over-expression on cyclic strain-induced apoptosis was also analyzed to 
determine whether Notch could protect against cyclic strain-induced apoptosis in 
VSMC
This study presents previously unreported evidence of a cyclic strain-induced 
decrease in Notch signalling pathway expression in VSMC Exposure to increased 
cyclic strain results in a similar decrease in expression of all Notch signalling pathway 
components analyzed Moreover, this study provides evidence that this decrease in 
expression due to cyclic strain occurs in and time- and force-dependent manner 
Therefore, this study adds components of the Notch signalling pathway to the list of 
genes regulated by changes in cyclic strain in vitro As expression of the active forms 
of Notch receptors and CBF-1-dependent Notch target genes are decreased following 
exposure to cyclic strain, it is unsurprising that this study has additionally shown a 
cyclic strain-induced decrease in Notch signalling pathway activity in VSMC 
Inhibition of CBF-1-dependent Notch signalling following exposure to cyclic strain is 
further confirmed by comparing the expression profile o f the Bcl-2 family o f genes 
following cyclic strain and CBF-1-dependent signalling inhibition with RPMS-I, which 
is virtually identical, as illustrated in Figure 26 below
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Figure 26 Bcl-2 family gene expression following cyclic strain and C B F-l-dependent signalling  
inhibition
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While this is the first study of its kind, the findings we present concur with the 
in vivo findings presented by Wang et o l , (2002a), who report a decrease in Notch 
receptor and Notch target gene expression following balloon injury and subsequent 
cellular distention, with the most dramatic decrease evident for the Notch 3 receptor and 
the HRT-1 target gene
This study has previously shown that the Notch signalling pathway confers a 
level of protection against serum deprivation-induced apoptosis in VSMC Therefore, 
we also investigated whether this anti-apoptotic effect of Notch was conserved against 
cyclic strain-induced apoptosis in VSMC This was analyzed through over-expression 
studies using Notch 3 IC, which was utilized as in vivo deformation of VSMC causes a 
greater down-regulation of Notch 3 as compared to other Notch receptors (Wang et a l , 
2002a) Over-expression of Notch 3 IC partially inhibited cyclic strain-induced 
apoptosis, as measured by the annexin V/propidium iodide dual stain One explanation 
for this could be that other signalling pathways co-operate with the Notch signalling 
pathway to regulate apoptosis in VSMC exposed to cyclic strain This is likely, as 
multiple signalling pathways are known to regulate apoptosis in most cell types studied, 
including VSMC (Gupta 2003) In addition, it is interesting to note that Notch 3 IC 
over-expression in VSMC exposed to cyclic strain resulted in a similar level of caspase 
3 activity to mock transfected un-strained cells This suggests that the Notch signalling 
pathway regulates cyclic strain-induced apoptosis in a caspase 3-dependent manner
We have previously shown that the pro-apoptotic bax gene, and the anti- 
apoptotic bcl-xi gene are both regulated by the Notch signalling pathway in VSMC In 
addition, we have presented evidence showing a down-regulation of bcl-XL and a
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concomitant up-regulation o f bax m response to cyclic strain Further to this, we 
investigated whether Notch 3 over-expression affects bcl-xL or bax expression under 
conditions of cyclic strain, in an attempt to elucidate the mechanism of the anti- 
apoptotic effect exerted by Notch 3 over-expression in response to cyclic strain-induced 
apoptosis Similar to the activity pattern m evidence for caspase 3, Notch 3 over- 
expression in VSMC exposed to cyclic strain resulted in a similar level o f bcl-xL 
expression to that seen in mock transfected un-strained cells Therefore, reversal o f the 
cyclic strain-induced decrease in the Notch signalling pathway abolished the cyclic 
strain-induced decrease in bcl~xL expression This suggests that Notch may mediate its 
anti-apoptotic effect against cyclic strain-induced VSMC apoptosis in a bcl-xi- 
dependent manner, and down-regulation of the Notch signalling pathway in response to 
increased cyclic strain results in a decrease in bcl-xi expression Bcl-xL acts to prevent 
against apoptosis in part by binding to the pro-apoptotic protein Bax, thus inhibiting the 
ability o f Bax to form homodimers This inhibits the ability o f Bax to increase 
mitochondrial membrane potential and cause activation o f  the caspase cascade 
Therefore, down-regulation o f bcl-xi could increase the formation o f Bax homodimers 
and caspase 3-activation A contributing factor to the increase in Bax homodimer 
formation would also be the increase in bax gene expression in VSMC following cyclic 
strain However, over-expression of Notch 3 m VSMC exposed to cyclic strain did not 
result in the expected attenuation of the cyclic stram-mduced increase in bax expression, 
but rather potentiated the response This suggests, although bax expression is regulated 
by the Notch signalling pathway in static VSMC, that additional factors affected by 
cyclic strain act to regulate and potentiate bax expression m VSMC
W hilst it is now well established that increased mechanical stress induces 
apoptosis in VSMC, the molecular mechanisms regulating this response are not yet fully 
elucidated As with regulation o f apoptosis by other stimuli, it is likely that several 
mechanisms may mediate the apoptotic response of VSMC to increased cyclic strain 
Wemig et a l , (2003) have recently shown that cyclic strain-induced apoptosis in VSMC 
is m ediated by the Pi-integrm-p38-p53 signalling pathways W hilst we have 
conclusively shown that the Notch signalling pathway also regulates cyclic strain- 
induced VSMC apoptosis, it is also possible that the Notch signalling pathway interacts 
with one or more components o f the Pi-integrin-p38-p53 signalling pathway Several 
reports provide evidence for these interactions, and will be reviewed in Chapter 7 In 
addition, (Li and Xu 2000) suggest that G proteins may be a primary mechanosensor in 
VSMC, as treatment of the cells with pertussis toxin (PTX), a G, inhibitor, resulted in
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the blocking of cyclic strain-induced p38MAPK activation In concurrence with this 
report, this study has identified a role for G proteins in mediating the cyclic strain- 
induced increase in caspase 3 activity in VSMC Preliminary data suggests that that 
treatment of VSMC with PTX also abolishes the cyclic strain-induced increase in 
caspase 3 activity Cyclic strain causes a 66 0±15 0% increase in VSMC (Figure 5 3), 
however, treatment of cells with PTX attenuates this increase, bringing caspase 3 
activity to within 5 0± 15% of that observed in un-strained cells (n=3, data not shown) 
As we have shown that G protein inhibition and over-expression of Notch 3 both result 
in the same abolition o f the cyclic strain-induced increase in caspase 3 activity, we 
suggest that an interaction between G proteins and the Notch signalling pathway could 
exist in VSMC Although further exploration of this was beyond the scope of this 
project, we propose further examination of this in future studies within the laboratory, 
and provide additional evidence from the literature o f the links between G proteins and 
the Notch signalling pathway, which will be discussed in more detail in Chapter 7
5 4 Conclusion
In summary, we have conclusively shown that cyclic strain induces apoptosis in 
VSMC Cyclic strain-induced apoptosis is attributable, at least in part, to a cyclic 
strain-induced decrease in expression and activity of Notch signalling pathway 
components In addition, we propose that over-expression of Notch 3 inhibits cyclic 
strain-induced apoptosis in a bcl-xL- caspase 3-dependent manner However, we 
acknowledge that the artery is a mechanically complex three-dimensional structure, 
therefore it is likely that in vitro cellular deformations cannot completely simulate in 
vivo mechanical stimuli Therefore, this study also investigates the effect of altered 
mechanical stress on Notch signalling pathway expression in vivo, which will be 
discussed in Chapter 6
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Chapter 6
Results
Effect of Alterations in 
Biomechanical Stress on the 
Notch Signalling Pathway and 
Apoptosis i n  v i v o
6 1  Introduction
As Notch signalling is relevant in vascular disease (Lindner et a l , 2001, Wang 
et a l , 2002) this study examines the relative expression of Notch receptors and target 
genes, in addition to apoptosis in vivo, using two models of vascular injury This study 
has previously established that increased mechanical stretch both increases apoptosis 
and decreases Notch signalling pathway expression in VSMC in vitro To determine 
whether this effect of altered biomechanical forces extrapolates to an in vivo situation, 
we investigated Notch signalling pathway expression and levels of apoptosis in animal 
models subjected to either carotid artery or portal vein ligation (PVL) Such models 
provide a template for the study of altered haemodynamic forces and resultant vascular 
remodelling
Mechanical forces associated with blood flow have been implicated with the 
regulation of vascular cell fate, both as a fundamental feature in development, and in the 
pathogenesis of vascular disease Apoptosis has, for example, been demonstrated 
following changes in blood flow after birth, in intimal arterial thickening following 
balloon catheter injury, and in both animal and human atherosclerotic plaques (Sho et 
a l , 2001) Apoptosis is virtually absent in normal adult vessels, but is a prominent 
feature of pathological conditions involving vascular remodelling (Xu 2000) Changes 
in VSMC fate decisions, including apoptosis, results in vascular remodelling, however, 
the molecular mechanisms of apoptosis, and its regulation, following alterations in 
biomechanical stress remain to be fully elucidated
Vascular remodelling is the structural re-orgamzation of a vessel, and is 
considered both a physiological and pathological process within the vasculature 
Physiological vascular remodelling is evident after birth, for example, during the 
closure of the ductus arteriosus (Slomp et a l , 1997) Inappropriate or pathological 
vascular remodelling is a common feature of many vascular disease states, and 
contributes to the progression of vascular disease Remodelling of an arterial wall 
occurs, for example, after chronic changes in blood pressure and blood flow in response 
to vessel injury, and plays a critical role in the degree o f vessel narrowing during 
cardiovascular disease progression Vascular remodelling can result in both arterial 
narrowing or arterial enlargement, termed inward and outward remodelling respectively 
(Mulvany 1999)
The models of altered haemodynamic forces, and subsequent vascular 
remodelling, analyzed in this study include the rat carotid artery and portal vein ligation
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models.
The carotid artery ligation model is a particularly powerful research tool, as it 
provides a model of bilateral carotid remodelling in a single animal. The simultaneous 
reduction in blood flow in the left (ligated) carotid artery and the increase in blood flow 
in the right carotid artery allows examination of the effects of altered haemodynamics 
on expression of vascular genes and apoptosis in a single animal. Indeed, many groups 
utilize this model in an attempt to elucidate the molecular mechanisms of vessel wall 
remodelling (Bryant et al., 1999; Kraemer 2002; Sullivan and Hoying 2002; Korshunov 
and Berk 2003). However, this model can be further sub-divided into two groups, the 
“partial ligation” model, utilized in this study, and the “flow-cessation” model. 
Korshunov and Berk (2003), show that the partial ligation of the left carotid artery 
results in a dramatic decrease (90%) in blood flow in the left carotid artery, with the 
maintenance of an intact endothelium and no thrombosis. A concomitant increase 
(70%) in blood flow was also observed in the right carotid artery. This study describes 
outward remodelling or vessel enlargement in both the left and right carotid arteries, 
which was maximal at 7 days post-ligation. Remodelling was greater in the right 
carotid artery, with a predominantly increased lumen, and little increase in the medial or 
adventitial layer, whereas the left carotid artery displayed a dramatic increase in both 
the medial and adventitial layers.
F igure 27: E xam ple o f C a ro tid  R em odelling  due to Left C a ro tid  L igation
F igu re  27: C a ro tid  rem odelling . Verhoeff Van 
G iesson staining of sham, right carotid artery (RCA) 
and left carotid artery (LCA) 14 days post-ligation. 
Sham (A, B, F); Ligated (C, D, E). Elastic fibres, 
black; nuclei, brown; collagen, red; other tissue 
structure, yellow. Partial ligation resulted in 
significant intimal form ation (in mouse model only) in 
the LCA, with small breaks (arrows) and thinning in 
the internal and external elastic laminae. In contrast, 
the elastic laminae and the media of shams remained 
intact (Korshunov and Berk 2003).
The “flow-cessation” model of carotid ligation is achieved by total ligation of 
the carotid artery, resulting in complete cessation or interruption of blood flow in this
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vessel Bryant et a l , (1999), utilize this model and have recorded a decrease in blood 
flow from 0 58±0 05 ml/min in normal vessels to zero in ligated vessels In contrast to 
the previous model, the ligated carotid artery displays inward vascular remodelling or 
arterial narrowing, and also endothelial denudation and thrombus formation, which 
lessens the physiological relevance of this model to study human cardiovascular disease 
(Korshunov and Berk 2003) In addition, Korshunov and Berk argue that the “partial 
ligation” model is more physiologically relevant in the study of cardiovascular disease, 
as although decreased blood flow is associated with human vascular disease, the no­
flow phenomenon that occurs with the “flow cessation” model is not generally seen in 
atherosclerotic/restenotic arteries Therefore, this study utilizes a physiologically 
relevant model of altered haemodynamic forces to determine the effect, if any, on Notch 
signalling pathway expression and apoptosis in the vascular wall
In addition, we also utilize a model o f partial portal vein ligation (PVL) as a 
model of altered haemodynamic forces, and compare this to a sham-operated control 
model PVL induces pre-hepatic portal hypertension, which is characterized by 
increased cardiac output and increased plasma volume (Yokoyama et a l , 2001) Blood 
pressure, and therefore, biomechanical forces, are increased in the ligated animals, as 
compared to the sham-operated control Yokoyama et a l , (2001), observed that portal 
pressure was increased in PVL rats to 13 2±0 9 mm Hg, compared to sham-operated 
control rats, who exhibited a portal pressure of 5 41 ±0 6 mm Hg It must be noted that 
whilst the expression of the Notch signalling pathway is described as being restricted to 
the arterial vessels, a number of exceptions to this pattern of expression exist, and 
components of the Notch signalling pathway have previously been identified in the 
portal vein (Villa et a l , 2001)
Whilst the importance of apoptosis in vessel remodelling and vascular disease is 
well established, the molecular mechanisms regulating this process remain to be fully 
elucidated This study has clearly demonstrated that over-expression of the Notch 
signalling pathway protects against cyclic strain-induced VSMC apoptosis Similarly, 
inhibition of this pathway, or decrease in Notch signalling pathway expression also 
results in VSMC apoptosis Therefore, this study also investigates whether alterations 
in mechanical forces affect Notch signalling pathway expression and apoptosis in two in 
vivo models Although two previous reports have examined Notch signalling pathway 
expression m rat carotid arteries following balloon injury, none have examined the 
effect o f a sustained increase in biomechanical force to date Linder et a l , (2001) report
that components of the Notch signalling pathway are up-regulated in rat carotid
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arteries in response to injury, whereas Wang et a I , (2002a) report a decrease in Notch 
signalling pathway expression in the carotid artery following injury Although these 
reports initially appear to contradict one another, a number of factors must be 
considered which may account for the discrepancies between the studies Firstly, the 
findings of Lindner et a l , were limited to the inner face of the artery, as they used en 
face  preparations for in situ hybridization They observed an increase in Notch 
signalling pathway component expression in both EC and SMC following injury 
However, the increase in SMC expression was observed following endothelial 
denudation, which does not occur normally within the vasculature, and may, in itself, 
affect gene expression and function of the underlying SMC Indeed, Langille et a l , 
(1993) have shown that the endothelium is a critical mediator of the flow-dependent 
remodelling response In addition, increases in gene expression in the innermost SMC 
is not necessarily representative of changes in gene expression m the medial SMC layer 
as a whole In contrast, Wang et a l , who report a co-ordinate down regulation of Notch 
receptors and HRT target genes in response to vascular injury, analyzed arteries 
following removal of the mtimal and adventitial layers Therefore the observed changes 
in gene expression are representative o f the medial SMC layer Whilst this study uses 
RNA and protein extracted from total vessels, we believe that the results are 
representative of changes in gene expression in VSMC, as these constitute the majority 
o f the cells analyzed
Although it would be tempting to analyze the effect of Notch signalling pathway 
manipulation on vessel apoptosis and vascular remodelling in vivo, the models utilized 
in this study do not permit this One possible method of such analysis would be 
generation of a transgenic animal model However, as both Notch over-expression and 
absence result in embryonic lethality, generation of such a model has proved elusive, 
until recently Liu and Lobe (2003) recently presented reports of a viable Notch 1 
transgenic mouse model, in which activation of Notch 1 IC is achieved post-natally to 
ensure viability Possible collaboration with this group, or future generation of a similar 
model could prove to be an exciting research tool, further validating the in vitro findings 
previously obtained within the laboratory
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6 2 Results
The following section presents data on the relative expression of Notch receptors 
and target genes, and the level of apoptosis using two in vivo models of vascular injury 
and remodelling
6 2 1 Expression of Notch Signalling Pathway Components Post-Carotid Ligation
The effect of altered mechanical forces on the Notch signalling pathway in vivo 
was initially studied using a rat carotid artery ligation model Notch signalling pathway 
component expression levels were examined in the carotid arteries of sham-operated 
animals (data on level of expression in right and left carotid of sham animals pooled) 
and compared to that ot the right and left carotid arteries of ligated animals Flow rates 
were significantly altered in both the right and left carotid arteries o f ligated animals, 
compared to that of the sham-operated animals (Figure 6 1) Measurements were taken 
at 0, 3 and 28 days post-carotid ligation, and expressed as fold change over sham- 
operated control (arbitrarily assigned a value of 100%) Flow rates in sham-operated 
animals remained constant over the time period examined, however the flow rates 
observed in the right carotid artery o f the ligated animal (“right ligated”) were 
significantly increased at both 3 days and 28 days post-ligation, to 165±13% and 
175±8% over sham-operated control The flow rates in the left ligated carotid artery 
were concomitantly decreased to 5±0 8% and 3±0 4% at 3 days and 28 days post- 
hgation respectively with respect to sham-operated controls
6 2 11 Three Days Post-Carotid Ligation
Altered mechanical forces in both the right and left carotid arteries of ligated 
animals resulted in increased protein expression o f Notch receptors and target genes, as 
compared to sham-operated control Equal protein loading on the gels was verified 
using a Ponceau S stain, as described in section 2 3 7 4 Notch 1 protein expression 
exhibited a slight increase in the right and left carotid arteries of the ligated animal over 
sham-operated control (arbitrarily assigned a value of 1) An increase of 1 19±0 04 was 
evident in the right carotid artery compared to control, and a slight but significant 
increase in the left carotid artery (1 21 ±0 02) o f the ligated animal was also evident
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(Figure 6 2) Similarly, Notch 3 protein expression was significantly increased in both 
the right and left carotid arteries of ligated animals, to 1 87±0 26 and 1 77±0 23 over 
sham-operated control respectively (Figure 6 3)
Significant increases in Notch target gene protein expression were also observed 
in the right and left carotid arteries of ligated animals, as compared to sham-operated 
controls (Figure 6 4) HRT-1 protein expression was increased to 2 07±0 1 and 2 0±0 2 
over sham-operated control in the right and left arteries of ligated animals respectively 
Similar fold increases were also evident in the right and left carotid arteries for HRT-2 
and HRT-3 protein expression HRT-2 expression was increased by 3 18±0 32 and 
3 0±0 32 fold in the right and left carotid arteries respectively Likewise, fold increases 
of 2 63±0 27 and 2 58±0 23 in HRT-3 expression were evident in the nght and left 
carotid arteries respectively This pattern of protein up-regulation was also evident for 
Hes-1 and Hes-5 expression Significant fold increases of 1 86±0 08 and 1 87±0 21, 
and 2 4±0 02 and 1 99±0 02 evident in the right and left carotids of ligated animals for 
Hes-1 and Hes-5 respectively In addition, the level of Hes-5 protein expression was 
significantly decreased in the left ligated artery when compared to the contralateral right 
carotid
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Fig 6 1 Blood Flow in Y oung R ats follow ing C arotid Ligation
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Fig 6 1  Graphs showing blood flow  rates in young rats post-carotid ligation  
com pared to sham  control anim als lh e  left carotid artery of young rats was ligated, 
and the blood flow rates measured in the left and right carotid arteries o f both ligated and 
sham -operated anim als using a Transonic flowprobe(g/m l/m m ) at 0, 3, and 28 days post- 
hgation Results are expressed as percentage increase in flow rate over sham operated 
animals, arbitrarily assigned a value o f 100% ° p<0 05, °°  p<0 005 as com pared to sham- 
operated control (student’s t test)
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Fig 6 2 C hanges in N otch 1 R eceptor E xpression in L igated versus
Sham -operated A nim als 3 D ays Post-C arotid  L igation
Notch 1
Right Sham Left Sham Right Ligated Left Ligated
Sham Right Ligated Left Ligated
Fig 6 2 Changes in Notch 1 receptor expression in the right and left carotid  
arteries o f  ligated anim als com pared to sham -operated controls I he lei t carotid 
artery of young rats were ligated at day 0 I he left and right carotids of both sham- 
operated and ligated animals were harvested 3 days post ligation Protein extracted 
from these vessels was assayed for Notch I using Western blot analysis Values are 
expressed as fold increase over sham -operated animals (arbitrarily assigned a value of 
1), n=2, two vessels were pooled for each protein preparation ° p<0 05 as com pared to 
sham -operated control (student’s t test)
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Fig 6 3 C hanges in N otch 3 R eceptor E xpression in Ligated versus
Sham -operated A nim als 3 D ays Post-C arotid  L igation
Notch 3
Right Sham Lett Sham Right Ligated Left Ligated
-90 kDa
Fig 6 3 Changes in Notch 3 receptor expression in the right and left carotid arteries 
o f ligated anim als com pared to sham -operated controls 1 he left carotid artery of 
young rats was ligated at day 0 The left and right carotids of both sham -operated and 
ligated animals were harvtsted 3 days post ligation Protein extracted from these vessels 
was assayed for Notch 3 using W estern blot analysis Values a r t  expressed as fold 
increase over sham-operated animals (arbitrarily assigned a value of 1), n=2, two vessels 
were pooled for each protein preparation ° p<0 05, ao p<0 005 as com pared to sham- 
operated control (student s t test)
217
Fo
ld 
Ch
an
ge
 
to 
C
on
tr
ol
 (
A/
U)
 
» 
Fo
ld 
Ch
an
ge
 
to 
C
on
tr
ol
 (
A
/U
)
Fig 6 4 C hanges in N otch T arget G ene E xpression in L igated versus
Sham -operated A nim als 3 D ays Post-C arotid  L igation
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E Hes-5
Right Sham Left Sham Right Ligated Left Ligated
Fig 6 4 C hanges in Notch Target Gene expression in the right and left carotid  
arteries o f  ligated anim als com pared to sham -operated controls The left carotid 
artery of young rats were ligated at day 0 1 he left and right carotids o f both sham- 
operated and ligated anim als w tre  harvested 3 days post ligation Protein extracted from 
these vessels was assayed for H R 1-I (A), H R !-2 (B), HRT-3 (C), Hes-1 (D) and Hes-5 
(E) using Western blot analysis Values are expressed as fold increase over sham- 
operated animals (arbitrarily assigned a value of 1), n=2, two vessels were pooled for 
each protein preparation 00 p<0 005, nan p<0 0005 as com pared to sham -operated 
control, $$ p<0 005 as com pared to right artery o f ligated animal (student s t test)
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The expression of Notch receptors and target genes were subsequently analyzed 
in animals at 28 days post-carotid ligation Again, protein expression was analyzed in 
the right and left carotid arteries of ligated animals, and expressed as fold change over 
sham-operated control levels (arbitrarily assigned a value of 1)
Notch 1 IC protein levels were decreased in both the right and left carotid 
arteries of ligated animals (Figure 6 5) Notch 1 IC expression was decreased by 
37 0±15 0% and 11 0±4 0% in the right and left carotid arteries respectively, as 
compared to sham-operated control A similar expression pattern was evident for Notch 
3 IC protein expression, with significant decreases in both the right (42 0±7 0%) and 
left (18 0±3 0%) carotid arteries as compared to sham-operated controls (Figure 6 6) In 
addition, Notch 3 IC protein expression was significantly decreased in the right carotid 
artery of the ligated animal, as compared to the left carotid artery
Subsequent analysis o f Notch target gene protein expression levels revealed a 
similar pattern of expression to that of the Notch receptors (Figure 6 7) Analysis of the 
right carotid artery of ligated animals revealed a significant decrease of 40 0±7 0% in 
HRT-1 protein expression, with respect to sham-operated animals (Figure 6 7A) This 
decrease in HRT-1 expression was also evident in the left ligated carotid artery 
(15 0±6 0%) As with Notch 1C receptor expression, HRT-1 expression was 
significantly decreased in the right carotid artery of the ligated animal, as compared to 
the left carotid artery
Similarly, HRT-2 expression was significantly decreased in the right carotid of 
the ligated animal by 37 0^11 0% of as compared to sham-operated control, with a less 
pronounced decrease of 16 0±6 0% evident in the contralateral left carotid artery 
(Figure 6 7B) Analysis of HRT-3 protein expression also revealed a significant 
percentage decrease in expression in both the right (49 0±4 0%) and left (19 0±5 0%) 
carotid arteries of ligated animals, as compared to sham-operated controls In addition, 
the level of HRT-3 protein expression between the right and left carotid arteries was 
significantly different, being substantially decreased in the right carotid over the 
contralateral left carotid artery The expression pattern o f the Hes family o f target genes 
followed a similar pattern to that of the related FTRT family Hes-1 protein expression 
was significantly decreased in the right carotid artery (43 0±6 0%) of ligated animals as 
compared to sham-operated controls The contralateral left carotid artery exhibited a
6 2 1 2  Twenty Eight D ays Post-C arotid Ligation
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slight fold decrease in Hes-1 protein expression over control (9 0±5 0%), this level of 
protein expression was significantly different to that evident in the right carotid artery 
Similarly, Hes-5 protein expression was significantly decreased in the right artery 
(51 0± 13 0%) as compared to sham-operated control, and a less pronounced fold 
decrease of 25 0±28 0% was evident in the contralateral left carotid artery
Fig 6 5 C hanges in N otch 1 R eceptor E xpression in L igated versus
Sham -operated A nim als 28 D ays Post-C arotid  L igation
Notch 1
Sham Left Ligated Right Ligated
Fig 6 5 Changes in Notch 1 receptor expression in the right and left carotid arteries 
o f ligated anim als com pared to sham -operated controls The left carotid artery of 
young rats w tre  ligated at day 0 I he left and right carotids of both sham -operated and 
ligated anim als were harvested 28 days post ligation Protein extracted from these 
vessels was assayed for Notch 1 using W estern blot analysis V alues arc expressed as 
fold increase over sham -operated animals (arbitrarily assigned a value of 1), n=2, two 
vessels were pooled for each protein preparation
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Fig 6 6 C hanges in N otch 3 R eceptor E xpression in Ligated versus
Sham -operated A nim als 28 D ays Post-C arotid  L igation
Notch 3
Sham Left Ligated Right Liaated
-90 kDa
Fig 6 6 Changes in Notch 3 receptor expression in the right and left carotid  
arteries o f  ligated anim als com pared to sham -operated controls The left carotid 
artery of young rats were ligated at day 0 T he left and right carotids of both sham- 
operated and ligated anim als were harvested 28 days post ligation Protein extracted 
from these vessels was assayed to r Notch 3 using W estern blot analysis Values are 
expressed as fold increase over sham -operated animals (arbitrarily assigned a value of 
1), n=2, two vessels were pooled for each protein preparation 00 p<0 005 as com pared 
to sham -operated control, $ p<0 05 as com pared to left ligated artery (student’s t test)
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Fig 6 7 C hanges in N otch T arget G ene E xpression in L igated versus
Sham -operated A nim als 28 D ays Post-C arotid  L igation
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E Hes-5
Sham Right Ligated Lcll Ligated
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Fig 6 7 C hanges in Notch Target Gene expression in the right and left carotid  
arteries o f ligated animals com pared to sham -operated controls The left carotid 
artery o f young rats were ligated at day 0 The left and right carotids of both sham- 
operated and ligated animals were harvested 28 days post ligation Protein extracted from 
these vessels was assayed for HRT-I (A), HRT-2 (B), HRT-3 (C), H es-l (D) and Hes-5 
(E) using Western blot analysis Values are expressed as fold increase over sham- 
opcrated animals (arbitrarily assigned a value of 1), n=2, two vessels were pooled to r each 
protein preparation ° p<0 05, 00 p<0 005, oou p<0 0005 as com pared to sham -operated 
control, $ p<0 05, $$ p<0 005 as com pared to right artery of ligated animal (student’s t 
test)
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6 2 2 Portal Vein Ligation
The portal vein ligation model was also used to analyze the effect of altered 
mechanical forces on the Notch signalling pathway in vivo Rat portal veins were 
ligated, and subsequently isolated from ligated and sham-operated models at timepoints 
over a period of 2 -15  days post-ligation
Splanchnic blood flow and splenic pressure (an index of portal venous pressure) 
was measured at each timepoint post-ligation in both sham-operated and ligated 
animals Blood flow was measured using a Transonic flow probe, and splenic pressure 
was measured using a Doppler probe, with measurements adjusted according to the 
weight of the animal Two days following PVL splanchnic blood flow was significantly 
decreased in the ligated versus sham-operated animal, as a result of the obstruction to 
portal inflow caused by ligation (Figure 6 8A) Splanchnic blood flow returned to 
sham-operated control levels 4 days post-ligation, but was significantly increased, as 
compared to sham-operated control, in the ligated animal by 44 0±17 0%, 44 0±13 0% 
and 92 0±6 0% at 6, 9, and 15 days post-ligation respectively Analysis of splenic 
pressure, and hence portal venous pressure, revealed significant increases in pressure in 
the ligated animals at all timepoints post-ligation (Figure 6 8B) Splenic pressure was 
increased by 76 2±17 6% and 79 1 ±19 1%, as compared to sham-operated control, at 2 
and 4 days post ligation respectively Similarly, increases of 34 1±14 4%, 62 8±18 9% 
and 49 2±14 1% in splenic pressure were observed in the ligated animals at 6, 9 and 15 
days post ligation respectively
Expression levels of Notch receptors, ligand and target genes in the ligated 
models were analyzed, and compared to that of the sham-operated animals at each 
timepoint (arbitrarily assigned a value of 1) The data presented represents the mean of 
two vessels pooled for each timepoint The Notch signalling pathway generally appears 
to exhibit a triphasic pattern of expression in response to portal vein ligation over the 
time period studied Expression of components of the signalling pathway was generally 
decreased initially, at 2 days post-ligation Expression of Notch signalling pathway 
components were then increased over sham-operated control levels at 4 days post- 
ligation, followed by an attenuation o f this increase, maintained over 6 - 1 5  days post- 
ligation
Notch 1 IC receptor expression remained unchanged in the ligated animal 2 days 
post-ligation, as compared to the sham-operated control, arbitrarily assigned a value of
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1 (Figure 6 9A) A considerable fold increase in Notch 1 IC protein expression was 
evident however 4 days post-ligation, with the level of Notch 1 IC protein increased in 
the ligated animal by 60% over sham-operated control However, Notch 1 IC protein 
levels examined at 6, 9 and 15 days post-ligation decreased by 58%, 50% and 75%, as 
compared to sham-operated control for each timepoint It is interesting to note that 
Notch 1 IC expression changes in both sham-operated and ligated animals following 
surgery, which is represented m Figure 6 9B Notch 1 IC expression in the sham- 
operated animal decreases from days 2 - 6 post-surgery, and subsequently increases 
from days 6 - 1 5  post-surgery
A similar expression pattern was also observed for Notch 3 IC protein (Figure 
6 10A) Notch 3 IC protein expression was initially decreased at 2 days post-ligation by 
11% as compared to sham-operated control, this expression was subsequently increased 
at 4 days post-ligation, to 55% over sham-operated control The increase in Notch 3 IC 
protein expression was attenuated at 6, 9, and 15 days post-ligation by 61%, 43% and 
58% as compared to sham-operated controls As with Notch 1 1C, Notch 3 IC 
expression is altered in sham-operated animals following surgery (Figure 6 10B) 
Notch 3 IC protein expression decreases from 2 - 6 days post-surgery, subsequently 
increases at day 9 and decreases at day 15 post-surgery Therefore, a tri-phasic pattern 
of Notch 3 IC expression is exhibited in sham-operated animals post-surgery
Similarly, analysis of Jagged protein expression revealed an initial decrease of 
12% with respect to sham-operated control 2 days post-ligation, and a subsequent 
increase in Jagged expression levels 4 days post-ligation, to 50% over sham-operated 
control samples (Figure 6 11 A) As was evident with the pattern of Notch receptor 
expression, this increase in Jagged expression was attenuated at 6 and 9 days post- 
ligation to expression levels of 14% and 11% lower than sham-operated control Jagged 
expression levels remained similar to those of sham-operated control in the ligated 
animal 15 days post ligation Jagged expression is also altered in the sham-operated 
animals following surgery (Figure 6 11B) Jagged expression decreases post-surgery 
from day 2 - day 4, subsequently increases from day 4 - day 9, and decreases at day 15, 
thus exhibiting a similar tn-phasic expression pattern to Notch 3 1C
In addition, analysis of Notch target gene protein expression levels revealed a 
similar pattern of expression to that of the Notch receptors (Figure 6 12 - Figure 6 16) 
HRT-1 expression analysis revealed a considerable decrease of 40% in expression 2 
days post-ligation, as compared to sham-operated control (Figure 6 12A) A subsequent 
increase in HRT-1 protein expression, to 30% over sham-operated control, was
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observed 4 days post-ligation This increase was attenuated to expression levels of 
50%, 40% and 60% decreased versus sham-operated control at 6, 9, and 15 days post- 
ligation respectively The pattern o f HRT-1 expression alteration in sham-operated 
control animals following surgery is illustrated in Figure 6 12B HRT-1 expression in 
sham-operated animals is decreased from days 2 - 4 post-surgery, subsequently 
increased at 6 days post-surgery, and remains unchanged thereafter
Similar to the pattern of HRT-1 expression, a 37% decrease in HRT-2 protein 
expression was observed in the ligated vessel 2 days post-ligation, as compared to 
sham-operated control (Figure 6 13A) Analysis of HRT-2 protein expression 4 days 
post-ligation revealed a 60% increase in expression over sham-operated control, which 
was attenuated at 6, 9 and 15 days post-ligation to expression levels of 53%, 8% and 
14% decreased versus sham-operated control The changes in HRT-2 expression 
following surgery in the sham-operated animal are illustrated in Figure 6 13B, as with 
HRT-1, a minimal change in HRT-2 expression is evident following surgery, as 
compared to the change in expression described following PVL
In addition, HRT-3 protein expression levels decreased slightly by 10% as 
compared to control levels 2 days post-ligation, however, an increase o f 46% over 
control levels was observed 4 days post-ligation (Figure 6 14A) Again, this increase 
was considerably attenuated at day 6 and day 15 post-ligation, with expression levels 
being decreased by 47% and 33% respectively, as compared to sham-operated control 
levels This attenuation was also evident 9 days post-ligation but to a lesser degree, 
with HRT-3 expression levels being 20% increased over sham-operated control HRT-3 
expression levels decrease in the sham-operated animals from day 2 - day 4 following 
surgery, and subsequently increase gradually from day 4 - day 15 after surgery (Figure 
6 14B)
Unlike the Notch receptors, or the HRT target genes studied, the Hes target 
genes exhibited an increase in protein expression of 33% and 70% over sham-operated 
control 2 days post-ligation respectively (Figures 6 15A and 6 16A) The subsequent 
expression pattern of these target genes, however, mirrors that of the other components 
of the Notch signalling pathway studied Hes-1 protein expression was increased 4 days 
post-ligation by 54% fold over sham-operated control (Figure 6 15A) An attenuation 
of this increase was observed at 6, 9 and 15 days post ligation respectively Hes-1 
expression levels were decreased by 42% and 37% compared to sham-operated control 
at 6 and 15 days post-ligation respectively Hes-1 expression was increased by 10% 
over sham-operated control at 9 days post-ligation, but is decreased as compared to
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Hes-1 expression levels at 4 days post-ligation Similarly, Hes-5 protein expression 
levels were found to be increased by 35% over control 4 days post-ligation, which is an 
attenuation of the 70% increase in Hes-5 expression evident 2 days post-ligation (Figure 
6 16A) This increase was further attenuated at 6, 9 and 15 days post-ligation 
expression levels decreased by 67%, 46% and 65% respectively, as compared to sham- 
operated control As with other components o f the Notch signalling pathway, both Hes- 
1 and Hes-5 expression levels are altered following surgery Hes-1 expression 
gradually increases from day 2 - day 15 post-surgery (Figure 6 15B), whereas Hes-5 
expression increases from day 2 - day 6 post-surgery, subsequently decreases at day 9, 
and increases at day 15 post-surgery to expression levels similar to those seen at day 6 
post-surgery (Figure 6 16B)
This data clearly shows altered expression of Notch signalling pathway 
components both following control surgery and PVL Therefore, analysis of the effect 
of PVL on protein expression requires that the expression in the ligated animal is 
compared to the appropriate sham-operated animal at each timepoint However, the 
presentation of the absolute protein expression values reveal that expression of Notch 
signalling pathway components is decreased at days 6, 9 and 15 post-ligation, as 
compared to sham-operated controls
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Fig 6 8 Splanchnic B lood Flow and Splenic Pressure follow ing Portal
Vein Ligation
A Blood Flow
Sham
PVL
B Splenic Pressure
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Fig 6 8 Graphs showing splanchnic blood flow and splenic pulse pressure in young  
rats post-PVL com pared to sham -operated control anim als A) A Transonic 
flowprobe was used to m easure splanchnic blood flow in both ligated and sham -operated 
am inals at at 2, 4, 6, 9 and 15 days post-ligation B) Portal venous pressure was measured 
indirectly with direct splenic puncture (splenic pulse pressure using a Doppler flow 
probe) n=3 t5p<0 05 as com pared to sham -operated control (student’s t test)
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Fig 6 9 C hanges in N otch 1 IC R eceptor E xpression in Portal Vein
L igated versus Sham -operated Anim als
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Fig 6 9 Changes in Notch 1 IC expression in portal vein ligated anim als com pared to 
sham -operated controls The porta) veins of young rats were ligated at day 0 The 
portal veins of both sham -operated and ligated anim als were harvested 2, 4, 6, 9 and \S 
days post ligation Protein extracted from these vessels was assayed for Notch 1 IC using 
W estern blot analysis A ) Values are expressed as fold increase over sham -operated 
anim als for each tim epoint (arbitrarily assigned a value o f 1), n = l, two vessels were 
pooled for each protein preparation B) Absolute densitom etry values showing changes in 
Notch 1 IC expression in both sham -operated and ligated am maN n=l two vessels were 
pooled for each protein preparation
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Fig 6 10 C hanges m  N otch 3 IC R eceptor E xpression in Portal Vein
Ligated versus Sham -operated A nim als
Sham Ligated
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Fig 6 10 C hanges in N otch 3 IC expression in portal vein ligated animals compared to 
sham -operated controls T he portal veins of young rats were ligated at day 0 I he 
portal veins of both sham -operated and ligated animals were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from these vessels was assayed for Notch 3 IC using 
W estern blot analysis A ) Values are expressed as fold increase over sham -operated 
anim als for each tim epoint (arbitrarily assigned a value o f 1), n = l, two vessels were 
pooled for each protein preparation B) A bsolute densitom etry values showing changes in 
Notch 3 IC expression in both sham -operated and ligated animals n=) two vessels were 
pooled for each protein preparation
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Fig 6 11 C hanges in Jagged E xpression in Portal V ein L igated versus
Sham -operated A nim als
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Fig 6 11 Changes in Jagged expression in portal vein ligated anim als com pared to 
sham -operated controls T he portal veins of young rats were ligated at day 0 The 
portal veins of both sham-operated and ligated anim als were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from these vessels was assayed for Jagged using 
W estern blot analysis A) Values are expressed as fold increase over sham -operated 
anim als for each tim epom t (arbitrarily assigned a value of 1), n = l, two vessels were 
pooled for each protein preparation B) Absolute densitom etry values showing changes in 
Jagged expression in both sham -operated and ligated animals, n = l, two vessels were 
pooled to r  each protein preparation
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Fig 6 12 C hanges in H RT-1 E xpression in Portal Vein Ligated versus
Sham -operated A nim als
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Fig 6 12 C hanges in HRT-1 expression in portal vein ligated anim als com pared to 
sham -operated controls T he portal veins of young rats were ligated at day 0 I he 
portal veins of both sham -operated and ligated anim als were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from these vessels was assayed for HRT-1 using 
W estern blot analysis A) V alues are expressed as fold increase over sham -operated 
animals for each tim epoint (arbitrarily assigned a value of 1), n = l, two vessels were 
pooled for cach protein preparation B) A bsolutt densitom etry values showing changes in 
HRT-l expression in both sham -operated and ligated animals, n = l, two vessels were 
pooled for each protein preparation
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Fig 6 13 C hanges in H R T-2 Expression in Portal V ein  L igated  versus
Sham -operated A nim als
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Fig 6 13 Changes in HRT-2 expression in portal vein ligated anim als com pared to 
sham -operated controls T he portal veins o f young rats were ligated at day 0 The 
portal veins of both sham -operated and ligated animals were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from  these vessels was assayed for HRT-2 using 
W estern blot analysis A ) V alues are expressed as fold increase over sham -operated 
anim als for each tim epoint (arbitrarily assigned a value of 1), n = l, two vessels were 
pooled for each protein preparation B) Absolute densitom etry values showing changes m 
HRT-2 expression in both sham -operated and ligated anim als, n = l, two vessels were 
pooled for each protein preparation
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AFig 6 14 C hanges in H R T -3 E xpression in Portal Vein L igated versus
Sham -operated A nim als
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Fig 6 14 Changes m HRT-3 expression in portal vein ligated anim als com pared to 
sham -operated controls The portal veins o f young rats were ligated at day 0 The 
portal veins of both sham -operated and ligated animals were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from  these vessels was assayed for HRT-3 using 
W estern blot analysis A) Values are expressed as fold increase over sham-operated 
animals for each tim epoint (arbitrarily assigned a value of 1), n = l, two vessels w'ere 
pooled for each protein preparation B) Absolute densitom etry values showing changes in 
HRT-3 expression in both sham -operated and ligated anim als, n=l two vessels were 
pooled fo rcach  protein preparation
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Fig 6 15 C hanges in H es-1 E xpression in Portal Vein L igated versus
Sham -operated A nim als
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Fig 6 IS C hanges in Hes-1 expression in portal vein ligated anim als com pared to 
sham -operated controls The portal veins of young rats were ligated at day 0 The 
portal veins of both sham -operated and ligated anim als were harvested 2, 4, 6, 9 and 15 
days post ligation Protein extracted from these vessels was assayed for Hes-1 using 
W estern blot analysis A) Values are expressed as fold increase over sham -operated 
anim als to r each tim epoint (arbitrarily assigned a value of 1) n= l tw o vessels were 
pooled for cach protein preparation B) Absolute densitom etry values showing chang ts m 
Hes-1 expression in both sham -operated and ligated anim als, n = l, two vessels were 
pooled for each protein preparation
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Fig 6 16 C hanges in H es-5 E xpression in Portal Vein L igated versus
Sham -operated A nim als
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Fig 6 16 C hanges in H es-5 expression in portal vein ligated anim als com pared to 
sham -operated controls The portal v tin s of young rats were ligated at day 0 The 
portal veins of both sham -operated and ligated animals were harvested 2, 4  6, 9 and 15 
days post ligation Protein extracted from these vessels was assayed for Hes-5 using 
W estern blot analysis A ) V alues are expressed as fold increase over sham -operated 
animals for each tim epoint (arbitrarily assigned a value of 1), n = l, two vessels were 
pooled for each protein preparation B) Absolute densitom etry values showing changes in 
Hes-5 expression in both sham -operated and ligated animals, n = l, two vessels were 
pooled for each protein preparation
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6 2 3 The Effect of Altered Mechanical Forces on Apoptosis in vivo
The effect of altered mechanical forces on apoptosis in vivo was studied using 
both the carotid ligation and portal vein ligation models Apoptosis was measured using 
caspase 3 activity assays and western blotting analysis for Bcl-2 on ligated and sham- 
operated samples
Caspase 3 activity in vessels 3 days post-carotid ligation was significantly 
decreased in the right carotid arteries of ligated animals as compared to sham-operated 
control (Figure 6 17A) Caspase 3 activity was reduced to 0 79±0 05 and 0 95±0 02 as 
compared to sham-operated control in the right and left carotid arteries respectively, 
which corresponds to decreases o f 21 0±5 0% and 5 0±2 0% Conversely, caspase 3 
activity was increased in both the right and left arteries of ligated animals 28 days post 
carotid ligation, as compared to sham-operated control (Figure 6 17B) The increase in 
caspase 3 activity for the right and left carotid arteries o f ligated animals was 1 46±0 1 
and 1 26±0 02 respectively over sham-operated control
Analysis of caspase 3 activity following portal vein ligation revealed significant 
fold increases in caspase 3 activity of 3 99±0 08, 2 75±0 1 and 1 49±0 04 at 2, 6 and 15 
days post-ligation (Figure 6 17C) In contrast, caspase 3 activity remained unchanged 
as compared to static control at 4 days (1 06±0 03) and 9 days (1 09±0 06) post-ligation 
Caspase 3 activity is altered in PVL sham-operated animals (Figure 6 17D) Increases 
in caspase 3 activity are seen from days 2 - 4  and days 6 - 9  post-surgery, whereas 
caspase 3 activity is decreased from days 4 - 6 and days 9 - 1 5  post-surgery
Western blot analysis revealed significant up-regulation of Bcl-2 protein in both 
the right and left carotid arteries 3 days post carotid ligation (Figure 6 18A) Bcl-2 
expression was increased in the right carotid by 31 0±2 0%, and in the left carotid by 
25 01 0%, as compared to sham-operated control Bcl-2 protein expression was 
decreased in the right carotid artery by 49 0±13 0% 28 days post ligation, as compared 
to sham-operated control (Figure 6 18B) However, expression of Bcl-2 at this 
timepoint in the left ligated carotid artery was similar to sham-operated control, 
decreased only by 5 0±7 0%, and was significantly increased over the expression level 
observed in the right carotid artery The level o f Bcl-2 expression following portal vein 
ligation was also analyzed Bcl-2 expression was considerably increased 2 days post 
ligation by 134% fold over sham-operated control, and lesser increases were also 
evident at 4 days (23%) and 9 days (27%) post ligation Conversely, decreases in Bcl-2 
expression of 47% and 65% as compared to sham-operated control were apparent 6 and
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15 days post-ligation respectively Changes in Bcl-2 expression were also noted in 
sham-operated animals post-surgical intervention Bcl-2 expression increases from day 
2 - day 6 post-surgery, decreases at day 9 and increases at day 15, thus exhibiting a tri­
phasic pattern of expression post-surgical intervention (Figure 6 18D)
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Fig 6 17 C hanges in caspase 3 activation in Ugated versus sham -operated animals
Changes in capase 3 activity the right and left carotid arteries of ligated animals com pared 
to sham-operated controls at 3 days (A) and 28 days (B) post ligation The left carotid 
artery of young rats were ligated at day 0 The left and right carotids of both sham- 
operated and ligated animals were harvested 3 and 28 days post ligation as indicated (C 
+ D) Changes in caspase 3 activity in portal vein Ugated anim als com pared to sham- 
operated controls T he portal veins of young rats were ligated at day 0 The portal veins 
of both sham -operated and ligated animals were harvested 2, 4, 6, 9 and 15 days post 
ligation Protein extracted from vessels was assayed for caspase 3 activity (C) V alues are 
expressed as fold increase over sham operated anim als (arbitrarily assigned a value of 1), 
n = l, two vessels were pooled for each protein preparation °  p<0 05, 000 p<0 0005 as 
com pared to sham -operated control (student’s t test (D) Values showing changes in 
caspase 3 activity in both sham -operated and ligated animals, n=I ,  two vessels were 
pooled for each protein preparation
244
A 3 Days Post-Carotid Ligation
F ig  6 18 C hanges in  B cl-2 E xpression  m  L igated
operated Anim als
Right Sham Left Sham Right Ligated Lett Ligated
a aa
a aa
Sham Right Ligated Left Ligated
B 28 Days Post-Carotid Ligation
 Sham Right Ligated Left Ligated
Sham Right Ligated Left Ligated
versus Sham-
29 kDa
29 kDa
245
C Bcl-2 E xpression Post-Portal Vein Ligation
Sham Ligated
- X'-
Day 2 4  6 9 15 Day 2 4  6 9 15
. 3
2 n 
B 2-1 o 
Ü
2
WD
§ HÆ
u  
2 
£
Sham
Ligated
29 kDa
I N I I I  In  I I I  I n
Day 2 Day 4 Day 6 Day 9 Day 15
D Bcl-2 Expression Post-Portal Vein Ligation
160 -, 
140
» 120 
3
78 loo
ÈÎ
4>
Ëo
80 i 
60
g  4 0 -
QJ
0  20
I
Expression Phase 
II III
Sham
Ligated
Day 2 Day 4 Day 6 Day 9 Day 15
Fig 6 18 Changes in Bcl-2 expression levels in ligated versus sham -operated anim als
Changes in Bcl-2 expression m the right and left carotid arteries of ligated animals 
com pared to sham -operated controls at 3 days (A) and 28 days (B) post carotid ligation 
The left carotid artery of young rats were ligated at day 0 The left and right carotids of 
both sham -operated and ligated animals were harvested 3 and 28 days post ligation as 
indicated n=2, 000 p<0 0005 as com pared to sham -operated control, $ p<0 05 as com pared 
to right artery of ligated animal (student’s t test) (C + D) Changes in Bcl-2 expression in 
portal vein ligated animals com pared to sham -operated controls The portal veins of both 
sham -operated and ligated anim als were harvested 2, 4, 6, 9 and 15 days post ligation 
Protein extracted these vessels was assayed for Bcl-2 using w estern blot analysis 
(C)Values are expressed as fold increase over sham -operated animals (arbitrarily assigned 
a value of 1) n=l ,  two vessels were pooled for each protein preparation (D) Absolute 
densitom etry values showing changes in Bcl-2 expression in both sham-operated and 
ligated anim als, n=l ,  two vessels were pooled for each protein preparation
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6 3 D iscussion
This study has clearly established the co-ordinate regulation of Notch signalling 
pathway component expression and apoptosis in vivo, using two models of vascular 
disease associated with vascular remodelling This complements our previous data 
showing the cyclic strain-mediated down-regulation of Notch signalling pathway 
expression and activity, in addition to the anti-apoptotic effect of this pathway on cyclic 
strain-induced apoptosis in vitro
Partial ligation of the left carotid artery in the rat results in a significant increase 
in blood flow in the contralateral right carotid artery, at both 3 and 28 days post- 
hgation In contrast, the left ligated carotid artery exhibits a significant decrease in 
blood flow 3 days post-1 igation, an effect which is also sustained at 28 days post- 
hgation The level of blood flow alteration observed in our model is consistent with 
previous reports using the same model (Sullivan and Hoying 2002, Korshunov and Berk
2003) These studies report a 40-70% increase in blood flow in the right carotid artery, 
and a concomitant 80-90% decrease in blood flow in the left carotid artery Korshunov 
and Berk 2003 also show that systolic blood pressure remains equal in sham-operated 
and ligated animals at both 3 and 28 days post-carotid ligation This suggests that a 
vascular remodelling event occurs in both the right and left carotid of the ligated animal 
to compensate for altered flow rates in these vessels As changes in cell fate decisions 
are associated with vascular remodelling, it is likely that changes in Notch signalling 
pathway expression is associated with vascular remodelling in both the right and left 
carotid arteries in vivo
Notch signalling pathway component expression was examined in this study in 
the rat carotid model at 3 and 28 days post-ligation, and in the PVL model over a time- 
course of 2 - 15 days post-ligation In both cases, a bi-phasic pattern of Notch 
signalling pathway component expression emerged when compared to sham-operated 
control expression levels
The rat carotid ligation model exhibits an up-regulation of Notch signalling 
pathway component expression 3 days post-1 igation, with respect to sham-operated 
control Whilst all receptors and target genes are significantly upregulated, the most 
dramatic increase in receptor and target gene expression is evident with Notch 3 and 
HRT-2 It is interesting to note that a similar level of up-regulation is observed in both 
the right and left carotid arteries of the ligated animal, suggesting that up-regulation of 
the Notch signalling pathway is an acute response to alterations in blood flow and
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biomechanical stress, and is associated with an acute remodelling event in both the right 
and left carotid arteries in vivo In contrast, analysis of Notch signalling pathway 
expression 28 days post-carotid ligation reveals a decrease in Notch signalling pathway 
component expression in both the left and right carotid arteries o f ligated animals, as 
compared to sham-operated control Interestingly, the level of Notch signalling 
pathway expression in the high flow right carotid artery is decreased, oftentimes 
significantly, compared to that in the low flow left carotid Therefore, in light of our 
previous results, we propose that the increased level of cyclic strain experienced in the 
right carotid artery may account for the decrease in Notch signalling pathway 
expression, as compared to that in the left carotid artery It is interesting to note that 
expression of Notch signalling pathway components is decreased under both low and 
high flow conditions as compared to sham-operated control This may initially appear 
surprising due to the increased and decreased flow rates, and subsequent biomechanical 
stress, in the right and left carotid arteries respectively However, despite this, a recent 
study has shown that both the right and left carotid arteries undergo outward vascular 
remodelling, with the level of remodelling increased in the right carotid artery as 
compared to its contralateral left counterpart Therefore, it is unsurprising that differing 
biomechanical stimuli that result in the same type of vascular remodelling affects Notch 
signalling pathway expression in a similar manner
An initial decrease in splanchnic blood flow 2 days post-PVL was observed in 
the ligated animal, as compared to the sham-operated control However, the subsequent 
increase in splanchnic blood flow compared to control evident at days 6 - 1 5  post- 
ligation, despite the continued obstruction to portal inflow caused by ligation, is 
suggestive of vascular remodelling in the ligated vessels at these timepoints Analysis 
of splenic pressure, and hence portal venous pressure, revealed significant increases in 
pressure in the ligated animals at all timepoints post-ligation versus sham-operated 
control, which is suggestive of increased vascular remodelling in the ligated vessel
Notch signalling pathway expression in the PVL model of portal hypertension 
reveals a bi-phasic pattern o f expression, as compared to sham-operated control, similar 
to that observed following carotid artery ligation The general pattern exhibited was an 
up-regulation of Notch signalling pathway expression 4 days post-ligation, and a 
subsequent down-regulation of expression 6 days post-ligation, which was generally 
sustained at 9 and 15 days post-ligation A tn-phasic pattern for both HRT-3 and Hes-1 
expression was also observed, in that increases in expression of these proteins was 
evident 9 days post-ligation, as compared to sham-operated controls Interestingly,
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although the bi-phasic pattern of expression was conserved with the Notch ligand 
Jagged, the fold change in expression was not as pronounced as with any of the other 
Notch signalling pathway components examined This suggests that, in addition to 
changes in Notch receptor activation, other factors, such as those affecting the level of 
Notch turnover within the cell, may also affect the level of Notch receptor and target 
gene expression Whilst all the Notch target genes exhibited a similar fold changes in 
expression, it is interesting to note that only the Hes target genes exhibited an increase 
in expression 2 days post-ligation, thus highlighting the oftentimes differential 
regulation of the Hes and HRT target genes, or suggesting that factors, other than the 
Notch signalling pathway, may be regulating Hes expression at this stage
The observed bi-phasic pattern o f Notch signalling pathway expression 
following both the carotid artery ligation and PVL models is somewhat unsurprising, as 
a group from the Morehouse School of Medicine, Atlanta (Campos et a l , 2002, Wang 
et a l , 2002a) claim to have observed a bi-phasic pattern of Notch signalling pathway 
expression following balloon catheter injury to the rat carotid artery However, the 
pattern of expression that they observe conflicts with our report They observed an 
initial down-regulation of Jagged, Notch 3 and HRT-1 3 days following balloon injury 
(Wang et a l , 2002a), and an up-regulation of both Jagged and Notch 3 expression 28 
days post injury, whilst no increase was observed in HRT-1 expression levels (Campos 
et a l , 2002) However, whilst these changes in Notch signalling pathway expression 
levels are no-doubt correct, the validity of their claim of bi-phasic expression must be 
questioned, as Wang et a l , measured expression in medial SMC, whereas Campos et 
a l , measured same in intimal SMC, and different SMC phenotypes often respond 
differently to the same stimulus (Cappadona et a l , 1999) Therefore, whilst this study 
does not tally with the bi-phasic expression observed in the two previous reports, we 
believe that we provide a more consistent model to claim bi-phasic regulation of the 
Notch signalling pathway in the vessel wall Also, unlike the aforementioned studies, 
which utilize a model of vascular intervention (balloon catheter injury), our study 
utilizes a model representative of vascular disease states, in which cells are exposed to 
consistently increased/decreased blood flow and biomechanical forces, and compared to 
sham-operated control In addition, another obvious difference between our study and 
those of Wang et a l , and Campos et a l , is the fact that we analyzed Notch signalling 
pathway expression in the vessel wall as a whole Future studies within the laboratory 
could additionally adopt the approach of Wang et a l , and analyze the medial SMC layer 
only, however, we believe that it is also important to determine the changes in Notch
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signalling expression in the entire vessel wall
The importance of apoptosis in vascular remodelling following injury is well 
recognized (Bennett 1999), however, the regulation of VSMC apoptosis is incompletely 
understood This study has, however, clearly shown that the Notch signalling pathway, 
at least in part, regulates VSMC apoptosis Therefore, using the rat carotid ligation and 
PVL models, we investigated whether alterations in biomechanical forces result in 
changes in vessel wall apoptosis in vivo This was achieved by analyzing caspase 3 
activity and anti-apoptotic Bcl-2 protein expression within the vessel, as activation of 
caspase 3 has been observed in atherosclerotic plaques at sites of VSMC apoptosis 
(Mallat et a l , 1997), and changes in Bcl-2 family expression are often observed during 
the pathogenesis of vascular disease (Bai et a l , 1999, Cook et a l , 1999)
Using the rat carotid ligation model, we observed what appears to be a bi-phasic 
pattern of apotosis following ligation Caspase 3 activity is decreased in the right, and 
to a lesser extent, in the left carotid artery 3 days post-ligation, compared to sham- 
operated control In addition, a concomitant increase in Bcl-2 protein expression was 
observed in the right and left carotid arteries of ligated animals This apparent decrease 
in apoptosis as an acute response to alterations in biomechanical forces within the vessel 
tallies with the observed increase in Notch signalling pathway component expression, 
and subsequent increased anti-apoptotic effect o f Notch at this timepoint Analysis of 
this model 28 days post-carotid ligation revealed an increase in caspase 3 activity in 
both the right, and to a lesser extent, the left carotid arteries This was coupled with a 
significant decrease in Bcl-2 expression in the right, but not the left, carotid artery This 
data suggests that increased apoptosis could be experienced in the right carotid artery, 
as compared to the left carotid artery at this timepoint This data, therefore, correlates 
with the suggestion that whilst both the right and left carotid arteries o f ligated animals 
undergo outward vascular remodelling, increased vascular remodelling is observed in 
the right carotid artery (Korshunov and Berk 2003) This could, in part, be attributable 
to the fact that Notch signalling pathway expression, and subsequent anti-apoptotic 
effects, are lower in the right than in the left carotid artery Whilst a bi-phasic pattern of 
apoptosis following carotid ligation has previously been reported (Sullivan and Hoying 
2002), the pattern of apoptosis we present differs from that in the literature Sullivan 
and Hoying, 2002 report an increase in apoptosis 4 days post-ligation, followed by a 
decrease in apoptosis 28 days post-ligation However, other studies claim that 
following arterial injury, where the long-term response to injury is also vascular 
remodelling, that VSMC apoptosis is detectable in two phases The first phase is a
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rapid increase in medial SMC apoptosis occurring within 30 min of vascular injury, 
whereas apoptosis of both mtimal and medial SMC also occurs as a later response, at 8- 
21 days post-injury (Han et a l , 1995, Perlman et a l , 1997)
In addition, we also analyzed the levels of apoptosis in the PVL model over a 
time-course of 2-15 days post-ligation A tn-phasic increase in caspase 3 activity was 
clearly evident in the PVL model at 2, 6 and 15 days post-ligation Analysis of Bcl-2 
protein expression at the same time-points revealed an unsurprising down-regulation of 
expression at 6 and 15 days post-1 igation However, Bcl-2 expression was increased 2 
days post-ligation, despite the significant increase in caspase 3 activity and subsequent 
apoptosis This suggests that other regulators of apoptosis, such as other members of 
the Bcl-2 family, may play a part in regulating apoptosis in response to changes in 
biomechanical stress As we have established bax and b c l-X i  as downstream mediators 
of the Notch signalling pathway, and bcl-xi as a factor in Notch signalling pathway 
protection against cyclic strain-induced apoptosis, analysis o f these components in in 
vivo models could prove interesting The similar levels of caspase 3 activity in the 
sham-operated and ligated vessels 4 days post-1 igation was surprising due to the 
consistent increases observed in Notch signalling pathway component expression at 
this timepoint Similar blood flow rates, but increased pressure are observed in the 
ligated versus the sham-operated control vessel at this timepoint, conditions which often 
precipitate inward vascular remodelling, and associated decreased apoptosis Therefore 
it is possible that caspase 3-independent apoptosis could occur at this timepoint The 
apparent increase in apoptosis at 6-15 days post-ligation tallies with the observed 
decrease in Notch signalling pathway expression at these time-points In addition, a 
significant increase in apoptosis was observed 2 days post-ligation with a concomitant 
decrease in HRT and increase in Hes target gene expression This suggests that the 
HRT target genes may mediate the anti-apoptotic effect of the Notch signalling pathway 
within the vasculature This is likely, as experiments within the laboratory have shown 
that inhibition of HRT target genes, using siRNA knockdown technology, increases 
expression of the pro-apoptotic bax gene and decreases anti-apoptotic bcl-xi expression, 
whereas Hes target gene inhibition achieves the opposite, but to a lesser extent (D 
Morrow personal communication)
6 4 Conclusion
This study provides previously unreported evidence o f alterations in Notch
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signalling pathway expression due to altered biomechanical forces in vivo, further 
validating the cyclic strain-induced decrease in Notch signalling pathway expression 
observed in this study in vitro We have also previously shown that cyclic strain- 
induced apoptosis is attributable, at least in part, to a decrease in Notch signalling 
pathway expression and activity Therefore, we propose that the observed alterations in 
levels of apoptosis in the in vivo models could also be partly attributed to changes in 
Notch signalling pathway expression Whilst we acknowledge that this is not 
conclusively proven m this study, due to limitations of the experimental models used, 
we feel that this study provides important preliminary evidence of in vivo regulation of 
Notch signalling pathway expression that could provide a basis for future investigations 
A model to pursue further studies has been proposed in the form of the Notch 1 
transgenic mouse model (Liu and Lobe, 2003) In addition, factors mediating the cyclic 
strain-induced regulation of Notch signalling pathway expression remain undefined, and 
should be further analyzed Possible candidates as mediators of Notch signalling 
pathway expression will be discussed in detail in Chapter 7
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Chapter 7
Discussion
D iscussion
This study has succeeded m its specific aims, clearly establishing the presence 
and activity of the Notch signalling pathway m adult VSMC, and providing further 
insight into the regulation of apoptosis in these cells, both in vivo and in vitro 
Increased understanding of VSMC apoptosis may contribute to future therapies against 
cardiovascular disease, as aberrant regulation of apoptosis is a common response to 
vascular injury, and a feature of many vascular disease states (Bai et a l , 1999, Pollman 
et a l , 1999) A concise summary of results will be presented here, but for more 
expansive explanations of results please refer to individual chapter discussions
This study comprehensively documents the presence of many components o f the 
Notch signalling pathway in RVSMC, some of which had previously remained 
undetected in these cells This study utilized antibodies directed against the IC portion 
of the Notch receptors, and as such detects both the uncleaved and cleaved (IC) portion 
of the receptors However, the appropriate molecular weight corresponding to Notch IC 
was unequivocally determined using antibodies from different commercial sources, 
appropriate blocking peptides, coupled with analysis of Notch IC over-expression with 
both Notch- and HA-directed antibodies, which confirmed the molecular weight of 
Notch IC This ensured that analysis o f Notch IC protein expression was indicative of 
the levels of Notch signalling pathway activity withm the cell We also present the 
novel finding that both Notch 1 IC and Notch 3 IC signal via a CBF-1-dependent 
pathway in VSMC, with both receptors exerting equivalent levels of pathway activation 
This complements data presented by Wang et a l , (2002b), claiming that Notch 3 signals 
in a CBF-1-independent manner in RVSMC Therefore, we can conclude that the 
Notch signalling pathway acts via both CBF-1-dependent and -independent manners in 
RVSMC, as has previously been shown for Notch signalling in EC (MacKenzie et a l , 
2004) In addition, this study has clearly shown that Notch signalling pathway 
activation increases expression and activity of Notch target genes in a CBF-1-dependent 
manner, and has established HRT-1 and Hes-5, but not Hes-1, as among the primary 
targets of the Notch signalling pathway in RVSMC This data was obtained using 
artificial stimulation o f the Notch signalling pathway through transient transfection To 
determine whether this data was relevant to a less artificial situation, and to begin to 
determine the factors regulating the Notch signalling pathway, we investigated the 
effect of serum on Notch pathway expression and activity m VSMC We provide 
previously unreported evidence that serum stimulation temporally promotes Notch
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signalling and target gene expression in a CBF-1-dependent manner This was achieved 
due to the observed up-regulation of Notch 1 IC and Notch 3 IC expression following 
serum stimulation In addition, we also found that endogenous ligand presentation 
significantly stimulated CBF-1-dependent Notch signalling in RVSMC, therefore we 
believe that the results obtained due to over-expression and serum stimulation o f the 
Notch signalling pathway are relevant under conditions o f physiological Notch 
signalling
The Notch signalling pathway is a highly conserved method of cell-cell 
communication, that controls cell fate decisions in many cell types, a function that is 
conserved from Drosophila to humans (Miele and Osborne 1999) As such, we 
postulated that the Notch signalling pathway might also regulate cell fate decisions in 
VSMC This study has clearly established that the Notch signalling pathway exerts an 
anti-apoptotic effect in VSMC, both endogenously within the cell, and in response to 
serum deprivation As it is unlikely that the Notch signalling pathway acts to control 
only one cell fate decision in VSMC, in particular due to the fact that the pathways 
controlling apoptosis and proliferation are closely linked, the regulation of other cell 
fate decisions by the Notch signalling pathway was also investigated within the 
laboratory Therefore, studies within the laboratory have also established additional 
roles for the Notch signalling pathway in regulating VSMC proliferation, migration and 
differentiation The Notch signalling pathway promotes VSMC proliferation, whilst 
concomitantly inhibiting migration and differentiation, in addition to apoptosis Whilst 
we have conclusively shown that that Notch signalling pathway acts to inhibit apoptosis 
in a CBF-1-dependent manner, we also provide evidence that Notch 3 IC additionally 
exerts a CBF-1-independent anti-apoptotic effect This is unsurprising as Notch has 
recently been shown to prevent apoptosis in EC in both a CBF-1-dependent and - 
independent manner (MacKenzie et a l , 2004) In addition, Wang et a l , (2002b) have 
shown that Notch 3 inhibits apoptosis in VSMC in a CBF-1-independent manner 
through up-regulation of c-FLIP, a primary inhibitor of the pro-apoptotic FasL 
signalling pathway The mechanisms through which serum deprivation induces 
apoptosis in VSMC appear to be complex and, to date, poorly defined This study 
proposes that serum deprivation-induced apoptosis may, in part, be due to a serum 
deprivation-induced decrease in the level of Notch signalling pathway expression and 
activity, thus decreasing the endogenous anti-apoptotic effect of this pathway on the 
cell
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Numerous molecular pathways are involved in the regulation of apoptosis m 
VSMC (Hengartner 2000) In an attempt to elucidate the mechanism through which the 
Notch signalling pathway exerts its anti-apoptotic effect on VSMC, Notch interaction 
with, and regulation of, a number of known regulators o f apoptosis, including members 
of the Bcl-2 and NF|3B families was examined This list is by no means exhaustive, 
indeed, it is likely that the Notch signalling pathway exerts its anti-apoptotic effect on 
VSMC through interaction with multiple regulators of apoptosis This study provides 
previously unreported evidence that the Notch signalling pathway regulates the level of 
expression of the pro-apoptotic box, and anti-apoptotic bcl-XL, members of the Bcl-2 
family of apoptotic genes In addition, it was established that neither Notch 1 IC nor 
Notch 3 IC activates the bfl-l promoter, suggesting that the anti-apoptotic effect of the 
Notch signalling pathway is not mediated through Bfl-l in VSMC This study also 
provides initial evidence of interaction of the Notch signalling pathway with member of 
the NF(3B family of transcriptional regulators in VSMC, which will provide a platform 
for further research within the laboratory
As this study has clearly established the anti-apoptotic properties of the Notch 
signalling pathway against serum deprivation-induced apoptosis in adult VSMC, the 
effect of this pathway on cyclic strain-induced apoptosis in VSMC was investigated 
As a result of these investigations, this study proposes that cyclic strain-induced 
apoptosis is attributable, at least in part, to a strain-induced decrease in Notch signalling 
pathway expression and activity in VSMC
Under conditions of cardiovascular disease, such as hypertension, or 
cardiovascular injury, such as that caused by balloon angioplasty, VSMC are often 
exposed to increased levels of cyclic strain (DeBakey et a l , 1985, Thubnkar and 
Robicsek 1995) This study, and others (Mayr et a l , 2000, Wermg et a l , 2003), has 
shown that increased cyclic strain induces apoptosis in VSMC However, this study 
presents the novel findings that cyclic strain acts to decrease Notch signalling pathway 
expression and activity in VSMC This was additionally confirmed through comparison 
of Notch target gene expression both following Notch inhibition and exposure of the 
cells to cyclic strain Both cyclic strain and CBF-1-dependent Notch signalling pathway 
inhibition result in a decrease in HRT and Hes target gene expression In addition, the 
effect of RPMS-I and cyclic strain on the expression profile of the Bcl-2 family is 
virtually identical, further proving that cyclic strain causes decreased CBF-1-dependent 
Notch activity in VSMC It was also clearly established that over-expression of Notch 3 
IC, at least in part, protects cells from cyclic strain-induced apoptosis, in a bcl-
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x^-caspase 3-dependent manner This study additionally provides previously unreported 
evidence of biomechanical regulation of the Notch signalling pathway and apoptosis in 
vivo, using both the carotid ligation and PVL models Notch signalling pathway 
expression was decreased at 3 days and increased at 28 days post-carotid ligation, which 
was accompanied by a concomitant increase and decrease in apoptosis respectively 
This pattern of an inverse relationship between Notch signalling pathway expression 
and apoptosis was generally maintained following PVL This validates the in vitro 
results obtained in this study, and proves that our in vitro model is representative of an 
in vivo situation
Whilst this study has provided evidence of the expression and activity o f the 
Notch signalling pathway in VSMC, and has contributed to the understanding of the 
regulation of VSMC apoptosis, it also, as any body of research should, poses a 
considerable number of questions Specifically, whilst we have established that both 
serum and cyclic strain regulate Notch signalling pathway expression, the mechanisms 
of this remain undefined In addition, whilst we have established a number o f possible 
mechanisms whereby the Notch signalling pathway regulates apoptosis, it is likely that 
these only constitute a small part o f what could prove to be a considerable list, but as 
yet, remain undefined The final aim of this study is, therefore, to postulate as to how 
these questions could be addressed, in the hope of providing a platform for what could 
prove to be exciting future investigations within the laboratory
The Notch signalling pathway is clearly activated by serum, however, the exact 
mechanism of this serum-mediated Notch activation is currently undefined One of the 
obvious candidates for Notch activation would be the presence of a Notch ligand in 
serum Although Notch ligands are primarily transmembrane proteins, secreted forms 
of these proteins have been identified (Klueg et a l , 1998, Qi et a l , 1999), and could 
potentially be present in serum as endogenous activators of the Notch signalling 
pathway This study has shown that serum stimulates increases in Notch signalling 
pathway component activity and CBF-1-dependent activity Serum deprivation 
conversely decreases expression and CBF-1-dependent activity of this pathway Serum 
deprivation inhibits Jagged expression in VSMC, therefore, it is possible that additional 
factors that regulate Notch signalling pathway activity in VSMC may act through 
regulating of Jagged expression One of the potential mechanisms of Notch signalling 
pathway regulation is via the presence of growth factors within serum Recent studies 
have shown that both VEGF and PDGF altei expression of Notch signalling pathway 
components in both vascular and other cell types (Ho and Scott 2002, Lawson et a l ,
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2002, Wang et a l , 2002)
The VEGF family comprises of six known ligand and three known receptor sub- 
types The ligands include VEGF, placenta growth factor, and VEGF-B - E, whilst the 
VEGF-receptor (VEGF-R) sub-family includes VEGF-R1 (Flt-1), VEGF-R2 (KDR/Flk- 
1) and VEGF-R3 (Flt-4) The most prominent ligand of the VEGF family is VEGF 
itself, which binds to VEGF-R1 and -R2 (Veikkola and Alitalo 1999)
VEGF is a major regulator of both physiological and pathological neo­
vascularization (Ferrara and Davis-Smyth 1997), a role that is conserved from 
development Gene knockout studies have revealed the critical role o f VEGF in 
developmental vasculogenesis and angiogenesis, in that mice with disputed VEGF-R1 
expression die embryomcally due to vascular defects (255-52) This is highly 
reminiscent of the effect of Notch signalling pathway disruption, which also results in 
embryonic lethality due to defects in vasculogenesis and angiogenesis (Xue et a l , 1999, 
Smith et a l , 2000) Consistent with the findings that VEGF induces Notch signalling 
pathway activity (Lawson et a l , 2002), and Notch acts to inhibit apoptosis in EC 
(MacKenzie et a l , 2004) VEGF has been shown to exert an anti-apoptotic effect on 
EC (Gerber et a l , 1998) It is possible, therefore, that any VEGF-mediated regulation 
of VSMC fate decisions could, at least m part, be mediated by the Notch signalling 
pathway The Notch and VEGF signalling pathways have a number of other similar 
functions, including regulation of arterial-venous differentiation in development, further 
highlighting the interaction between these two pathways Lawson et a l , (2002) has 
recently shown that VEGF acts upstream of the Notch signalling pathway to determine 
arterial cell fate, and furthermore that Notch signalling is required to mediate VEGF- 
mduced arterial differentiation (Lawson et a l , 2002) Additional studies have revealed 
that VEGF-mediated activation of the Notch signalling pathway appears to be self- 
hmiting, as over-expression of components o f the Notch signalling pathway decreases 
VEGF-R levels Henderson et a l , (2001) have shown that over-expression of HRT-1 in 
EC down-regulates VEGF-R2 mRNA expression levels, and inhibits VEGF-meditated 
cell fate decisions in these cells in vitro Similarly, zebrafish notch 5 has been shown to 
repress VEGF-R3 expression in venous EC in vivo (Lawson et a l , 2001) Therefore the 
presence of VEGF in serum could, at least in part, account for the serum-mediated 
increase in Notch signalling pathway expression and activity The fact that VEGF- 
mediated increase in Notch signalling appears to be self-limiting could account for the 
return of Notch signalling pathway component expression and activity towards baseline 
levels at 24 h post-serum stimulation
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As VEGF is an important factor in Notch signalling pathway regulation, we 
must also consider factors that mediate VEGF expression, as these will also affect 
expression of Notch signalling pathway components Transcription of VEGF mRNA is 
induced by a variety o f growth factors and cytokines, many of which are present in 
serum, including PDGF-BB, EGF, TNF-j3, TGF-pi and interleukin-1-|3 In addition, 
two groups have recently shown that Sonic hedgehog (Shh), a member of the Hedgehog 
signalling family, acts upstream of VEGF, and therefore upstream of the Notch 
signalling pathway, increasing VEGF expression and therefore regulating its function 
(Pola et a l , 2001, Lawson et a l , 2002)
The Hedgehog signalling family was first identified in Drosophila, and was so 
named as haploinsufficiencies of this family of genes produces a phenotype resembling 
a hedgehog (Nusslein-Volhard and Wieschaus 1980) As with the Notch signalling 
pathway, the Hedgehog signalling pathway shows a high degree of evolutionary 
conservation, from Drosophila to humans
Components of the Hedgehog signalling pathway include three highly conserved 
ligands, Shh, Indian hedgehog (Ihh) and Desert hedgehog (Dhh), the hedgehog receptor, 
Patched (Ptc), the transmembrane protein Smoothened (Smo) and the transcription 
factor Gli, which is the principal mediator of the Hedgehog signalling pathway 
(Villavicencio et a l , 2000, Pola et a l , 2001)
The hedgehog family of molecules are secreted proteins that undergo several 
post-translational modifications to gain full activity The hedgehog precursor protein is 
autolytically cleaved to generate an N-terminal active polypeptide, and a C-terminal 
fragment that appears to have no function other than catalyzing the autolytic cleavage 
During this reaction a cholesterol moiety is attached to the C-terminal end of the N- 
terminal hedgehog fragment This cholesterol moiety is thought to mediate hedgehog 
binding to cell membranes A further modification of the hedgehog protein 
subsequently occurs, with the addition of a palmitoyl group to the N-terminus of the 
mature active protein (Weed et a l , 1997, Ho and Scott 2002, Nybakken and Perrimon
2002) These processes are mediated by proteins known as Skinny hedgehog, Rasp and 
Central missing, and are believed to regulate hedgehog activity, diffusion and potency 
Hedgehog proteins are subsequently secreted in a process that is mediated by the 
transmembrane protein Dispatched m Drosophila, although no vertebrate homologue 
has been identified to date Secreted hedgehog proteins can act at sites proximal or 
distal to the site o f secretion Post-translational modifications o f hedgehog facilitate 
this, as following secretion hedgehog molecules form a multi-dimeric complex with the
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hydrophobic regions aggregating at the centre of the complex, whilst the exposed 
hedgehog molecules interact with proteoglycans that facilitate their transport (Nybakken 
and Perrimon 2002).
F igure 28: H edgehog M odification  and  S ecretion  in a H edgehog P roducing  Cell.
F igure 28: Representation of post-translational modification and secretion of hedgehog protein in a 
hedgehog-producing cell.
The hedgehog receptor Ptc consists of twelve TM domains with two large ExC 
loops. In the absence of hedgehog binding within the cell, the Ptc receptor acts to 
repress the Hedgehog signalling pathway. This is achieved through Ptc-mediated 
inhibition of Smo, a seven TM protein that is required for hedgehog signal transduction 
in both vertebrates and invertebrates. The method of Ptc-mediated inhibition of Smo is 
unknown, but is most likely indirect as Ptc-Smo interaction is not required, as was 
originally thought (Bijlsma et a l, 2004). In the absence of hedgehog signalling, Ptc is 
principally found on the surface of the cells, whereas Smo is mainly located intra- 
cellularly. Signalling downstream of Smo remains somewhat obscure. However, it is 
known that, in Drosophila (accepted as the standard model of hedgehog signalling), 
Smo signals to a complex containing the proteins Fused/Costal 2/Cubitus interruptus 
(Fu/Cos2/Ci). Ci is the Drosophila homologue o f the mammalian transcription factor 
Gli. To date, three Gli homologues have been identified in humans, designated Gli-1, - 
2 and -3. These transcription factors, similar to CBF-1 in the Notch signalling pathway, 
are multifunctional as they can act as transcriptional repressors or activators 
(Villavicencio et a l, 2000). In the absence of hedgehog signalling the Fu/Cos2/Ci acts 
to sequester the transcription factor Ci through binding to microtubules, which is aided
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by an antagonist of the hedgehog pathway, Suppressor of Fused (Su(Fu)). The full 
length Ci molecule is phosphorylated by a number of kinases, and subsequently cleaved 
to form a 75 kDa product, which translocates to the nucleus, and acts as a suppressor of 
hedgehog target genes.
In response to hedgehog binding, the Ptc receptor is internalized which results, 
indirectly, in the movement of Smo to the cell surface, perhaps due to the association of 
Smo with lipid rafts (Karpen et a l , 2001). Positioning of Smo on the cell surface 
results in hyperphosphorlyation of Smo, perhaps due to its proximity with other 
activator molecules (Ho and Scott 2002). Smo signals, through unknown mechanisms, 
to the Fu/Cos2/Ci complex, resulting in the phosphorylation of Fu and Cos2 causing the 
complex to partially detach from the microtubules. This results in stabilization of full 
length Ci, as it is no longer subject to phosphorylation, which can then translocate to the 
nucleus and function as a transcriptional activator of the Hedgehog signalling pathway 
(Ho and Scott 2002; Nybakken and Perrimon 2002; Bijlsma et al, 2004).
F igure 29: P roposed  M echanism  o f H edgehog Signal T ra n sd u c tio n  P athw ay
F igu re  29: P roposed  m echanism  o f hedgehog signal tran sd u c tio n . A: absence of hedgehog 
signal, B: presence of hedgehog, refer to text (Bijlsm a et al., 2004).
It is interesting to note that, like the Notch signalling pathway, the hedgehog 
pathway can induce activation of a Gli-independent pathway, involving the activation of 
the orphan nuclear receptor, COUPTF-II (Pola et al., 2001; Pola et al., 2003).
Downstream target genes of the Gli-dependent Hedgehog signalling pathway 
include Ptc and Gli itself, which are therefore both components and target genes of the 
Hedgehog signalling pathway. Other target genes of the hedgehog family include bone
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morphogenic protein-4, and members of the TGF-(3 and Hox gene families (Roberts et 
al, 1995). Activation of the Hedgehog signalling pathway also affects the expression 
o f a number of other growth factors. Hedgehog, for example, down-regulates 
expression of basic fibroblast growth factor (bFGF) in fibroblasts in a Gli-dependent 
manner (Pepicelli et a l, 1998). In addition, Pola et al., (2001) describes Shh as an 
indirect angiogenic agent, as it acts to up-regulate expression members of two families 
of angiogenic growth factors, including VEGF and Angiopoietin 1 and 2. As no Gli 
response elements are present on either VEGF or Angiopoietin 1/2, it is likely that 
hedgehog signalling up-regulates these components in a Gli-independent manner. 
Subsequent studies confirmed the fact that Shh acts upstream of both the VEGF and 
Notch signalling pathways (Lawson et a l, 2002; Pola et a l, 2003). The VEGF and 
Notch signalling pathways are required for arterial EC differentiation. Lawson et al., 
(2002) however, demonstrated that cells lacking Shh failed to undergo arterial 
differentiation, and that this was rescued with over-expression of Shh mRNA. 
Furthermore, this lack of arterial differentiation in Shh negative cells is also rescued 
with the over-expression of VEGF (in the presence of Notch), or over-expression of 
Notch itself. In addition, Pola et al., (2003) demonstrated that Shh-responding cells up- 
regulate VEGF expression and angiogenesis in response to skeletal muscle ischaemia, 
and that this is blocked with Shh-blocking antibody treatment. It has recently emerged 
that the Notch signalling pathway also influences expression of Shh (Lopez et al,
2003). Members of the Notch signalling pathway, specifically Notch IC and presenilin, 
act to up-regulate Shh expression in Xenopus embryos, and as regulation of these 
pathways are highly conserved, it is likely that this is the case in other species. 
However, we know that Shh causes up-regulation of both VEGF and Notch expression, 
and Notch causes up-regulation of Shh and down-regulation of VEGF expression 
(Henderson et a l, 2001; Lawson et a l, 2001). This suggests that the Notch signalling 
pathway also influences VEGF expression in a Shh-independent manner, which remains 
undefined.
As with Notch, the importance of the Hedgehog signalling pathway within the 
vasculature is increasingly recognized. Ptc-1 is expressed throughout the vasculature in 
both juvenile and adult mice, suggesting that adult cardiovascular tissues may contain 
several cell populations responsive to hedgehog signalling (Pola et a l, 2001). The 
Hedgehog pathway also plays a pivotal role in development, regulating many of the 
same functions as the Notch signalling pathway, such as limb and neural tube 
development, further highlighting the functional interactions between these pathways
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(Artavanis-Tsakonas et a l , 1995, Weed et a l , 1997, Artavams-Tsakonas et a l , 1999) 
Hedgehog signalling also appears to be important in proper development of the vascular 
system Similar to the Notch signalling pathway the correct level o f Hedgehog 
signalling appears to be important, as both up- and down-regulation of hedgehog 
proteins results in vascular defects (Sullivan and Bicknell 2003), mutations of the 
Hedgehog signalling pathway, for example, results in lack of proper vascularization in 
the developing mouse lung As with the Notch signalling pathway, the Hedgehog 
pathway is implicated in regulating cell fate decisions, Shh regulates both proliferation 
and survival of oligodendnte precursors, and acts to promote proliferation and inhibit 
differentiation in both neuronal and non-neuronal cell types (Ho and Scott 2002) 
Dysregulation of both the Hedgehog and Notch pathways lead to dysregulated cell 
growth and abnormal cellular accumulations, contributing to many types of cancers 
(Miele and Osborne 1999, Villavicencio et a l , 2000) Therefore, although it is likely, 
whether the Hedgehog signalling pathway regulates cell fate decisions through the 
Notch signalling pathway remains to be fully established
Additional studies withm the laboratory have established the presence of 
components of the Hedgehog signalling pathway within RVSMC, and have shown that 
inhibition of this pathway decreases Notch 3 expression in these cells In addition, both 
Notch over-expression and serum stimulation increase Hedgehog signalling pathway 
component expression and/or activity levels This appears to occur, at least in part, in a 
CBF-1-dependent manner (D Morrow personal communication) Therefore, we can 
conclude that serum stimulation of the Notch signalling pathway involves the activation 
of both the VEGF and Hedgehog signalling pathways, however, the precise regulation 
of this remains to be fully determined
My work has clearly established the presence of one developmental pathway, 
the Notch signalling pathway, within VSMC Complementary studies within the 
laboratory have identified the presence of an additional developmental pathway, the 
Hedgehog signalling pathway in these cells Moreover, combined analysis of the 
regulation of these pathways suggests that they may be functionally coupled This 
study, and others within the laboratory have revealed that mechanical forces exert 
similar effects on expression of both the Hedgehog and Notch signalling pathways 
Cyclic strain down-regulates expression of both Hedgehog and Notch signalling 
pathway components, both in vivo and in vitro However, several other studies have 
indicated that cyclic strain increases VEGF expression in bovine VSMC and 
cardiomyocytes (Smith et a l , 2001, Zheng et a l , 2001) This suggests that the cyclic
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strain-mediated down-regulation of the Notch signalling pathway is not regulated in a
VEGF-dependent manner, but is affected by other components, or by mechanical strain
directly, which in turn causes down-regulation of the Hedgehog signalling pathway
Possible candidates involved in cyclic strain-mediated regulation of the Notch
signalling pathway include PDGF, Angiotensin II (Angll) and endothelin-1 (ET-1)
The PDGF family is composed of ligands and receptors that are widely
implicated in regulating cell fate decisions The biologically active form of the PDGF
ligand is a homo- or heterodimer of A and B polypeptide chains, which determines the
biological activity o f the ligand The PDGF-receptor (PDGF-R), a member of the
receptor tyrosine kinase family, is also a dimer o f P or p chains The PDGF-R dimer is
only formed after ligand binding, so that the P P constituent of the receptor is influenced
by the form of PDGF present PDGF-R-P binds all forms of PDGF, whilst PDGF-R-p
binds PDGF-BB and -AB only (Xu 2000) Ligand binding results in tyrosine
phosphorylation o f the receptor, and triggers sequential activation of MAPK cascades,
which play a pivotal role in regulating cell fate decisions (Cano and Mahadevan 1995)
PDGF are important mediators of vascular remodelling and lesion formation,
and several groups have shown that PDGF-R and PDGF-B expression are up-regulated
in response to mechamcal stress in VSMC both in vivo and in vitro (Bryant et a l , 1999,
Ma et a l , 1999) Similarly, the level of PDGF-R-P phosphorylation is increased m
VSMC in response to cyclic strain (Li and Xu 2000) Wang et a l , (2002a) have
recently shown that PDGF decreases Notch receptor and HRT target gene expression in
VSMC via an ERK-dependent pathway Therefore, the cyclic strain-induced increase in
PDGF expression and activity could, at least in part, account for the cyclic strain-
mediated decrease in Notch signalling pathway expression observed in this study
Wang et a l , report a time- and dose-dependent decrease in Notch signalling pathway
expression following PDGF administration, which may account for the time- and
strength-dependent decrease in Notch expression observed in this study following
exposure to cyclic strain Interestingly, both PDGF and vascular injury cause the
greatest down-regulation in Notch 3 expression, which further suggests that PDGF is
responsible for injury-induced decrease in Notch signalling pathway expression
Another possible candidate for regulating Notch signalling pathway expression
in response to cyclic strain is Ang II Ang II is part of the Renin-Angiotensin system,
which plays an important role in regulating blood volume, arterial pressure and cardiac
and vascular function Ang II is the active vasopressor derived from activation of this
system, and is generated by enzymatic cleavage of its precursor, Ang I Cyclic
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strain has also been shown to increase Ang II levels in VSMC (Li et a l , 1997) In 
addition, Ang II affects Notch signalling pathway component expression, in a similar 
manner to PDGF Campos et a l , (2002) have shown that Ang II markedly down- 
regulates both Notch 3 and Jagged 1 expression in an ERK-dependent manner in VSMC 
in vitro Therefore, cyclic strain-induced increase in Ang II expression may contribute 
to the strain-induced decrease in Notch signalling pathway expression levels In 
addition, Ang II causes a time-dependent decrease in Notch expression, which may 
contribute to the time-dependent decrease in Notch signalling pathway component 
expression in response to cyclic strain observed in this study
It is possible that cyclic strain exerts its effects on the Notch signalling pathway 
through a concerted effort of these, and other, molecules It is likely that many VSMC 
components interact with, and regulate expression of the Notch signalling pathway, 
however as the study of this pathway in VSMC is in its infancy, it is possible that these 
interactions have not yet been determined One possible additional candidate for 
regulating Notch signalling in response to cyclic strain could be ET-1
ET-1 is a potent vasoconstrictor produced in many cells, including EC and 
SMC ET-1 has a variety of functions, including the regulation of cell fate decisions, 
and has been shown to inhibit apoptosis in VSMC (Wu-Wong et a l , 1997) As cyclic 
strain decreases ET-1 expression in VSMC, it is possible that cyclic strain-mediated 
apoptosis is regulated, at least in part, in an ET-1-dependent manner The link between 
ET-1 and the Notch signalling pathway is a tenuous one, but could provide the basis for 
further clarification of Notch signalling pathway interactions in VSMC Embryonic 
ET-1 and Jag-1 mutations produce the same phenotype in the form of cardiac outflow 
tract defects (Srivastava and Olson 2000), suggesting that these pathways may interact 
with one another in the vasculature, whether this is true in adult cells remains to be 
determined
This study has established interactions between the Notch signalling pathway 
and both the NFJ3B signaling pathway, and the Bcl-2 family in VSMC However, it is 
likely Notch interacts with multiple signalling pathways in VSMC to regulate apoptosis, 
which could provide the basis for further investigation into the mechanism of Notch- 
mediated cell survival in VSMC
This study reveals that serum deprivation-induced apoptosis is attenuated by the 
over-expression of both Notch 1 IC and Notch 3 IC in VSMC Serum deprivation- 
induced apoptosis in VSMC is also attenuated by TGF-pl, and the extent of the
attenuation is similar to that seen with Notch over-expression (Pollman et a l , 1999)
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TGF-p and related proteins bind two different types of senne/threomne kinase 
receptors, and transmit intracellular signals through Smad proteins Receptor-regulated 
Smads are directly activated by the receptor and function as components of transcription 
factor complexes in the nucleus The TGF-P signalling pathway has been shown to 
control cell fate decisions in many cell types, and mutations of the receptors and Smad 
proteins have been implicated in many types of cancers, including colorectal and 
pancreatic (Miyazono et a l , 2003) A number of studies indicate an interaction 
between the Notch and TGF-p signalling pathways, and the fact that they exert similar 
effects on serum deprivation-induced apoptosis in VSMC suggests a possible 
interaction in VSMC Activation of TGF-p signalling in myogenic cells up-regulates 
Hes-1 expression both in vivo and in vitro (Blokzijl et cil, 2003), and TGF-p has been 
shown to induce both Jagged 1 and HRT-1 expression in development (Zavadil et a l ,
2004) In addition, both TGF-p and Notch 3 have been implicated in the regulation of 
the cell-cycle inhibitor, p27klp (MacDonald et a l , 1996, Campos et a l , 2002) TGF-p 
acts to up-regulate VEGF (Veikkola and Alitalo 1999), a known Notch signalling 
pathway regulator, therefore it is possible that TGF-P up-regulates Notch in a VEGF- 
dependent manner Whether the interaction between these two pathways is conserved 
in VSMC remains to be defined, but could promise to be an exciting new area of 
research
As activation of the Notch signalling pathway is coupled to the regulation of 
both apoptosis and proliferation (Miele and Osborne 1999), it is tempting to speculate 
that Notch may interact with other families, such as the Myc family, that also govern 
both apoptosis and proliferation The cellular-myc (c-myc) gene, part o f the myc gene 
family, was discovered as the cellular homologue of the retroviral v-myc oncogene, and 
has since been shown to be elevated in many tumour types Burkitts lymphoma, for 
example, exhibits a point mutation m, and subsequent up-regulation of, its c-myc gene 
This protein plays a role in the initiation of apoptosis and transformation in many cell 
types, two mechanisms that are important for tumourigenesis (Dang 1999) Several 
lines of evidence point to the interaction of the Notch signalling pathway and c-myc, 
and suggest a functional link in the regulation of apoptosis Similar to the Notch 
signalling pathway, c-myc is highly conserved from Drosophila to humans, and targeted 
mutations in murine c-myc gene results in widespread embryonic lethality, suggesting 
that it is critical in development (Davis et al 1993) In addition, Myc proteins are 
helix-loop-hehx (HLH) proteins (class B) as they contain a HLH motif at their C-
265
terminus, which mediates protein dimerization with other proteins containing the same 
motif Notch target genes are also part of the HLH family o f genes (class C), and 
interaction between Myc and Hes proteins have been observed (Swiss Institute o f  
Bioinformatics) Class C bHLH proteins, such as Hes and HRT, are known to bind to 
some degree to the class B bHLH proteins, such as c-Myc (Iso et a l , 2003) As 
described previously, HRT are known to bind to a number of E box motifs on their 
target genes (Nakagawa et a l , 2000), therefore using bioinformatics, and the cloned c- 
myc promoter sequence (Ray and Miller 1991) this study analyzed whether any of the 
HRT binding sequences were present on the c-myc promoter It was determined that 
although the preferential CACGTG E box motif was not present, three other HRT E 
boxes were present on the c-myc promoter region, these being CAACTG, CACCTG and 
CACTTG, further highlighting the potential interaction between the Notch signalling 
pathway and c-myc In addition, c-Myc is a direct target o f EBNA-2, which shares 
many functional similarities with Notch IC (Schlee et a l , 2004) The effect of EBNA-2 
on c-myc expression is unclear, as some studies report that c-myc is down-regulated by 
EBNA-2 (Strobl et a l , 2000), whereas others maintain that EBNA-2 induces c-myc 
expression (Kaiser et a l , 1999)
Serum deprivation-dependent apoptosis in VSMC is dependent on endogenous 
c-myc expression (Shichin et a l , 2000) This study has established that Notch 1 1C and 
Notch 3 IC attenuates serum deprivation-induced apoptosis in VSMC In addition, 
other studies have documented that Notch IC represses c-myc expression in B cells 
(Strobl et a l , 2000) Therefore it is possible that one of the mechanisms of Notch- 
mediated repression of apoptosis is via c-myc down-regulation in VSMC
It is interesting to note that a recent paper describes the effect of TGF-p on c- 
myc in VSMC (Khanna 2004), in that TGF-p inhibition in these cells resulted in an 
increase in c-myc expression, however, the mechanism mediating the increase was not 
addressed As the literature has shown that TGF-p activates the Notch signalling 
pathway, and Notch acts to decrease c-myc expression in other cell types, we propose 
that TGF-p mediated regulation of c-myc could be regulated by the Notch signalling 
pathway in VSMC
VSMC apoptosis is regulated in both a p53-dependent and -independent manner
However, VSMC apoptosis, mediated by c-myc expression following serum deprivation
is dependent on, and mediated by p53 (Bennett et a l , 1995) This, coupled with several
recently reported links between the Notch signalling pathway and p53 family members,
suggests that Notch could mediate VSMC apoptosis through interaction with the
266
p53 family
The first link between the Notch signalling pathway and p53 family members 
reported that p63 and p73 up-regulated expression of the Notch ligands Jagged 1 and 
Jagged 2 respectively (Sasaki et a l , 2002) In the case of p63, up-regulation of Jagged 
1 resulted in increased expression of the Notch target gene hes-1 In addition, this study 
identified a /?6J-binding site in the second mtron of the jagged I gene, and direct 
interaction between p63 and jagged 1 was demonstrated p63 and p73 are members of 
the p53 family that play a critical role in development The interaction between these 
genes and the Notch signalling pathway suggests p63 and p73 may function in 
development through modulation of this pathway This study, and the fact that both the 
Notch signalling pathway and p53 are de-regulated in many cancers indicate an 
interaction between Notch and p53, which has subsequently been reported in some cell 
types
Notch 1 IC is reported to increase p53 expression and activity in both human 
hepatocellular carcinoma cells (Qi et a l , 2003) and neural progenitor cells (Yang et a l ,
2004) Notch 1 IC also induces extensive apoptosis in these cells, in a p53-dependent 
manner Although these studies clearly provide a link between the Notch signalling 
pathway and p53, it is likely that this positive effect of the Notch signalling pathway on 
p53 is cell type specific Therefore, it is possible that a decrease in p53 expression and 
activation will be observed in cells in which Notch exerts an anti-apoptotic effect
The link between the Notch signalling pathway and p53 is further confirmed by 
the observation that activation of Notch 1 signalling prevents apoptosis induced by p53 
over-expression in an immortalized human epithelial cell line (Nair et a l , 2003) 
Additionally, the crosstalk between the Notch signalling pathway and p53 appears to be 
bi-directional, as p53 negatively regulates Notch 1 activation during T-cell development 
(Laws and Osborne 2004) Two possible mechanisms have been proposed for this 
regulation p53 negatively regulates PS1 expression, which is required for Notch IC 
cleavage, thus resulting in decreased Notch activation In addition, p53 associates with 
the transcriptional co-activatior CBP/p300 in the nucleus, therefore it is suggested that 
p53 decreases Notch activity through competition for CBP/p300 binding Both of these 
models suggest that p53 inhibits CBF-1-dependent Notch signalling pathway activation, 
and do not address whether p53 also inhibits CBF-1-independent Notch signalling 
Several observations point to the fact that p53 might also act to decrease Notch 
signalling pathway component expression in VSMC Cyclic strain increases p53
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expression (Mayr et a l , 2002) and decreases Notch signalling pathway expression in 
VSMC, suggesting that p53 could act to negatively regulate Notch component 
expression in these cells Therefore, p53 can also be added to the list of possible 
regulators of the cyclic strain-meditated alteration in Notch signalling pathway 
expression
The importance of p53 in VSMC apoptosis is increasingly recognized p53 
accumulation has been observed in human atherosclerotic and restenotic lesions (Speir 
et a l , 1994, Ihling et a l , 1998), suggesting that p53 may play an important role in the 
pathogenesis of human vascular disease In addition, decreased apoptosis was observed 
in p53 7 lesions (Sata et a l , 2003) VSMC apoptosis is a prominent feature of the 
vascular response to injury and subsequent formation of the neointima This is 
increasingly recognized as being due to up-regulation of pro-apoptotic, and down 
regulation of anti-apoptotic mediators (Morishita et a l , 1993) As Notch signalling 
pathway expression is decreased following vascular injury (Wang et a l , 2002), one of 
the precursors of vascular remodeling and lesion formation, and p53 is up-regulated in 
vascular lesions, it is tempting to speculate that Notch could mediate VSMC apoptosis 
through regulation of p53
Therefore, this study has established the presence of the Notch signalling 
pathway in VSMC both in vivo and in vitro and its importance in the regulation of 
apoptosis in these cells However, whilst the regulation of the Notch signalling pathway 
in VSMC remains undefined, we propose a number of potential molecules, including 
VEGF, Shh, PDGF, Ang II and perhaps ET-1, which may act synergistically or 
competitively with one another in the regulation of this pathway In addition, this study 
has elucidated potential mechanisms of Notch signalling regulation of apoptosis in 
VSMC Numerous molecular pathways are involved in the regulation of apoptosis in 
VSMC, and it is likely that Notch interact with many of these pathways to mediate 
apoptosis We propose that TGF-p, c-myc and p53 pathways are potential mechanisms 
through which the Notch signalling pathway may regulate apoptosis, which provides a 
basis for further investigation into the mechanism of Notch-mediated cell survival in 
VSMC The ultimate aim of any body of molecular health related research is to 
elucidate and define potential new pathways and to increase an expanding repertoire of 
knowledge on disease states The present problem of cardiovascular disease in Ireland, 
and the growing concern of public health and epidemiologic statistics in this area show 
a worrying trend The epidemic of obesity will accentuate these statistics The social 
costs and productivity issues surrounding these diseases directly and indirectly, indicate
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the importance of research in this field Further knowledge on the mechanisms of 
vascular cell death and remodelling may give us crucial new insights into the molecular 
basis of atherosclerosis, arteriosclerosis, hypertensive disease and restenosis post­
treatment The ability to alter these disease states via new potential therapeutic targets 
represents a vital and exciting challenge within the field of cardiovascular research
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